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Abstract 
 
Background 
Betel (areca) nut is the fourth most widely used psychoactive substance globally, accounting for 
10-20% of the world’s population.  Its most basic form is betel ‘quid’ which consists of betel leaf, 
betel nut (the main psychoactive ingredient) and slaked lime. Evidence that betel quid and betel nut 
alone are associated with oral cancer has been established. 
While there is a substantial body of evidence on the impact of health-risk behaviours 
including smoking and drinking alcohol on adverse pregnancy outcomes, studies on the impact of 
betel quid chewing on pregnancy outcomes are sparse and heterogeneous. Although several studies 
report the negative impact of betel quid chewing on pregnancy outcomes, the evidence is 
inconclusive. One of the challenges in understanding the impact of betel quid is to distinguish the 
impact of betel quid chewing from the impact of smoking. Bhutan, where low prevalence of 
smoking and high prevalence of betel-quid chewing are reported, provides a natural experimental 
environment for taking a close look at the impact of betel quid chewing alone.  
As a part of the global agenda to address preterm births (PTB) as a public health priority 
and in order to provide evidence to inform efforts to reduce neonatal morbidity and mortality in 
Bhutan, this study explores the impact of betel quid chewing on birth outcomes and its importance 
in relation to other risk factors. 
 
Methods 
This study used a multi-centre case-control design. A case was defined as a mother of a singleton 
live born infant whose gestational age is less than 37 completed weeks and/or an infant whose birth 
weight is less than 2500 g.  A control was defined as a mother of singleton live born term babies 
whose birth weight was more than 2500g and gestational age was greater than 37 weeks. 
Information was collected using a semi-structured questionnaire from February 2015 to the 
beginning of March 2016 at the three referral hospitals in Bhutan. Study participants were recruited 
by a trained interviewer during their post-delivery stay before discharge from each hospital. A 
statistical approach and a causal directed acyclic graph (DAG) approach were used for building 
logistic regression models. 
 
Results  
Of the 669 study participants, 55% of the case mothers and 52% of the control mothers chewed 
betel quid during pregnancy. About 22% of cases and 22% of controls used commercial betel 
products during pregnancy. In total, 60% of the case mothers and 57% of the control mothers 
chewed either betel quid or packaged betel products during pregnancy. Neither the statistical 
approach nor DAG approach provided clear evidence of an association between betel quid use and 
low birth weight (LBW) or PTB. The adjusted odds ratio (aOR) of term LBW was 1.07 (95% CI: 
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0.54-2.13, p=0.845) in the statistical approach while the aOR of term LBW was 1.30 (95% CI: 0.74-
2.27, p=0.439) in the DAG approach. Using the DAG approach, the aOR of PTB in association 
with betel quid chewing during pregnancy was 1.20 (95% CI: 0.72-2.00, p=0.614). When the total 
number of betel nuts consumed during the last three months of pregnancy was used as an exposure 
variable, the aOR for mothers who consumed more than one nut per day was 1.39 for term LBW 
(95%:0.52-3.68, p=0.514) and the aOR of PTB was 0.66 (95% CI: 0.27-1.66, p=0.383) compared 
to non-chewers. For a secondary outcome, the data suggest betel quid chewing is associated with 
increased odds of anaemia (aOR 2.09, 95% CI 1.27-3.43, p=0.004). Using the DAG approach, 
tobacco and alcohol use during pregnancy, low gestational weight gain, and urinary tract infection 
showed a clear association with term LBW and PTB. 
 
Conclusion  
In the present study, the results provide no clear evidence of an association between term LBW or 
PTB and betel quid chewing during pregnancy. For a secondary outcome, the data suggest betel 
quid chewing is associated with increased odds of anaemia. The present study provides rich baseline 
data for mothers and established a cohort of cases and controls, which could be followed up to 
understand the short- and long-term effects of LBW and PTB and may help design effective 
interventions.  
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Chapter 1  
Background 
 
This chapter introduces the thesis and gives background information on the burden of low birth 
weight (LBW) and pre-term birth (PTB) and Bhutan, where the fieldwork for the thesis was 
undertaken. This chapter ends with a description of the research aims and an outline of the thesis.  
 
1.1 Introduction 
“The state shall strive to promote those conditions that will enable the pursuit of Gross National 
Happiness” – Article 9, the Constitution of Bhutan 
Globally, despite an improvement in under-5 mortality rates, much less progress has been 
made for neonatal mortality rates (deaths in the first 28 days of life) [1-3]. In 2010, 7.6 million 
children were estimated to have died before their fifth birthday and two fifths of these occurred in 
the first 28 days of life [4]. Almost all (99%) neonatal deaths occur in low-income and middle–
income countries (LIMC) [3]. In 2010, the number of neonatal deaths was highest in Southeast Asia, 
accounting for approximately 1.1 million deaths or 52.3% of regional deaths in children younger 
than 5 years [4]. The crucial importance of reducing neonatal deaths has been widely recognized in 
the global agenda [2, 4, 5].   
Complications of PTB are the leading direct cause of neonatal mortality, accounting for 
35% of 3.5 million neonatal deaths every year and are the second most common cause of under-5 
deaths after pneumonia [2][5]. Babies born prematurely are at risk due to loss of body heat, inability 
to take enough nutrition, breathing difficulties and infections [1].  In 2010, 14.9 million babies were 
estimated to be born preterm, representing 11.1% of all live births worldwide [6]. Preterm babies 
often have LBW; however, babies can often have a LBW because they are born small for gestational 
age (SGA), or a combination of both prematurity and SGA [7, 8]. Prematurity and LBW are both 
strongly associated with neonatal mortality and morbidity and weight at birth and gestational age 
are both used indicators for the newborn’s chances for survival, growth, long-term health and 
psychosocial development [9]. In particular, birth weight is most commonly used partly because it 
is relatively easy to measure with validity and precision [7].  In 2004, it was estimated that more 
than 20 million LBW babies were born each year, accounting for 15.5% of all live births worldwide 
[10] and this number is believed to be similar today. More than half of these babies were born in 
South Asia [3, 10].  
Bhutan, which lies between China and India, has made great progress in reducing under-5 
child mortality from an estimated 123 per 1,000 live births in 1990, to 69 per 1,000 live births in 
2010 [8], an approximately 50% decline.  The is in keeping with ultimate goal of the Royal 
Government of Bhutan which is “to maximize the happiness of all Bhutanese and to enable them 
to achieve their full and innate potential as human beings” (The Bhutan Vision 2020) [11]. This has 
been achieved through an emphasis on development in the social and health sectors, including the 
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provision of essential health care services free of charge [12]. Article 9 of the Bhutan constitution 
clearly states that the state shall provide free access to basic public health services in both modern 
and traditional medicines. 
Approximately 48% of under-5 mortality is estimated to occur during the first month after 
birth in Bhutan [1]; therefore in order to reduce under-5 mortality it is essential to address the issues 
of PTB and LBW in Bhutan through prevention and improved care.  
Prevention of PTB and LBW depends on an understanding of the underlying risk factors 
[9]. There have been many studies on the risk factors for LBW and PTB which show that they are 
caused by a broad range of socioeconomic, behavioural, biological, and environmental factors. 
However, there are some features unique to Bhutan and her neighbours, which means that it may 
not be possible to extrapolate from elsewhere.  One particular feature is the habit of chewing of 
betel quid, locally known as “doma”,  - a concoction of betel nut and betel leaf with a dash of lime.  
Betel quid chewing is very popular in the general population of Bhutan.  According to the 
2010 Gross National Happiness Survey, 72% of the respondents aged 15 to 98 had ever chewed 
doma in their life and 58.5% of men and 61.5% of women were currently chewing doma [13]. It is 
also one of the major commercial agricultural products, yielding 9,781 tonnes in 2011 and 6,250 
tonnes in 2013 [14]. 
Betel nut, also known as areca nut, is the fruit of the Areca catechu tree. As the terms ‘betel 
nut’ and ‘betel nut chewing’ are more common than the areca nut, they are used throughout this 
thesis.  It is the fourth most widely used psychoactive substance in the world and is commonly used 
in Central, Southern, and South-east Asian countries, accounting for 600 million people worldwide 
or 10-20% of the world’s population [15, 16]. The nut contains alkaloids, including arecoline and 
arecaidine, which have been reported to stimulate the central nervous system [15]. The effects of 
betel nuts on the autonomic nervous system include feeling warm, sweating, cardioacceleration, 
salivation, and heightened alertness [17]. The maturity of the betel nut used and the contents of the 
quid vary between individuals locally and across countries [18, 19]. The ripe nut has a high 
concentration of arecoline compared to the unripe nut [18]. The content of the quid, including the 
maturity of the nut, and spitting or swallowing of the quid may induce different health effects. In 
some cultures, betel nut is used with tobacco and it may be that this combination is most harmful 
[20].  
With regard to health effects, in 2004 the International Agency for Research on Cancer 
(IARC) evaluated the carcinogenic risks of betel-quid and betel nut alone and concluded that both 
betel quid with or without tobacco and betel nut are carcinogenic to humans [19].    
While there is a substantial body of evidence on the impact of health-risk behaviours 
including smoking and alcohol on adverse pregnancy outcomes, studies on the impact of betel quid 
chewing on pregnancy outcomes are sparse and heterogeneous. Although several studies report the 
negative impact of betel quid chewing on pregnancy outcomes, the evidence is inconclusive. One 
of the challenges in understanding the impact of betel quid is to distinguish the impact of betel quid 
chewing from the impact of smoking. Bhutan, where low prevalence of smoking and high 
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prevalence of betel-quid chewing are reported, provides a natural experimental environment for 
taking a close look at the impact of betel quid chewing alone.  
As a part of the global agenda to address PTB as a public health priority and in order to 
provide evidence to inform efforts to reduce neonatal morbidity and mortality in Bhutan, this study 
will explore risk factors for adverse pregnancy outcomes focusing on betel quid chewing. 
 
1.2 Key concepts 
 
Low birth weight (LBW): is defined by WHO as a birth weight of less than 2500 g[21]. 
Preterm Birth (PTB): is defined by WHO as all births before 37 completed weeks of 
gestation or fewer than 259 days since the first day of the mother’s LMP [22]. PTBs 
can be classified according to the gestational age at which they occur [23]. Those 
with gestational age at delivery of less than 28 weeks (<28 weeks) are extremely 
preterm, 28 weeks to less than 32 weeks (28 to <32 weeks) are very preterm, and 
32 weeks to less than 37 weeks (32 to <37 weeks) are moderate to late preterm 
births.  
Intrauterine growth retardation (IUGR) or small for gestational age (SGA): is 
defined by WHO as birth weight below the tenth percentile of the recommended 
gender-specific birth weight for gestational age reference curves [24]. 
 
1.3 Burden of LBW and PTB 
Birth weight and gestational age are major indicators of neonatal mortality and morbidity, and are 
also related to health in later years.  
 In 2004, it was estimated that more than 20 million LBW babies are born each year, 
accounting for 15.5% of all live births worldwide [10] and this is believed to still be the case in 
2016. More than half of these births were in South Asia [3, 10]. In 2010, 14.9 million babies were 
estimated to be born preterm, representing 11.1% of all live births worldwide [6]. In Bhutan, 72.2% 
of babies surveyed in the 2010 Bhutan Multiple Indicator survey were weighed at birth and 
approximately 9.9 % of infants were estimated to weigh less than 2,500g [13]. PTB was estimated 
to be 10.2% of live births in 2010 [6]. 
PTB is a major cause of mortality, morbidity and disability worldwide [2, 25, 26].  Complications 
of PTB account for 35% of 3.5 million neonatal deaths every year and are the second most common 
cause of under-5 deaths after pneumonia [2][5]. Babies born preterm are more likely to die during 
the first 28 days and in the first year of life than babies born full term [23].  Gestational age is a 
strong predictor of outcomes of PTB and costs of care [8, 26, 27].  Katz et al estimated that overall 
pooled RRs of mortality for PTB across all regions in low- and middle- income countries were 6.82 
(95% CI, 3.6-13.07) for neonatal mortality and 2.50 (95% CI, 1.48-4.22) for post-neonatal mortality 
[8]. In Asia, the estimated RRs of mortality are 2.64 for gestational age 34 to <37 weeks, 5.44 for 
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32-33 weeks and 16.60 for <32 weeks [8]. Regional statistics on mortality, LBW, and prematurity 
are summarized in Table 1.1.  
Even if preterm babies survive, complications of PTB arise from immature organ systems 
that are not sufficiently well developed to support life outside the mother [23]. In the short term, 
survivors are at risk of respiratory distress syndrome, intraventricular haemorrhage, necrotizing 
enterocolitis, sepsis and retinopathy of prematurity [2, 23, 25]. In the long term, the effect of PTB 
may increase the risk of cerebral palsy, learning disabilities, visual and hearing impairment, chronic 
lung disease of prematurity and non-communicable disease [2, 25, 28, 29]. Furthermore, a large 
body of studies demonstrated that retarded growth in foetal life and infancy increases the risk of 
chronic diseases such as cardiovascular disease, hypertension, and diabetes or developmental 
outcomes in adult life [30-34].  
Preterm infants have more hospital readmission in the first year after discharge, often due 
to respiratory illness, than full term babies [35, 36]. Approximately 80% of infants born before 27 
weeks of gestation will develop respiratory distress syndrome (RDS) [23]. Chronic lung disease 
follows RDS in preterm infants as a result of inflammation, injury and scarring of the airways and 
the alveoli [23]. The primary cause of chronic lung disease is lung immaturity which is associated 
with growth, health and neurodevelopmental problems during childhood [23].  
A growing body of studies shows that birth weight and gestational age at birth may be 
related to health in adult life. Two main hypotheses in the literature that aim to explain potential 
long-term effects are the foetal origins hypothesis, known as the “Barker hypothesis” [37], and the 
rapid catch up hypothesis. A systematic review identified 21 studies that investigated the Barker 
hypothesis and 18 studies that investigated the rapid catch-up hypothesis before 2013 [38]. The 
foetal origins hypothesis suggests that alterations in foetal nutrition and endocrine status result in 
development adaptations that permanently change structure, physiology, and metabolism, which 
may lead to increased risks of cardiovascular disease, hypertension, and diabetes in adult life [39]. 
The rapid catch up growth hypothesis suggests that undernutrition during early development is 
followed by improved nutrition later in development, SGA newborns retain some capacity to 
compensate, by increasing their growth rate [31, 38]. As a result, SGA newborns who were exposed 
to rapid postnatal growth may have an increased risk of chronic diseases in adulthood [31].   
Increasing mortality and morbidity arising from low birthweight and PTB also imposes a 
heavy financial burden on families, society and the health system [2, 23, 27, 40].  Examples of 
direct costs include the value of the resources used to treat the condition, such as medical care and 
special education [23]. Indirect costs are the value of resources lost to society, such as missed 
opportunities for labour or a reduced level of household productivity due to morbidity or premature 
mortality [23].  In a study that reviewed economic consequences of PTB in the USA, Australia, the 
UK, and Finland, the hospital costs associated with initial hospitalization varied between £584 per 
full term baby and £317,166 per extremely preterm survivor using 2008 prices [41]. Furthermore, 
in the USA, societal economic burden associated with PTB was estimated to be $26.2 billion or 
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$51,600 per PTB using 2005 prices [23, 41]. A summary of the key findings on the burden of LBW 
and PTB is provided in Table A.1 in Appendix A.  
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Table 1.1. Mortality, LBW and prematurity in Bhutan and neighbouring countries. 
Countries 
First day mortality 
(per 1000 live 
births)1 
Share of U5 deaths 
that occur on the 
first day2 
Neonatal mortality 
(per 1000 live 
births)3  (2011) 
Share of U5 deaths 
that occur during 
the first month4 
Infant Mortality 
Rate (per 1000 live 
births)5 (2011) 
U5 Mortality 
(per 1000 live 
births)6 (2011) 
LBW infants (% of 
live births)7 (2007-
2011) 
Prematurity 
estimates (% of live 
births) (2010)8 
Nepal 10 21% 27 58% 39 48 18% 14% 
India 11 19% 32 53% 47 61 28% 13% 
Sri Lanka 3 22% 8 63% 11 12 17% 10.7% 
Bangladesh 9 21% 26 60% 37 46 22% 14% 
Bhutan 9 17% 25 48% 42 54 10% 10.2% 
World 8 15% 22 43% 37 51 15.5%9 11.1% 
                                                          
1 Save the Children, State of the World’s Mothers 2013 
2 ibid 
3 UNICEF, WHO, World Bank, UN Population Division, Levels and trends in child mortality. 2012. 
4 Save the Children, State of the World’s Mothers 2013 
5 UNICEF, WHO, World Bank, UN Population Division, Levels and trends in child mortality. 2012. 
6 ibid 
7 UNICEF, UNICEF Multiple Indicator Cluster Survey. 
8 Blencowe, H., et al.(2012) 
9 UNICEF, Low Birthweight: Country, Regional and Global Estimates, 2004. 
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1.4 Bhutan 
1.4.1 General background 
The Kingdom of Bhutan is a small land-locked country in the eastern Himalayas, lying between the 
Tibetan Plateau in the north and the Indian plains in the south [42]. A total population of 0.76 
million [14, 22] reside in the total area of 38,394𝑘𝑚2 [42]. The county is mountainous with an 
elevation ranging from about 160m above sea level in the south to more than 7500m above sea level 
in the north [42]. Approximately 70% of the total land is under forest cover [14, 42]. GDP per 
capita was US$ 2532.5 in 2015 [43]. Bhutan’s absolute monarchy was established in 1907 and 
moved towards a constitutional monarchy in 1953 [44]. In 2008, Bhutan held its first national 
democratic elections and the parliament endorsed the country’s first constitution [45]. The country 
aims to maximize Gross National Happiness for people, supported by four pillars – sustainable 
socio-economic development, preservation and promotion of culture, environmental conservation, 
and good governance [46]. The royal government of Bhutan recognizes health and education as 
pre-requisites for economic and spiritual development, poverty reduction and the road to Gross 
National Happiness. Article 9 of the constitution mandates the state to provide free access to basic 
public health services in both modern and traditional medicines and to provide free education to all 
children of school age up to tenth standard and ensure that technical and professional education is 
made generally available and that higher education is equally accessible to all on basis of merit 
(Article 9, The Constitution of the Kingdom of Bhutan). 
 
1.4.2 The health system  
Bhutanese formal health care originated in Tibetan medicine known as Gso-ba Rig-Pa (science of 
healing), believed to be introduced by the founder of Bhutan, Zhabdrung Ngawang Namgyal, and 
developed by traditional doctors who underwent training in Tibet [45]. Western biomedicine was 
introduced to Bhutan mainly through British medical officers who accompanied political missions 
from India to Bhutan [45]. The first hospital was established in 1956 in the capital, Thimphu [47]. 
Today the integrated services of both traditional medicine and western biomedicine are offered by 
the government inside the same facilities across the country, not to compete but to complement 
each other[45].  
The parliament oversees the government, including the health sector [45]. The Gross 
National Happiness Commission (GNHC) prepares the five-year plan which set targets and goals 
for the country’s socio-economic development, negotiates budgets with the sector ministries and 
monitors progress towards the stated goals [45]. The Ministry of Health is responsible for 
formulating policies and guidelines and regulating and monitoring the health sector, while the 
districts have authority over, and responsibility for the provision and implementation of health 
services in their respective areas [45].  
The National Health Policy, approved in 2011, shapes the development of the health sector 
along with three acts: the Bhutan Medical and Health Council (BMHC) Act 2002 to provide the 
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basis for regulation of the medical and health profession; the Medicines Act 2003 to set a framework 
for medicines and supplies, their import, sales and use in the country; and the Tobacco Act 2010 to 
ban commercial tobacco import, trade and use [45].   
The provision of health services is predominantly through the public sector. Since 2015, 
healthcare services have been delivered through 31 hospitals (including one indigenous medicine 
hospital in the capital), 235 basic health care units (BHUs) and sub-posts and 562 outreach clinics 
in all 20 districts (Table 1.2) [47]. In BMIS 2010, each region was coded into three categories: 
Western Region (Thimphu, Paro, Ha, Samtse, Chhukha, Punakha, and Gasa), Central Region 
(Wangduephodrang, Daga, Tsirang, Sarpang, Zhemgang,Trongsa, and Bumthang), and East Region 
(Lhuntse, Mongar, Pemagatsel, Samdrup Jongkhar, Trashigang, and Trashi Yangtse). Nationally, 
there are 251 doctors (including Bachelor of Medicine graduates and specialists), 47 indigenous 
medicine physicians, 1105 nurses, and 548 health assistants [47]. The national referral hospital is 
located in the capital, Thimphu. There are two regional referral hospitals; one in Mongar in eastern 
Bhutan and one in Gelephu in the South. District hospitals have basic diagnostic facilities including 
x-ray, blood glucose levels and microscopic services for diagnosing tuberculosis and malaria with 
generally two doctors, four to five nurses, one laboratory technician and health assistants [12]. 
BHUs are staffed with three health assistants who have completed 2 years of training at the Royal 
Institute of Health Sciences (RIHS) [12]. These health assistants assist at normal deliveries and 
organize outreach health clinics once a month to provide maternal and child health services in 
remote communities [12]. Referral hospitals, district hospitals and BHUs refer patients to a higher 
level and back to the community for monitoring and rehabilitation [12]. The government sponsors 
patients who need treatment that is not available in Bhutan to benefit from treatment outside of the 
country, mainly in India, based on the national referral guidelines. 
The free health services are financed through the funding from the Royal Government of 
Bhutan, International Aid, Royal Bhutan Army, and out-of-pocket expenditure [45]. Government 
funding accounts for approximately 60% of the total health expenditure,  comprising revenues and 
donor grants [45, 48]. The Government of India has provided the largest external financial support, 
especially for the construction of the referral hospitals in Thimphu, Mongar and Gelephu [45]. Total 
expenditure on health per capita in 2012-2013 was Bhutanese Ngultrum (BTN) 5409 or US 81 
dollars (at $1 =BTN 66) and total expenditure on health as a percentage of GDP was 3.6% in 2012 
[48, 49]. With prolonged life-expectancy and an increasing number of non-communicable diseases 
such as diabetes and cancer, the referral cost is sharply increasing, totalling BTN 90 million in  2010 
[45]. This imposes a financial challenge on the sustainability of free health services in Bhutan. 
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1.4.3 General statistics 
Life expectancy at birth improved dramatically from 52 years in 1990 to 70 years in 2015 [50]. Use 
of improved drinking water sources was 100% (in both urban and rural) while access to improved 
sanitation remained only 50% (urban 78% vs rural 33%) in 2015 [50].The primary enrolment ratio 
between 2009 and 2012 was 89.3% [50]. The total literacy for adults was 53% and for youth (15-
24 years) the literacy rate was 80% for males and 68% for females between 2009 and 2014 [50]. 
Of pregnant mothers, 98% received at least one antenatal care (ANC) visit and 85% received at 
least four visits between 2010 and 2015 [50]. 
 
1.4.4 Betel quid chewing 
Betel nut is the fourth most common addictive substance in the world after tobacco, alcohol, and 
caffeine [15, 16] and is an indispensable part of Bhutanese culture and lifestyle. It is offered during 
celebrations, religious rituals, festivals, and gatherings and is widely consumed by both men and 
women. In 2010 61.5% of women in Bhutan were reported that they were current betel quid chewers 
[51]. 
In Bhutan, typically one betel quid contains one quarter of a ripe nut and slaked lime 
wrapped in a piper betel leaf (Figure 1.1). Unripe nuts are usually seasonally available in May and 
June but ripe nuts are available throughout the year and more commonly consumed. A package of 
betel quid is prepared at retail shops. One quid contains one leaf, a pinch of lime, and a quarter of 
one betel nut. Three sets of betel quid were sold for Bhutanese Ngultrum (BTN) 10 or US 0.15 
dollar (at $1 =BTN 66) on average in 2014.   
 
 
Figure 1.1. Preparation of betel quid in Bhutan. 
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1.4.5 Packaged betel nut products (Pan Masala) 
Betel nut products are available under several names, mostly marketed as mouth refresher and 
imported from India. Wiz and Rajiniganda are the most popular brands for flavoured pan masala: 
Two packages of Wiz are sold for BTN 5 or US 0.08 dollar in Bhutan.  A small Rajiniganda package 
weighs 4 grams and is sold for BTN 20 or US 0.30 dollar. 
 
 
  
Figure 1.2. Package (1.4 gram) and content of Wiz. 
 
  
 
Figure 1.3. Package (4 grams) and contents of Rajiniganda. 
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1.4.6 Smoking and smokeless tobacco 
According to the Tobacco Act  2010, the cultivation, harvest, manufacture, supply, distribution and 
sale of tobacco products is banned in Bhutan [52]. Though sale of tobacco products is banned, 
consumption is not prohibited except in areas identified as smoke-free zones by the government. 
Cigarettes, piped tobacco and other tobacco products can be imported for personal consumption in 
specific import quantities. Tobacco products cannot be imported for sale. It is “illegally” sold at 
retail shops. One cigarette cost BTN 15 or US 0.23 dollar in 2014.   
In Bhutan, current smokers among females aged 15 and above ranged between 2.1% [53] 
in 2014 and 2.4% in 2010 [51] in the interviewer-administered population-based surveys after the 
ban on tobacco in 2010. However, prevalence of current smokers among girls aged between 13 and 
15 was higher (6.6%) in the self-administered population-based survey [54]. Smokeless tobacco 
use was 9.9 % in 2014[53].   
Smokeless tobacco was also banned under the Tobacco Act 2010. The brand “Baba”, 
imported from India, is one of the most commonly used smokeless tobacco products in Bhutan, 
sold “illegally” at retail shops. The average package contains 10 grams for BTN 15 or US 0.23 
dollar in 2014.  
 
 
    
Figure 1.4. Package and content of Baba, a smokeless tobacco product available in Bhutan. 
 
 
1.4.7 Alcohol 
Alcohol is widely produced and consumed on cultural, social, and religious occasions [55]. Home-
produced alcohol is very common and widely available, although the sale of home-made alcohol is 
banned [56]. Home-brewed alcohol accounts for more than 40% of alcohol expenditure in the 
household (32.2% in urban areas and 52.9% in rural areas) [57]. Common home-produced alcohol 
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products are spirits (Ara) and wines (Changkey, Singchang, and Bangchang), made from maize, 
rice, wheat, millet and fruits [55, 56]. A study conducted in Tashiyangtse in eastern Bhutan in 2010 
found that females consumed more than five times more home-brewed alcohol than industry-made 
alcohol, while males consumed more than twice as much home-made alcohol as industrial alcohol 
[56]. Estimates of female current drinkers in the surveys between 2010 and 2014 were 32.8% [51, 
53], which is similar to the prevalence in a research study in Tashiyangste (30%) [56]. Out of 81 
female current drinkers in the Tashiyangste study, 60.5% drank for medical use while 39.5% were 
social drinkers [56]. 43% of the total respondents believed that alcohol was necessary for reducing 
pain and for the initiation of breast feeding during the post-partum recovery period [56].  There is 
a local belief that “Changkey” will enhance production of breastmilk. This drink is made of rice 
mixed with yeast and stored in a bucket for more than three months. It is usually prepared hot, 
sometimes with eggs. Similarly, heated “Ara” with eggs and dry meat is also believed to be 
nutritious and good for pregnant women. In southern Bhutan, “Tongpa”, a fermented drink made 
of millet is often consumed for the same reason.   
Industrial alcoholic beverages sold in Bhutan are available in 750 ml, 650 ml (beer), 500 
ml (canned beer), 335 ml (spirits), 180 ml (spirits) measures [55]. Widely available and consumed 
local beer (Druk 11000) contains 8% (v/v) and locally produced whiskies contains 42.8% alcohol 
(v/v) [55]. Among industrial products, beer is most popular  [56]. The strength of home-brewed 
drinks has never been measured using biochemical analyses [55, 56]. Standard size of home-brewed 
alcoholic beverages are not available as serving size varies depending upon the different cups and 
vessels used and the amount poured for each serving also differs from home to home. This poses a 
significant challenge in quantification of alcohol consumption. Only a few studies have attempted 
to quantify per-capita consumption [55, 56]. One study used the 2010 trade and production data and 
unrecorded information from a 2007 population-based survey based on assumptions of average 
alcohol strengths of 25-30% for ara, 15-20% for bangchang, 20-25% for singchang and 15-20% for 
tongba [55]. The per capita adult pure alcohol consumption was estimated to be 8.47 litres based 
on the production, imported and domestic sales statistics and 0.97 litres based on data derived from 
the Bhutan Standard Living Survey 2007 [55]. Another study assumed the strengths of local wine 
and local sprit (ara) to be 5% and 15% respectively and estimated that annual per capita alcohol 
consumption was 5442 g for men and 2566 g for women [56]. 
The societal and healthcare burden of alcohol-related morbidities and mortality is high in 
Bhutan. In 2014, alcohol liver disease was the leading cause of hospital impatient mortality and 
accounts for more than 40% of mortality related to non-communicable diseases in 2013 [14, 58].  
There is a huge urgent need for research and interventions in this area. 
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Figure 1.5. Takin wine, a local wine widely available in retail shops (alcohol concentration, 16% v/v). 
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Table 1.2. Health facilities and deliveries attended by trained personnel (modified from Annual Health Bulletin 2013). 
District Number of health facilities  Deliveries attended by trained personnel 
Referral 
hospital 
District 
Hospital 
BHU I BHU II  Absolute 
number of 
deliveries 
% Referral 
Hospitals 
District 
Hospitals 
BHU I BHU II 
Bumthang  0 1 0 5  196 1.8% - 159 - 37 
Chhukha 0 3 1 12  1073 9.9% - 944 34 95 
Dagana 0 1 2 7  175 1.6% - 94 37 44 
Gasa 0 0 1 3  6 0.1% - - 1 5 
Haa 0 1 1 3  110 1.0% - - 93 17 
Lhuentse 0 1 0 11  156 1.4% - 78 - 78 
Mongar 1 0 1 23  929 8.6% 640 - 30 259 
Paro 0 1 0 3  442 4.1% - 420 - 22 
Pemagatshel 0 1 1 11  230 2.1% - 115 45 70 
Punakha 0 1 0 6  666 6.2% - 627 - 39 
Samdrup Jongkhar 0 2 2 8  450 4.2% - 310 63 77 
Samtse 0 3 0 9  491 4.6% - 366 - 125 
Sarpang 1 1 0 11  951 8.8% 771 68 - 112 
Thimphu 1 4 1 9  3418 31.7% 3342 52 14 10 
Trashigang 0 3 2 17  567 5.3% - 275 75 217 
Trashiyangtse 0 1 0 7  109 1.0% - 51 - 58 
Trongsa 0 1 0 6  113 1.0% - 57 - 56 
Tsirang 0 1 0 6  217 2.0% - 174 - 43 
Wangdue Phodrang 0 2 0 9  336 3.1% - 251 - 85 
Zhemgang 0 1 2 12  156 1.4% - 28 32 96 
 Total 3 29 14 178  10791 100% 4753 4069 424 1545 
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1.5 Research aim and objectives 
The aim of this research is to understand LBW and PTB in Bhutan and the impact of betel quid 
chewing on birth outcomes and to draw policy implications. The specific objectives are: 
 
1. To explore modifiable risk factors for LBW and PTB in Bhutan 
2. To develop methods for assessing betel quid use during pregnancy  
3. To describe the pattern of betel quid chewing during pregnancy among Bhutanese women 
4. To examine the impact of betel quid chewing on birth outcomes  
5. To disseminate the research findings to inform policy makers  
 
The findings of this study will improve our understanding of PTB and LBW in Bhutan by 
exploring risk factors and the impact of betel quid chewing on pregnancy outcomes. The study will 
also provide baseline data to inform policy makers to improve modifiable risk factors. 
 
1.6 Outline of the thesis 
The thesis is divided into four parts (and eight chapters). Part 1 introduces the thesis (Chapter 1). 
Part 2 presents a brief overview of the literature (Chapter 2). It also comprises an overview of the 
methods used and a detailed description of how the questionnaire to assess risk factors and betel 
quid chewing was developed and how each covariate was modelled and used in the subsequent 
analyses (Chapter 3). Part 3 presents results of the validation of outcomes (Chapter 4), descriptive 
analyses of the various risk factors identified in the literature (Chapter 5) and patterns of betel nut 
chewing during pregnancy in addition to drinking and smoking (Chapter 6), and logistic regression 
analysis (Chapter 7). Part four concludes with the overall discussion, recommendations for future 
research, and the implications for policy and practice (Chapter 8). 
 
1.7 Contribution of the author 
The author conducted a literature review to design the study and drafted the semi-structured 
questionnaire. She organized and led a research team comprised of policy makers, medical 
professionals and research assistants and trained research nurses who collected data and monitored 
data collection. She obtained all the ethical and administrative approvals. She served as a data 
supervisor to clean and finalize a double-entered dataset and conduct all descriptive and regression 
analyses. She also interpreted the results and did all the writing. 
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Chapter 2  
Literature review  
 
This chapter provides the context of the thesis with a literature review on measurement issues of 
outcome, risk factors for PTB and LBW in the literature, areca nut and measurement of exposure. 
The first section describes the general background on issues of measuring birthweight, gestational 
age, and SGA. The second section presents and discusses a variety of risk factors in the literature. 
The third section introduces a systematic review of previous studies on the relationship between 
areca nut chewing and adverse outcomes in order to identify a research gap. The fourth section 
reviews existing tools for the measurement of exposure. The chapter ends with a summary followed 
by an introduction of the conceptual framework and causal diagrams. 
 
2.1  Definitions and issues in measuring birth weight, gestational age  
and small for gestational age 
Size at birth is the combined result of foetal growth and gestational duration [1]. LBW may be the 
result of either shortened gestation (preterm birth) or slowed rate of growth (intrauterine growth 
restriction). There are various ways to measure the size of a baby including birth weight, length and 
head circumference.  Among these, birth weight is most easily measured. Measuring length and 
other aspects of growth such as head circumferences requires more skills and training, and therefore 
is less commonly performed [1]. 
 
2.1.1 Birth weight 
Birth weight is determined by both duration of gestation and rate of foetal growth [1, 2]. LBW is 
defined by WHO as a birth weight of less than 2500g. One of the main criticisms of this simple cut-
off is that although boys tend to be heavier than girls, the definition of LBW does not take gender 
into account [1].  
 
2.1.2 Gestational age 
Gestational age is defined as the time elapsed between the first day of the last menstrual period and 
the day of delivery [1].  There are several ways to estimate gestational age.  In the last menstrual 
period method (LMP), the average pregnancy is assumed to last 280 days from the first day of the 
last menstrual period, mainly the woman’s self-reported LMP. Ultrasonography (US) can be used 
to estimate or confirm gestational age if it is done early in the pregnancy [1].  Various measurements 
of the foetus, such as biparietal diameter and/or the length of the femur, are taken and compared 
against age-specific references using standard formulae. LMP measures the length of pregnancy 
and US measures the size of the foetus [3].  An estimate of gestational age based on the LMP 
confirmed by an early second trimester US scan is often considered as the most reliable estimate or 
gold standard [1, 3]. However, in low-income settings, lack of US machines, lack of trained staff, 
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late presentation to the first antenatal care, and lack of quality control of US measures make reliable 
US-based gestational age less available [4-7]. 
Other ways to estimate gestational age include neonatal assessments such as the Ballad 
Score and the Dubowitz Score, as well as measurements during pregnancy including symphysis 
pubis-fundal height (SFH) (single or multiple measurements), quickening, and mid- and late 
pregnancy foetal biometry [6].  
The Ballard Score assesses the neuromuscular and physical maturity of new born infants 
[8]. Neuromuscular maturity is measured using six parameters: posture, square window, arm recoil, 
popliteal angle, scarf sign, heal to ear, and skin. Physical maturity is measured using seven 
parameters: skin, lanugo, plantar surface, breast, ear, genitals. The sum points for each parameter 
are used to estimate gestational age. 
The Dubowitz Score assesses an infant for apparent gestational age by considering both 
neurological and external signs of development [9]. Ten neurological signs include posture, square 
window (wrist), ankle dorsiflexion, arm recoil, leg recoil, popliteal angle, heel to ear scarf sign, 
head lag, and ventral suspension.  Twelve external signs include edema, skin texture, skin colour, 
skin opacity, lanugo, plantar creases, nipple formation, breast size, ear form, ear firmness, genitals 
(female/male). The total points for each parameter are used in a formula to estimate gestational age. 
White et al. (2011) proposed a formula that incorporates at least three measurements of   symphysis-
pubis fundal height (SFH), the distance measured from the top of the symphysis pubis to the 
depression in front of the pad of the middle fingers making the top of the uterine fundus in the 
middle of the woman’s abdomen, to predict gestational age as a low-cost alternative to US [5].  It 
has been suggested that this may be more reliable than previously published methods such as LMP, 
the new Ballard score or the Dubowitz given a realistic number (6-7) of repeated SFH 
measurements, at least two weeks apart with corresponding dates derived from routine ANC. 
In comparing different approaches to measurement of gestational age, LMP is usually 
considered the most low-cost and simple approach. However, the limitation is that the accuracy of 
the gestational age depends on accurate LMP recall which is often correlated with mothers’ literacy 
rate, regularity of the menstrual cycle, and factors that could influence ovulation timing such as 
previous oral contraceptive use, a recent pregnancy or breastfeeding[3]. It could also depend on 
how health workers enquire about LMP [6]. While early second-trimester US is superior to LMP-
based dating in predicting the actual date of delivery, accurate estimation also depends on the 
gestational age at the time of the US examination, the accuracy of the measurement and the quality 
of the US equipment and on whether the assumption holds, that foetal growth is uniform. A 
systematic review of 83 publications from 32 countries including low, middle, and high income 
countries between 1971 and 2008 found substantial heterogeneity of methodology used in US 
studies of foetal biometry [10]. There were also significant differences in median values and 
percentile curves and the review suggested standardisation of methodologies. Although gestational 
age estimates are often clinically used for care, both the Ballard and Dubowitz scores require more 
technical skills to perform [5, 11].  
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In order to assess the accuracy of the LMP approach in low-income settings, the literature 
comparing LMP to US-based gestational weeks in low-income settings was systematically searched 
on 24 March 2015. Details of the search strategy are given in Appendix B.1.  In addition, in order 
to compare the predictivity of the SFH formula by White et al. [5] to LMP or US-based gestational 
age, academic papers citing the SFH formula were also searched and included in the review. The 
key findings of the selected studies are summarized in Table 2.1.  
The search identified studies conducted in Gambia  [4], Guatemala [12], Papua New Guinea 
(PNG) [6], Bangladesh [11] and the Thai-Myanmar border [5, 7]. For studies with US-based 
gestational age used as a gold standard, there were differences in terms of which measurements 
were taken during US scans according to different gestational weeks and which reference was used 
(local [4] vs Hadlock growth curve). None of the studies explained how mothers were questioned 
about their LMP or how certain mothers were about their LMP details. The sample sizes ranged 
from 80 [4] to 2,437 [5].   
Mean LMP underestimated gestational age by  0.6 days  in Gambia  [4],  1 day in 
Bangladesh [11], and 5.4 days (0.77 weeks) in Guatemala [12], while overestimating by 3 days in 
PNG [6]. Ballard overestimated gestational age by 6 days in the PNG study [6] and underestimated 
by 2.9 days in Bangladesh [11]. Dubowitz overestimated gestational age by 2.57 weeks in the Thai-
Myanmar study [7] and by 3.9 days in the Bangladesh study [11]. While estimation based on a 
single SFH resulted in a huge variation of about 10 weeks, six SFH measurements resulted in a 
prediction accuracy of ± 14 days using the new formula proposed by White et al. [5]. However, in 
a later study in the same population, in 2015, the multiple SFH formula overestimated by 3.94 
weeks (95% LOA: 2.5 to 5.38) [6]. This could be because the group, on average, only collected a 
maximum of three fundal height measurements as explained by the authors. 
In summary, lack of US machine, lack of trained staff, late presentation for the first ANC, and 
lack of quality control of ultrasound measures constrain availability of reliable US-based gestational 
age in low-income settings. Furthermore, estimation of gestational age ultrasound could produce 
significant errors. LMP and fundal height are more reliable than other clinical measures.  
 
2.1.3 Small for gestational age (SGA) 
In order to separate the effects of gender and gestational age, growth reference values are developed 
for each gender and gestational age separately in terms of percentiles or standardized scores, also 
known as standard deviation scores. There is no universally accepted definition of SGA.  A common 
working classification is birth weight below the tenth percentile of the recommended gender-
specific birth weight for gestational age reference curves [13]. In terms of the reference curves that 
are used to classify SGA infants, a number of studies generated and validated the reference curves 
using different methods and populations, and have produced more than 104 published charts since 
1990 [14]. The challenges to classifying SGA infants are that it depends on the measurement of 
gestational age which could be erroneous and also that there are many reference curves to decide 
the percentiles. 
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Until the late 1970s, various growth charts were used clinically to assess child growth. In 
1977, the National Center for Health Statistics (NCHS) published a new set of growth charts for 
children aged under 18 years, based on data from the Fels Longitudinal Growth Study and nationally 
representative surveys [15, 16]. In 1978, the USA Center for Disease Control and Prevention (CDC) 
extrapolated the published percentiles to compute z scores, allowing for the generation of more 
extreme cut-offs, including 2 and 3 standard deviations below the median [15]. WHO then 
recommended that these z scores be used as a global reference for the definition of malnutrition 
[16]. Although the curves began to be used worldwide, there were numerous methodological 
limitations to these charts, including a lack of racial diversity in the infant sample, a sample 
composed of infants who were almost all formula fed, and a disjunction in length and stature 
measurements when transitioning from the charts for younger children to those for older children 
[15, 16].  Other charts were still being developed. Hadlock and colleagues used the US 
measurement, between 10 and 41 weeks of gestation, of 392 pregnant women of the European 
Continental Ancestry Group living in the USA to create an optimum growth equation [17, 18]. 
Gardosi and colleagues proposed an individualized approach that took into account ethnic origin, 
maternal height and weight, parity, and sex of the infant [19]. To respond to the need for upgraded 
international growth standards to assess the growth and development of infants and young children 
around the world, WHO initiated the Multicentre Growth Reference Study (MGRS) from 1997 to 
2003 in six sites (Pelotas, Brazil; Accra, Ghana; Delhi, India; Oslo, Norway; Muscat, Oman; and 
Davis, California) to generate new growth curves to assess the growth of infants and young children 
throughout the world.  One of the main challenges in any approach was that the growth curve should 
show how children should grow rather than describe how they grow and that international sampling 
should include diverse ethnic groups.  In 2006, the WHO Child Growth Standards for children 
under 5 years was generated based on this study and was supplemented by INTERGROWTH-21st 
.in 2014 [14]. INTERGROWTH-21st is a population-based project that assessed foetal growth and 
new born size in eight geographically defined urban populations: Pelotas, Brazil; Turin, Italy; 
Muscat, Oman; Oxford, UK; Seattle WA, USA; Shunyi County in Beijing, China; the central area 
of Nagpur, India, and the Parklans suburb of Nairobi, Kenya [14]. A cohort of 20,486 pregnant 
women were selected, according to strict inclusion criteria to identify a population at low risk of 
impaired foetal growth, and followed up. New born anthropometric measures were obtained within 
12 hours of birth by identically trained anthropometric teams using the same equipment at all sites. 
Sex-specific observed and smoothed centiles for weight, length, and head circumference for 
gestational, age at birth were calculated and the observed and smoothed curves were almost 
identical. What differentiates INTERGROWTH-21st from other studies is that it is a prospective 
multi-centre study that attempted to define an international birth weight standard in the context of 
optimal maternal health and foetal growth using accurate information on gestational age and other 
critical measurements to produce the reference curves while previous studies focused on simply 
describing the birth weights among the general population [20]. While MGRS and  
INTERGROWTH-21st  reference curves assume that children grow uniformly worldwide before the 
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age of five, another group from WHO provides a global reference curve that can be adjusted to any 
local population according to the mean birth weight at 40 weeks of gestation and standard deviation 
of birth weight using data from 24 countries in Africa, Latin America, and Asia that participated in 
the 2004-08 WHO Global Survey on Maternal and Perinatal Health (237,025 births) [17]. 
 
2.1.4 Mother’s subjective assessment of the size of the infant 
Although birth weight is the most reliable and widely reported measure to assess size at birth, not 
all the infants are weighed at birth globally, especially in locations where infants are not delivered 
in health facilities. When infants are not weighed at birth, mother’s recall is often used to estimate 
the prevalence of LBW to estimate the percentage of infants with LBW in Demographic and Health 
Surveys (DHS) and other surveys. The mothers are often asked, “When (the name of the infant) 
was born, was he/she very large, larger than average, average, smaller than average or very small?” 
in the surveys.  A study which critically examined the data used to produce estimates of the 
proportion of infants with LBW showed that birth weights reported by mothers are rounded up or 
“heaped” in multiples of 500 grams and those who were weighed were more likely to have mothers 
who live in urban areas and are educated and to be born in a medical facility with medically-trained 
personnel [21]. It suggested that the current survey-based figures for the prevalence of LBW are 
underestimated.  
 
2.1.5 Relevance to Bhutan 
In Bhutan, according to BMIS 2010, a total of 72.2 % of new borns were weighed at birth.  
Gestational age is recorded based on mother’s recalled LMP, ideally confirmed by US. In terms of 
US scans, the following are advised to be measured to estimate gestational age: gestational sac 
diameter (GSD) for less than 8 weeks; crown-rump length (CRL) for 9-12 weeks; biparietal 
diameter (BPD) and head circumference (HC) for 12-16 weeks; and BPD, HC and abdominal 
circumference (AC) and femur length (FL) for more than 16 weeks[22]. According to the Ministry 
of Health Mother and Child Health Handbook [23],  if estimates by LMP and US are different by 
less than one week, and US is done early, the expected date of delivery (EDD) by LMP is recorded 
in the ANC records.  If the difference is more than one week and US is done within 24 weeks of 
gestation, EDD by US is recorded.  
Neonatal estimates are currently not widely practiced even at the referral hospital level as 
of November 2015. In recent years resident doctors were trained on the new Ballad score and it has 
been introduced for clinical care only at the NICU at the Jigme Dorji Wangchuck National Referral 
Hospital (JDWNRH). Length (Lt) and head circumference (HC) were not widely measured at any 
of the three referral hospitals although in late 2015, the JDWNRH birth centre started to put more 
effort into measuring HC and Lt (according to personal communication with the nurse in charge). 
Considering 77.3 % of women go to four ANC visits or more in Bhutan according to BMIS 2010, 
the multiple SFH formula proposed by White et al.[5] could be also used to predict gestational age. 
It should be noted that accuracy of prediction depends on the quality of recording and measurement 
 41 
 
of SFH and the opportunity for mothers to have a minimum of six measures as using only three 
measures can result in a huge variation of gestational age [5, 7].  
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Table 2.1. Validation of measurements to predict gestational age in low-income settings. 
 Authors 
(Year)  
Sample size and population  Measurements 
compared  
Definition of reliable 
menstrual history  
Ultrasound timing  
  
Dubwoitz, Ballard, SFH  
  
Major findings  
Moore et 
al.(2015) 
[7]  
Retrospective analysis of clinical 
records of 2 cohorts of women 
who gave births to live 
singletons on the Thai-Myanmar 
Border:   
 
1. 250 women who 
attended ANC between 
July 2001 and May 
2006 with both US 
CRL and a Dubowitz 
gestational age 
assessment.  
 
2. 975 women attending 
ANC between April 
2007 and October 
2010 who had US 
CRL, SFH, US (BPD 
and HC) between 16 
and 50 weeks 
gestation.  
US CRL (reference)  
 
Late US (BPD and 
HC) between 16 and 
40 weeks  
 
Dubowitz  
 
SFH formula 
(multiple) by White et 
al (2011)[5].  
NA  CRL between 7 and 
before 14 weeks by 
trained sonographers  
Trained staff, monitored 
regularly  
For preterm babies,   
 
Dubowitz overestimated GA by 2.57 
weeks (95% Limits of Agreement 
(LOA): 0.49 to 4.65).  
 
SFH overestimated by 3.94 weeks 
(95% LOA: 2.5 to 5.38)  
 
Late US scan of HC underestimated 
by 0.39 weeks (95% LOA: -2.60 to 
1.82)  
 
Late US scan of BPD overestimated 
by 0.83 weeks (95% LOA: -0.93 to 
2.58)  
       
Karl et al. 
(2015) [6]  
668 singleton pregnancies from 
rural Papua New Guinea 
between November 2009 and 
December 2012 at 8 health 
facilities in the Madang 
municipality.  
US (reference)  
 
LMP  
 
Ballard  
 
SFH (single/multiple 
developed by White et 
al.(2011)[5]  
 
Quickening  
Maternal recorded date  British Medical 
Ultrasound Society 
guidelines  
 
CRL for 6-13 weeks; 
HC weeks for 13-25 
weeks 
 
Before 24 weeks by 
trained clinicians and 
checked by external 
expert  
Nurses underwent biannual 
training sessions  
LMP overestimated GA by 3 days 
(LOA: -37 to 44 days)  
 
 SFH (repeated) overestimated GA 
by 4 days (LOA: -19 to 26 days)  
 
 Ballard overestimated GA by 6 days 
(LOA:-27 to 39 days)  
 
 Quickening underestimated by 6 
days (LOA: -46 to 35 days)  
       
 43 
 
White et 
al. (2011) 
[5]  
2,437 women with US-
dated pregnancies and SFH 
measurements from 5 clinics on 
the Thai-Myanmar border 
between  April 2002 and May 
2006.  
US (reference)  
  
A new SFH formula 
that requires a 
minimum of three 
SFH measurements  
NA  CRL 8 - < 11 weeks 
and BPD, femur length 
and abdominal 
circumference for 16- 
<21 weeks  
 Not mentioned  The multiple measures model using 
the six SFH measurements resulted 
in a predication accuracy of ± 
2weeks.  
       
Taylor et 
al. (2010) 
[4] 
80 singleton babies at the 
Medical Research Council’s 
(MRC) station in Keneba, Kiang 
West, an isolated district of 
Lower River Division in the 
Gambia.   Between May and 
November 2007.  
  
US (reference)  
  
LMP  
  
The External Ballard 
Examination (EBE)  
Recalled from mothers 
at first booking  
1st/early 2nd trimester 
US by a trained 
clinician  
  
CRL for less than 14 
weeks and BPD for 14-
24 weeks using charts 
validated in African 
populations  
EBE (modified Ballard 
score: only 6 external 
criteria(skin appearance, 
presence of lanugo hair, 
plantar creases, breast 
tissue, ear formation, and 
external genitalia 
formation) were scored) by 
one trained midwife with 
previous experience  
EBE underestimated US-based GA 
by 15.6 days (LOA:-5.9 to 37.1)  
  
EBE underestimated LMP-based 
GA by 15.4 (LOA:-30 to 61 days)  
  
Mean LMP-dated US 
underestimated GA by 0.6 day  
       
Rosenberg 
et al. 
(2009) 
[11] 
355 out-born infants admitted to 
the Special Care Nursery at the 
Dhaka Shishu Hospital in 
Bangladesh who enrolled in a 
trial of topical emollient therapy 
from 1998 to 2003.  
US (reference)  
  
LMP  
  
Ballard  
  
Dubowitz criteria  
  
  
Reported by the mother 
or family  
  
  
  
  
  
1st/2nd trimester at 
various centers at 
Dhaka  
Not mentioned  LMP underestimated GA by one day 
(±11) with concordance coefficient 
for LMP0.878  
  
Ballard underestimated GA by 2.9 
days (±7.8) with concordance 
coefficient 0.914  
  
Dubowitz overestimated GA by 3.9 
days (±7.1) with concordance 
coefficient 0.886  
       
Neufeld et 
al. (2006) 
[12]  
171 women aged between 19 and 
34 years old from 4 rural villages 
in eastern Guatemala from 
August 1996 until June 1999.  
US (reference)  
  
LMP  
  
The Capurro neonatal 
examination  
  
SFH (multiple)  
Maternal recalled date  BPD using the 
regression equation of 
Hadlock et al 
conducted between 15 
and 24 weeks by one of 
two trained 
obstetricians  
Five physical items (size of 
mammary gland, nipple 
form and areola size, ear-
fold development, skin 
texture and plantar creases)  
 
Within 72 hours of birth  
 
SFH by trained nurses at 
each prenatal visit  
LMP underestimated GA by 0.77 
weeks on average (Range: -22 and 
17 weeks).  
  
The Capurro estimates 
underestimated GA by 3.33 weeks 
(Range: -33 and 25 weeks).  
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2.2 A summary of published literature on risk factors for LBW and PTB 
Adverse pregnancy outcomes could be reduced by diagnosis and timely treatment of pregnancy 
complications or by eliminating or reducing modifiable risk factors [24]. Babies can be LBW 
because they are born early (preterm), are born SGA, a proxy for interuterine growth restriction 
(IUGR), or a combination of the two [25, 26]. PTB and IUGR can differ in potential risk factors. A 
Lancet paper estimates that 83% of LBW infants were SGA and 33% were PTB using eight datasets 
from Bangladesh, India, Nepal, Pakistan, Philippines and Thailand [26]. LBW, SGA and PTB may 
result from a broad range of socioeconomic, behavioral, biological, and environmental factors [24]. 
A review of the literature on risk factors for LBW and PTB was conducted to bring into focus the 
modifiable risk factors that are relevant to Bhutan by identifying a broad range of risk factors, 
categorizing them into modifiable and non-modifiable factors, and prioritising the risk factors 
according to magnitude of association and prevalence in Bhutan. As the multitude of different risk 
factors makes it impossible to discuss them all, the selection discussed here focuses on those most 
relevant to Bhutan. This will help the study identify covariates, control for appropriate confounding 
variables, and design the content of the questionnaire. 
Systematic reviews and other peer reviewed papers in MEDLINE and the Cochrane library 
were systematically searched with no date restriction on 29 May 2013 and updated on 8 April 2016. 
No language restriction was applied. There was no study type restriction. For infant outcomes, the 
following keywords were used: exp infant, LBW/ or exp infant, small for gestational age/ or exp 
infant, very LBW/ or exp infant, premature/OR LBW* OR PTB* OR small for gestational age OR 
intrauterine growth retardation. For determinants, exp risk/ or exp logistic models/ or exp risk 
assessment/ or risk factors/ or exp regression analysis/ or exp epidemiologic research design/OR 
risk factor* OR determinant* OR associat* were used. In addition to these search terms, the 
systematic review filter was used. The reference lists of relevant papers were also manually 
searched and other academic papers were searched in Google scholar and PubMed in April 2016. 
Abstracts were then screened for possible relevance to developing countries, Southeast or South 
Asia, or Bhutan. If there were several versions of systematic reviews on a similar subject, the most 
recently updated article was included in the review if there were no major disparities in the results.  
The key findings from the selected studies are summarized in Table 2.2.  
 
2.2.1 Modifiable risk factors in the short run 
(a) Maternal health-risk behaviours 
Certain maternal behaviours such as smoking and drinking alcohol hamper foetal growth. Heavy 
alcohol consumption during pregnancy increases the risk of PTB by 23% (RR 1.23, 95% CI 1.05-
1.44) whereas light to moderate alcohol consumption shows no effect. Tobacco chewing and 
smoking have been widely reported to be risk factors for LBW and PTB due to carbon monoxide 
and nicotine [24, 27-30]. A systematic review reported that any maternal smoking increased the 
risk of preterm delivery by 27% (1.27, 95% CI 1.21-1.33), compared to non-smoking [29].  Caffeine 
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is the most commonly used psychoactive substance in the US and Europe and a meta-analysis 
showed that each 100-mg per day increment (around one cup of coffee) in maternal caffeine intake 
increased the risk of LBW by 13% (RR 1.13, 95%CI 1.06-1.21) [31]. 
In Bhutan, alcohol consumption is common. A cross-sectional survey in Tashiyangtse in 
eastern Bhutan reported that 18.5% of women aged 18 years and above consumed more than 40g 
of alcohol per drinking episode, the level defined as high-intensity drinking in the study [32]. On 
the other hand, the sales of tobacco was banned in 2004 and this ban was legislated and strengthened 
by the Tobacco Act of 2010 [33]. The rate of smoking is 2.8% according to the 2011 report [33].  
The most popular recreational substance use in Bhutan is chewing betel quid known as 
“doma”, betel nut and betel leaf with a dash of lime. According to the 2010 Gross National 
Happiness Survey, 72% of the population had ever chewed betel quid in their life and 58.5% of 
men and 61.5% of women were currently chewing betel quid [34]. Betel quid is the fourth most 
widely used psychoactive substance globally and is commonly used in Central, Southern, and 
South-east Asian countries, accounting for 600 million people worldwide or 10-20% of the world’s 
population [35, 36]. In its most basic form, betel quid consists of betel leaf, areca nut (the main 
psychoactive ingredient) and slaked lime (calcium hydroxide). While evidence of the carcinogenic 
risk of betel quid and areca nut alone is widely established, studies on the impact on adverse 
pregnancy outcomes are scarce and the quality of the studies is heterogeneous. This will be explored 
in detail in the next section. 
 
(b) Infectious diseases 
Some studies suggest that intrauterine infection may account for 25-40% of PTBs [25, 28, 37-39]. 
Although the exact magnitude of sexually transmitted infections in Bhutan is not known, syphilis 
prevalence among pregnant women screened during the antennal care visits was 2.3% in 2007 [40].  
In Bhutan, malaria has significantly declined with an incidence of 6.1 cases per 100,000 population 
in 2012 [41, 42]. A short cervix may induce intrauterine infection by shortening the distance 
between microorganisms in the lower genital tract and chorioamniotic membranes [43]. Maternal 
periodontal disease may be associated with increased risk of PTB and LBW through organisms 
such as fusobacterium nucleatum, similar to those associated with genital tract infection and 
through production of inflammatory mediators such as cytokines and prostaglandins, known to be 
associated with the onset of labour and PTB [44-47]. A number of studies show that betel quid 
chewers may be predisposed to periodontal disease [48, 49]. In Bhutan, the prevalence of 
periodontal disease is unknown and screening and treatment of dental health is limited.  
 
(c) Nutritional factors 
Normal foetal growth and development depend on maternal nutritional intake and stores [24]. Thus, 
insufficient caloric intake, inadequate micronutrient intake including folate, iron, zinc, vitamins A, 
B6, B12, C, E and riboflavin, and low gestational weight gain during pregnancy are associated with 
LBW, SGA or PTB [24, 50-53]. Gestational weight gain comprises protein, fat, water, and minerals 
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deposited in the foetus, placenta, amniotic fluid, uterus, mammary glands, blood, and adipose tissue 
[54] and modifiable behaviours such as dietary intake and physical activity influence the amount of 
weight gained in pregnancy [55].  
Anaemia, particularly iron-deficiency anaemia, may increase the risk for LBW and PTB 
[56-59]. A meta-analysis showed that maternal anaemia during early pregnancy increased the risk 
of PTB by 32% [60]. In Bhutan, traditionally, red rice, ema dates (chilli pepper and cheese stew) 
and suja (salted butter tea) are the national dishes and salt intake is believed to be high among the 
Bhutanese [61]. Although there are no publicly available data on vitamin A deficiency or anaemia, 
WHO estimated that 16.6% of pregnant women are deficient in vitamin A and 50% of pregnant 
women are anaemic [62, 63]. Iodized salt is widely consumed in Bhutan[64]. 
 
(d) Antenatal care (ANC) 
The relationship between ANC (timing of first visit, frequency, and quality of care) and LBW is 
still uncertain [24, 65-68]. Routine ANC aims to deliver effective and appropriate screening, 
preventive, and treatment interventions [67]. Thus, some adverse outcomes could be prevented by 
early diagnosis and timely treatment of pregnancy complications or by eliminating or reducing 
modifiable risk factors [24]. Modifiable risk factors include smoking, alcohol consumption, genital 
tract infection, and caloric consumption. For instance, a recent Cochrane review found that 
antenatal nutritional advice, which aims to increase energy and protein intake in the general 
obstetric population, appears to be effective in reducing the risk of PTB, increasing head 
circumference at birth and increasing protein intake[66].   
 
2.2.2 Modifiable risk factors in the long-run or un-modifiable risk factors 
(a) Socioeconomic status 
Different measures of socioeconomic disadvantage such as family income, maternal education, 
occupation, and marital status are reported to be associated with LBW, PTB or SGA [24, 69, 70].  
A recent systematic review found that LBW, PTB or SGA were most prevalent among women in 
the most socioeconomically disadvantaged group [69]. These women may have limited access to 
basic sanitation, good nutrition, psychosocial support, and health services and may be more exposed 
to heavy workload during pregnancy, stress, heavy alcohol consumption and smoking. Furthermore, 
it may be more difficult for them to comply with health messages due to their social circumstances 
and lack of education.   
In terms of socioeconomic variations in Bhutan, in the eastern region, more households are 
rural  (85%) than in the western (80%)  and central (70%) regions [71]. In the eastern region, lack 
of access to roads going to and from markets hampers commercial farming [72]. Moreover, the 
main agricultural product in the eastern region is maize, accounting for 72% of total maize 
production [72]. Although farm households consume rice in three to four meals a day, maize 
substitutes for rice in the eastern region [72]. From the public health perspective, few studies have 
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been conducted on the eastern region of Bhutan. Thus, this regional variation should be taken into 
account in the study design and analysis. 
 
(b) Maternal pre-pregnancy weight, short birth spacing, very young maternal age 
Considering maternal pre-pregnancy weight as a predictor for nutritional stores potentially available 
to the growing foetus, maternal underweight may be associated with LBW and PTB [24, 51].  Very 
young maternal age and short birth spacing may increase the risk of bearing a LBW infant. Very 
young maternal age may have a negative, biological impact on maternal growth and infant growth 
due to foeto-maternal competition for nutrients [73]. Closely spaced pregnancies do not allow 
mothers to fully recover the macro- and micro-nutrients necessary for the next pregnancy and may 
lead to LBW or PTB for mothers and infants [74].  
 
(c) Maternal and obstetric factors 
Potential maternal characteristics associated with PTB and LBW include ethnicity and race [24, 37, 
75], and chronic medical conditions [24, 76, 77].  Previous history of adverse pregnancy outcomes 
such as PTB, intrauterine growth, abortion, neonate loss, and stillbirth are also reported to increase 
the risk of PTB, LBW, and SGA in a subsequent pregnancy [24, 78-80].  A meta-analysis reported 
that women with a previous preterm singleton birth at <37 weeks had an increased unadjusted risk 
for recurrent PTB compared with women with a previous term birth (unadjusted OR 5.43, 95% CI 
4.03-7.31) using a random-effects model [80]. Paternal factors including age, height, and paternal 
LBW may be risk factors [81].  In addition, medically-indicated preterm deliveries are reported to 
account for 15-20% of all PTBs and the most common medical indications for preterm delivery are 
pre-eclampsia, foetal distress, SGA, and placental abruption [78, 82]. 
Nulliparity was associated with a significantly increased unadjusted risk of LBW or SGA 
birth but not with PTB, although this could be affected by confounders [24, 83]. A meta-analysis 
shows that unadjusted odds of LBW increased among nulliparous mothers compared to parous 
(parity 2-4) mothers by 41%. Prior history of PTB may increase the risk of PTB in the next 
pregnancy [28, 84]. One study reported mothers with a prior spontaneous PTB carried a 2.5-fold 
increase in the risk of spontaneous preterm delivery in the current gestation compared to mothers 
with no prior spontaneous preterm delivery [85]. PTB is more common in boys [56, 86] but girls 
weigh less than boys for the same gestational age [87].  
Obesity may increase the risk of PTB and LBW as obese women are more likely to have 
infants with congenital anomalies, and or, develop pre-eclampsia and diabetes, which is likely to 
lead to provider-initiated preterm delivery [28, 88-90]. While micronutrient deficiency is still 
prevalent, Bhutan has experienced a recent increase in adult obesity. A population-based survey 
conducted in Bhutan between April and June 2014 analysing 1748 women aged 18-69 reported that 
the prevalence of obesity was 6.5% (95% CI 4.9-8.1) among women aged 18-39 and 12.1% (95% 
CI 8.7-15.4) among women aged 40-69 respectively [91].  A survey conducted in the capital of 
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Bhutan in 2008 analysing 1342 women aged 25-74 reported the prevalence of diabetes was 4.5% 
among women aged 25-34 and 4.5% among women aged 35-44 [85].   
 
(d) Hypertensive disorders 
Hypertension in pregnancy is a leading cause of maternal mortality and adverse birth outcomes [92]. 
Many efforts during antenatal care are made to detect and manage hypertensive disorders during 
pregnancy [93]. A meta-analysis of  USA data showed chronic hypertension increased PTB and 
LBW 2.7 times [76]. The association between pre-eclampsia or gestational hypertension and poor 
foetal growth is inconclusive [2, 94-101] (Appendix B.3.). 
Pre-eclampsia is defined as hypertension (diastolic blood pressure of ≥ 90 mm Hg) 
accompanied by proteinuria (≥ 300 mg or more per 24- hour period), and usually occurs during the 
second half of pregnancy (at or after 20 weeks’ gestation) [95, 96].  Pre-eclampsia complicates 2%-
8% of pregnancies [95-97, 102]. Women with moderate pre-eclampsia generally have no symptoms 
[95]. Women with severe pre-eclampsia, or with very high blood pressure, may feel unwell, with 
symptoms such as headache, upper abdominal pain, or visual disturbances [95]. One hypothesis of 
the pathogenesis of pre-eclampsia is that reduced placental blood flow hampers foetal growth with 
an increased risk of IUGR and LBW [98]. Moreover, PTB could be a result of treatment for pre-
eclampsia [78].   
The 2014 population-based survey reported that 9.1% of women aged 18-39 had been 
diagnosed with hypertension in last 12 months compared with 25.8% of women aged 40-69[91]. 
The prevalence of pre-eclampsia in Bhutan is not known.  
 
(e) Psychosocial factors 
Poor mental health and intimate partner violence are reported to be associated with LBW and PTB 
[56]. A meta-analysis suggests women who reported physical, sexual or emotional abuse during 
pregnancy were 40% more likely than non-abused women to give birth to a LBW baby [103].  Meta-
analyses reported increased risk of LBW and prematurity due to maternal anxiety [104] and 
depression [105]. Association with IUGR is inconclusive [105]. One potential pathway is that 
maternal psychological stress/distress releases stress hormones such as cortisol and catecholamines, 
which results in placental hypo-perfusion and the consequent restriction of oxygen and nutrients to 
the foetus, which may lead to foetal growth impairment and or precipitation of PTB [105-108]. 
Although the prevalence of intimate partner violence in Bhutan is not known, the National 
Commission for Women and Children of Bhutan conducted an exploratory study in 2007 and 
showed that 574 out of 688 married women said that verbal conflicts were common in their marriage 
and 188 (32.8%) said that these verbal conflicts normally led to physical conflicts[109].   
 
(f) Altitude 
In addition to the above socioeconomic, behavioural, and biological factors, research findings 
suggest the negative impact of a high altitude on birth weight in South America (including Bolivia 
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and Peru), Tibet, and the USA [110-115] (Appendix B.3.). Altitude is one of the contextual factors 
that is particular to Bhutan. Bhutan’s elevation varies about 160m above sea level in the south to 
more than 7500m above sea level in the north [116].   
Although there is no precise definition of “high altitude”, the majority of individuals 
experience certain clinical, physiological, anatomical, and biochemical changes above 3,000m with 
a huge individual variation [117]. A commonly used working definition is altitudes of 2,500 meters 
and above. It is estimated that 83 million people live above 2,500 meters, mostly between 2,500 m 
and 4,000m [117]. Only Asia and South America have sizable populations residing above 4,000m 
[117]. Indigenous populations have resided in the Tibetan, Andean and East African plateaus for 
10,000 (Andeans) to 20,000 years (Tibetans) [118]. European or Han populations have lived at high 
altitudes for less than 500 years (less than 400 years in South America, less than 150 years in North 
America, and less than 50 years in western China) [119].  
The unique stress at high altitude is hypobaric hypoxia.  Other factors could be cold, aridity, 
solar radiation, diet, disease ecology, and life style [117]. For example, altitude may constrain 
agricultural production and increase the cost of transporting fresh food products, which may result 
in maternal nutritional deficiencies [111]. Hypoxia is a frequent complication of prenatal life. The 
chronic hypoxia at high altitudes was reported to be associated with a birth weight reduction.  
Research shows different patterns of birth weight reduction in relation to altitude within a range of 
less than 500g. Several studies show a linear relation between birth weight reduction and altitude 
[120]. Most of the evidence suggests that the decline in birth weight is curvilinear with the 
breakpoint occurring at about 2000m [118]. The entire distribution of birth weights is shifted to 
lower values [121].  
When prolonged, hypoxia is associated with IUGR and increased perinatal mortality and 
morbidity [118]. Research shows that foetal growth starts to slow in the third trimester after 28-31 
weeks’ gestation, leading to a reduction in birth weight at high altitude.  
One study in South America evaluated the marginal effect of altitude [111] and most of the 
studies compared the means of birth weight controlling for confounding variables in two 
communities at  extremely low and high altitudes.  No studies used multi-level analyses to account 
for neighbourhood effect. One study showed that birth weight declined an average of 102g per 3300 
ft (1000m) elevation, increasing the percentage of LBW by 54% from the lowest to the highest 
elevations in Colorado, USA, after controlling for gestational age, weight gain, parity, cigarette 
consumption, number of ANC visits, and hypertensive complications of pregnancy [110].  Several 
studies suggest that the reduction in birth weight at altitude is largely attributable to IUGR rather 
than prematurity. A few studies suggest the presence of protective mechanisms against altitude-
associated foetal growth retardation in Bolivians and Tibetans from prolonged high-altitude resident 
ancestry [115, 122, 123].  In past studies, ancestry has been identified using last names [122], place 
of birth [124], or self-identification confirmed by dress, language, and parental information [123] 
and was controlled for in the models to estimate the effect of altitudes on birth weight. The results 
suggest that birth weight reduction may be less severe in populations that have resided longer at 
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high altitudes. Birth weight declines by an estimated 88 or 89g per 1000m increase in elevation 
among Tibetan and Andean new borns but by 119 and 153 g per 1,000m for European and Han 
Chinese new borns respectively [123]. The physiology behind this protection and whether these 
mechanisms are at the maternal and/or placental and/or foetal level remain unknown.  
Several studies shows that the incidence of pre-eclampsia is increased at high altitude and 
this is likely to contribute to the altitude-associated birth weight decline [110, 114, 120, 122]. Pre-
eclampsia and gestational hypertension were 1.7 times (95% CI: 1.3-2.3) more frequent at high 
altitude in Bolivia comparing 300m and 3600m [114] and 3.6 times more frequent (95% CI: 1.1-
11.9) in Colorado comparing 1260m and 310 m [120].  
 
(g) Season 
Several systematic reviews reported seasonal patterns of adverse pregnancy outcomes in both high 
income countries and low/middle income countries [125-127].  The time of birth than the time of 
conception were more documented as an exposure in the past studies[125]. The seasons that are 
associated with an increased risk of adverse pregnancy outcomes vary depending on countries due 
to geographical and climate variations. Seasonal patterns  of adverse pregnancy outcomes may be 
explained by seasonal patterns in food availability and infection, or exposure to cold temperature, 
humidity, or sunlight[127]. For example, exposure to cold temperatures during mid-gestation could 
compromise placental blow flood and may lead to lower birth weight[128]. Bhutan has four seasons 
and seasonal rainfall with monsoon rains occurring from June to September [42]. Seasonal food 
insecurity and hunger due to shortage of grain from May to July is often observed in the eastern 
region [129]. 
 
(h) Other environmental factors 
Other environmental factors include indoor air pollution from solid fuel use. A systematic review 
suggests that such pollution is associated with increased risk of percentage LBW by 38% and 
stillbirth and reduced mean birth weight [27].  In Bhutan, 53.6% of the household population in the 
rural areas use solid fuel [71].  
 
(i) Neighbourhood effect 
The neighbourhoods in which people live may influence health through the availability and 
accessibility of health services, healthy foods, clean water, social support, the prevailing attitudes 
towards health and health related behaviours, and environmental pollution [130, 131]. One of the 
early studies which analysed the impact of macro-level factors on LBW suggested that multilevel 
models should be used in future analyses of maternal and child health outcomes [130]. The study 
examined both neighbourhood-level and individual-level risk factors for LBW by combining 
individual data from the city health department’s Bureau of Biostatics and census tract level data 
including per capita income and information on household wealth, home ownership, number of 
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housing violations issued and per capita crime data between 1985 and 1989 in Baltimore, USA 
(n=50,757). The study indicated that there is substantial interaction between macro-level factors 
and individual-level risk factors. A review of neighbourhood effects on health, which reviewed 25 
studies from developed countries before June 1998, found that 23 of the 25 studies reported a 
statistically significant association between at least one neighbourhood measure of socioeconomic 
status and health, controlling for at least individual socioeconomic status [131]. Although there is 
a chance of overestimation of the effect of neighbourhood due to inadequate control of individual 
socioeconomic status, it suggests the importance of investigating neighbourhood level effects. In 
Bhutan, there is a cultural diversity across the regions and where mothers live can determine 
accessibility to health services. 
 
2.2.3 Relevance to Bhutan 
The review of the literature suggests that PTB and LBW can be caused by a broad range of 
socioeconomic, behavioural, biological, and environmental factors. Regarding potentially 
modifiable risk factors particularly relevant to Bhutan, there is a knowledge gap in the literature on 
the impact of betel quid chewing on PTB and LBW. Considering the high prevalence rate of this 
habit in the Bhutanese population, there is a need for further studies to examine its impact on 
pregnancy outcomes.  
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Table 2.2. Summary of systematic reviews of determinants of LBW, PTB and SGA. 
 Outcomes Author Review method Summary of the key findings 
Overall 
summary 
Determinants of 
LBW 
Kramer (1987) [24] Methodological assessment 
and meta-analysis (1970-1984) 
43 determinants of LBW were analysed from 895 published papers in the English and French 
literature from 1970-1984. In developed countries, the most important factor was cigarette 
smoking, followed by nutrition and pre-pregnancy weight. In developing countries the major 
determinants were racial origin, nutrition, low pre-pregnancy weight, short maternal stature, and 
malaria. For gestational duration, pre-pregnancy weight, prior premature birth or miscarriage, 
diethylstilbestrol exposure and smoking were the major determinants, but the majority of PTBs 
were unexplained in both developed and developing countries. 
     
Modifiable in 
the short run 
Alcohol 
consumption 
Patra et al. (2011) 
[132] 
Systematic review of case-
control or cohort studies (1 
January 1980-1 August 2009) 
36 studies were included. Compared with abstainers, the overall dose-response relationships for 
LBW and SGA showed no effect up to 10 g pure alcohol/day (an average of about 1 drink/day) and 
PTB showed no effect up to 18 g pure alcohol/day (an average of 1.5 drinks/day); thereafter, the 
relationship showed a monotonically increasing risk of LBW and SGA for increasing maternal 
alcohol consumption. The risk of PTB for mothers who consumed more than three alcoholic drinks 
per day increased by 23%, compared to nondrinking mothers (RR 1.23, 95% CI 1.05-1.44). 
     
 Smoking Lumley et al. (2009) 
[133] 
Intervention review of 
randomised controlled trials 
(searched in June 2008) 
Smoking cessation: The 21 trials to promote smoking cessation in pregnancy with information on 
perinatal outcomes revealed a reduction in LBW (RR 0.83, 95% CI 0.73 - 0.95), a reduction in PTB 
(RR 0.86, 95% CI 0.74 -0.98), and an increase in mean birth weight of 39.26 g (95% CI 15.77 g - 
62.74 g) in the treatment group. 
  Shah and Bracken 
(2000) [29] 
Systematic review and meta-
analysis of prospective studies 
(1966-1997) 
Maternal smoking: 20 prospective studies were included. Most studies controlled for maternal age, 
race, gravidity, parity, income, and other social and demographic factors. The pooled OR of PTB 
for any maternal smoking during pregnancy versus no smoking is 1.27 (95% CI 1.21-1.33). 
     
 Smokeless tobacco 
(SLT) 
Suliankatchi and 
Sinha (2016) [134] 
Systematic review and meta-
analysis (31 July 2015) 
2 cohort studies conducted in India were included. One study failed to control for smoking. SLT 
was statistically associated with LBW (OR 1.88, 95% CI 1.38-2.54); PTB (OR 1.39, 95% CI 1.01-
1.91); and still birth (OR 2.85, 95% CI 1.61-5.01).  
  Inamdar et al.  
(2014) [135] 
Systematic review (searched in 
July 2013) 
9 studies (7 cohort studies, 1 case-control study and 1 cross-sectional study from Asia (6 studies), 
Sweden (1), USA (1), and South Africa (1) were included. Significant associations with SLT use 
were see in 5/7 studies for LBW, in 3/6 studies for preterm, in all 4 studies for still birth and in 1/2 
studies assessing SGA. 3 studies did not report any confounding factors. Studies of oral forms of 
khat and betel quid without tobacco were excluded.  
     
 Caffeine intake Chen et al. (2014) 
[31] 
Systematic review (searched 
on 17 July 2013) 
13 prospective studies were included from HICs. Caffeine was statistically significant with LBW 
(50-149 mg/day: RR 1.13, 95% CI 1.06-2.08; 150-349 mg/day: RR 1.38, 95% CI 1.18-1.62; and 
≥350 mg/day: RR 1.60, 95% CI 1.24-2.08 compared to <50 mg). In the dose-response analysis, 
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each 100-mg/day increment in maternal caffeine intake was associated with 13% increased risk of 
LBW (RR 1.13, 95% Ci 1.06-1.21). 
     
 Maternal infectious 
disease 
Gomez et al. (2013) 
[37] 
Systematic review and meta-
analysis (searched in 
December 2011)  
Syphilis: 6 studies were included. Random-effects meta-analyses found that prematurity or LBW 
are 5.5% more frequent among untreated pregnant women with syphilis than among women 
without syphilis.  
  Corbella et 
al.(2012)[47] 
Systematic review and meta-
analysis (searched in January 
2011) 
Periodontal disease: 17 case-control studies were included (10,148 women). The fixed effect 
models show that periodontal disease was associated with an increased odds of PTB (OR 1.78, 95% 
CI 1.58-2.01, 14 studies), LBW(OR 1.82, 95 % CI 1.51-2.20, 7 studies), and preterm LBW (OR 
3.00, 95% CI 1.93-4.68, 3 studies). 
  George et al. (2011) 
[44] 
Systematic review and meta-
analysis (searched in 2010) 
Periodontal treatment: 10 randomised trials were included (5,645 women, 1 study from India). 
Using the random-effects model, the periodontal treatment significantly decreased the risk of PTB 
(OR 0.65, 95% CI 0.45-0.93) and LBW (OR 0.53, 95% CI 0.31-0.92).   
  Leitich and Kiss 
(2007) [38] 
Systematic review and meta-
analysis (updated on May 
2005) 
Bacterial vaginosis: 32 studies were included for meta-analysis (30,518 women). Bacterial 
vaginosis was associated with preterm delivery in asymptomatic patients (OR 2.16, 95% CI 1.56-
3.00) and in patients with symptoms of preterm labour (OR 2.38, 95% CI 1.02-5.58). 
     
 Micronutrient 
supplementation 
Haider and Bhutta 
(2015) [136] 
Systematic review and meta-
analysis (searched on 11 March 
2015) 
Multiple micronutrients supplementation (MMN): 17 trials (137,791 women: 15 trials from LMIC) 
were included. MMN resulted in a significant decrease in LBW (RR 0.88, 95%CI 0.85-0.91), SGA 
(RR 0.90, 95% CI 0.83-0.97) but not with PTB (RR 0.96, 95%CI 0.89 – 1.03) using the fixed effect 
models. 
  Lassi et al. (2013) 
[137] 
Intervention review (searched 
on 21 December 2012) 
Folic acid supplementation: 4 studies were included (3,113 participants) for birth weight. Folic acid 
supplementation during pregnancy did not show any impact on reducing LBW (RR 0.83, 95% CI 
0.66-1.04).  3 studies were included (2,959 participants) for PTB. Administration of folic acid 
supplementation during pregnancy has no impact on reducing PTB (RR 1.01, 95% CI 0.73 - 1.38). 
  Kawai et al. (2011) 
[52] 
Meta-analysis and meta-
regression (searched on 1 
August 2010) 
MN: 15 trials were included. Fixed-effect meta-analyses found that pregnant women who received 
micronutrient supplements were less likely to deliver LBW infants (RR 0.86, 95% CI 0.79-0.93) or 
SGA infants (RR 0.85, 95% CI 0.78-0.93) than women who received iron and folic acid 
supplements. Micronutrient supplementation had no effect on PTB (Pooled RR 0.99, 95% CI 0.95-
1.03). 
 Gestational weight 
gain 
McDonald et al. 
(2011) [50] 
Systematic review and meta-
analysis (1950-2 January 2009) 
Gestational weight gain (GWG): 28 studies were reviewed (2,124,907 women). High GWG was 
associated with lower risk of LBW (RR 0.64, 95% CI 0.53-0.78) using 25 to 35 lbs as the reference 
GWG. Women with high GWG had a decreased risk overall of PTB < 37 weeks (RR 0.75, 95% CI 
0.60 - 0.96), PTB 32 to 36 weeks (RR 0.70, 95% CI 0.70 - 0.71), and < 32 weeks (RR 0.87; 95% CI 
0.85 - 0.90). However, women with high weekly GWG were at increased risk of PTB. Women with 
the highest weekly GWG had greater risks of PTB (RR 1.51, 95% CI 1.47 - 1.55) than women with 
moderately high weekly GWG (RR 1.09, 95% CI 1.05- 1.13). Women with high weekly GWG 
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were at increased risk of PTB 32 to 36 weeks (RR 1.14, 95% CI 1.10-1.17 and < 32 weeks (RR 
1.81, 95% CI 1.73 - 1.90).  
     
 Anaemia Haider et al. (2013) 
[59] 
Systematic review and meta-
analysis (PubMed:1966 -1 May 
2012, Embase:1974 - 31 May 
2012) 
Anaemia: 48 randomised trials (17,793 women: 21 studies from LMICs) and 44 cohort studies 
(1,851,682 women: 22 studies from LMICs) were included. In analyses of cohort studies, anaemia 
(defined as Hb<100g/L to <115g/L) was associated with an unadjusted OR of LBW (1.25, 95% CI 
1.08-1.45) and adjusted OR of PTB (1.28, 95% CI 1.12-1.47) but not adjusted OR of LBW (1.13, 
0.94-1.35), using random effects.  
  Kozuki et al. (2011) 
[57] 
Systematic review and meta-
analysis (searched in February 
2011) 
Anaemia: 7 studies were included for meta-analysis. Moderate to severe maternal anaemia (the 90< 
or <80-g/L) was associated with a 53% increase in risk of the new born being SGA (pooled OR 
1.53, 95% CI: 1.24-1.87). Mild anaemia (the <110- and <100-g/L category) showed no significant 
relationship with SGA.    
     
 Work activities Palmer et al. (2013) 
[138] 
An updated review of meta-
analysis (1966-2011) 
56 studies were reviewed for birth weight. Any risks from long working hours, shift work, 
prolonged standing, heaving lifting and high physical workload associated with LBW are at most 
small. 
     
 Antenatal care 
(ANC) 
Carroli et al. (2001) 
[67] 
Systematic review of 
randomised trials (searched in 
June 2000 and updated in 
December 2000)  
Number of ANC: 7 studies were included (57,418 women). There was no clinically differential 
effect of a reduced number of antenatal visits when the results were pooled for LBW (OR 1.04, 
95% CI 0.93-1.17).  
  Hodnett et al.  
(2010) [68] 
Intervention review 
randomised controlled trials 
(searched on January 2010)  
Additional social support during ANC: 17 trials (12,264 women) were reviewed. Programs offering 
additional social support for at-risk pregnant women were not associated with improvements in any 
perinatal outcomes. 11 trials (10,429 women) were included for PTB (RR 0.92, 95% CI 0.83-1.01). 
11 trials (8681) were included for LBW (RR 0.92, 95% CI 0.83-1.03). However, there was a 
reduction in the likelihood of antenatal hospital admission (three trials; n = 737; RR 0.79, 95% CI 
0.68 - 0.92) and caesarean birth (nine trials; n = 4522; RR 0.87, 95% CI 0.78 - 0.97).  
  Ota et al. (2012) 
[66] 
Intervention review of 
randomised controlled trials 
(search updated on 12 July 
2012) 
Nutritional advice during ANC: 4 trials (790 women) of nutritional advice were reviewed. Women 
given nutritional advice had a lower relative risk of PTB (two trials, 449 women) (RR 0.46, 95% CI 
0.21 - 0.98), head circumference at birth was increased in one trial (389 women) (mean difference 
(MD) 0.99 cm, 95% CI 0.43 - 1.55) and protein intake increased (three trials, 632 women) (protein 
intake: MD +6.99 g/day, 95% CI 3.02 - 10.97). No significant differences were observed in any 
other outcomes. 
     
Modifiable in 
the long run or 
unmodifiable 
factors 
Socioeconomic 
measures 
Ruiz et al. (2015) Meta-analysis of prospective 
cohort studies (April 1983- 
October 2006) 
Mother’s education: 12 prospective cohort studies (75296 births between April 1983 and October 
2006) in Europe were included. The excess risk of PTB associated with low maternal education 
was 1.48 (95% CI 1.29-1.69) when using the prevalence ratio of the child outcome between 
children at the lowest and those at the highest end of the maternal education hierarchy and 1.84 
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(95% CI 0.99-2.69) when using the prevalence difference of the child outcome between the two 
ends, adjusting for child sex, maternal age, and ethnicity.   
  Shah et al. (2011) 
[70] 
Systematic review and meta-
analysis (until April 2010) 
Marital status: 21 studies were included. Unadjusted odds of LBW were increased among 
unmarried (OR 1.46, 95% CI 1.25-1.71), single (OR 1.65, 95%CI 1.44-1.88) and cohabitating (OR 
1.29, 95% CI 1.25-1.32) mothers, compared to married mothers. PTB was increased among 
unmarried (OR 1.22, 95% CI 1.14-1.31), single (OR 1.54, 95% CI 1.39-1.72) and cohabitating (OR 
1.15, 95% CI 1.08-1.23 mothers).  SGA birth was increased among unmarried (OR 1.45, 95%CI 
1.32-1.61), single (OR 1.70, 95%CI 1.47-1.97) and cohabitating (OR 1.36, 95% CI 1.30-1.42) 
mothers. 
  Blumenshine et al. 
(2010) [69] 
Systematic review (1999-2007) Socioeconomic disadvantage: 106 studies in industrialized countries defined by OECD were 
included. Socioeconomic disadvantage was consistently associated with increased risk of LBW, 
PTB or SGA across socioeconomic measures and countries. Many studies observed racial/ethnic 
differences in the effect of socioeconomic measures.  
     
 Parity Shah et al. (2010) 
[83] 
Systematic review and meta-
analysis (until October 2009) 
41 studies were included. Unadjusted odds of LBW increased among nulliparous mothers 
compared to parous (parity 2-4) mothers (OR 1.41, 95% CI 1.26-1.58). Nulliparity was associated 
with increased unadjusted odds of SGA (OR 1.89, 95% CI 1.82-1.96), but not with PTB (<37 
weeks) (OR 1.13, 95% CI 0.96-1.34). 
     
 Early age at first 
childbirth 
Gibbs et al. (2012) 
[73] 
Systematic review and meta-
analysis (searched on 31 
January 2011) 
20 studies were reviewed. The evidence suggests the effect on LBW for very young maternal age 
(<15 years or 2 years post-menarche) is moderate. Meta-analysis of 9 studies indicates moderate 
association between young maternal age and PTB (OR 1.68, 95%CI 1.34-2.11).  
     
 Birth spacing Kozuki et al. (2013) 
[139] 
Systematic review and meta-
analysis (searched in February 
2009) 
Birth intervals (the time between the previous and index live birth): short (<18 months) and long (> 
60 months): 5 cohort studies from LMICs were included. Short IPIs are associated with PTB (aOR 
1.58, 95% CI 1.19-2.10) and SGA (aOR 1.51, 95% Ci: 1.31-1.75) using the random-effects model. 
Long IPIs (>60 months) was associated with SGA (aOR1.14, 95% CI 1.07-1.39) but not with PTB.  
  Wendt et al. (2012) 
[74] 
Systematic review and meta-
analysis 
Short inter-pregnancy intervals (the time between birth and conception) (<12 months): 5 studies 
were reviewed for the meta-analyses. Short intervals are associated with LBW (<6 m adjusted OR 
1.44, 95% CI 1.30-1.61, 6-11 m adjusted OR 1.12, 95% CI 1.08-1.17). The evidence suggests 
significant impacts of short inter-pregnancy intervals on extreme PTB (<6 m adjusted OR 1.58, CI 
1.40-1.78, 6-11 m adjusted OR 1.23, 95% CI 1.03 -1.46) and moderate PTB (<6 m adjusted OR 
1.41, 95% CI 1.20-1.65, 6-11 m adjusted OR 1.09, 95% CI 1.01-1.18). 
     
 Maternal 
underweight and 
obesity 
Han et al. (2010) 
[51] 
Systematic review and meta-
analysis (1950-2 January 2009) 
Maternal underweight: 78 studies were reviewed (1,025,794 women). In both developed and 
developing countries, underweight women were at increased risk of having an LBW infant (RR 
1.48, 95% CI 1.29-1.68, and RR 1.52. 95% CI 1.25-1.85, respectively). The overall risk of PTB 
was increased in the cohort studies of underweight women (adjusted RR 1.29, 95% CI 1.15-1.46) 
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with adjusted RR 1.32 (95% CI 1.10-1.57) for spontaneous PTB and adjusted RR 1.21 (95% CI 
1.07-1.36) for induced PTB. 
  McDonald et al. 
(2010) [140] 
Systematic review and meta-
analysis (1950 – 2 January 
2009) 
Maternal overweight or obesity: 84 studies were included (1,095,834 women), predominantly from 
developed countries. The definition of exposure varied across the studies. There was no statistically 
higher risk of PTB for overweight or obese women with singleton pregnancies (RR 1.06, 95% CI 
0.87-1.30, 38 studies) whereas the risk of induced PTB increased (RR 1.30, 95% CI 1.23-1.37, 5 
studies). Overweight and obesity was associated with a decreased risk of having an infant of LBW 
(RR 0.84, 95% CI 0.75-0.95, 28 studies). The decrease was higher in developing countries (RR 
0.58, 95% CI 0.47-0.71, 11 studies, 4,710 women) compared to developed countries. After 
accounting for publication bias, the protective effect of overweight and obesity on LBW 
disappeared (RR0.95, 95% CI 0.85-1.07) whereas the risk of PTB appeared to increase in 
overweight and obese women (RR1.24, 95% CI 1.13-1.37). 
     
 Maternal chronic 
diseases 
Bramham et al. 
(2014) [76] 
Systematic review and meta-
analysis (searched in June 
2013) 
Chronic hypertension: 55 studies (795,221 women) were included (mostly from HICs, 4 studies 
from Asia: India, China, Taiwan, and Japan). In meta-analyses of US studies (22 studies) using the 
random-effects model, chronic hypertension increased PTB (2.7, 95% CI 1.9-3.6) and LBW (2.7, 
95% CI 1.9-3.8), compared to the USA national population dataset.  
     
 Maternal obstetric 
history 
Kazemier et al. 
(2014) [80] 
Systematic review and meta-
analysis (searched on 8 January 
2013) 
History of previous preterm singleton: 6 studies were included (4 USA, 1 Taiwan and 1 Demark). 
Women with a previous preterm singleton birth at <37 weeks had an increased risk for recurrent 
PTB compared with women with a previous term birth (unadjusted OR 5.43, 95% CI 4.03-7.31) 
using the random-effects model.  
     
 Psychosocial 
stress, anxiety, and 
abuse 
Wosu et al. (2015) 
[141] 
Systematic review (1992-2010) Maternal history of childhood sexual abuse (CSA): 6 studies from developed countries (4 USA, 1 
Norway, 1 Germany) were included. The associations of maternal history of CSA and PTB were 
inconclusive. 3 studies reported statistical significant associations and 3 studies did not observe 
statistically significant differences.   
  Ding et al. (2014) 
[142] 
Systematic review and meta-
analysis (up to June 2013) 
Maternal anxiety: 12 (17,304 women from prospective cohort studies in HICs) studies for PTB and 
6 studies (4,948 women) for LBW were included. Maternal anxiety during pregnancy was 
significantly associated with an increased risk of PTB (RR 1.50, 95% CI: 1.33-1.70) and LBW (RR 
1.76, 95% CI: 1.32-2.33) using the fixed effects model. 
  Grote et al. (2010) 
[105] 
Systematic review and meta-
analysis (January 1980-
December 2009) 
Maternal depression: 29 studies were included (12 non-USA countries including 2 LMICs). Using 
the random effects models, maternal depression was statistically significantly associated with LBW 
(RR1.18, 95% CI 1.07-1.30), PTB (RR 1.13, 95% CI 1.06-1.21), but not with IUGR (RR 1.03, 95% 
CI 0.99-1.08). 
  Murphy et al. (2001) 
[103] 
Systematic review and meta-
analysis (1966-1999) 
Maternal physical, sexual or emotional abuse during pregnancy: 8 studies were selected for meta-
analysis including a few studies that did not adjust for confounders. Fixed-effect meta-analyses 
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found that women who reported physical, sexual or emotional abuse during pregnancy were more 
likely than non-abused women to give birth to a LBW baby (OR 1.4, 95% CI 1.1–1.8). 
     
 Paternal factors Shah et al. (2010) 
[81] 
Systematic review (searched 
on March 2009) 
36 studies were included for a systematic review with qualitative synthesis. Paternal age, height, 
and birth weight may be associated with LBW. 
     
 Indoor air pollution Pope et al. (2010) 
[27] 
Systematic review (1966-2008)  5 studies were reviewed for LBW.  Fixed-effect meta-analyses found that indoor air pollution from 
solid fuel use was associated with increased risk of percentage LBW (OR 1.38, 95% CI 1.25-1.52)  
     
 Agricultural 
pesticide 
Shirangi et al. 
(2011) [143] 
Systematic review (1950-2007) 25 studies were reviewed. The strength of evidence for an association between living near 
agricultural pesticide applications and adverse reproductive outcomes is generally weak although it 
may be an important source of ambient environmental exposure. The exposure measurements and 
outcome measures need to be improved. 
     
 Neighbourhood 
effect 
Pickett and 
Pearl(2001) [131]  
Systematic review (before June 
1998) 
25 studies from developed countries (13 USA, 9 UK, 2 Netherlands, and 1 Finland) which adjusted 
for at least one individual level socioeconomic status were reviewed. 16 studies used single level 
linear and logistic regression analysis and Cox proportional hazards models to estimate the impact 
of neighbourhood factors on health and 9 used multilevel models. 23 out of 25 studies reported a 
statistically significant association between at least one neighbourhood measure of socioeconomic 
status and health, controlling for individual socioeconomic status. 3 studies only controlled for one 
measure of individual level socioeconomics status, which may lead to overestimation of 
neighbourhood level effect as proxies for unmeasured aspects of individual socioeconomics status. 
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2.3 The impact of betel quid chewing on pregnancy 
In order to understand prior studies on the impact of betel quid chewing on pregnancy and help 
design the present study, relevant literature was systematically searched in MEDLINE and 
EMBASE with no date restriction in January 2014 and updated in March 2016. No language 
restriction was applied. There was no study type restriction.  For areca, the following keywords 
were used: exp Areca, Areca*, betel*, Supari, Puwak, Mak, Gua, Pinang, Daka, Piper, Catechu, 
Catechu*, OR doma. For infant outcomes, exp Premature Birth, exp infant, low birth weight/ or 
exp infant, small for gestational age/ or exp infant, very low birth weight/ or exp infant, premature/ 
OR low birth weight*, preterm birth*, OR small for gestational age OR intrauterine growth were 
used. In total, abstracts of 530 articles were screened for possible relevance to developing countries, 
Southeast or South Asia, or Bhutan. The reference list was manually searched and other academic 
papers were searched in Google scholar and PubMed. All papers that referred to the relationship 
between adverse pregnancy outcomes and betel quid chewing in humans were assessed. As a result, 
10 research articles and two case reports were identified and reviewed in depth. Issues on the 
measurement, potential causal pathways, strengths of an association, and confounders identified in 
the literature were summarised in narratives. A meta-analysis was conducted to estimate the crude 
odds ratio from each study and the pooled estimate using the random effect model. Table 2.5 
summarises key findings from 10 observational studies and two case reports. 
 
2.3.1 Overall description of the studies 
Findings from the 10 observational studies and two case reports show that the impact of betel (areca 
nut) quid chewing (BQ) during pregnancy is inconclusive. The pregnancy outcomes and indicators 
of maternal health status that have been described in the literature in association with BQ include 
LBW, birth weight, PTB, birth length, infant gender ratio, and maternal anaemia and folate 
deficiency. Studies have been conducted in PNG [144-146], Bangladesh [147], India [148, 149], 
the Thai-Myanmar border [150, 151], and Taiwan [152-154]. The sample size of studies varied 
from 186 [154] to 7,685 [151]. All the studies except for the two case reports used interviewer-
administered questionnaires to obtain use and patterns of BQ. Only Yang et al. (1999, 2001, 2008) 
[152-154] in Taiwan validated the questionnaire using test-retest reliability. 
One study from India combining BQ with smokeless tobacco [148, 149] and five studies 
measuring BQ independently from smoking in Taiwan [152-154] and PNG [144, 145] reported an 
association between BQ and LBW and PTB and reduction in birth weight. On the other hand, two 
studies with more than 1,000 participants did not report any evidence of association [146, 151]. 
The observational studies which reported an association between BQ, independently 
measured from smoking, and LBW and/or PTB and reduction in birth weight [144, 145, 152-154] 
suggest that the magnitude of this association is modest.  
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2.3.2 A summary of key findings on the associations between BQ and adverse birth outcomes 
In Taiwan, the unripe areca nut, slaked lime, and a piece of unripe fruit from the species Piper betel 
are the most common ingredients in betel quid [153, 155]. Tobacco is not added to BQ [155]. Yang 
and colleagues [152-154] conducted several studies to assess the risk posed by BQ on adverse birth 
outcomes among aborigines in Taiwan using a questionnaire validated by test-retest reliability [154]. 
All the three studies reported a statistically significant association between BQ and pregnancy 
outcomes. Most recently, a 2008 study collected detailed information about BQ and reported a 
statistical significant impact of BQ on birth weight loss and LBW among aboriginal women. This 
was a retrospective study conducted with a total of 1,264 aboriginal women who had just given 
birth in 10 hospitals in southern and eastern Taiwan between January 2003 and February 2004. 
Trained nurses administered a questionnaire to collect the data including a detailed history of 
consumption of betel quid, alcohol, cigarettes, over-the-counter drugs and illicit drugs with regard 
to frequency and amount consumed both pre-pregnancy and during pregnancy before the mothers 
were discharged from their respective hospitals. Betel quid chewers were defined as women who 
had ever used betel nut at any stage during pregnancy including those who subsequently abstained. 
Non-users were defined as those who had never chewed betel quid during the period of pregnancy. 
The prevalence rate of betel quid chewing during pregnancy was 36.7% with a daily average of 
5.68 quids consumed among the chewers [153]. The chewers were more likely to have a lower 
educational level, and be unmarried, or unemployed p<0.0001). Chewers tended to smoke more 
than non-chewers (non-chewers: 13.4% [107/800] vs chewers: 42.67% [198/464], p<0.0001) and 
drank more (non-chewers: 12.3% [98/800] vs 53.0% [246/800], p<0.0001). Pre-pregnancy BMI 
was higher among chewers (non-chewers: 22.3 vs 24.4, p<0.0001) whereas maternal gestational 
weight gain during pregnancy was lower among chewers (non-chewers: 15.3 kg (SD=6.1) vs 13.6 
kg (SD=7.1), p<0.0001). Maternal betel quid use is significantly associated with a loss of 89.54 g 
in birth weight (p=0.0028) and a reduction of 0.43 cm in birth length (p=0.0466) after adjusting for   
alcohol, cigarettes, drugs, maternal age, marital status, education level, employment status, BMI, 
gestational weeks, weight gain during pregnancy and newborn sex. Compared to mothers who did 
not drink, smoke or chew betel quid, chewers had a higher risk of delivering a LBW newborn (aOR 
2.40, 95% CI 1.21–4.80) adjusting for maternal age, marital status, education level, employment 
status, gestational weeks, parity, weight gain during pregnancy, BMI, maternal drug use and 
newborn sex. The study did not find a statistically significant association between preterm delivery 
and BQ in the univariate analysis (p=0.0628).  
Senn et al. (2009) investigated the sociological behaviours associated with betel nut use, 
and its effects on adverse pregnancy outcomes in PNG [144]. In PNG, unripe or uncured ripe areca 
nut is chewed, sometimes with betel leaf, betel inflorescence or wild ginger and tobacco is never 
added [155]. A total of 310 of mothers were recruited and interviewed by a trained nurse using a 
semi-structured questionnaire including the frequency and amount consumed during pregnancy, the 
reasons for chewing and understanding of the risks and benefits of chewing, during the 3 days 
following delivery at a health center. Women who ever chewed during pregnancy were included as 
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users including those who stopped during the pregnancy. The prevalence rate of “users” was  94% 
with 44% of the users chewing more than 5 nuts a day. There were no demographic differences 
between chewers and non-chewers. Smoking was 10% among chewers and 0% in non-chewers but 
not statistically significantly different. Unlike this study, drinking alcohol was less than 1%. After 
controlling for primigravidity, low BMI of mothers, BQ was associated with an average reduction 
of birth weight of 238g (p=0.02). The study did not find a statistically significant association 
between BQ and LBW (OR 1.9, 95% CI 0.4-17) or preterm delivery (OR 0.6, 95% CI 0.1-5.4).  The 
small sample size led to the wide confidence intervals and high prevalence of betel quid limits the 
validity of the findings from this study. Prior to this study, a matched case-control study conducted 
between April and June 1981, reported that mean birth weight was 2998.5g (SD=492.5) for daily 
users (n=400) and 3079.5g (SD=464.1) among non-users(n=400) (0.01<p<0.02) [145]. 
On the other hand, Ome-Kaius et al. (2015) assessed the impact of BQ on adverse 
pregnancy outcomes including stillbirth, LBW and anaemia at delivery in a longitudinal cohort of 
2700 pregnant women residing in rural lowland PNG between November 2009 and February 2013 
[146]. The researchers questioned whether women chewed or not, the frequency of chewing, and 
the amount of BQ per day (less than one nut per day, 1-2 nut per day, 3-5 nut per day, more than 6 
nuts per day) at enrolment. However, the study assumed chewing patterns as reported at baseline 
would continue during pregnancy and this can lead to underestimating the impact of BQ if mothers 
quitted chewing BQ after they found out about their pregnancy. The study reported 47.8% chewed 
more than 3 nuts per day. It did not report evidence of associations between betel quid chewing and 
LBW in the multivariate logistic regression models adjusting for smoking, malaria, ethnic group 
(highlander), income, primigravida, mother’s height, mother’s mid-upper arm circumference, 
frequency of ANC visits and receipt of insecticide treated bed net (aOR 0.94, 95% CI: 0.65-1.38, 
p-value=0.77). 
Prior to this study, a large retrospective cohort study was conducted with a total of 7685 
pregnant women attending ANC on the Thai-Myanmar border between July 1997 and November 
2006 [151]. This study also measured BQ at the first ANC and reported no statistical association 
between BQ and adverse pregnancy outcomes. The proportions of heavy betel quid use (defined as 
daily or more than once a day) was 23.7% (1174/4963) and was significantly higher amongst 
women who also smoked (31.5%, 782/2479) compared to non-smokers (15.8%, 392/2484). There 
was no information on maternal education level or socioeconomic status of the study participants. 
The study also did not provide evidence of associations between BQ and adverse birth outcomes in 
the multivariate analysis adjusting for primigravida, first ANC visit after the first trimester, malaria, 
smoking, gestational age at birth (weeks), and maternal weight at enrolment. The adjusted odds 
ratio was not provided in the original manuscript. The crude odds ratio calculated with the data 
provided is 0.92 (95% CI: 0.80-1.06, p-value=0.264). 
Two studies reported an association between BQ and maternal anaemia [146, 150]. Ome-
Kaius et al. (2015) reported pregnant chewers were more likely to be anaemic (haemoglobin 
<11g/dL) at delivery than non-chewers (aOR 1.67, 95% CI: 1.27-2.20, p<0.001) [146]. Prior to this 
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study, two studies in PNG reported no association between anaemia and BQ. Senn et al. (2009) 
reported that mean haemoglobin level was 94 g/l (95% CI 92-96), slightly lower among chewers 
and 100 g/l (95% CI 95-106) among non-chewers but not statistically significant[144]. This could 
be due to the small sample size and high prevalence of betel chewing (94%). De costa (1982) 
reported that slightly more chewers (48%, 192/400) had a haemoglobin value of less than 10 
g/100ml on at least one occasion compared to non-chewers matched on parity and province of origin 
(46%, 184/400) but the difference was not statistically significant. This could be due to baseline 
differences of chewers and non-chewers[145]. Chue et al. (2012) reported that chewers were more 
anaemic (defined as Haematocrit <30%) than non-chewers (non-chewers:17.3% [425/2,459] vs 
chewers: 19.4% [868/4,422], p=0.031) in the univariate analysis but no association was apparent 
after controlling for smoking, malaria, multigravida, anaemia at first ANC visit, and first ANC visit 
after the first trimester[151]. Anaemia was treated at each ANC visit. However, using the same 
population, Stuetz et al. (2016) reported that daily BQ had a negative effect on haemoglobin 
level(g/L) after adjusting for smoking, parity and BMI at the time of sampling (Beta -2.90., 95% -
4.62 to -1.16)[150]. Anaemia treatment was not controlled for. In the Chue et al. (2012) study, over-
adjustment of covariates in the models may bias the estimate towards the null, especially by 
controlling the factors in the causal pathway between BQ and anaemia[151].   
One study reported an association between BQ and folate deficiency [147]. Using data from 
730 pregnant women aged 14-50 in a large randomised control trial of food and multiple 
micronutrient supplementation in Matlab, Bangladesh, Kader (2016) examined folate deficiency at 
14 weeks of gestation. Women were asked about their consumption of BQ during their last 
pregnancy at the time of their postpartum visit. Almost two-thirds (61% [376/730]) of women 
consumed BQ during their last pregnancy. Of the 376 chewers, 10.7% women consumed 2-3 times 
per day, 13.4% consumed once per day, and 5.6% consumed less than once a day. Dry nuts were 
more commonly consumed than fresh nuts (dry 57.7 % vs fresh 3.6%, denominator unknown). Less 
than 10% (9.8%, denominator unknown) of women added chewing tobacco to the quid. Adjusting 
for calculated asset score, women’s age, vitamin B-12 status and literacy, the women who 
consumed betel nut with chewing tobacco were 2.57 times more likely to have folate deficiency 
compared to the non-chewers (aOR 2.57, 95% CI 1.23-5.36; P=0.012). BQ use two to three times 
per day (regardless of whether combined with tobacco or not) was significantly associated with 
folate deficiency among users compared to non-users adjusting for calculated asset score, women’s 
age, vitamin B-12 status, and literacy (aOR 2.51, 95% CI 1.07-5.92, P=0.035). There was no 
information as to whether this chewing pattern during the last pregnancy changed during the current 
pregnancy.  
Ome-Kaius et al. (2015) reported that chewers more commonly had male babies than non-
chewers (non-chewers: 39.8% [123/309] vs chewers: 46.1% [670/1455], p=0.045) while Yang et 
al. (2008) reported a reduced male new born rate (non-chewers: 56.4% vs chewers: 48.7%, 
p=0.0084) [153]. Yet, Chue et al. (2012) did not find sufficient evidence of associations between 
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betel chewing and the sex of new borns (non-chewers: 51.8% [1080/2083] vs chewers: 53.3% 
[2346/4401], p-value not reported).   
Two case reports documented neonatal withdrawal syndrome and the presence of arecoline 
in the placenta among Asian immigrant mothers in Spain [156, 157].  
The majority of the studies did not describe dose-response while one study explored dose-
response in relation to folate deficiency [147]. Two main methodological limitations were identified 
in the studies: measurement of exposure and insufficient control of the confounders. A number of 
research questions could be formulated for further understanding of the impact. For example, 
whether timing of exposure during pregnancy (1st trimester vs 3rd trimester) or the amount of 
exposure would make a difference. If there is a difference between acute or chronic exposure is also 
unanswered. 
 
2.3.3 Patterns and prevalence of BQ during pregnancy 
The maturity of the betel nut used and the contents of the quid vary between individuals locally and 
across countries (Table 2.4) [151, 155]. Ripe nuts were preferred at the Thai-Myanmar border[151] 
whereas unripe nuts were more often consumed in PNG [144, 146] and Taiwan [153]. Use of BQ 
during pregnancy was common although there is a variation in the reported magnitude (83.3% 
[146]- 94.4% [158] in PNG, 64.6% [151] in the Thai-Myanmar border, 61% [147] in Bangladesh 
and 36.7% [153] in Taiwan). This variation could be due to true prevalence or differences in the 
measurement. Daily use  was 27.7% in the Thai-Myanmar border [150]. In PNG, 47.8% used more 
than 3 nuts per day [146]. In Bangladesh, frequency (how many times per day) was reported rather 
than the number of nuts per occasion [147].  
 
2.3.4 Measurement of BQ 
The majority of the studies simply defined “users” as women who reported having ever chewed 
betel quid during pregnancy and did not separate regular users from light users. This may 
underestimate the effect of BQ by including a large number of women with very little use of betel 
nut, for example, even just once in pregnancy in the users group.  
In the studies that used a questionnaire to measure BQ, it was mostly measured during the 
post-delivery stay [144, 153],  before entering the labour ward [145], or at ANC visits [148, 150, 
151]. The problem of measuring only once at ANC in the Thai-Myanmar border [151] and PNG is 
that mothers may have stopped BQ after the first ANC. This could lead to biasing the effect of BQ 
towards the null.  
The majority of the papers did not attempt to quantify the “dose” of BQ and to relate this 
to response in terms of birth weight, or to describe whether the pattern of use changed through 
pregnancy. Data on how a woman prepares and consumes her betel quid, the type of areca nut (ripe 
or unripe), estimated number of nuts per day, contents of the quid and whether the woman chews, 
spits or swallows were non-existent or sparse in the literature. The actual questions used in Taiwan, 
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the Thai-Myanmar border and PNG are summarized in Table 2.3. These were obtained from the 
literature [153, 158] or the author [151].  
 
2.3.5 Potential causal pathways 
Potential mechanisms as to how BQ could lead to adverse birth outcomes may include indirect 
pathways through anaemia, hypertension, periodontal diseases, and disrupted blood flow.  
There are several potential pathways for BQ to cause maternal anaemia; firstly, by 
suppressing the appetite and secondly, by blocking vitamin D absorption. Several studies suggests 
that areca nut chewers have a higher resting metabolic rate due to areca nut metabolites that effect 
the thermoregulatory pathways, altering the thermogenic effects of the meal and also through 
centrally mediated effects by decreasing the appetite for food[159]. This may be associated with a 
reduction in food intake including essential nutrients such as iron, leading to iron-deficiency 
anaemia. Another study suggests BQ could aggravate the effects of vitamin-D deficiency [160].  
A second possible mechanism is through hypertension. The association between 
hypertension and BQ is not well-studied in the literature.  A systematic review by Yamada et al. 
(2013) identified two studies examining BQ and high blood pressure between 1951 and January 
2013 [161]. A study using the data from 44,000 Taiwanese women with type 2 diabetes mellitus 
(T2DM) interviewed by phone between March 1995 and April 2002 reported that prevalence of BQ 
(current and ex-chewers compared to non-chewers) was 1.1% (471/44,000) [162].  BQ was 
associated with an increased risk of hypertension (aOR 1.897, 95% CI 1.534–2.346) adjusting for 
age, BMI, diabetic duration, and smoking. In Bangladesh, among the 251 women, BQ was 
associated with 67% increased odds of hypertension (aOR1.67, 95% CI 1.08–2.59) after adjusting 
for baseline age, pack-years of tobacco smoking, BMI at baseline, use of hypertensive medications 
at follow-up, education, land ownership, religion, marital status, and daily intake of meat, 
vegetables and fruit, baseline blood pressure, change in weight over the time period and diabetes at 
baseline [163]. There was no study on pregnancy-induced hypertension. Ome-kaius et al. (2015) 
reported that there was no statistical difference in the mean arterial pressure (mmHg) among 
chewers and non-chewers (p=0.41)[146]. De Costa (1982) reported 39/400 of chewers presented 
signs of preeclampsia not requiring drug treatment compared to 45/400 among non-chewers 
matched on parity and province of origin. Preeclampsia requiring drug treatment was excluded from 
this study [145].  Other studies did not provide any information on hypertensive disorders during 
pregnancy [147, 151, 152, 154].  
The third possible mechanism is through periodontal disease. The red juice from betel quid 
can stain oral structures and the teeth may become nearly dark brown after chewing habitually for 
many years [164]. A number of studies show that betel quid chewers may predispose to periodontal 
disease [48, 49]. Maternal periodontal disease may be associated with increased risk of PTB and 
LBW [44]. Of the 10 studies that examined the relationship between adverse birth outcomes and 
BQ, no study reported information on periodontal diseases.  
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Finally, maternal-foetal blood flow may be disrupted when the central nervous system gets 
simulated by BQ, causing acceleration of heart rate, increase of blood flow in carotid arteries and 
decrease in diastolic blood pressure via a peripheral cholinergic effect [153].   
 
2.3.6 Covariates adjusted in the models in the literature:  
The studies reviewed above are heterogeneous in the sample size, study design, measurement, and 
covariates controlled in the models. Four observational studies examined an association between 
LBW and BQ during pregnancy. No causal assumptions were explicitly mentioned in these studies 
and the covariates controlled seemed to be determined by using a statistical approach. As a result, 
covariates controlled in the model were highly heterogeneous.  In the study by Yang et al. (2008), 
nine variables were included (maternal age, marital status, education level, employment status, 
gestational weeks, parity, weight gain during pregnancy, BMI, maternal drug use and newborn sex). 
Chue et al. (2010), included six variables (primigravida, first ANC visit after the first trimester, 
malaria, smoking, gestational age at birth (weeks), and maternal weight at the first ANC). Ome-
Kaius et al. (2015) controlled nine covariates (smoking, malaria, ethnic group (highlander), income, 
primigravida, mother’s height, mother’s mid-upper arm circumference, frequency of ANC visits 
and receipt of insecticide treated bed net). Senn et al. (2009) controlled for primagraividity and low 
BMI for the birth weight analysis but did not specify the covariates used to estimate the effect on 
LBW. 
Alcohol use and tobacco could confound the association between BQ and pregnancy 
outcomes. Alcohol use and smoking are known risk factors of adverse pregnancy outcomes and 
they may be associated with BQ. In Thailand, Myanmar, The Lao People’s Republic, Cambodia, 
and the Philippines, unlike Taiwan and PNG, tobacco is often added to areca nut, slaked lime, 
catechu (an extract from the acacia tree), and betel leaf [36, 155]. Smokers were slightly higher 
among BQ users in PNG [146] and significantly higher in Taiwan [152]. Tobacco use was more 
likely in women who used more than one whole areca nut per day compared with women who use 
less than one nut per day in the Thai-Myanmar border [151]. However, a few studies in the review 
fail to measure smoking and alcohol use. Alcohol use was not measured in the Thai-Myanmar 
border as sale of alcohol is prohibited in the study site [150, 151]. Neither smoking nor alcohol use 
were measured or reported in the Bangladesh study [147] and in Bhutan, BQ is rarely mixed with 
tobacco.  
In addition, season could confound the association between BQ and pregnancy outcomes. 
Several systematic reviews seasonal patterns of adverse pregnancy outcomes [125-127]. Due to the 
effect of increasing body temperature, BQ consumption may increase in winter. BQ is widely 
consumed during the festivals or occasions in Bhutan. Hence, more people tend to chew BQ during 
the festival seasons. Season was not explored in any of the studies. 
In addition to the measurement issues described in the above, insufficient control of 
confounders or over-adjustment of covariates also makes it difficult to assess the true association 
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between BQ and pregnancy. For example, maternal hypertensive disorders were not taken into 
consideration in any of the models above.  
A meta-analysis of crude RR of LBW among BQ users compared to non-users from four 
observational studies was conducted using the random effects model. The forest plot is shown in 
Figure 2.1. Analyses were conducted using STATA 14.1 with user-contributed commands for meta-
analyses: metan [165]. The number of BQ users, non-users, LBW, and non-LBW were extracted 
from the original manuscripts. The estimates of effect size and corresponding 95% CIs were 0.94 
(95%CI: 0.79-1.27)[146], 0.92 (95% CI: 0.80-1.06)[151], 1.70(95% CI: 0.45-6.40)[144], and 1.95 
(95% CI: 1.41-2.71)[153]. The pooled crude RRs for LBW was 1.20 using the random effects model 
(95% CI: 0.81 - 1.80). The result shows a high heterogeneity across studies ( 𝐼2= 83.2 % , p<0.0001). 
 
2.3.7 Issues of measurement and validation of BQ 
A further literature review was conducted in order to understand how betel quid use has been 
measured and validated in other BQ studies. As the information pertaining to the measurement of 
BQ was insufficient, the search was further extended to learn from the measurement of other 
associated health risk behaviours such as drinking and smoking.  
Health-risk behaviours including smoking, drinking and other drug use are often measured 
by administering questionnaires that require retrospective self-reports about engaging in these 
behaviours. The validity of self-report questionnaires can be influenced by cognitive factors and 
situational factors. For the former, errors can arise at each stage of cognitive processes for 
answering questions including comprehension, retrieval, decision-making, and response generation 
[166]. One example is a recall bias. A systematic review reported recall beyond a 1 year-period 
tends to be inaccurate when asking adolescents to recall the age at which they initiated tobacco use 
[166].  Self-reported use might be underreported because of concerns about social desirability and 
fear of reprisal, especially for behaviours that are illegal, stigmatised, or associated with moral 
implications [166]. Brener et al. suggested reporting of alcohol and tobacco use is affected by 
perceptions of privacy and confidentiality and found that the self-administered questionnaire format 
produced higher reported rates of alcohol and other drug use compared to interviewer-administered 
questionnaires in the studies on adolescents they included in a review [166].  
One way to validate consumption reported by the respondent is to compare the self-reports 
against biochemical measures of the substance or one of its metabolites [166, 167]. For example, 
for  tobacco exposure,  the amount of cotinine, a metabolite of nicotine has been measured in the 
blood or urine  as a biomarker of exposure[168].  There is evidence to suggest that there is strong 
agreement between self-reported and biochemical measures of tobacco use [166]. However, in 
terms of alcohol, biomarkers tend to lack sensitivity and specificity [166, 167]. For example, a 
breath test can only capture alcohol use within the 24 hours preceding the test [166].  
Where reliable biochemical measures are not available, other options to validate 
questionnaires have been explored. These include a “bogus pipeline” approach and corroboration 
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of self-report data with collateral information. A bogus pipeline is an approach where respondents 
are led to believe their true behaviour can be detected even though it cannot [166, 167].  Several 
studies used a saliva test as a bogus pipeline to examine the validity of self-reported drinking [166, 
167]. However, these studies reported limited impact of the bogus pipeline on the validation of self-
reported alcohol use [166, 167].  Other studies tried to assess the validity of self-report data by 
examining the concordance of such information with that obtained from collateral sources, such as 
spouses, children, parents, or close friends who know the person well [169]. A study using a large 
clinical trial data compared self-reported alcohol use collected periodically for one year, 
periodically collected collateral interviews, and biochemical tests and concluded biochemical tests 
and collateral informant reports do not add sufficiently to self-report measurement accuracy [170]. 
Several other studies and reviews concluded self-reports of alcohol use are considered as reliable 
and valid approaches to measuring alcohol [166, 167, 170, 171].   
Of the three studies that reported dose response between BQ and health outcomes including 
oral cancer, cardiovascular, and metabolic diseases, the amount of betel quid chewing was most 
often measured in self-administered[172] or interview-administered questionnaires [173, 174]. In 
most of the studies, assessment of the validity of the self-administered or interview-administered 
questionnaire was not reported [172-174].  
The amount of exposure could be considered in dimensions of amount of consumption, 
frequency of consumption, and duration of consumption. For example, Lin et al. (2009) [172] 
assessed the association between betel quid chewing and obesity, they collected data on the duration 
(years), frequency (times/day), quantity (numbers/times) of betel quid chewing among 2,359 
Taiwanese citizens over 40 years old using self-administered questionnaires.  Average betel quid 
chewing was defined as the average amount of areca nut consumed each time across the interviews 
(quids/times). The average frequency of betel quid chewing was recorded as times/day. Cumulative 
quids/day-years of betel quid chewing was calculated as areca nut consumed each time X daily 
average frequency of areca nut chewing X exposure years.  
As for biochemical markers of betel quid chewing, a few recent studies attempted to use 
arecoline and arecaidine as biomarkers of a chewing habit. One study reported that after 
administration of areca nuts extracts, the major urinary metabolite was arecaidine with a half-life 
of 4.3 hours and very low levels of arecoline with a half-life of 0.97 hours [175]. For the quantitative 
analysis of blood arecoline and arecaidine, serum arecoline and arecaidine was reported to be good 
measurement of the quantities of betel quid used before the day of drawing blood and arecoline or 
arecaidine [176].  Therefore, biochemical markers of betel quid chewing seem to be good indictors 
for recent betel quid exposure but may not be appropriate to measure habitual use quantity in adults. 
However, acute and chronic foetal exposure might be measured by biomarkers as a case report 
detected arecoline in the placenta and meconium in 2014 [177]. 
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2.3.8 Relevance to Bhutan 
Biochemical analyses was not felt to be technically possible or appropriate for the present study. In 
terms of measuring BQ, methods from alcohol and tobacco studies were used to inform the 
development of measurement of BQ.  In particular, the questionnaire needed to take into account a 
possible change of behavior during pregnancy and to attempt to collect detailed information on 
patterns to improve understanding of BQ during pregnancy. Quantification and dose-response may 
provide more information on exposure to BQ.   
 
2.3.9 Summary of key findings 
In conclusion, a review of the literature revealed that heterogeneous contents of betel quid chewing 
and population across the studies makes it difficult to assess the effect of betel quid chewing on 
PTB, LBW and birth weight reduction. Also presence or magnitude of dose response between betel 
quid chewing and those pregnancy outcomes is not clear. The methods and design of the study so 
far have several limitations including lack of validation of measurement, insufficient control of 
confounding variables, simplified categorisation of betel quid chewing, and failure to capture the 
change of behaviours during pregnancy. There is a need to develop methods to measure BQ to 
understand the true effect of BQ on pregnancy.   
 
 
Table 2.3. Questions used to measure betel quid chewing in the literature. 
Author (year) Questions used to measure betel nut consumption during pregnancy Validation 
Yang et al. (2008) [153] Do you chew betel quid during pregnancy? (yes/ no) 
If yes: how frequently do you chew betel quid during pregnancy? 
(ever use but abstained, <1 day/week, 1-3days/week, 4-6 days/week and daily) 
On average, how many betel quids do you chew per day when you chew betel 
quid during pregnancy? 
Not reported 
Senn et al. (2009) [144]  Do you chew betel nut? (yes/no) 
If yes: how many nuts do you chew per day?  
(none, less than 5 nuts, 5-10, more than 10) 
Why do you chew betel nut during your pregnancy? 
Do you think betel nut chewing will have an effect on your baby? 
Not reported 
Chue et al. (2012) [151] Do you eat betel? yes/no (never takes betel) 
If yes: how often – sometimes (not every day); daily; more than once daily 
Same questionnaire design used for smoking was applied: 
Please give an average number of nuts consumed per day. 
When do you take betel nut? 
When you take betel do you take it with piper leaf? (yes/no) 
Do you add tobacco when you take betel? (yes/no) 
Do you add slaked lime when you take betel? (yes/ no) 
Do you spit when you are eating betel? (yes/no) 
Not reported 
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Table 2.4. Constituents of betel quid (Gupta 2002 [36]). 
Constituent Preparation 
Areca nut Sliced fresh ripe nut 
 Roasted 
 Dried/baked 
 Fermented 
Piper Betel Fresh leaf 
 Inflorescence 
Lime From coral 
 From shell fish 
 From limestone 
Tobacco Fermented 
 Sun dried 
 Powdered with molasses with lime 
Catechu Extract of acacia catechu 
 Extract of acacia suma 
Spices Cloves 
 Cardamom 
 Aniseed 
Sweeteners Coconut 
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Table 2.5. A summary of literature on betel quid chewing during pregnancy. 
Outcome of 
main 
interest  
Authors 
(Year) 
Study design/ 
Sample size 
Measurements of 
BQ 
Timing of 
measurement of 
BQ 
Validation 
(Biochemical 
measures or 
others) /category 
of users 
Outcome Confounders Model Key 
findings  
LBW, PTB, 
Anaemia 
Stuetz et al. 
(2016) [150] 
Cross-sectional 
study/1,048 
pregnant women 
who received 
micronutrient 
supplements (1st to 
3rd trimester) in 
the ANC clinic on 
the Thai Myanmar 
border (in Jun 
2004 and Nov 
2006) 
Questionnaire 
(details not 
reported) 
At enrolment  NA/daily 
consumption of 
betel  
Anaemia: 
Hemoglobin (Hb) 
in the blood 
sample collected 
once:  
<110g/L in 1st and 
3rd  and <105g/L in 
2nd trimester  
Smoking, parity, 
and BMI at the 
time of sampling 
(no information on 
alcohol) 
Linear regression  Prevalence of daily 
use of BQ: 
19.7% (2004) and  
27.7% (2006) 
Prevalence of 
smoking: 
28.1%(2004) and 
26.8% (2006) 
Reduction of Hb 
(g/L): -2.90, 95% 
CI: -4.62 to -1.16 
 Ome-Kaius et 
al. (2015) 
[146] 
Prospective cohort 
study/ 
2,700 pregnant 
women residing in 
rural lowland PNG 
(Nov 2009 – Feb 
2013)  
Interview-
administered 
questionnaire 
At enrolment (first 
ANC)  
NA/Non-users vs 
users (occasional 
users <1 nut/d; 
mild users 1-2 
nuts/d; moderate 
users 3-5 nuts/d; 
and heavy users 
>5 nuts/d) 
Primary: (1) BW 
within 24 h of 
delivery and LBW 
(BW<2,500g) 
(2) PTB: US-
Based GA before 
37 weeks  
Secondary:  
Anaemia: 
Hb<11g/dL at 
delivery 
Smoking, malaria, 
gravida, alcohol 
use, income, 
education, bed net 
use, maternal 
height, number of 
ANC visits, infant 
gender, maternal 
nutritional status, 
timing of bw/Hb 
measurement, 
receipt of 
intermittent 
preventive 
treatment in 
pregnancy   
Multivariate 
logistic regression 
or linear 
regression (no 
imputation of 
missing data) 
Prevalence of BQ: 
83.3% (47.8 % 
used more than 3 
nuts) 
Prevalence of 
smoking: 18.9% 
(21.7% for BQ 
users) 
LBW: aOR 0.94, 
95% CI: 0.65-1.38 
Anaemia: aOR 
1.67, 95% CI: 1.27-
2.20 
PTB: OR not 
reported 
 Chue et al. 
(2012) [151] 
Retrospective 
cohort study/7,685 
refugee pregnant 
women in the 
ANC clinic on the 
Interview-
administered 
questionnaire 
At enrolment (first 
ANC) 
NA/Non-users vs 
users (heavy users 
who used daily or 
more than once 
daily and light 
BW within 72 h of 
delivery and 
LBW(BW<2,500g) 
 
 
LBW: gravida, 
trimester of first 
ANC, malaria, 
infant gender, 
smoking, GA at 
Multivariate 
logistic regression 
Prevalence of BQ: 
64.6% (76.8% used 
occasionally – 
number of nuts not 
defined) 
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Thai-Myanmar 
border (July 1997 
– Nov 2006) 
users who do did 
not take every 
day) 
birth, and mother’s 
weight at the first 
ANC 
 
Anaemia: gravida, 
smoking, both BQ 
users and smokers, 
trimester of first 
ANC, anaemia at 
first ANC, and 
malaria 
(no information on 
alcohol as 
Alcohol is 
prohibited in the 
camp) 
Prevalence of 
smoking: 11.3% 
LBW: aOR was 
reported as not 
significant (NS) 
and aOR not 
reported. 
Anaemia: aOR NS 
(OR not reported) 
 Senn et al. 
(2009) [144] 
Cross-sectional 
study/310 mothers 
at Alexishafen 
health center, 
Madang Province 
in PNG (Sep 
2007-Jun 2008) 
Interview-
administered 
questionnaire 
Within 72h of 
delivery during the 
post-delivery stay 
in the health center 
NA/ Non-users vs 
users (including 
mothers who 
abstained during 
pregnancy)  
BW, 
LBW(<2500g),  
PTB 
Primigravidity, 
and low BMI 
Univariate and 
multivariate 
analysis  
Prevalence of BQ: 
94% 
Hb(g/l) (chewers vs 
non-chewers): 94 
vs 100 (NS) 
BW: a reduction of 
238g (p<0.02) by 
BQ 
LBW: crude OR 
1.9 (95% CI: 0.4-
17) 
Term LBW: OR 
3.0, 95% CI: 0.4-
13.0, p=0.48 
PTB: OR 0.6, 95% 
CI 0.1-5.4, p=3.4 
 
 Yang et al. 
(2008) [153] 
Retrospective 
cohort study/1,264 
aboriginal women 
who gave birth in 
10 hospital in 
Southern and 
Eastern Taiwan 
Interview-
administered 
questionnaire 
During the post-
delivery stay 
(within 72 h on 
average) In the 
hospitals 
As described in 
Yang et al. 
(1999)/Non-users 
vs users who had 
ever used betel nut 
at any stage during 
pregnancy 
BW, 
LBW(<2500g), 
PTB (<37 weeks), 
birth length 
Maternal age, 
marital status, 
education level, 
employment 
status, BMI, GA, 
weight gain during 
pregnancy and 
infant gender, 
Multivariate 
logistic regression 
Prevalence of 
BQ:36.7 % with a 
daily average of 
5.68 quids 
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(Jan 2003 – Feb 
2004) 
including those 
who abstained. 
maternal drug use, 
smoking, and 
alcohol  
 
 
 
 
 
 
 
 
 
Smoking:24.1% 
(42.7% for BQ 
users) 
LBW: aOR 2.4, 
95%CI: 1.21-4.80 
Birth length 
reduction: 0.43 cm 
(p=0.0466) 
 Gupta and 
Sreevidya 
(2004) [148, 
149] 
Prospective 
cohort/1167 
pregnant women 
who were 3 to 7 
months pregnant 
recruited in 8 
primary health 
post areas in the 
city of Mumbai, 
India (Jun – Nov 
2002) 
Interview-
administered 
questionnaire  
At enrolment (3 -7 
months of 
pregnancy, asking 
about daily use in 
the past 6 months) 
NA/ users are 
defined as 
smokeless tobacco 
product at least 
once a day for the 
past six months 
(light users: 1-4 
times/day or 
heavy: ≥5/ times 
day) 
BW, LBW, PTB 
(<37 weeks) 
Maternal age, 
education, 
socioeconomic 
status, weight, 
anaemia, ANC, 
and GA 
(alcohol and 
smoking not 
controlled, 
smokers excluded 
from the study). 
Multivariate 
logistic regression 
(missing data 
excluded) 
Prevalence of daily 
smokeless tobacco 
use: 17.10% 
BW reduction: 105 
g (95% CI 30 to 
181 g) 
LBW: aOR 1.6, 
95% CI: 1.1 – 2.4 
PTB: 1.4, 95% CI: 
1.0-2.1 
 Yang et al. 
(2001) [152] 
Retrospective 
unmatched case-
control study/229 
aboriginal women 
(32 with adverse 
pregnancy 
outcomes and 197 
controls) in a 
regional hospital 
in Eastern Taiwan 
(Feb-Sep 1998) 
Interview-
administered 
questionnaire 
During the post-
delivery stay 
(majority within 
72 h) in the 
hospital  
As described in 
Yang et al. 
(1999)/non-users 
and non-users 
(details not 
reported) 
Adverse pregnancy 
outcomes: (1) 
LBW (BW<2500g 
& GA >37 weeks), 
(2) PTB (GA<37 
weeks) or (3) Any 
malformation 
Maternal age, 
cigarette smoking, 
alcohol 
consumption  
Conditional 
logistic model 
Prevalence of BQ 
(cases vs 
controls):68.7% vs 
48.9% 
Smoking: 37.5% vs 
62.5% 
Adverse pregnancy 
outcomes: aOR 5.7, 
95% CI: 1.6-20.3 
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 Yang et al. 
(1999) [154] 
Retrospective 
matched case-
control study/ 186 
aboriginal women 
(62 with adverse 
pregnancy 
outcomes and 124 
age-matched 
controls with 
normal pregnancy 
outcomes) in 
Southern Taiwan 
(Mar – Oct 1994)  
Interview-
administered 
questionnaire 
At home 
(information about 
previous 
pregnancies such 
as timing was not 
mentioned and 
could be a source 
of potential biases 
if recall was about 
more than 1 year 
ago) 
Test-retest 
reliability: 0.78-
0.89 for 
continuous and 
0.85-0.91 for 
categorical 
variables after 4 
weeks of the first 
interview/non-
users vs users 
during pregnancy 
(details not 
reported) 
Adverse pregnancy 
outcomes (not 
specified) 
Maternal illness 
and number of 
previous 
pregnancies (not 
possible to control 
for age as samples 
were matched on 
age, alcohol and 
smoking were not 
controlled in the 
model as it was 
not associated with 
the outcome) 
Conditional 
logistic model 
Prevalence of BQ 
(cases vs controls): 
14.5% vs 8.1% 
Prevalence of 
smoking:43.6% vs 
38.7%  
Adverse pregnancy 
outcomes: aOR 2.8, 
95% CI 1.2-6.8 
 De Costa, C. 
(1982) [145] 
Case-control 
study/400 mothers 
who use BQ daily 
during pregnancy 
and 400 mother 
who have never 
used at Port 
Moresby General 
Hospital in PNG 
(Apr-Jun 1981) 
Self-report at 
enrolment (details 
not reported) 
At enrolment 
(booked patients 
entering the labour 
ward) 
NA/non-users vs 
daily users 
BW Both cases and 
controls reported 
no use of smoking, 
alcohol, and 
drugs), matched 
on province of 
origin and parity 
within the 3 
groups (1, 2-5, >5) 
Chi-square test Mean BW (cases vs 
controls): 2,998.5 
vs 3,079.5 (p<0.05) 
Other aspect 
of pregnancy 
Kader, M. 
(2016) [147] 
Retrospective data 
from a randomised 
control trial/ 
730 pregnant 
women in Matlab, 
Bangladesh (2002) 
Interview-
administered 
questionnaire 
During the 
postpartum visit 
NA/ 
(1) Non-users vs 
users (less than 
daily, once daily, 
2-3 times daily)  
(2) non-users vs 
users (with BQ 
only and BQ with 
chewing tobacco) 
Folate deficiency 
at 14 weeks of GA 
(serum folate <6.8 
nmol/L) 
Asset score, 
women’s age, 
vitamin B-12 
status and literacy 
(alcohol and 
smoking were not 
controlled in the 
model) 
(frequency of BQ 
consumption) 
Multivariate 
logistic regression  
Prevalence of BQ: 
61% 
Prevalence of 
smoking: cigarette 
smoking not 
measured 
Mean serum 
reduction (users vs 
non-
users):1.56(nmol/L) 
(p<0.05) 
Folate deficiency 
for BQ 2-3 times a 
day: aOR 2.51, 
95% CI 1.07-5.93 
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 Garcia-Algar 
et al. (2014) 
[157] 
Prospective 
clinical 
observation 
study/6 Asian 
mothers during 
pregnancy and 
newborn at the 
time of delivery at 
the Hospital del 
Mar in Barcelona 
Spain  
Biological 
matrices 
Clinical 
examination 
during the 
pregnancy 
Arecoline 
concentration in 
meconium and 
placenta (µg /g) 
Clinical signs of 
birth outcomes 
(neonatal 
withdrawal 
syndrome, LBW 
(BW<2500g), 
small for GA, low 
intrauterine 
growth, 
hyporeflexia, 
hypotonia) 
NA Observation  2 adverse birth 
outcomes were 
found in the six 
exposed newborns. 
 Lopez-Vilchez 
(2006) [156] 
Case-report/ a 
healthy 38-year-
old mother who 
was an immigrant 
from Bangladesh 
and came to the 
obstetrics 
emergency 
department for 
childbirth 
Biological 
matrices, 
observation of 
dental condition (a 
brownish-red 
discoloration of 
the oral mucosa 
and tongue) 
Clinical 
examination 
during treatment 
of the neonate  
Arecoline in the 
placenta 0.012 
µg/g of placental 
tissue 
Clinical signs of 
neonate 
withdrawal 
syndrome  
NA Observation A diagnosis of 
neonatal abstinence 
syndrome resulting 
from maternal 
consumption of 
areca nut was 
established. 
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Figure 2.1. Forest plots of betel quid chewing during pregnancy and LBW using the random effects model.10 
 
                                                          
10 I–V Overall = Fixed effect meta-analysis. D+L Overall = Random effect meta-analysis.  
I-V Overall  (I-squared = 83.2%, p = 0.000)
Chue et al.(2012)
Senn et al.(2009)
D+L Overall
Ome-Kaius et al.(2015)
Yang et al.(2008)
authors
1.03 (0.91, 1.16)
0.92 (0.80, 1.06)
1.70 (0.45, 6.40)
1.20 (0.80, 1.80)
0.94 (0.70, 1.27)
1.95 (1.41, 2.71)
RR (95% CI)
100.00
Weight
69.07
0.83
%
16.42
13.68
(I-V)
  
1.156 6.4
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2.4 Review of existing tools to measure alcohol, smoking and betel quid chewing 
A review of the literature on the impact of betel quid chewing on pregnancy revealed that the 
methods and design of measuring betel quid in the literature so far have several limitations such as 
lack of validation of measurement, insufficient control of confounding variables, simplified 
categorisation of betel quid chewing, and failure to capture the change of behaviours during 
pregnancy. In particular, accurate measurement of alcohol, which was considered to be highly 
prevalent in Bhutan and a strong confounder, is critical to separate the effect of betel quid chewing 
adjusting for alcohol. In section 2.4.1, published and grey literature, as well as government reports 
from Bhutan, are reviewed to seek a validated questionnaire to measure betel quid chewing, alcohol, 
and tobacco. Section 2.4.2 provides findings from a review of globally available tools. 
 
 2.4.1 A summary of review of existing tools to measure alcohol, smoking, and betel quid-
chewing in Bhutan 
Seven key publications on betel quid chewing, alcohol, or  tobacco use, published before October 
2014, were identified (five population-based surveys [34, 91, 178-180], one monograph [181], and 
one research article [32]). If there were several versions of the population-based surveys, the most 
recently updated version was reviewed. Betel quid chewing was measured in the 2012 Bhutan 
Living Standard Survey (BLSS) [178] and the 2010 Gross National Happiness Survey (GNH) [34].  
Alcohol was measured in a study conducted in the eastern part of Bhutan by Subady et al. (2012) 
[32], the 2014 NCD Step Survey (STEP) [91], the International Tobacco Control (ITC) Policy 
Evaluation Project: The ITC Bhutan Project Report (2011) [180], and the 2010 GNH [34]. In 
addition to the above article and surveys, Dorji, L. (2012) described the history and context of 
alcohol, alcohol products, and health care costs relating to alcohol abuse in his monograph. Tobacco 
was measured in the 2013 Global Youth Tobacco Survey (GYTS) Bhutan Report [179] and the 
2014 NCD Step Survey [91]. Supplementary materials used in the STEP survey were obtained from 
the Royal Government of Bhutan where available. The key findings from the review of existing 
tools in Bhutan are summarised in  Table 2.6. 
All five population-based surveys used a variation of Quantify-Frequency measures (QF) 
which capture quantity within an event and frequency within a reference period [182]. The mode 
of interview was predominantly interviewer-administered. Only one population-survey for youth 
[179] used a self-report questionnaire. 
Typical questions included: 
 
▪ Betel quid chewing: Did you chew doma (betel quid) in the past 12 months? Do 
you chew daily or occasionally? 
▪ Alcohol: How often do you drink and how many cups or glasses do you usually 
take when you drink alcohol?; and 
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▪ Smoking: Do you smoke/ use manufactured cigarettes daily, at least weekly, less 
than weekly, or not at all? 
 
Major challenges of the QF measures to assess alcohol consumption are that most of the 
QF measures cannot capture combined drinks and often underestimate the true volume consumed.  
 As for tools other than QF measures, only one research article conducted in Bhutan, in 
which only alcohol was measured, was available. The research article aimed to detect harmful 
alcohol use and used the Alcohol Use Disorders Identification Test (AUDIT), a simple 10-item 
questionnaire developed by WHO for early detection of hazardous or harmful alcohol use [183] 
and a tri-level method. AUDIT askes “how many drinks containing alcohol do you have on a typical 
day when you are drinking” and “how often do you have six or more drinks on one occasion”. 
While AUDIT is a simple tool for screening of harmful drinking and globally used [184], a problem 
arises when there is no agreed concept of a standard drink as is the case in  Bhutan. A tri-level 
method asks what type of alcoholic beverage and what quantity per occasion for maximum level, 
medium level and lower level. Although it captures combined drinks, the concept of high, medium 
and low could be subjective.  
By reviewing existing tools in Bhutan, it was identified that there was no existing tool to 
sufficiently measure betel quid to understand the pattern and quantity of betel quid chewing during 
pregnancy and that measuring alcohol imposed a methodological challenge in the present study. 
All the questionnaires used in Bhutan so far to measure potentially toxic behaviour faced a number 
of methodological challenges to be adopted in this research. Although a past survey shows much 
higher prevalence of chewing betel than tobacco[34], it was often included in smokeless tobacco 
and not explored in detail. Another key finding was that measurement of alcohol imposes a 
challenge to the present study. First, it is difficult to capture a variety of alcohol beverages, which 
are often home-brewed. Second, the percentage of alcohol in the home-brewed beverages is 
unknown [32, 181].  Finally, there is no agreed definition of a standard drink size [181]. As a result, 
quantifying alcohol consumption is challenging, which makes it difficult to understand the true 
prevalence and burden of alcohol abuse. No information regarding drinking, smoking, and chewing 
betel nuts during pregnancy in Bhutan was available. To overcome the challenge of measuring 
alcohol in Bhutan, globally available tools are explored in the next section. 
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Table 2.6. A summary of key literature reviewed for development of the questionnaire. 
Source Study objective Questions Mode of 
Interviews 
Validated 
(reference 
questionnaires) 
Sample size Strengths Weaknesses Main Findings: 
Subady et al. 
“Prevalence, 
patterns and 
predictors of 
alcohol 
consumption in a 
mountainous 
district of 
Bhutan.” 
 (2012) [32] 
Detection of 
harmful alcohol 
use, patterns and 
quantification of 
alcohol consumed 
and attitude and 
beliefs.   
A 10-item questionnaire(AUDIT) 
 
Tri-level method to ask the quantity and 
the type of alcohol beverage in terms of 
high-, medium, and low-level drinking 
and the number of days in the past 12 
months such as: 
Starting with a special occasion where 
you drank maximum level, what type of 
alcoholic beverages you usually drink 
and how much? (Type of beverages, 
Alcohol %, Volume (ml)) 
How often did you drink like this in the 
past 12 months? (Every day, 5-6 
days/week, 3-4 days/week, 1-2d/week, 2-
3d/month, 1d/month, 7-11d / 12month, 
4-6d/12month, 2-3 d/12month, or 1 d/12 
month) 
 
 5 questions as attitude and beliefs.   
Interviewer 
administered  
AUDIT, 
Tri-level method 
442 respondents 
aged ≥18 of 270 
household in 17 
villages of 
Tashiyangtse 
dzongkhag 
 
Sampling methods: 
multi-stage 
systematic sampling 
 
Interview periods: 
2012 
Quantification of 
alcohol 
consumed using 
validated 
methods. 
Limited sample 
population. 
 
Uncertain 
assumptions of 
alcohol % used 
to quantify 
alcohol: local 
wine 5% and 
local sprit (Ara) 
15%.  
Female current drinkers: 
30% 
Annual female per capita 
alcohol consumption: 
2566g.  
Annual per capita home-
made alcohol was 2127g. 
2014 NCD Step 
Survey [91] 
Prevalence and 
patterns of 
drinking and 
smoking. 
Frequency and 
amount of alcohol, 
tobacco, and 
smokeless tobacco.  
Perception of 
tobacco control 
policy 
Identification of 
heavy episodic 
drinking. 
17-25 questions each for smoking (betel 
quid is included in smokeless tobacco). 
and drinking such as: 
Have you consumed any alcohol within 
the past 12 months? (Y/N) 
During the past 7 days, did you consume 
any home-brewed alcohol, any alcohol 
brought over the border/from another 
country, any alcohol not intended for 
drinking or other untaxed alcohol? (Y/N) 
On average, how many standard drinks 
of the following did you consume during 
the past 7 days? (Homebrewed spirits, 
e.g. ara, homebrewed beer or wine, e.g. 
beer, palm or fruit wine, alcohol brought 
Interviewer 
administered 
A variation of QF 
measures 
2,822 adults aged 18 
to 69  
 
Sampling methods:  
multiple stage 
stratified cluster 
sampling 
 
 
Interview periods: 
April-June 2014 
Wide coverage. 
Example of 
pictures of 
drinks were 
provided.   
No concept of a 
standard drink: 
 
No detailed 
information 
about betel quid 
chewing  
Female current drinkers in 
the past 30 days: 32.8% 
Female current daily 
smokers: 2.1% 
Female current daily users 
of smokeless 
tobacco:9.9% 
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over the border/from another country, 
alcohol not intended for drinking, e.g. 
alcohol-based medicines, perfumes, after 
shaves, other untaxed alcohol in the 
country) 
2013 Global 
Youth Tobacco 
Survey (GYTS) 
Bhutan Report 
[179] 
Prevalence and 
pattern of 
consumption of 
tobacco and 
smokeless tobacco 
among youth.  
Frequency and 
amount and 
perceptions.  
60 multiple-choice questions in English 
(43 questions from the GYTS Standard 
Core Questionnaire, 15 selected optional 
questions, and two country-specific 
questions). 
Self-
administered 
in the 
classroom 
A variation of QF 
measure (GYTS 
Standard Core 
Questionnaire) 
1,378 students aged 
13–15  
 
Sampling methods: a 
national-level 
representative 
sample of students in 
grades 7–9 from 25 
sampled schools and 
random classes 
selected within the 
sampled schools 
  
Interview periods: 
March-June 2013) 
Prevalence 
among youth 
aged 13-15. 
No information 
on drinking  
Current smokeless tobacco 
users among girls aged 13-
15: 18.9% 
Current smokers among 
girls aged 13-15: 6.6% 
Bhutan Living 
Standard Survey 
(2012) [178] 
Expenditure on 
betel quid 
chewing, alcohol, 
and tobacco. 
6 tobacco and betel items: cigarette, 
bedi, chewing tobacco, doma, pan, doma 
khamtok 
 
5 alcohol items: ara, bangchang, other 
wines, beer, liquor.  
 
Questions regarding the last 7 days, 30 
days and 12 months: 
What quantity did you consume? 
(Quantity and Unit) 
Total value (Nu.) Amount spent (if 
purchased), or estimated market value (if 
home produced. 
Interviewer 
administered 
NA (The World 
Bank Living 
Standards 
Measurement 
Study (LSMS) 
methodology) 
8,968 households 
with a total of 
39,825 individuals 
selected 
 
Sampling methods:  
a stratified two-stage 
sampling of 
households  
 
Interview periods: 
March-May 2012: 
August 2012 in one 
gewog (Lunana) of 
Gasa dzongkhag due 
to accessibility  
Wide coverage:  No information 
on types, 
amount and 
frequency of 
drinking 
Tobacco and betel quid 
chewing: mean monthly 
household expenditure: 
246.84 NU 
Per capita: 54.33 NU 
 
Alcohol:  
mean monthly household 
expenditure:295.36 NU 
Per capita: 65.01 
The International 
Tobacco Control 
(ITC)Policy 
Evaluation 
Psychosocial and 
behavioural effects 
of Bhutanese 
tobacco control 
ITC global survey questionnaire: 
Extensive questionnaires on Tobacco 
products such as: 
Interviewer 
administered 
QF measure (ITC 
global survey 
questionnaire) 
 
1,806 respondents 
from Bumthang, 
Chukha, Thimphu, 
Globally 
comparable. 
Limited to only 
4  
No information 
on betel quid 
chewing. 
Current female  having 
used tobacco products 
(either smoked or 
smokeless including snuff) 
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Project: The ITC 
Bhutan Project 
Report(2011) 
[180] 
legislation, 
including a 
nationwide ban on 
the sale of tobacco 
Do you smoke/ use manufactured 
cigarettes daily, at least weekly, less than 
weekly, or not at all? (Y/N) 
Ask if respondent's last purchase of 
tobacco was smokeless tobacco such as 
Baba, Raja Chap, Surti, Golden Khaini, 
Chaini, Snuff, other smokeless (specify)  
How often is smokeless tobacco 
available in your area? (Always, Most of 
the time, Sometimes, Rarely, Never, 
Refused, Don't know) 
 
Alcohol (4 questions): 
Do you drink alcohol? (Y/N) 
How often do you drink alcoholic 
drinks? (Every day or nearly every day, 
most days, 2 or 3 days a week, about 
once a week, Less than once a week, 
refused, don't know) 
When you drink alcohol, how many cups 
or glasses would you drink? (1 cup, 2-3 
cups, 4-6 cups, 7 cups, more than 7 cups: 
cups/glasses) 
How often would you drink more than [4 
(females)/ 6 (males)] drinks in one 
session? 
and Trashigang. 
(age:≥18) 
 
Sampling methods:  
multiple-stage 
sampling 
 
Interview periods: 
Sep-Nov 2009) 
districts No explanation 
of a standard 
size of cup 
No information 
on types of 
alcohol  
 
at least once within the 
last 30 
days(weighted):4.9%  
 
Current drinkers:35% (no 
information by gender) 
2010 Gross 
National 
Happiness Survey 
[34] 
General history of 
betel quid 
chewing, alcohol, 
tobacco. 
Alcohol (4 questions):  
In your entire life, have you ever 
consumed any kind of alcohol? 
How old were you when you first started 
drinking? (Y/N) 
Have you consumed any type of alcohol 
during the past 12 months? (Y/N) 
How often did you consume alcohol 
during the past 12 months? 
 
Tobacco (6 questions): 
Does anyone in your household smoke 
regularly inside the house? (Y/N) 
Have you ever smoked cigarettes? (Y/N) 
At what age did you begin to smoke? 
Interviewer 
administered 
(average: 3 
hours) 
QF measures  7,142 respondents 
aged 15 to 98 with 
the mean of 41 years 
 
Sampling methods:  
multi-stage sampling 
 
Interview periods: 
April – December 
2010 
 
 
Wide coverage 
of individuals 
 
Provides current 
prevalence of 
smoking, 
alcohol, betel 
quid chewing 
and  
overview of the 
pattern. 
 
Extensive 
information (750 
variables) 
No information 
on types, 
amount and 
frequency of 
drinking 
Female current smokers in 
the past 12 months: 2.4% 
Mean initiation age 
(years): 19.4 (urban) 
20.2(rural)  
Female current betel 
chewers in the past 12 
months: 61.5%  
Female current drinkers in 
the past 12 months: 32.8% 
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Did you smoke during the last 12 
months? (Y/N) 
Do you smoke daily or occasionally? 
(Y/N) 
How many cigarettes do you smoke each 
day now? 
 
Tobacco includes Baba, Raja, Surti, 
Leaf, snuff, others (4 questions): 
Have you ever chewed/snuffed tobacco? 
(Y/N) 
At what age did you begin to chew/snuff 
tobacco? 
During the last 12 months, did you 
chew/snuff tobacco? (Y/N) 
If yes, do you chew/snuff tobacco daily 
or occasionally? (Y/N) 
 
Betel quid chewing (5 questions): 
Have you ever chewed doma? (Y/N) 
At what age did you begin to chew 
doma? 
Did you chew doma during the past 12 
months? (Y/N) 
Do you chew daily or occasionally? 
 How many khamto do you chew each 
day now? 
 
For smoking, alcohol, and drug use 
(scale question): 
From what you know and heard, are the 
following issues, a concern in the 
schools in your community? (A Major 
concern/Of Some Concern/A Minor 
Concern/Not a Concern/ Don’t know)  
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2.4.2 A summary of the review of globally available tools to measure alcohol 
To solve the challenge of measuring alcohol, globally available tools were sought and reviewed to 
adapt to the context of Bhutan. Once tools were identified, their applicability to measuring smoking 
and betel quid chewing was considered.  
Sobell et al. (1995) assessed five major drinking measures which are used with adults and 
adolescents for both males and females and with clinical and normal drinker populations: Lifetime 
Drinking Measures, Drinking Self-Monitoring Log, Form 90, the Alcohol Timeline Followback 
(TLFB), and Quantify-Frequency Measures (QF) for their recommended use, advantages and 
limitations [171]. The Lifetime Drinking Measures is a good estimate for a lifetime overall picture 
of alcohol consumption rather than a detailed daily account. The Drinking Self-Monitoring Log is 
used for collecting various aspects of drinking such as amount, frequency, mood, and urges 
prospectively, especially to assess and monitor treatment. Form 90 and TLFB both use a calendar 
method and TLFB is recommended to understand drinking patterns of more than the last 90 days 
[171]. TLFB is a calendar-based measure of self-reported use of alcohol, tobacco, and illicit 
substances which aims to evaluate specific changes and is the most widely used and validated in 
high/middle/low income countries [185-187]. It is administered by interviews or self-administered 
in person or on a computer in research. QF measures estimate average quantity of drinking per 
occasion and average frequency of occasion and is available in a number of different formats. The 
Graduated-Frequency (GF) Measure is one of the few QF measures which can account for occasions 
when different types of beverages were combined [182]. Typical GF questions ask the largest 
number of drinks an interviewee had on any single day during the past 12 months (24 or more 
drinks, 12-23, at least 8 but less than 12 drinks, 5-6 drinks, 3-4 drinks or 1 or 2 drinks). However, 
GF still has a limitation in that there is no standard drink size.  
The majority of research on drink size has been conducted in high income countries. In 
low- and middle- income countries, the lack of commonly agreed standard drinks and a wide range 
of alcoholic beverages presents serious challenges to the accurate assessment of alcohol 
consumption [188]. In India, Nayak et al. (2008) explored beverage types, beverage-specific 
standard drink sizes and pour-size using key informant interviews and participant observation and 
performed biochemical analyses to measure ethanol content of local beverages in three different 
study sites (Delhi, Goa and Rajasthan) [188]. In Goa, approximately 2,000 study participants 
including both men and women (exact sample number not provided) were interviewed while only 
a small sample of men were studied in Delhi (n=172) and Rajasthan (n=172). The study confirmed 
a wide range of alcohol drinks with varied ethanol concentrations and differences in drink sizes and 
pour-sizes, and recommended accounting for the variations in future research.  Later in 2010, the 
same group proposed a new adaptation of the GF measure, the Fractional GF (F-GF) to be used in 
the context where no standard drink size is available, and validated it against AUDIT and a 28-day 
diary among 743 male drinkers aged 18 to 49 years in Goa, India [189].  
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The F-GF first establishes the maximum amount consumed on any day in the previous 12 
months by asking, for different beverage types, the numbers of various drink pours associated with 
the type. Once the maximum is determined, the profile is developed by asking how often the 
respondent drank about this amount (the maximum); then about how often the respondent drank 
about three-quarters of that amount (3/4 the maximum); followed by identical questions for “about 
half that amount” and finally “about one quarter of that amount.”  
In terms of applicability of these tools to smoking and drinking, TLFB is also widely 
applied to quantify tobacco[190], marijuana and other drug use [191]. On the other hand, examples 
of shortcomings include: time required and difficulty in capturing a variety of containers and vessels 
used for drinking; and the variation in the content of alcohol in Bhutan. 
The F-GF is most relevant for the present study to measure alcohol to take into account a 
wide variety of home-brewed alcohol drinks and absence of standard size. However, F-GF has not 
been applied to other substances. Additional questions to measure betel quid and tobacco 
consumption are required for the present study to adopt the F-GF. The development of the 
questionnaire is further discussed in Chapter 3.  
 
2.5 Summary and introduction of conceptual framework and causal diagrams 
Chapter 2 presented the background and context of the present study. Based on the review of the 
available studies presented in this chapter, Figure 2.2 shows the conceptual framework used for this 
study, followed by directed acyclic graphs (DAGs) in Figure 2.3 and Figure 2.4 [192]. The 
framework is specifically intended to describe Bhutan, where data collection was conducted. 
The conceptual framework was informed by Dahlgren &Whitehead’s social model [193] 
of health and Kramer’s epidemiology of LBW [194]. Risk factors were stratified by maternal factors, 
paternal factors, household factors, and environmental factors and also if risk factors were 
modifiable in the short term or modifiable in the long term or unmodifiable. The main risk factor 
of interest is betel quid chewing. 
While the conceptual framework presents potential risk factors, it does not show how the 
present study assumes causal relationships between variables. In order to explicitly present causal 
assumptions to identify covariates needing to be controlled in the models, causal diagrams were 
constructed.  Directed acyclic graphs (DAGs) help the study to identify whether there is 
confounding and which variables should be controlled or not controlled in order to achieve 
conditional exchangeability, conditional on assumptions [192, 195]. The DAGs identify a set of 
factors that are associated with betel quid chewing during pregnancy and term LBW and PTB. 
Within these DAGs, the relationships between the factors are assumed rather than proven. The 
following analyses in Chapter 7 are conducted with covariates informed by the DAGs using the 
backdoor criterion to identify sufficient sets of confounders. Hence, if the assumptions of 
underlying relations are wrong, the results of the analyses may be biased.  
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DAGs were constructed using a six-step approach suggested by Shrier and Platt [196]. In 
the DAG approach, a child is defined as the direct effect of a particular variable and a parent is a 
direct cause of a particular variable. A descendant is a direct effect or indirect effect of a particular 
variable and an ancestor is a direct cause or indirect cause of a particular variable. 
Step 1. The covariates chosen to reduce bias should not be descendants of the exposure 
variable or X (BQ during pregnancy).  
Step 2. Delete all variables that satisfy all the following criteria: 1) non-ancestors of X, 2) 
non-ancestors of the outcome and 3) non-ancestors of the covariates that one is including 
in the model to reduce bias.  
Step 3. Delete all lines emanating from X. 
Step 4. Connect any two parents sharing a common child. 
Step 5. Strip all arrowheads from lines. 
Step 6. Delete all lines between the covariates in the model and any other covariates 
If X is dissociated from the outcome after Step 6, then the statistical model chosen minimizes the 
bias of the estimate of X on the chosen outcome. 
These DAGs visualise the relations between variables in the analyses. Single-headed 
arrows represent causal effects from exposures to outcomes. The absence of an arrow or a variable 
implies that there is assumed to be no corresponding causal effect. The ways in which different 
factors may influence betel quid chewing during pregnancy and/or the adverse birth outcomes (term 
LBW or PTB), either directly or indirectly, are shown. Factors that are important but unobserved 
in the present study are shown in grey circles. The unobserved factors included stress, anxiety, or 
abuse during pregnancy, periodontal diseases, paternal factors such as father’s height and 
birthweight, and genetic factors.  History of delivering a LBW and/or PTB infant was not included 
as many causal factors were believed to be overlapping. ANC visit was also not included in the 
causal diagram as it is considered to be an intervention to reduce the impact of potential risk factors. 
This graph can be viewed as a simplified representation of selected aspects of the 
associations and provides an easily understood depiction of the assumptions about the relationships 
between betel quid chewing and the adverse birth outcomes (term LBW or PTB). The framework 
is useful for identifying variables that must be measured and controlled to obtain un-confounded 
measures of association given the assumptions outlined in the graph. For example, based on Figure 
2.3 and Figure 2.4, betel quid chewing before pregnancy is a confounder of the association between 
betel quid chewing before pregnancy and adverse birth outcomes, whereas micronutrient deficiency, 
anaemia and periodontal diseases are on the causal pathway between betel quid chewing and 
adverse birth outcomes.  
The selected covariates are explained in details in Chapter 3.  
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Figure 2.2. Conceptual Framework. 
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Figure 2.3. DAG for term LBW. 
Exposure 
Outcome 
Ancestor of outcome 
Ancestor of exposure and 
outcome 
Unobserved (latent) 
Causal path 
Biasing path 
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Figure 2.4. DAG for PTB.  
Exposure 
Outcome 
Ancestor of outcome 
Ancestor of exposure and 
outcome 
Unobserved (latent) 
Causal path 
Biasing path 
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Chapter 3  
Methods 
 
This chapter describes methods of the case-control study and consists of four parts. The first part 
gives details of the study design. The second part describes questionnaire development and 
preparation for data collection. The third part contains data collection and management. The chapter 
ends with methodological information on the data analysis. 
 
Part I    Study Design 
The first methodological section introduces the study design and justification (3.1), testable 
hypothesis (3.2), and sample size calculation (3.3). 
 
3.1 Justification 
In order to achieve the objectives, a hospital-based unmatched case-control study was conducted 
using a semi-structured questionnaire to collect information on the details of betel quid chewing 
and potential confounding variables from the mothers of LBW and/or PTB (cases) and normal 
weight (control) babies.  
An observational study rather than experimental study was chosen, as the main aim of this 
study was to examine a causal factor rather than learning about a prevention or treatment for a 
disease. Although there is a greater chance of bias due to the retrospective nature of the data 
collection compared to a cohort study, a case-control study was chosen because the prevalence of 
LBW and PTB is estimated to be approximately 10%. When the disease is rare, as defined as a 
frequency of 20% or less, a case-control study is more efficient than a cohort study in terms of the 
cost and time [1]. Given the multifactorial nature of LBW and PTB, a case-control design also 
allows multiple risk factors or exposures for one outcome to be assessed [2]. However, it should be 
noted that the study designs provide evidence of association but not causation [3].  
An unmatched case-control study was selected in order to avoid the selection bias 
introduced by the matching process. If there is a confounder in the source population, the process 
of matching will superimpose a selection bias over the initial confounder, generally leading to 
biasing the results toward the null value of effect [4]. If controls are selected to match the cases on 
a factor that is correlated with the exposure, controls who are more like cases with respect to 
exposure will be selected compared to when controls are randomly selected [4]. As a result, the 
crude exposure frequency in controls will become similar to that of cases.  
 A hospital-based case-control study, particularly based at JDWNRH in Thimphu and the 
two referral hospitals in Sarpang and Mongar, was chosen over population-based study mainly for 
two reasons. First, it was reasonably assumed that almost half of all facility births in Bhutan occur 
at these three referral hospitals. According to BMIS 2010, 63% of births in Bhutan were delivered 
in public health facilities [5]. In 2012, approximately 47% (4,751), of all health facility births 
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(10,169) were recorded at the three health facilities [6]. These hospitals are also located in three 
distinctly different regions and there inclusion of all three ensured that regional variations should 
be captured. The second reason was for the ease of implementation. A hospital-based case control 
study would enable interviewers to contact cases and controls soon after delivery and facilitate data 
monitoring and data quality assurance within a given time and budget. Extensive training for 
interviewers and close monitoring of data were required. It was believed that this would be done 
better by organizing an interviewer team consisted of the co-investigators and focal points at each 
study site rather than sending an individual interviewer to interview mothers at their households. 
 
3.2 Testable hypotheses 
Using a case control study design, there were many possible hypotheses that could be tested.  The 
ones that I chose to focus were as follows:  
  
1. Betel quid chewing (yes or no) increases the rate of LBW 
2. Betel quid chewing (yes or no) increases the rate of PTB 
3. Betel quid chewing (yes or no) increases the rate of maternal anaemia  
4. There is a dose-response relationship between betel quid chewing and the odds of 
LBW and/or PTB deliveries. 
5. There is a dose-response relationship between betel quid chewing and the odds of 
maternal anaemia.  
 
3.3 Sample calculations 
The sample size was calculated based on the above-mentioned hypotheses 1 and 2 using Epi Info 7 
based on the formula proposed by Fleiss for an unmatched case-control study [7]. As odds ratios 
and proportion of cases and controls with exposure (betel quid chewing) in the literature are not 
applicable to the Bhutanese population, a sample size table was created for different scenarios 
(Table 3.1).   
The following assumptions were used: For 80% power, Z=.84; For 0.05 significance level, 
Z=1.96; r=1 (equal number of cases and controls); and the proportion exposed in the control group 
and case group. 
Given that 61.5% of women were currently chewing betel quid according to the 2010 Gross 
National Survey [8], the estimates for exposure in the case group from 40 to 90% were used, while 
exposure in the control group was estimated to be lower than that in the case group.  
The response rate in recent surveys in Bhutan ranged from 82% (7,142 respondents out of 
8,700 samples) of the 2010 Gross National Happiness Survey to 97% of the 2012 Bhutan Living 
Standards Survey. There were no published data on case-controls or other facility-based 
observational studies in Bhutan at the time of calculating the sample size. To allow for an 
uncertainty in the response rate, 80% was used for sample size calculation. With the most 
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conservative scenario of minimum sample size of 388 in both the case and control group, with an 
80% response rate, an estimated 485 participants were required in each group. This sample size 
would be sufficient to show an odds ratio of at least 1.5 with 60% of cases and 50% of controls 
being exposed.  
 
 
Table 3.1. Sample size table.  
Proportion of exposure 
(betel quid chewing) in 
the control group 
Proportion of exposure (betel quid chewing) in the case group 
(power =0.8 & significant level =0.05) 
40% 50% 60% 70% 80% 90% 
10% 32 21 15 11 8 7 
20% 83 40 24 16 11 8 
30% 356 95 44 25 16 11 
40% - 388 99 44 24 14 
50% - - 388 95 40 20 
60% - - - 356 83 33 
70% - - - - 295 63 
80% - - - - - 201 
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Part II   Questionnaire development and preparation for data collection  
Part II of Chapter 3 covers issues pertaining to preparation for data collection. These include 
questionnaire development, pilot testing and finalisation, training and assignment of field staff, data 
monitoring, data entry and data cleaning. 
 
3.4 Development of questionnaire 
3.4.1 Introduction  
The 22-page semi-structured questionnaire in English was developed and used to collect 
information on potential confounding variables from the mothers.  
The questionnaire was developed according to the following steps [9-11]: 
 
1. Identify domains and items based on literature review of the factors associated with 
PTB and LBW (Chapter 2.2) 
2. Search for relevant validated survey instruments (Chapter 2.4) 
3. Review relevant questionnaires used in studies and surveys of betel quid chewing 
(Chapter 2.4) 
4. Draft questionnaire  
5. Seek advice from an expert panel including health professionals in Bhutan  
6. Pilot the questionnaire with 13 participants from the three hospitals. The 
participants were asked about clarity, comprehensibility, relevance to the topics 
and length of the questionnaire. Revision and repeat pre-testing of the 
questionnaire were done until it was satisfactory  (Chapter 3) 
 
The questionnaire consisted of 154 questions on the mother’s general information, obstetric 
and medical information, and behavioural information. The majority of the questions were multiple-
choice closed ended questions. Obstetric history, morbidity, and the results of ANC examinations 
were obtained from the MCH and hospital records. To supplement medical records, mothers were 
asked if they had been told that they had hypertension or high blood pressure and if they had selected 
symptoms of infectious diseases. As maternal psychosocial factors are difficult to measure in a 
quantitative questionnaire, and evidence from the literature is mixed, information regarding these 
issues was kept in the observational notes. Observations by the interviewers, interviewers’ 
impression, any unexpected events, and other information captured during the interview were also 
recorded in the open space in the end of the questionnaires. The questionnaire was finalised in 
December 2015. The final questionnaire is attached in Appendix F.  
 
3.4.2 Availability of routinely collected data 
To avoid redundancy of data collection and mitigate the burden on the interviewers, routine 
collected information was reviewed. Although the MOH and JDWNRH were working on building 
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an electronic information system to keep patient records, at the time of this study the majority of 
the records were paper based and carried by the patients themselves.  At each site there was also a 
paper-based birth registry book11 in which nurses record details of the pregnancy and birth with a 
slight variation of the formats and information. Only at JDWNRH, were the data routinely being 
put into an electronic (Excel) database.  
For the purpose of this study, relevant data were extracted from the birth registry books at 
each site and input into an Excel-based database for the year for 2015 in order to estimate the 
prevalence of LBW and PTB. This was undertaken by the author and her research team with 
agreement from the MOH and the study sites.  
 
3.4.3 Content of the questionnaire 
The content of the questionnaire was determined by the findings of the literature review (Chapter 
2) according to their relevance to Bhutan. Factors included in the survey ranged from environmental 
factors (altitude, exposure to agriculture, accessed health care services, and access to improved 
water and sanitation), household factors (socio-economic factors and ethnic group), maternal 
factors (chronic diseases, obstetric factors, genetic factors, education, maternal weight and height), 
mother’s life style factors (smoking, drinking, betel quid chewing, gestational weight gain, caloric 
and nutrient intake, physical activity, workload during pregnancy, and infectious diseases) to 
paternal factors. Published and grey literature, as well as government reports, were searched to 
identify a validated tools for measuring key independent variables, especially potentially toxic 
behaviour such as tobacco, alcohol, and betel nut consumption, applicable to the Bhutanese 
population (Chapter 2.4). Socio-demographic questions were positioned at the beginning to serve 
as a warm-up and behavioural and other sensitive questions were positioned in the later part of the 
questionnaire. 
A summary of measurement of selected variables is provided below.   
 
 
 
 
 
                                                          
11 Information included in the birth register books: serial number, registered number, admission date & time, 
delivery date & time, name, age, address and phone number of the mother, name of attendant if any, obstetric 
histories (gravida, para, abortions, still births, preterm, alive, dead, other medical problems), blood group, 
VDRL/RPR, mode of delivery (SVD, breech, LSCS and Indication of LSCS, forceps, vacuum, and others) 
and birth outcomes (single/twins, sex of the infant, birth weight, alive/dead, Apgar score, full-
term/premature/post mature, IUGR, deformity, and other information if any). Maternal complications (circle 
if any) for JDWNRH and ERRH: APH, PPH, retained placenta, prolonged labour, obstructed labour, PIH, 
eclampsia, ruptured uterus, dead, and others (comments). Maternal complications are recorded in an open 
space at CRRH. Name of the medical professionals who conducted the delivery, and referral information if 
any. In addition, JDWNRH collects information on: number and place of ANC visits, maternal height and 
maternal weight from last ANC record, booking weight (kg), occupation, educational level, and income level 
of the mother.  
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 (a) Outcome variables 
 
Birth weight (Question 54) 
Birthweight was measured within 24 hours of delivery at respective hospitals using 
the birth scales mentioned in Appendix H.  
Gestational age (Question 55) 
Date of first day of LMP by mother’s recall, estimated date of delivery by first US 
scan, date of first US scan, and gestational age at first US scan were obtained from 
the MCH. 
Mother’s subjective assessment of the size of the infant at birth (Question 62) 
When infants have not been weighed at birth, mother’s recall has often been used 
to decide if the new born is LBW in order to estimate the percentage of infants with 
LBW in Demographic and Health Surveys (DHS) and other surveys. The question 
was taken from BMIS 2010 [5] to compare mother’s subjective assessment of the 
size of the infant at birth and actual birthweight and gestational age. 
 
 (b) Independent variables 
In relation to independent variables, ethnicity, altitude of residence, urban/rural residence, 
gestational weight gain, pre-pregnancy and pregnancy intervals were constructed from the 
information collected.  Calculations, quantification, and modelling of the variables are 
explained in the following section (Section 3.11.2). 
 
Maternal age (Questions 12 and 13) 
Mother’s stated age in completed years was recorded. The birth date, month, and 
year was recorded from the MCH if available. 
Mother’s name, permanent, current address (Questions 11, 14 and 18) 
Mother’s stated address was recorded. The MCH was also checked to validate the 
information.  
 
Maternal anthropometric measures 
 
Maternal height (Question 21) 
Mother’s height was recorded from the ANC initial general examination from the 
MCH. 
Pre-pregnancy weight (Question 61) 
Mothers’ recalled pre-pregnancy weight and height were recorded during the 
interview.  
Maternal weights (Questions 21 and 43) 
Records of weights at the ANC visits and dates were recorded from the MCH.  
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Socioeconomic Status (Questions 93-105) 
Questions were taken from BMIS 2010[5]. 
 
Quantifying the welfare of individuals or household is often difficult [12]. In theory, the 
best indicator of welfare is the actual consumption of the individuals and ideally this 
consumption would include both food and other goods as well as consumption of services 
such as education and health. However, in agricultural/rural economies home production 
may account for a significant proportion of a household’s consumption. The valuation of 
such production is a major issue for the calculation of both expenditure and income for 
households that are both producers and consumers [12]. In Bhutan, health and education 
are provided free of costs. The 2012 Bhutan Living Standard Survey reported that 
consumption expenditure was 34% higher than income on average, possibly owing to 
underreporting of income including unreported transactions in agricultural products in the 
informal market and consumption of home-produced food and food received as gifts [13]. 
Therefore, income may be an inadequate measure to construct a socioeconomic variable. 
An asset based-approach is often used in these settings and was chosen for this study. Asset 
based measures or wealth index reflect long-run household wealth or living standards [14]. 
However, it should be noted that asset-based measures do not take account of short-run or 
temporary interruption, or shocks to the household and do not capture the quality of the 
assets [12].  
In the present study, the principal component analysis (PCA), a multivariate 
statistical technique used to reduce the number of variables in a dataset into a smaller 
number of dimensions [12, 15], was used.  Clumping and truncation are major challenges 
in producing PCA-based asset indices [16]. Clumping or clustering is defined as households 
being grouped together in a small number of distinct clusters [15]. Truncation refers to a 
more even distribution of socio-economic status (SES), but spread over a narrow range, 
making differentiating between socioeconomic groups difficult [15]. To avoid problems of 
clumping and truncation, it should be ensured that a broad range of asset variables that 
capture inequality between households and the stability of household calcification into SES 
groups are included. 
 
Maternal education attainment, marital status, and partner’s education 
attainment (Questions 16, 20, 72) 
Information was recorded in multiple-choice questions from the MCH and 
confirmed with the mothers during the interview. 
Maternal occupation and partner’s occupation (Question 68, 69, and 73) 
Mother’s self-reported occupation was recorded using multiple choice questions. 
Mother’s description of work was recorded using open-ended questions. Partner’s 
occupation and description work were also recorded using open-ended questions.  
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Access to the delivery hospital, means of transportation, hours of travel from 
home to the delivery hospital and reasons for delivery at the referral hospitals 
(Questions 64-67) 
Information regarding access to health facility such as mother’s self-reported mode 
of transportation and travel time from home to the delivery hospital were recorded. 
Reasons to deliver at the referral hospitals were recorded using a multiple-choice 
question. 
Gravida, parity, number of abortions, children alive, and children dead 
(Questions 33-37) 
Information was obtained and respective number was recorded from the MCH and 
confirmed with the mother during the interview. 
Month and year of last pregnancy (Question 38) 
Month and year the last pregnancy ended were recorded.  
Number of ANC visits and the timing of the first ANC visit (Questions 39-42) 
Information was recorded from the recall of the mothers and the MCH.  
Obstetric records (Questions 22-26) 
The following information was obtained from the ANC records where they were 
recorded as “yes/no” responses:  Previous still birth or neonate loss; history of three 
or more consecutive spontaneous abortions; birth weight of last baby less than 2500 
grams; birth weight of last baby more than 4500 grams; admission for hypertension, 
pre-eclampsia, or eclampsia in the last pregnancy;  diastolic BP over 90mm Hg; 
pelvic mass; suspected STI/RTI, vaginal bleeding; cardiac disease; hypertension; 
thyroid disease; family history of twins; family history of congenital defects; 
known “substance “ abuse; diabetes; hepatitis; tuberculosis; blood transfusion; 
renal disease.  
Test results for syphilis, hepatitis B, and diabetes were recorded with dates 
from the ANC records. The MOH guideline advises against writing the test results 
in the MCH book. If positive, it was indicated in the MCH book and hospital 
medical records. Hence, absence of test results could imply negative results. 
Anaemia (Question 46) 
Interviewers ticked “Yes” in the questionnaire if mother’s haemoglobin level in the 
MCH book and medical records was less than 10 g/dL. Detailed information on 
haemoglobin concentration was not collected. 
Diabetes (Question 47) 
Interviewers ticked “Yes” in the questionnaire if mothers were diagnosed with 
diabetes in the ANC or medical records. All pregnant women between 24- 28 
weeks’ gestation with 75g at the Oral Glucose Tolerance Test are screened at 
JDWNRH, ERRH and CRRH. Gestational diabetes mellitus is diagnosed if any 
one of the two readings are abnormal: fasting blood sugar ≥92 mg /dL(≥5.1 
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mmol/L) and 2 hours after 75g glucose ≥140mg/dL (≥7.8 mmol/L). Detailed 
information on level of sugar or glucose was not collected in the questionnaire. 
Hypertensive disorders (Questions 42, 43 and 57) 
Information on gestational hypertensive complications was obtained from medical 
records and ANC records and recorded as “Yes/No/Unknown” (Q.43). Blood 
pressure measures from ANC records were recorded with the dates if available 
(Q.42). Mothers were asked if they had been told that they had high blood pressure 
or hypertension (Q.57).  
Bhutan’s definition was consistent with the widely-used definition of 
hypertensive disorders[17] as below: 
 
Pre-existing or chronic hypertension 
Blood pressure greater than or equal to 140 and/or 90 mmHg occurring on 
two occasions at least four hours to a week apart before the twentieth week 
of pregnancy. 
Pregnancy-induced hypertension (PIH) or Gestational hypertension 
Blood pressure greater than or equal to 140 and/or 90 mmHg occurring on 
two occasions at least four hours to a week apart after the twentieth week 
of pregnancy without proteinuria. 
Pre-eclampsia 
Blood pressure greater than or equal to 140 and/or 90mmHg occurring on 
two occasions at least four hours to a week apart after the twentieth week 
of pregnancy.  
AND 
Proteinuria: ≥ 300 mg in 24 hours urine specimen 
Eclampsia 
Occurrence of seizures (convulsions) in association with pre-eclampsia. 
 
Urinary Tract infection (UTI) (Question 44) 
Information on UTI was obtained from the medical records and recorded as “Yes” 
or “No”. Information on classification of microbiologically-confirmed/not-
microbiologically-confirmed was not collected. 
Symptoms of potential infectious diseases (Question 56) 
To supplement hospital records, mothers were asked if they had the following 
symptoms [18] and recorded as “Yes”, “No”, or “Unknown”: [a] Constant feeling 
of needing to urinate, even after having just urinated; [b] Pain or burning while 
urinating, or straight afterwards; [c] Pain in the lower belly, behind the front of the 
pelvis; [d] Cloudy or bloody urine; [e] Fever, feeling very hot and sweating; [f] 
Feeling very sick or weak; [g] Flank pain (in one or both sides); [h] Repeated 
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vomiting requiring medical treatment; [i] Chills, rigours or shivering persistently; 
and [j] Having a rash.  
Mode of delivery (Question 52) 
Hypertensive disorder during pregnancy may affect both the mother and foetus. 
Because there is no effective cure for preeclampsia other than delivery, delivery is 
always the treatment of choice for the mother [17]. Mode of delivery (spontaneous 
vaginal delivery (SVD), caesarean section (CS)-elective, CS-emergency, vacuum, 
forceps, breech, unknown) was recorded from medical records.  
Working hours /shift during pregnancy (Question 70 and 71) 
Information on working hours per week, whether they worked in shifts and if this 
included night shifts was collected by the interviewer. The questions did not take 
into account changes or interruption during pregnancy such as maternity leave or 
sick leave12.  
Physical activity (Questions 76-92) 
General lifestyle, physical activity during work and leisure, and sedentary activities 
were asked about using questions and visual aids from the Bhutan STEP survey 
2014 [19].  The STEP survey adopted the Global Physical Activity Questionnaire 
(GPAQ) developed by WHO for physical activity surveillance in countries. It 
collects information on physical activity participation in three settings (activity at 
work, travel to and from places, and recreational activities) in addition to sedentary 
behaviour, comprising 16 questions. The questionnaire defined vigorous intensity 
as “physical activities that cause large increases in breathing or heart rate” and 
moderate intensity as “physical activities that cause a small increase in breathing 
or heart rate.” The American College of Obstetricians and Gynaecologists 
(ACOG)’s guidelines recommend at least 150 minutes per week of moderate-
intensity aerobic activity (equivalent to brisk walking) for healthy pregnant and 
postpartum women [20]. The guidelines suggested that the activity should be 
spread throughout the week and adjusted as medically indicated. Mother’s self-
evaluation of physical activities during pregnancy (very active, moderately active, 
somewhat active, and not active) was also recorded.  
Maternal nutrition intake during pregnancy (Questions 140-153) 
Assessment of maternal nutritional status can be complicated. There are various 
approaches to assess individual nutritional status and these can be classified into 
two main categories: the retrospective reporting of intake from the recent or remote 
past and the prospective recording of consumption.  Weighed dietary records 
involve recording the weights of all foods prior to their consumption [21]. “Precise 
                                                          
12 As per the Bhutan Civil Service Rules (BCSR) 2012, civil servants, including teachers and nurses, were 
entitled to three month maternity leave before March 2016 which was extended to six months in March 
2016. Duration of voluntary leave from work before delivery depends on the individual. 
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weighing” which measures all ingredients of the cooked composite dishes are 
weighed raw, before cooking and after cooking is considered the most accurate of 
all available methods and is often used as the gold standard in validation studies 
[21].  Chemical analyses of diets require the individual to provide a duplicate of all 
foods consumed, including beverages, over the stipulated number of days and 
different chemical analyses are conducted according to interest of the research [21].  
Typical forms of questionnaire-based methods to measure retrospective intakes are 
dietary history method, food frequency questionnaires (FFQ), and 24-hour recall 
method. As these are often based on recall of the individuals, they are subject to 
recall bias. The 24-hour recall was designed to quantitatively assess current 
nutrient intake [22]. Food frequency questionnaires are most commonly used in 
epidemiological studies to estimate habitual energy and nutrient intake, especially 
in large cohorts [22].  They are inexpensive and easy to administer and demonstrate 
relatively high validity in validation studies [23, 24].  Challenges are lengthy 
questionnaires that ask how often a standard portion of each food or beverage was 
consumed during the previous year. The number of food and beverage items 
included in the FFQs could vary significantly from less than 22 to 170. The FFQs 
have been applied to pregnant mothers in epidemiological studies [23, 24]. In the 
present study, after reviewing several nutritional surveys using the FFQ approaches, 
questions regarding vegetable and fruit intake and the visual aid of examples of 
fruits were taken from the 2014 STEP Survey in Bhutan [19]. Frequency of food 
and appetite questions were adapted from Health and Nutrition Questionnaire from 
the Vermont Department of Health (USA) [25]  In addition, questions regarding 
dried meat, local butter tea which contains butter, salt, and hot water, coffee and 
milk tea with sugar were taken from the Bhutan STEP Survey 2007 [26]. 
Exposure to betel quid chewing (including commercial betel nut products), 
smoking (cigarettes and smokeless tobacco), and alcohol (Questions 106-139) 
As this research aimed to measure betel quid chewing during the course of 
pregnancy and sufficiently control confounders such as drinking and smoking, the 
applicability of timeline followback (TLFB) and the fractional graduated-
frequency (F-GF) introduced in the previous chapter of this thesis was assessed to 
understand the pattern of smoking, drinking and chewing betel nuts during the pilot 
study. The original questionnaires for TLFB and F-GF were obtained and adapted 
to Bhutan with the authors’ permission. 
TLFB can collect rich information on content, amount, and pattern of daily 
use, and can yield high reliability. TLFB is also widely applied to quantify tobacco 
[27], marijuana and other drug use [28]. However, several challenges were 
identified: time required, the variety of containers and vessels used for drinking; 
and the variation in the alcohol content in Bhutan. In terms of application to this 
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research, one of the main concerns was time and risk of exhausting both the 
mothers, who had recently delivered, and interviewers by collecting daily 
consumption for all alcohol, tobacco, and betel quid chewing. The main study 
questionnaire (18-20 page) was expected to take approximately one hour. Adding 
the TLFB calendar to ask about the amount of drinking , smoking, and betel quid 
chewing in the  past 90 days was expected to add another 10-15 minutes for each 
substance [29]. In addition, checking medical records was expected to take 
additional 20 minutes. 
The F-GF has the advantage of taking into account a variety of alcoholic 
drinks as commonly used in Bhutan, although no previous studies have used this 
tool among the obstetric population. One of the concerns before the pilot study was 
whether Bhutanese mothers can understand the concept of three quarters, half and 
a quarter of an amount. 
To compare the applicability of TLFB and F-GF to this study, the TLFB 
3-month calendar and F-GF questions to measure maximum alcohol, in addition to 
a set of questions and a 10-month (pregnancy period), monthly calendar were 
added to the questionnaire. The 10-month calendar asked how much betel 
quid/how many smokeless tobaccos/how many cigarettes a participating mother 
used on an average day in each month during the past 10 months and approximately 
how many days the mother drank in each month during the past 10 months.  
During the pilot study between October and December 2015, the 18-page 
questionnaire including the F-GF questions and the TLFB 3-month calendar 
including the Bhutanese event days was administered to both cases and controls at 
the three study sites. An identical plastic cup was provided for each study site and 
by showing the cup to the mothers, nurses asked how many cups (of this size) of 
alcoholic drink the mother took. To explain the concept of three-quarters, the half 
and one quarter to mothers, a visual aid card depicted a beaker with fluid levels at 
three quarters, half and a quarter of the full beaker (the greatest amount) was 
provided. This process was standardised across the study sites.   
 
3.4.4 Validation of the questionnaire  
Validity refers to whether a questionnaire is measuring what it intends to [10, 30]. The present study 
validated the questionnaire in respect of content validity and face validity. Content validation 
ensures the content of the questionnaire has enough items and adequately covers the domain under 
investigation and is usually undertaken by a group of experts [30]. Face validity indicates where 
the instrument appears to be assessing the desired qualities [31]. To assess content validity, a group 
of health professionals from London School of Hygiene and Tropical Medicine and from Bhutan 
was asked to assess the questionnaire. Each question and definition was reviewed and confirmed 
by all the co-investigators and interviewers at the meetings prior to the pilot study.  
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A pilot study was conducted at each site to evaluate feasibility, readability, consistency of 
style and formatting and the clarity of the language used for face validity [31]. The pilot 
questionnaire included three questions for mothers and five questions for the interviewers at the 
end to ask the mothers and the interviewers if questions were understood by respondents; questions 
were in the right order; all questions were necessary and sufficient; instructions to interviewers were 
adequate; and space and process of the interview was appropriate (Appendix E). After the pilot 
study at each site, the answers were reviewed and necessary changes were made based on the 
feedback.  
 
3.4.5 Training and piloting 
Training for interviewers was conducted at the three study hospitals from October to December 
2014. The process of randomisation, timing and process of recruitment of cases and controls, how 
to obtain informed consent and how to build a rapport were demonstrated to research nurses and 
co-investigators and questionnaires and the process were evaluated and revised during the 
discussion after the pilot study. In total, 70 nurses and 6 co-investigators participated in the training. 
Continuing Medical Education (CME) credit was granted to each participant for training to 
everyone who completed the initial training and certificates will be given to those who participated 
in the actual data collection at the end of study. During the monitoring visits, trained interviewers 
were invited to capacity-building lectures. A list of the interviewers is provided in the annex. 
Pilot studies were conducted at each study site to try out the process of data collection and 
questionnaire application. In total, 13 mothers were interviewed (Table 3.2). During the pilot studies, 
the questionnaire was revised and pre-testing was repeated until satisfactory.  Mothers participating 
in the pilot studies were given a baby towel as a token of appreciation (Figure 3.1). 
 
 
Table 3.2. Dates and number of participants in the pilot study, by study site. 
Hospital Date Number of Cases Number of Controls Total 
JDWNRH 3 Nov – 16 Nov 2014 5 5 10 
CRRH 22 Nov 1 
(training purpose only not 
qualified for data analysis 
as home delivery) 
1 2 
ERRH 5 Dec 1 0 1 
Total  7 6 13 
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Figure 3.1. A set of the questionnaire and visual aids used in the study and thank you gift for mothers. 
 
 
3.4.6 Finalisation of the questionnaire 
TLFB [32] and F-GF combined with QF questions and responses to the questions were compared 
to measure patterns of drinking, smoking and betel chewing. During the pilot study, 8 out 13 
mothers reported their history of smoking, drinking, and/or betel nut chewing during pregnancy. 
Two mothers left the TLFB-calendar blank and three mothers reported having stopped before the 
last three months of pregnancy. Four mothers answered both TLFB-calendar and relevant questions 
that measure the same content. Four mothers answered the same frequency and quantity in the 
TLFB calendar compared to QF questions. One mother reported lower consumption of betel quid 
in the TLFB calendar than she reported in the question that asked average number of quids per day 
in each month in the past 10 months (Figure 3.2). Although there were not enough questionnaires 
to conduct statistical analyses, a few challenges of TLFB were identified. First, daily consumption 
was not well recalled during the interview and left blank or the same number was entered for every 
day. The questions which ask about average days or quantity for each month over the past 10 months 
revealed that the 3-month TLFB which asked about the previous three months does not capture the 
change of behaviour if mothers changed their behaviour during the pregnancy.  In the pilot study, 
3 out of 8 mothers stopped drinking after the first or second trimester when they realised that they 
were pregnant. This led to a decision to keep only the F-GF questions to measure drinking combined 
with a set of QF questions and 10-month calendar to record the quantity of average consumption of 
cigarettes, smokeless tobacco, betel quid and number of days of drinking.  
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Figure 3.2. Completion of TFLB calendar in the pilot study. 
 
 
3.5 Mode of interview 
Health-risk behaviours including smoking, drinking and other drug use are often measured by 
administering questionnaires that require retrospective self-reports about engaging in these 
behaviours. Self-reported use might be underreported because of concerns about social desirability 
and fear of reprisal, especially for behaviours that are illegal, stigmatised, or associated with moral 
implications compared to mearing the actual consumption [33]. Brener et al. suggested alcohol and 
tobacco use is affected by perceptions of privacy and confidentiality and found that the self-
administered questionnaire format produced higher reported rates of alcohol and other drug use 
than interviewer-administered questionnaires in the studies on adolescents they included in their 
review [33].  In this study, in order to interview the mothers about their tobacco, smokeless tobacco, 
alcohol, and betel quid chewing during pregnancy, the questions were administered by the 
interviewers later in the interview after they felt they had built enough rapport with the mothers and 
again mothers were reminded that these questions were only for research purposes and would not 
be reported to the government. However, the ban on import and production of tobacco and smoking 
in public in Bhutan by the Tobacco Act of 2010 could have stigmatised smoking. There is a chance 
of underreporting of smoking and alcohol due to cultural shame. Interviewers closely observed the 
mothers. For example, if they observed teeth with betel quid stains in mothers who reported that 
they do not chew betel nuts, a note was added to the questionnaire after the interview. The 
quantitative analysis was conducted as per mothers’ stated information but the observational notes 
were reviewed for future research implications.  
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3.6 Interview language and translation 
In Bhutan, English is the language of education. Dzongkha is the national language and the only 
language with a literacy tradition. Different dialects are spoken depending on the region. The 
questionnaire was developed in English and training was conducted in English to make sure the 
definition was clearly communicated. The questionnaire was translated into Dzongkha or other 
dialects (Sharchoop, Lhotsham (Nepali), Bumpat, Khengkha, and others if any) if necessary during 
the interviews by the interviewers. Ambiguities regarding translations were discussed and shared 
during the training and monitoring.  The language in which the interview was conducted was 
recorded in the questionnaire. 
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Part III   Data collection 
Part III describes data collection and data management including the study sites and population, 
ethical consideration, data entry and data cleaning. 
The study was conducted at the three referral hospitals between February 2015 and March 
2016. 
 
3.7 The study sites and population 
The study population was the LBW or PTB neonates born at these three hospitals, and their mothers.  
A case was defined as a mother of a singleton live born infant whose gestational age is less than 37 
completed weeks and/or an infant whose birth weight is less than 2500 g [2].  
A control was defined as a mother of singleton live born term babies whose birth weight 
was more than 2500g and gestational age was greater than 37 weeks. 
Mothers were excluded from the study in the case of:  
 
▪ Multiple pregnancy; 
▪ Still births; 
▪ Maternal age younger than 17 years old at time of delivery;  
▪ Referred to the hospital after home delivery; or   
▪ Refused to participate in the study. 
 
In general, mothers without complications were discharged between 12 and 24 hours after 
delivery and mothers who delivered by Caesarean section were discharged after 72 hours at the 
studysites. Figure 3.3 summarises the flow of recruitment process. 
All mothers of a singleton live born preterm or/and LBW infant were approached to take 
part in the study and recruited by a trained interviewer during their post-delivery stay before 
discharge from each hospital.     
Each time a new case was recruited, a list of mothers who were staying in the same 
maternity ward within +/- 3 days of the birth of the case was checked for a control.  Mothers of 
singleton live born term babies whose birth weight was more than 2500g and gestational age was 
greater than 37 weeks were recruited during their post-delivery stay.  If there was more than one 
control for one case, a standardised programmed excel file was used to randomly select the control. 
The purpose of the study was explained to all eligible subjects and their consent obtained by a 
trained interviewer.  
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Figure 3.3. Recruitment process. 
 
 
3.8 Estimates of gestational age used in the recruitment process 
In Bhutan, the Maternal and Child Health Handbook (MCH) guideline by the Ministry of Health 
(MOH) advises that if the difference between the LMP and US estimates was different by less than 
one week and US is done early, the LMP estimate should be used to estimate gestational age,  and 
if the difference is more than one week, then the US-based estimate should be used [34]. For those 
without US estimates, LMP is used. This policy was widely practiced across the country at the time 
of the study. For logistical reasons, recruitment in this study was based on gestational estimates in 
the MCH or hospital records and the validity of using this estimate of gestational age was explored 
in the analysis.  
 
3.9 Ethical considerations and the informed consent process 
Ethical approval for this research was obtained from the Royal Ethics Board of Health of the Royal 
Government of Bhutan (REBH/Approval/2014/017 (Amendment)) and the London School of 
Hygiene and Tropical Medicine (8348‐01). Initial ethical approvals were obtained from the London 
School of Hygiene (8348) and Research Ethics Board of Health, Royal Government of Bhutan 
(REBH/Approval/2014/017) in July 2014. After the pilot studies, approvals for amendments were 
obtained in February 2015. Monitoring of one of the study sites, CRRH, was blindly conducted by 
REBH in May 2015 and checked for compliance. Good compliance was confirmed. 
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Informed consent forms were prepared in both English and Dzongkha as required by the 
Royal Government of Bhutan. Confidentiality and anonymity were explained to each participant 
and informed consent was obtained. As some of the mothers may have lost babies in previous 
pregnancies, some questions may raise powerful and upsetting issues. The interviewers were trained 
to be extremely sensitive and to respond appropriately if a participant did become upset. The trained 
interviewers clearly explained that participation was voluntary and that there were no consequences 
for refusing to take part in the study or to answer specific questions. A written informed consent 
form was read by the participants or read out loud by a trained interviewer if the participant could 
not read. If the mother agreed to participate, she was asked to sign the consent form. If she was 
unable to sign, her fingerprint and a witness’s signature were obtained. The witness was a family 
member, friend, patient advocate, or someone independent of the research team. The mother was 
given a copy of the information sheet and consent form to keep (Appendix D). 
 
3.10 Data entry and data management 
3.10.1 Assignment of field staff 
Questionnaires were administered to mothers by trained interviewers.  At each site, at least two 
trained interviewers were in charge of managing the questionnaires and sending them regularly to 
the central data entry site (KGUMSB). The assignment of nurses and trainings was conducted with 
approval from each hospital and the MOH. One research assistant was recruited for entering the 
pilot study data and four research assistants (one site manager at JDWNRH, two data entry clerks 
and one data manager) who are fluent in English, Dzongkha, and Lhotsham (Nepali) with basic 
EXCEL and Microsoft skills and attention to detail were recruited during the data collection period. 
All the data entry clerks were trained on confidentiality and anonymity of data and EpiInfo7. 
  
3.10.2 Data entry 
A data entry form was developed using both EpiData and EpiInfo7 and tested using data from the 
pilot study by local staff. After assessment, EpiInfo7 was preferred. At the end of data collection 
cycles (every two months from CRRH and ERRH and every two weeks from JDWNRH), 
questionnaires from each study site were sent to KGUMSB and data from the questionnaires was 
centrally entered into an Epi Info 7 database at KGUMSB, including scripts from the open questions 
and observation notes. After the first data entry clerk scanned and entered data from the 
questionnaires, the paper questionnaires were handed over to the data entry clerk to enter the same 
questionnaires. As a result, two datasets were produced at the end of study period. The two datasets 
and scanned copies of the questionnaire were electronically stored and reported to the author by the 
data manager. The original questionnaires were kept secured in a locked room at the KGUMSB by 
the data manager.   
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3.10.3 Monitoring of recruitment and data quality 
During the data collection period from February 2015 to the beginning of March 2016, recruitment 
of cases and controls and the quality of data was closely monitored by co-investigators and the 
author. The hospital registration records were checked to see if there were any cases discharged 
before being contacted. In the early stage of data collection, due to the high burden of routine work 
at the JDWNRH, missing eligible cases was identified as a challenge. One site manager who was a 
former nurse in the birthing centre and was studying to upgrade her qualification to Bachelor of 
Public Health at the KGUMSB, adjacent to the JDWNRH, was recruited to back up data collection. 
All questionnaires were checked at the start of data collection and randomly selected samples of the 
questionnaires were manually checked by the author who was based at the KGUMSB throughout 
the data collection period. Problems were detected and corrected immediately. Data entry clerks 
also reported potentially erroneous responses to the author. The author frequently visited JDWNRH 
and maintained communication by email and phone with the focal points at each study site to clarify 
any questions and to correct problems throughout the study. In addition to the initial training and 
pilot study, two monitoring visits to regional referral hospitals were conducted (CRRH: March 2015 
and September 2015, ERRH: April 2015 and October 2015). Three interim analyses were conducted 
to monitor data quality and sample size in the field. Any ambiguities or problems were clarified and 
discussed in person and detailed feedback was shared during the monitoring visits.  
 
3.10.4 Data cleaning 
After the study period, the two datasets were compared by the author using STATA version 14 “Cf” 
command. Any discrepancies between the two datasets were compared to the original questionnaire. 
If further clarifications were needed, the interviewers were contacted. At the end of data cleaning 
process, the final dataset was produced for analysis.   
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Part IV   Data Analysis 
Part IV describes how variables were modelled for analysis. The methods of descriptive analysis 
and logistic regression modelling, using a statistical approach and directed approaches, and 
handling of missing data are explained.  
 
3.11 Modelling of dependent and independent variables: 
In this section, construction and categorisation of dependent and independent variables is described. 
 
3.11.1 Modelling of outcome measures 
 
Low birth weight 
LBW was defined as a birth weight of less than 2500 g and modelled as a binary variable. 
Gestational age at birth in days 
As described previously, in Bhutan, the MOH MCH guideline advises that if the difference 
between the LMP and US estimates is less than a week and US is done early, the LMP 
estimates should be used and if the difference is more than 1 week, the US estimates should 
be used [34]. For those without US estimates, LMP or clinical estimates are used. This 
policy was widely practiced across the country at the time of the study. Recruitment was 
based on the hospital recorded gestational age. To understand the validity of hospital 
recorded gestational age, two estimates were calculated: gestational age at birth (in days) 
from LMP (date of birth - date of LMP) and US estimate calculated by [280-(estimated 
date of delivery – date of birth)].  The final gestational age reported in the present study 
was based on the US estimate where available.  If US estimates were missing or erroneous, 
gestational age from hospital records was used.   
Preterm birth 
The US and LMP estimates were compared to the hospital recorded gestational age used in 
the recruitment to finalise classification of PTB. When classification of preterm by the three 
methods did not agree (n=26), the details were examined.  
PTB was defined as a gestational age at birth of less than 259 days or before 37 
completed weeks by the hospital records or by US estimate and modelled as a binary 
variable. 
Case/control 
Case was defined as PTB and/or LBW and modelled as a binary variable.  
Small for gestational age (SGA) (Appendix B.2) 
SGA was defined as a birth weight below the 10th percentile of a sex-specific birth weight 
distribution by gestational age. 
Although SGA was not included in the main analyses, it was calculated using 2 
different distributions: the US 2000 birth weight reference for gestational ages 20-44 weeks 
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[35] and the International Fetal and Newborn Growth Consortium for the 21st Century 
(INTERGROWTH-21st) birth weight standard for gestational ages 24-42 weeks [36]. Two 
references differ mainly on the point that the INTERGROWTH-21st birth weight standard 
is a description of birth weight in foetuses in eight countries that experienced optimal 
growth whereas the US 2000 reference is a description of birth weight in the population, 
not a description of optimal birth weight. The details are given in Chapter 2. 
 
3.11.2 Modelling of independent measures 
 
Maternal Age 
Age was calculated as (the date of delivery – the date of birth of the mother). In Bhutan, it 
was common to register the date of birth as January 1 of the birth year in the census due to 
the ambiguity of the actual date of birth. If the birth month and birth year were missing, 
January 1 was used. If the birth year was missing, self-reported age by the mother was used 
as age. Age was modelled as a categorical variable with six categories (<20, 20-<25, 25-
<30, 30-<35, 35-<40, 40+ years) in the descriptive analysis and three categories (<20, 20-
35, and 35+ years) in the logistic regression analysis after checking the distribution in the 
descriptive analyses.   
Socioeconomic status 
Using questions taken from BMIS 2010[5], a descriptive analysis was conducted on 
information on the following: ownership of consumer goods (watch, mobile phone, bike, 
motorcycle/scooter, car/truck, computer, foreign bow, camera, VCR/VCD/DVD player, 
and occasional dresses made with silk [sersho gho/kira or silk suits/sari]), dwelling 
characteristics (persons per sleeping room, type of floor, type of roof, type of wall, and type 
of cooking fuel), and access to improved water and sanitation. 
A binary variable was produced to examine problems of truncation and clumping.  
Then, tetrachoric or polychoric correlation coefficients for the binary variables were 
calculated and the resulting correlation matrix was used.  Weights (factor scores) were 
assigned to each household asset. A wealth score based on these weights and the assets 
owned by that household was assigned to each household; it ranged from 0.01 to 1.46.  In 
the final analysis, 13 variables (ownership of watch, mobile phone, bicycle, motor cycle, 
car, computer, foreign bow, camera, VCR/VCD, DVD player, occasional dresses made 
with silk, access to improved sanitation, finished walls, finished floor, number of persons 
in a sleeping room) were included. The household population in the study was then ranked 
into five equal quintiles from lowest (poorest) to highest (richest) based on the wealth score. 
Finally, socio-economic status (SES), called “wealth index”, was created by dividing the 
sample population into quintiles.  
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Urban/rural 
Residences were classified to urban or rural based on the population census classification 
using a list of village and thromdes codes obtained from the National Statistics Bureau and 
reviewed by a local research assistant for consistency.   
Obstetric records 
The following information was treated as binary variables in the analysis:  previous still 
birth or neonate loss; history of three or more consecutive spontaneous abortions; birth 
weight of last baby less than 2500 grams; birth weight of last baby more than 4500 grams; 
admission for hypertension, pre-eclampsia, or eclampsia in the last pregnancy; diastolic BP 
over 90mm Hg; pelvic mass; suspected STI/RTI; vaginal bleeding; cardiac disease; thyroid 
disease; family history of twins; family history of congenital defects; known “substance 
“abuse; diabetes; hepatitis; anaemia; tuberculosis; blood transfusion; and renal disease. 
Hypertensive disorders 
Hypertensive complications were modelled as a categorical variable, classed as: no 
complications (reference), pre-existing or chronic hypertension, gestational hypertension, 
pre-eclampsia, and eclampsia in the descriptive analysis. In the process of regression model 
building, it was modelled as a categorical variable with four categories: 0: no complications 
(reference), 1: pre-existing or chronic hypertension; 2: gestational hypertension; 3: pre-
eclampsia, and 4: eclampsia. In the final model, eclampsia and pre-eclampsia were 
combined into one category. In the logistic regression models using the conventional 
approach, hypertension was modelled as a categorical variable with three categories (0: no 
hypertensive disorder, 1: chronic hypertension, 2: gestational hypertension, and 3: pre-
eclampsia or eclampsia).  In the logistic regression models using the DAG approach, 
chronic hypertension and pregnancy-induced hypertension composed of gestational 
hypertension, pre-eclampsia or eclampsia were modelled as a binary dummy variable 
respectively.  
HIV, syphilis, and hepatitis B 
HIV, syphilis, and hepatitis B were modelled as a binary variable if positive in the 
respective test results. The MOH guideline advises against writing the test results in the 
MCH book but if the test was positive, it was indicated in the MCH book and hospital 
medical records. Hence, absence of test results could imply negative results. The percentage 
of mothers with missing records was reported.  
Urinary tract infection 
Information on UTI was obtained from the medical records and categorised as a binary 
variable. Information on classification of microbiological-confirmed and not-
microbiologically-confirmed results was not collected. A potential source of bias is that 
UTI is often undetected and unreported in Bhutan, which leads to misclassification of 
mothers with UTI as non-UTI. This leads to biasing association towards the null. 
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Symptoms of potential infectious diseases 
The percentage of mothers with selected symptoms of infectious diseases were reported in 
the descriptive analyses.  
Mode of delivery 
In the descriptive analysis, mode of delivery was modelled as a categorical variable with 
five categories (SVD, CS-elective, CS-emergency vacuum, and breech; no forceps delivery 
in the study participants) and three categories (SVD as reference and CS-elective or CS-
emergency) in the logistic regression analyses after checking the distribution in the 
descriptive analyses.   
Pre-pregnancy weight and height 
Mothers’ recalled pre-pregnancy weight and height were modelled as a continuous variable. 
The accuracy is unknown and subject to recall bias. Another possible bias could be that 
mothers who remember or measure their weight could be more health conscious or more 
literate.  Accordingly, more mothers of controls could remember their weight than mothers 
of cases Also, overweight women tend underreport their weight [37]. Potential bias could 
lead to biasing towards the null. 
Self-reported pre-pregnancy body mass index (BMI): 
Although systematic reviews exploring the relationship between BMI and birth outcomes 
show heterogeneous cut-off points used in the literature [38-40], this study follows the 
international classification recommended by WHO [41]. 
Pre-pregnancy BMI was calculated as weight divided by height in (kg/m2) and categorised 
as underweight (< 18.5), average (18.5–25.0), overweight (≥25) and obese (≥30). 
As this is calculated based on mothers’ recalled pre-pregnancy weight, it is subject to recall 
bias. 
Pre-pregnancy BMI was used as, while several studies in the literature used first 
trimester BMI, only 18% of women went to ANC in the first trimester in the present study. 
Gestational weight gain (GWG) 
Three major options to measure GWG were identified: (1) the difference between the self-
reported pre-pregnancy weight and the final pre-delivery weight; (2) linear weekly gain 
using a linear regression model; and (3) calculating the area under the GWG curve [42]. In 
this study, the difference between the self-reported pre-pregnancy weight and the final pre-
delivery weight was calculated as the most feasible option. The Institute of Medicine 
recommends the GWG range according to pre-pregnancy BMI (for underweight: 28-
40lbs/12.5-18kgs; normal: 25-35 lbs/11.5-16 kgs; overweight: 15-25lbs/7.0-11.5 kgs; 
obese: 11-20lbs/5-9kgs) [43]. GWG was modelled as a categorical variable with three 
categories: 0 (as per IOM recommendations); 1 (High GWG); and 2 (Low GWG). When 
the mothers were missing pre-pregnancy BMI in the complete case analysis, BMI 23-35 
was used.  As this is calculated based on mothers’ recalled pre-pregnancy weight, it is 
subject to recall bias.  
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Maternal nutrition intake during pregnancy 
All the food intake was modelled as a binary variable in the descriptive analyses. 
Quantification was not undertaken for most food intake. Hence, a dose response was not 
examined in the present study.  
Parity 
Parity was categorised into 4 categories: 0 (nulliparous), 1, 2-3, more than 4 in the 
descriptive analyses. While controlling for parity was important, having more categories 
did not materially change the results. As parsimonious models were preferred, the number 
of categories was reduced to a binary variable (nulliparity or not) in the logistic regression 
models.   
Pregnancy intervals 
Inter-pregnancy interval was modelled as a categorical variable, classed as: less than 12 
months, 12-<18 months, 18-<24 months, 24 -<60 months, and 60 months or more. 
Pregnancy intervals could be subject to a recall bias. Although the questionnaire asked the 
month that the last pregnancy ended, more than 40% of the mothers (42.78%) did not 
remember the month. Thus, difference between the year of last pregnancy and the year of 
the most recent delivery was used to calculate pregnancy intervals when mothers were 
missing the month of last pregnancy.  
Number of ANC visits and the timing of the first ANC visit 
Number of ANC visits was coded into four categories: 0 (No ANC visits), 1-3, 4-8, more 
than 8 visits. The cut-off of four was used as WHO recommends at least four ANC visits.  
The timing of first ANC visit was examined and mean gestational weeks at the first ANC 
visit was reported. In the logistic regression models, number of ANC visits was modelled 
as a continuous variable as number of ANC visits per gestational week between the first 
ANC and time of delivery.   
Ethnicity 
Ethnicity was classified by the mother’s name by a member of the research team and 
modelled as a binary variable (reference: Northern Bhutanese).  
Working hours /shift during pregnancy 
In the literature, prolonged working hours is often defined as more than 40 hours per week. 
In order to make comparison with other studies easy, this definition was used [44].  
Working hours were classified into categories: 0 for less than 20 hours, 1 for 20 - 40 hours 
and 3 for >40 hours. Information on the shift work, whether mothers worked in shifts and 
if this included night shifts was collected. The questions did not take into account changes 
or interruption during pregnancy such as maternity leave or sick leave.  
Physical activity 
The percentage of mothers who reported having engaged in at least 10 minutes of vigorous 
or moderate physical activity through work or leisure and mean minutes of each activity 
were reported. The percentage of mothers who did not meet at least 150 minutes of 
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moderate-intensity activity per week was reported. Mother’s self-evaluation of physical 
activities during pregnancy (very active, moderately active, somewhat active, and not 
active) was also reported in the descriptive analyses. 
Access to health facility 
In order to estimate geographical accessibility to health services, mean travel time to each 
delivery hospital from the mother’s current residence was calculated based on the mother’s 
self-reported travel time in hours. Mode of transportation was also asked about in the 
questionnaire. The place of the mother’s first ANC visit, number of participants, and 
proportion of cases and controls were visualised using ArcGIS Desktop 10.3 (ESRI 2011. 
Redlands, CA: Environmental Systems Research Institute). ArcGIS is a Geological 
Information System (GIS) software. GISs are designed to capture, store, manipulate, 
analyse, manage, and present all types of geographical data. GIS programmes are capable 
of merging and analysing data on geographical positioning and attributes using a unique 
identifier. Coordinate systems define how points relate to each other and to the earth’s 
surface, using X, Y, and Z (altitude) coordinates. X and Y can be expressed as a latitude 
and longitude (in degrees), in minutes and seconds or in units that are specific to a large 
selection of map projections. The XY codes of health facilities in Bhutan were obtained 
from the MOH. Other options such as straight line or Euclidean distance or distance along 
a path, road, train or other transport network were considered. However, as Bhutan does 
not have an address system for individual houses and identification of individual locations 
is difficult, measuring straight lines or Euclidean distance using ArcGIS was not feasible 
in the present study.   
Altitude 
Mean altitude of permanent and current altitudes in meters at Gewog level (administrative 
unit below prefecture or dzongkhag level) and difference in altitudes in meters between 
permanent and current residence Gewogs were calculated to understand the impact of 
altitude of residence on adverse birth outcomes. As information on altitude at the individual 
residence level was not available, the altitude of the Gewog centre was used as a proxy for 
altitude of residence. Information on the altitudes of Gewog centres was obtained from the 
Royal Government of Bhutan.  Altitude was examined as continuous in the descriptive 
analyses and modelled as a categorical variable with four categories (<0 m (reference), 0-
<1000 m, 1000-<2000 m, and 2000 m≤).  
Seasonality 
Month of delivery in the study participants was examined and explained when there was a 
difference in the number of participants in the study. A categorical variable of season of 
month of delivery (0: Fall [September, October, and November]; 1: Winter (reference) 
[December, January, and February]; 2: Spring [March, April, and May]; 3: Summer [June, 
July and August]) was analysed in the logistic regression models.   
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Exposure to betel quid chewing (including commercial betel nut products), tobacco (cigarettes 
and smokeless tobacco), and alcohol 
 
Betel quid chewing and packaged betel nut products 
The number of nuts consumed during the last three months of pregnancy was estimated as 
explained below in order to examine the dose response. In the logistic regression models, 
consuming betel quid or packaged betel nut products were combined and modelled as 
binary variables after checking prevalence and distribution.  A categorical variable of betel 
nuts consumed during the period (0: none; 1: less than or equal to 1 nut per day; 2: more 
than 1 nut per day) was also analysed in the logistic regression. 
Calculating betel nut consumption 
Aggregate consumption during the last three month of pregnancy was calculated based on 
mother’s self-reported average number of quids per day and frequency. 
The daily consumption was multiplied by the frequency of betel quid chewing to 
calculate cumulative quids in the last three months of pregnancy. The average frequency of 
betel quid chewing was recorded as daily, weekly, monthly and others (specified). A few 
assumptions were made for “daily”- once a day or 30 days per month; for ”weekly”- once 
a week or four times a month; and for “monthly” - once a month unless specified others. 
“Rarely”, “sometimes”, and “frequently” were reclassified as “monthly”, “weekly” and 
“daily” respectively.   
In the present study, chemical analyses were not conducted and serum arecoline 
levels were not measured. 
Commercial betel nut products (Pan Masala) 
The percentage of mothers who used betel nut products during pregnancy and frequency 
was reported in the descriptive analysis.  
Tobacco (cigarettes and smokeless tobacco) 
Dose response was examined using the amount of consumption of tobacco during the last 
three months of pregnancy. In the logistic regression models, consuming cigarettes or 
smokeless tobacco during pregnancy was combined and modelled as a binary variable after 
checking prevalence and distribution in the descriptive analyses. A categorical variable of 
the total grams of smokeless tobacco with two categories (0: none; and 1: less than 5 grams 
per day) was also analysed. 
Cigarettes 
The percentage of maternal cigarette use, patterns, and quantity were reported in the 
descriptive analysis. 
Smokeless tobacco 
The question asked how many packets of smokeless tobacco the mother used on an average 
day in each month in the past 10 months.  Mean smokeless tobacco consumption in grams 
was calculated assuming one package of smokeless tobacco contains 10 grams.  
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Alcohol 
The number of days mothers drank as opposed to aggregate ethanol grams was used to 
examine a dose effect of alcohol. In the logistic regression models, consuming alcohol 
during pregnancy was modelled as a binary variable and a categorical variable. 
The graduated frequency (GF) measure was adapted. First, the maximum amount 
consumed on any day in the past 10 months was asked for different types of alcohol drinks 
(beer, wine, local sprits, local wines, liquor). Table 3.3 provides the grid used. Once the 
maximum is determined, the mother is asked how often she drank about this amount (the 
maximum), then how often did she drink about three quarters of that amount, followed by 
about half that amount and finally about one quarter of that amount.  The visual aid card 
depicted a beaker with fluid levels at three quarters, half, and a quarter full and a plastic 
cup to show the size of the cup (200ml) was used. Three variables were constructed: (1) 
total maximum volume of consumption per occasion by using the grid (sum of number of 
cups * amount of ethanol (grams) in 200 ml of each drink) was calculated: (2) total amount 
of ethanol was calculated by multiplying the amount of ethanol and frequency: and (3) 
drinking intensity was classified based on maximum volume of ethanol in grams into low 
(<20 grams), moderate (20-40 grams), and high(>40 grams).  
 
 
Table 3.3. Assumptions of alcohol concentrations in the commonly-consumed alcoholic drinks in 
Bhutan. 
Type of alcohol Brand % (v/v) Grams of 
ethanol per 200 
ml cup 
Local spirit Ara 25% 39.7 g 
Local wine Changkey, Singchang, Bangchang, Tongpa 15% 23.8 g 
Industrial Beer A Dansberg, Budweiser, Heineken, Singha 
Beer, Chang beer, Calsberg, Orchim, 
Haywards, Royal challenge, Golden eagle, 
San Miguel 
5% 7.9 g 
Industrial Beer B Druk 11000, HIT 8% 12.7 g 
Industry-made wine drink SPY 5% 7.9 g 
Table Wine Takin, Santa Barbara, Happiness 16% 25.4 g 
Port Wine  18% 28.6 g 
Liquor  Rum, Whisky, Brandy 42.8% 68.0 g 
*Gram equivalents of pure alcohol = ethanol concentration of beverage consumed X metric volume X 0.794 (relative 
weight of alcohol). Assumptions from Dorji (2012) [45] were adopted. 
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3.12 Statistical methods 
This section describes methodologies relating to the statistical analyses for outcome validation, 
descriptive analysis, logistic regression analysis using a statistical approach and a causal directed 
acyclic graph (DAG) approach, and sensitivity analysis. 
 
3.12.1 Examining validity of classification of preterm 
The distribution of gestational age at birth (in days) from LMP (date of birth - date of LMP) and 
US [280-(estimated date of delivery – date of birth)] were compared. The difference in days 
between the LMP and US estimates was calculated (LMP estimate – US estimate, hereafter referred 
to as “gestational age difference”) and analysed as a continuous variable and categorised into five 
groups (<-14, -14 to -8, -7 to +7, +8 to +14 and >+14 days). Positive values indicate that the LMP-
based gestational age estimate exceeds the US estimate and negative values indicate that the LMP-
based gestational age estimate is shorter than the US-based estimate.  
The LMP estimate of gestational age was compared to the measure of the US gold standard 
using Lin’s concordance correlation coefficient and Bland-Altman analysis for exact comparison 
of continuous values for continuous gestational days and Kappa’s coefficient for classification into 
PTB. The chi-square test for trend was used to analyse the differences in proportion of selected 
maternal and infant characteristics in five categories of the discrepancy between gestational 
estimates by LMP and US scan and in the mothers with early scans and late or no scans. Where the 
count was smaller than five, the Fisher’s exact test was reported.  Multivariate logistic regression 
was used to investigate the association between selected maternal and infant characteristics and the 
magnitude and direction of the discrepancy and the probability of having early scans compared. 
Results were presented as adjusted odds ratios with 95% confidence intervals. P-value <0.05 was 
considered statistically significant. 
 
3.12.2 Descriptive analysis 
A descriptive analysis was performed in order to understand the socioeconomic situation, 
nutritional status, physical activity, health seeking behaviours and intake of alcohol, tobacco and 
betel nut during pregnancy, as well as key obstetric factors in the study participants.  
For categorical variables, the differences in the proportion of controls and cases were tested 
using the chi-squared test.  Where the count was smaller than five, the Fisher’s exact test was 
reported. The number of study participants in each category, percentages and the corresponding P 
value were presented. 
 For continuous variables, the two-sample t test was used. When variance was not equal, 
Welch's t test was used. The number of study participants in each category, mean, standard 
deviation, and the corresponding P-value were presented. 
Similarly, controls and the mothers of term LBW or preterm were compared and presented 
in the same tables as cases.  P-value <0.05 was considered statistically significant. 
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3.12.3 Logistic regression modelling 
(a) A statistical approach 
Selected independent variables were analysed in the univariable analysis. Covariates that were 
significant at p<0.10 in addition to wealth quintile, education, ethnicity, and number of ANC visits 
were included in a multivariate logistic regression model.  Modelling of each variable was finalised 
considering its distribution and nature of the relationship with the outcome. 
Multivariable analysis models were built using Akaike Information Criterion (AIC) to 
minimise the AIC (Table J.1 in Appendix J). Multicollinearity was checked to see how the standard 
error changed as variables were added to the model (Table J.2 in Appendix J). If there is a sudden 
big increase in a standard error when a variable is added to the model, it indicates a problem.  
Two models were used. They only differed in the modelling of betel quid chewing, tobacco, 
and drinking. Model 1 used a binary variable of betel nuts during pregnancy including betel quid 
chewing or packaged betel products during pregnancy, tobacco during pregnancy including 
cigarette smoking and smokeless tobacco, and drinking during pregnancy. Model 2 used a 
categorical variable of number of betel quids consumed during the last three month of pregnancy 
with three categories (0: none; 1: less than or equal to 1 nut per day; 2: more than 1 nut per day), a 
categorical variable of the total grams of smokeless tobacco with 2 categories (0: none; and 1: less 
than 5 grams per day), and a categorical variable of number of days of drinking during the last three 
months of pregnancy with 3 categories (0: none; 1: less than or equal to once a week; and more than 
once a week). 
 
Model 1 
Logit (P) = α + 𝛽1CRRH + 𝛽2 ERRH + 𝛽3 Season(fall) + 𝛽4 Season(spring) + 𝛽5 
Season(summer) + 𝛽6 Female Infant + 𝛽7 age(<20) +  𝛽8 age(35<) + 𝛽9 
education(NFE) + 𝛽10 education(primary school) + 𝛽11 education(secondary 
school) + 𝛽12 education(diploma) + 𝛽13 wealth(poorest) +  𝛽14 
wealth(second) +  𝛽15 wealth(fourth) +  𝛽16 wealth(richest) +  𝛽17 number of 
ANC + 𝛽18 ethnicity + 𝛽19 GWG(high) +  𝛽20 GWG(low) +  𝛽21 number of 
meals per day + 𝛽22 urinary tract infection + 𝛽23 nulliparity + 𝛽24 previous 
history of preterm + 𝛽25 hypertensive disorders(chronic/pre-existing 
hypertension) + 𝛽26 hypertensive disorders(gestational hypertension) + 𝛽27 
hypertensive disorders(pre-eclampsia/eclampsia) + 𝛽28 mode of delivery(cs-
elective) +  𝛽29 mode of delivery(cs-emergency) +  𝜷𝟑𝟎betel quid/betel 
products during pregnancy + 𝛽31 cigarette/smokeless tobacco during 
pregnancy + 𝛽32alcohol during pregnancy  
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Model 2 
Logit (P) = α + 𝛽1 CRRH + 𝛽2 ERRH + 𝛽3 Season(fall) + 𝛽4 Season(spring) + 𝛽5 
Season(summer) + 𝛽6 Female Infant + 𝛽7 age(<20) +  𝛽8 age(35<) + 𝛽9 
education(NFE) + 𝛽10 education(primary school) + 𝛽11 education(secondary 
school) + 𝛽12 education(diploma) + 𝛽13 wealth(poorest) +  𝛽14 
wealth(second) +  𝛽15 wealth(fourth) +  𝛽16 wealth(richest) +  𝛽17 number of 
ANC + 𝛽18 ethnicity + 𝛽19 GWG(high) +  𝛽20 GWG(low) +  𝛽21 number of 
meals per day + 𝛽22 urinary tract infection + 𝛽23 nulliparity + 𝛽24 previous 
history of preterm + 𝛽25 hypertensive disorders(chronic/pre-existing 
hypertension) + 𝛽26 hypertensive disorders(gestational hypertension) + 𝛽27 
hypertensive disorders(pre-eclampsia/eclampsia) + 𝛽28 mode of delivery(cs-
elective) +  𝛽29 mode of delivery(cs-emergency) + 𝜷𝟑𝟎 number of betel 
quid(≤1 nut per day) during the last three months of pregnancy + 𝜷𝟑𝟏 
number of betel quid(>1 nut per day) during the last three months of 
pregnancy + 𝛽32 less than 5 grams of smokeless tobacco during the last three 
months of pregnancy + 𝛽33 frequency of drinking during the last three 
months of pregnancy(≤ once a week) +  𝛽34 frequency of drinking during the 
last three months of pregnancy( > once a week) 
 
First, the LBW and/or PTB (case) was used as an outcome and the results are provided in 
Appendix Table.J.3. Next, the sub-analyses of term LBW and PTB were conducted separately to 
compare with the DAG approach. Adjusted odd ratios are presented with their 95% CI. 
 
(b) A causal directed acyclic graph (DAGs) approach  
The aforementioned statistical models embody many parametric assumptions that are not known to 
be correct and may well be incorrect [46]. Without taking direct and indirect causal assumptions 
into account, covariates informed in a statistical approach may lead to biased estimates by 
controlling for an intermediate variable or due to an introduction of associations which are 
otherwise not related [47]. For example, if two covariates both cause a third covariate (it is called a 
“collider” in the DAG as two directed arrows collide at the covariate), then adjustment for the third 
covariate creates a conditional association between the first two covariates and could introduce bias 
[46-48]. Causal diagrams are graphical models for causal relations that can complement 
conventional models. Minimum sets of covariates controlled for in the models were identified based 
on the two criteria: (1) they should not be on the causal pathway between the exposure and outcome 
and should not be a collider; and (2) controlling them blocks every path between the exposure and 
the outcome [49].  DAGs used in the present study are provided in Chapter 2. Preterm and term 
LBW were considered separately in the DAGs as it was assumed that there were slightly different 
causal pathways from betel quid chewing leading to preterm and term LBW deliveries (Figure 2.3. 
DAG for term LBW. and Figure 2.4. DAG for PTB.). Sufficient sets from the DAGs were determined 
using DAGGITY software [50]. Separate logistic analyses were conducted using the minimum sets 
of covariates for different exposure variables.  
Table 3.4 and Table 3.5 summarise covariates controlled in the model informed by the DAG. In the 
logistic models, wealth quintile and education variables were used to represent SES. Delivery 
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hospital was used as a proxy for regionality. Number of meals per day was used as a proxy for 
inadequate or imbalanced diet.  
As for alcohol and tobacco, it was originally assumed that low SES has an indirect 
relationship with alcohol and tobacco consumption during pregnancy through psychosocial factors 
such as stress, anxiety, and abuse. Also it was assumed that there is a direct causal relationship 
between the psychosocial factors on preterm or term LBW deliveries. With these assumptions, if 
psychosocial factors were observed, a set of covariates that should be controlled for to estimate the 
total effect of alcohol on PTB or LBW would have been ethnicity, psychosocial factors, regionality, 
and seasonality. A set of covariates that should be controlled for to estimate the total effect of 
tobacco use during pregnancy on PTB or LBW would have been SES and psychosocial factors. 
However, as the present model did not aim to measure psychosocial factors, it was not possible to 
estimate the total effect of alcohol or tobacco on PTB or LBW.   
In order to measure the total effect of alcohol and tobacco on adverse birth outcomes, 
assumptions on SES and psychosocial factors were slightly modified and the modified DAG is 
presented as DAG3. DAG3 assumes that there is no direct or indirect effect of psychosocial factors 
and that there is a direct effect of SES on alcohol or tobacco consumption, leading to term LBW 
(Figure 3.4) or PTB (Figure 3.5). In this model, the total effect of alcohol on PTB can be estimated 
by controlling for several different sets of covariates such as (ethnicity, SES, regionality, and 
seasonality) or (betel quid chewing during pregnancy, ethnicity, SES, chronic hypertension, 
maternal height, maternal age, pre-pregnancy weight, and seasonality). Similarly, the total effect of 
alcohol on term LBW can be estimated by adjusting for betel quid chewing during pregnancy, 
ethnicity, SES, chronic hypertension, maternal height, maternal age, pre-pregnancy weight, and 
seasonality. Using the same DAG, the total effect of tobacco on term or preterm LBW can be 
estimated adjusting for SES. 
For the secondary outcome, anaemia, seasonality was adjusted based on the assumed causal 
framework provided in DAG 4 (Figure 3.6) and seasonality and SES were adjusted based on the 
assumed casual framework in DAG 5 (Figure 3.7). Although there seemed to be no causal effect 
between SES and betel quid chewing in Bhutan, DAG 5 was compared to DAG 4 to see the 
plausibility of the causal assumptions in DAG 4.  
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Figure 3.4. DAG3 (LBW) assuming there is no indirect or direct causal relationship between psychosocial factors and term LBW. 
Exposure 
Outcome 
Ancestor of outcome 
Ancestor of exposure and 
outcome 
Unobserved (latent) 
Causal path 
Biasing path 
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Figure 3.5. DAG3 (PTB) assuming there is no indirect or direct causal relationship between psychosocial factors and PTB. 
 
Exposure 
Outcome 
Ancestor of outcome 
Ancestor of exposure and 
outcome 
Unobserved (latent) 
Causal path 
Biasing path 
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Table 3.4. Sets of covariates to estimate the total effects on preterm delivery for different exposure variables identified in the DAG approach. 
Exposure Factors adjusted for 
Betel quid chewing during pregnancy Covariates sets 1: Ethnicity, SES, chronic hypertension, maternal height, maternal age, pre-pregnancy weight, regionality, 
seasonality  
Covariates sets 2: BQ chewing before pregnancy, seasonality 
  
Gestational weight gain Covariates sets 1: BQ during pregnancy, ethnicity, SES, chronic hypertension, imbalanced diet, maternal height, maternal 
age, regionality, seasonality  
    
  Covariates sets 2: Imbalanced diet, maternal height, pre-pregnancy weight 
    
UTI SES, seasonality 
  
Chronic hypertension BQ during pregnancy, ethnicity, SES, maternal height, maternal age, pre-pregnancy weight, regionality, seasonality 
  
PIH, Pre-eclampsia or Eclampsia  
(PIH, PE/Eclampsia) 
Alcohol during pregnancy, BQ during pregnancy, ethnicity, chronic hypertension, imbalanced diet, maternal age, tobacco 
during pregnancy 
  
C-section PIH, PE/Eclampsia, chronic hypertension, gestational weight gain, UTI 
  
Wealth quintile Regionality 
    
Education Regionality 
    
Maternal age SES 
    
Male infant No adjustment is necessary 
  
Ethnicity No adjustment is necessary  
  
 Alcohol DAG 3 : BQ during pregnancy, ethnicity, SES, chronic hypertension, maternal height, maternal age, pre-pregnancy weight, 
seasonality 
  DAG 3: Ethnicity, SES, regionality, seasonality 
  
Tobacco DAG 3: SES 
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Table 3.5. Sets of covariates to estimate the total effects on term LBW for different exposure variables identified in the DAG approach. 
Exposure Factors adjusted for 
Betel quid chewing during pregnancy Covariates set 1: Ethnicity, SES, chronic hypertension, maternal height, maternal age, pre-pregnancy weight, regionality, seasonality 
  Covariates set 2: BQ chewing before pregnancy, seasonality 
  
Gestational weight gain Covariates set 1: BQ during pregnancy, ethnicity, SES, chronic hypertension, imbalanced diet, maternal height, maternal age, regionality, 
seasonality 
  Covariates set 2: Imbalanced diet, maternal height, pre-pregnancy weight, seasonality 
  
Chronic hypertension BQ during pregnancy, ethnicity, SES, maternal height, maternal age, pre-pregnancy weight, regionality, seasonality 
  
UTI SES, seasonality 
  
Nulliparity Maternal age 
  
Wealth quintile Regionality 
    
Education Regionality 
    
Maternal age SES 
    
Sex of the infant  No adjustment is necessary  
  
Ethnicity No adjustment is necessary  
  
Alcohol DAG3: BQ during pregnancy, ethnicity, SES, chronic hypertension, maternal height, maternal age, pre-pregnancy weight, seasonality 
  
Tobacco DAG 3: SES 
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Figure 3.6. DAG 4 to show causal assumptions between betel quid chewing during pregnancy and anaemia 
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Figure 3.7. DAG 5 to show causal assumptions between betel quid chewing during pregnancy and anaemia assuming there is a direct causal relationship between SES and betel 
quid chewing  
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Sensitivity analyses for the DAG approach: 
For the DAG approach, three sensitivity analyses were conducted: (1) limiting data to mothers with 
early scans (first scan before 24 weeks) and certain LMP dates; (2) multiple imputation based on 
Missing at random (MAR) assumption; and (3) sensitivity analysis using missing not at random 
(MNAR) assumption. Handling of missing data is described in detail in the next section. Finally, 
as the second outcome variable, the relationship between anaemia and betel quid chewing during 
pregnancy was examined using the DAG approach. 
 
3.12.4 Handling of missing data 
Estimating the causal effect of interest from these data requires consideration of the measurement 
error in the exposure, and the possibility of unmeasured confounders, as well as missing data.  
Missing data may lead to biased and inefficient parameter estimates if inadequately handled 
during the analysis [51, 52]. There are several ways to handle missing data and the missing data 
mechanism plays a central role in informing the analysis.  
Rubin (1976) classified the process that governs the probability of being missing into three 
categories [53].  
 
(1) Missing completely at random (MCAR : the missingness mechanism is unrelated to any 
inference we wish to draw; 
(2) Missing at random (MAR): the missingness mechanism does not depend on the unobserved 
data; and 
(3) Missing not at random (MNAR): the missingness mechanism depends on the unobserved 
data, even after taking into account all the information in the observed data. 
 
Different missing mechanisms can result in different implications for the analysis. 
Although several tests are proposed to test MCAR versus MAR, they are not widely used and it is 
not possible to test MAR versus MNAR since the information that is needed for such a test is 
missing [53]. In practice, it is advised to postulate a missingness mechanism; identify its class, and 
perform a valid analysis for that class of missingness mechanism. In addition, sensitivity analyses 
should explore the robustness of conclusions to the suggestion of alternative plausibility when 
considering missing data [52].   
There are different ways of handling missing data. In much research, multiple imputation, 
developed by Donal B. Rubin in the 1970s is widely used to deal with incomplete data. Multiple 
imputation is a general approach which aims to allow for the uncertainty about the missing data by 
creating several different plausible imputed datasets and appropriately combining results obtained 
from each of them [54]. 
  The analysis starts with observed, incomplete data. Multiple imputation creates several 
complete versions of the data by replacing the missing values with plausible data values drawn from 
a distribution specifically modelled for each missing entry. The imputed datasets are identical for 
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the observed data entries, but differ in the imputed values. The magnitude of these differences 
reflects our uncertainty about what value to impute. The second step is to estimate the parameters 
of interest from each imputed dataset and then pool those parameter estimates into one estimate and 
estimate variance. The variance combines the conventional sampling variance (within imputation 
variance) and the extra variance caused by the missing data (between-imputation variance) [53]. 
The STATA “mi impute chained” command was used. In the imputation, binary variables 
were imputed in the logistic regression models. Nominal variables were imputed in the multinomial 
logistic regression models. Continuous variables were imputed in the regression models.  The 
“Augment” option was used to deal with perfect prediction. The “mi passive” command was used 
to transform variables after imputation.  
 To check the multiple imputation model, the Monte Carlo error was checked to see if it was 
reasonably small (Table J.4 and Table J.5 in Appendix J) and convergence was checked by plotting 
the mean estimate against the cycle (iteration) number (in this study, 100) for each variable with a 
high proportion of missing data (Figure J.1 - J.6 in Appendix J). If the imputation model is working 
well, the mean values from the imputations at successive iterations should move around randomly 
in the trace plots.   
The Monte-Carlo error represents how much variability there is due to the fact we have 
used 100 imputations. With an infinite number of imputations, the Monte-Carlo error would be zero.  
White et al. (2010) propose the following guideline to decide the number of iterations [55].  
 
1. The Monte Carlo error of a coefficient should be less than or equal to 10% of its standard 
error; 
2. The Monte Carlo error of a coefficient's T-statistic should be less than or equal to 0.1; 
and 
3. The Monte Carlo error of a coefficient's P-value should be less than or equal to 0.01 if 
the true P-value is 0.05, or 0.02 if the true P-value is 0.1. 
 
In the present research, both the multiple imputation and complete record analysis were 
conducted and if they differed, the assumptions and mechanisms causing the distinct results were 
explained. 
Finally, as the multiple imputation model assumes MAR, a sensitivity analysis was 
conducted using two MNAR assumptions to check if the variables included in the imputation model 
make MAR plausible. The multiply imputed datasets were produced with 100 times iterations in 
SAS 9.4 (SAS Institute Inc., Cary, NC, USA) using a fully conditional specification (FCS) 
statement, MNAR, and ADJUST option with an adjustment parameter (SHIFT). The MNAR 
statement imputes missing values by using the pattern-mixture model approach, assuming the 
missing data are MNAR [56]. The rest of the analysis was conducted using the aforementioned 
methods in STATA 14.1. Inferential results for these values under MNAR and results for imputed 
under MAR were compared.   
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Chapter 4  
Results of validation of outcome measurements  
 
Chapters 4 to 7 presents the results. Chapter 4 provides validation of outcome measurements. 
Chapter 5 provides a descriptive analysis of covariates, followed by a descriptive analysis of betel 
quid chewing, packaged betel products, smoking and drinking in Chapter 6. Chapter 7 provides the 
results of the multivariate analysis and sensitivity analysis.  
 
4.1 Methods 
When analysing potential risk factors for PTB, accurate classification of preterm is a very important 
factor to understand the validity of the analysis. Hence, before going to the detailed analysis of 
potential risk factors, the validity of outcome measurements, especially if there was 
misclassification of preterm, and potential impact of misclassification on the results of the studies, 
if any, was examined and discussed.  
 Uncertainties around measuring gestational age (GA) in Bhutan can arise mainly from the 
availability of early US scans and recording and accuracy of LMP.  To examine these, first, the 
percentage of mothers with information about LMP and early scans was described. Then, mothers 
with early scans were compared to mothers with late scans on selected maternal and infant 
characteristics.  Subsequently, GA estimates using the first day of LMP by mother’s recall were 
compared to the estimates by US scan. Finally, factors contributing to the differences in the 
estimates were examined.  
The details of statistical methods were described in Ch3 (see Section 3.13.1). 
 
4.2 Description of mothers with early scans and mothers with late scans 
 A total of 672 mothers were interviewed (351 cases and 321 controls) during the study period.  
Three mothers with LBW and/or PTB babies were excluded due to the exclusion criteria (age =<16 
years). A total of 669 mother-baby pairs were included in the analysis.   
 
4.2.1  Proportion of mothers without information on LMP and US scans and  
timing of US scans (n=669) 
Out of 669 mothers who participated in the study, 26% or 176 mothers of the mothers were missing 
records of the first day of LMP and 3% mothers were missing US estimates. Eighteen percent or 
117 mothers had US scans after 24 weeks or no scans. Eight percent or 51 mothers had neither 
recalled LMP nor early scans before 24 weeks’ gestation. The mean GA at the first US scan was 
16.4 (95% CI 15.9-17.0) weeks for the total study participants. The mean GA at birth by LMP 
estimate was 267 days (95% CI: 265-270) while the mean GA at birth by US was 266 days (95% 
CI: 264-268). The average difference between LMP and US estimates was 1 day (±17 days).  GA 
difference between LMP and US was within +/-7 days for 54% of the mothers, +/- 14 days for 
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73.0% and +/- 30 days for 90% among the 480 mothers with both LMP and US estimates. Among 
669 mothers, 26 % or 171 were classified as PTB by US estimate of GA. On the other hand, due to 
the large number of the mothers who were missing LMP, fewer mothers were classified as PTB by 
LMP (22.7%). The agreement was 87%. The Kappa coefficient for classification into two categories 
was 0.67, which indicates good agreement [1]. In total, 193 mothers were classified as PTB in the 
study.  Among 193 mothers, 80% had a GA based on early scans before 24 weeks and 20% were 
based on late scans or clinical estimates. 
 
4.2.2  Comparison of maternal and neonate characteristics between mothers  
with early scans and mothers with late scans 
There were no statistical differences between mothers with early scans and mothers with late scans 
in terms of proportion of cases, LBW and PTB (Table 4.1). However, more mothers with late scans 
were missing LMP estimate than mothers with early scans. 
In terms of socio-economic background, more mothers with late scans were under 20 years old or 
over 40 years old and single, divorced, or widowed, and students, unemployed, or self-employed. 
More mothers with late scans were classified in the third wealth quintile or below, had a parity 
greater than one and smoked during pregnancy (Table 4.2).  
Controlling for any other variables in the model in Table 4.3, mothers who were younger 
than 25 years old compared to age 25-<30, who smoked during pregnancy, whose parity was greater 
than two, who were single, divorced, or widowed had higher odds of having late scans or no scan. 
Interestingly, mothers who drank during pregnancy tended to have a higher odds of having early 
scans. This could be due to insufficient control of confounding factors.  Another explanation could 
be that drinking alcohol may not indicate a lack of concern about their health in the cultural context 
of Bhutan where many women believe that alcohol has medical benefits [2].  
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Table 4.1. Comparison between early scans and late scans in relation to outcome categories. 
Outcome categories 
Early scan (n=552)  Late or no scan (n=117) 
P value 
N %  N % 
Case  280 50.7  68 58.1 0.146 
        
Low birthweight  247 44.8  59 50.4 0.263 
        
Preterm Preterm 154 27.9  39 33.3 0.176 
 Missing 0 0.0  3 2.6  
        
Missing LMP  125 22.6  51 43.6 <0.0001 
        
Missing US  5 0.9  18 15.4 <0.0001 
        
Difference between 
LMP and US estimates 
<-14 41 7.4  18 15.4 <0.0001 
 -14 to -8 26 4.7  4 3.4  
 -7 to 7 240 43.5  19 16.2  
 8 to 14 55 10.0  7 6.0  
 >14 days 60 10.9  10 8.6  
 Missing  130 23.6  59 50.4  
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Table 4.2. Comparison between early scans and late scans in relation to selected maternal and neonate characteristics. 
Maternal and neonatal characteristics 
Early scan (n=552)  Late or no scan (n=117) 
P value 
N %  N % 
Delivery hospital JDWNRH 382 69.2  73 62.4 0.187 
 Gelephu 81 14.7  17 14.5  
 Mongar 89 16.1  27 23.1  
        
Sex of infant Male 257 46.6  65 55.6 0.244 
        
Age <20 27 4.9  14 12.0 <0.0001 
 20-<25 144 26.1  40 34.2  
 25-<30 211 38.2  18 15.4  
 30-<35 101 18.3  23 19.7  
 35-<40 50 9.1  13 11.1  
 40+ 19 3.4  9 7.7  
        
Marital status Single, divorced, widow  10 1.8  7 6.0 0.009 
 Married or living with a partner 539 97.6  109 93.2  
 Missing 3 0.5  1 0.9  
        
Education Never attended school 134 24.3  33 28.2 0.221 
 Non-formal education (NFE) 37 6.7  12 10.3  
 Primary 84 15.2  18 15.4  
 Middle Secondary or Secondary 252 45.7  49 41.9  
 Diploma, College, and postgraduate 45 8.2  4 3.4  
 Missing 0 0.0  1 0.9  
        
Occupation Housewife 331 60.0  73 62.4 <0.0001 
 Unemployed 3 0.5  4 3.4  
 Student  2 0.4  5 4.3  
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 Self-employed 74 13.4  20 17.1  
 Employee 140 25.4  15 12.8  
 Missing 2 0.4  0 0.0  
        
Wealth quintile Poorest 102 18.5  32 27.4 0.003 
 Second 104 18.8  28 23.9  
 Third 105 19.0  28 23.9  
 Fourth 118 21.4  15 12.8  
 Richest  119 21.6  13 11.1  
 Missing 4 0.7  1 0.9  
        
Ethnicity Southern Bhutanese 170 30.8  35 29.9 0.851 
        
Parity 0 249 45.1  47 40.2 0.001 
 1 162 29.4  21 18.0  
 2 or 3 122 22.1  35 29.9  
 4>= 18 3.3  11 9.4  
 Missing 1 0.2  3 2.6  
        
Maternal height categorical <145 42 7.6  10 8.6 0.823 
 145 - <150 108 19.6  17 14.5  
 150-<155 191 34.6  34 29.1  
 155<= 180 32.6  32 27.4  
 Missing 31 5.6  24 20.5  
        
Pre-pregnancy BMI Underweight (< 18.5) 32 5.8  3 2.6 0.473 
 Average (18.5–25.0) 245 44.4  51 43.6  
 Overweight (≥25)  83 15.0  12 10.3  
  Obese (≥30) 18 3.3  2 1.7  
 Missing 174 31.5  49 41.9  
        
Betel nut chewing during pregnancy  Yes 303 54.9  56 47.9 0.149 
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 Missing 3 0.5  0 0.0  
        
Smoking during pregnancy Yes 11 2.0  8 6.8 0.004 
        
Smokeless tobacco during pregnancy Yes 37 6.7  13 11.1 0.095 
 Missing 6 1.1  2 1.7  
        
Pan masala during pregnancy Yes 128 22.3  27 23.1 0.884 
 Missing 9 1.6  1 0.9  
        
Alcoholic drinks during pregnancy Yes 151 27.4  28 23.9 0.447 
        
Hypertensive disorder No hypertensive complications  435 78.8  80 68.4 0.478 
 Pre-existing or chronic hypertension 16 2.9  3 2.6  
 Gestational hypertension 44 8.0  11 9.4  
 Pre-eclampsia 25 4.5  8 6.8  
 Eclampsia 7 1.3  0 0.0  
 Missing 25 4.5  15 12.8  
        
UTI Yes 49 8.9  11 9.4 0.696 
 Missing 53 9.6  18 15.4  
        
Mode of Delivery SVD 336 60.9  77 65.8 0.908 
 CS-Elective 62 11.2  13 11.1  
 CS-Emerg.  144 26.1  26 22.2  
 Vacuum 7 1.3  1 0.9  
 Breech 3 0.5  0 0.0  
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Table 4.3. Crude and adjusted odds of having late scans or no US scans compared to the mothers with early scans by selected maternal characteristics. 
Maternal characteristics  Late scans vs. early scans (reference) 
Crude Odds 
Ratio 
95% CI P value Adjusted Odds 
Ratio (n=644) 
95% CI P value 
Delivery hospital (ref: JDWNRH) Gelephu 1.10 0.62-1.96 0.751 1.04 0.53-2.04 0.905 
 Mongar 1.59 0.96-2.61 0.069 1.39 0.73-2.65 0.313 
        
Age (reference: 25-<30) <20 6.08 2.72-13.60 <0.0001 5.39 1.95-14.90 0.001 
 20-<25 3.26 1.80-5.91 <0.0001 3.21 1.61-6.39 0.001 
 30-<35 2.67 1.38-5.17 0.004 2.18 1.02-4.60 0.048 
 35-<40 3.05 1.40-6.63 0.005 1.72 0.77-4.73 0.244 
 40+ 5.55 2.20-14.04 <0.0001 2.81 0.82-8.40 0.082 
        
Marital status (ref: Married or 
living with a partner) 
Single, divorced, widow  3.46 1.29-9.29 0.014 1.66 0.42-6.58 0.471 
        
Education (ref: Never attended 
school) 
Non-formal education (NFE) 1.32 0.62-2.80 0.474 1.53 0.66-3.57 0.324 
 Primary 0.87 0.46-1.64 0.668 0.96 0.47-2.00 0.921 
 Middle Secondary or Secondary 0.79 0.48-1.29 0.343 1.70 0.87-3.33 0.122 
 Diploma, College, and postgraduate 0.36 0.12-1.07 0.067 1.46 0.35-6.05 0.605 
        
Occupation (ref: Housewife) Unemployed 6.05 1.32-27.59 0.020 8.9 1.54-51.49 0.015 
 Student  11.34 2.16-59.58 0.004 14.9 1.96-113.57 0.009 
 Self-employed 1.23 0.70-2.14 0.473 1.9 1.02-3.63 0.045 
 Employee 0.49 0.27-0.88 0.016 0.8 0.38-1.66 0.539 
        
Wealth quintile (ref: Third) Poorest 1.18 0.66-2.09 0.580 0.85 0.43-1.66 0.626 
 Second 1.01 0.56-1.82 0.975 0.89 0.46-1.71 0.726 
 Fourth 0.48 0.24-0.94 0.033 0.49 0.23-1.03 0.060 
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 Richest  0.41 0.20-0.83 0.014 0.37 0.16-0.86 0.020 
        
Ethnicity (ref: Northern Bhutanese) Southern Bhutanese 0.96 0 .62-1.48 0.851 1.01 0.59-1.74 0.959 
        
Parity (ref: Nulliparity) 1 0.69 0.40-1.19 0.181 1.28 0.66-2.50 0.469 
 2 or 3 1.52 0.93-2.48 0.093 2.89 1.33-6.31 0.007 
 4>= 3.24 1.44-7.29 0.005 5.30 1.51- 18.62 0.009 
       
Chewing betel or pan masala during pregnancy 0.77 0.52-1.16 0.215 0.80 0.49-1.31 0.377 
       
Chewing smokeless tobacco or smoking during pregnancy 2.18 1.24-3.85 0.007 2.87 1.46-5.65 0.002 
       
Drinking during pregnancy 0.84 0.53-1.33 0.448 0.56 0.32-1.00 0.049 
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4.3 Understanding the difference in estimated gestational age (GA) between LMP 
estimates and US estimates 
4.3.1. Testing for normality of distribution of the GA difference between LMP estimates 
and US estimates  
The Shapiro-Wilk W test for normal data (<0.001) and the Skewness/Kurtosis tests for Normality 
(<0.001) suggest the difference in estimated GA by the two methods is not normally distributed 
(Figure 4.1and Figure 4.2). The skewness is -0.62 indicating that the difference in the estimated 
GS is skewed to the left. The Kurtosis is 6.3. 
 
 
Figure 4.1.  Distribution of the difference in estimated GA for the study participants. 
 
 
Figure 4.2. Q-Q plot of the difference in estimated GA difference. 
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4.3.2 Examining the relationship between the two estimates 
The Bland-Altman limits of agreement test analyses the differences of paired variables against the 
average of the two values in a pair (Figure 4.3) [3]. The mean difference is 1.1 (95% CI: -0.4 to 2.7) 
and the limits of agreement (Reference Range for difference) were -35.4 to 33.1. The overall Lin’s 
concordance correlation coefficient was 75.6% (95% CI: 0.720 -0.792) (Figure 4.4). 
 
 
 
Figure 4.3. Bland-Altman plots of the estimated GA by prenatal ultrasound (eddpregdays) with LMP in 
days. The B&A graph plot represents every difference between two estimates against the average. The 
mean difference is 1.135 (95% CI: -0.432 to 2.703) and the limits of agreement (Reference Range for 
difference) are -35.392 to 33.121. 
 
 
 
Figure 4.4. Concordance correlation coefficient ultrasound with LMP. 
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4.3.3  Understanding the factors contributing to the difference in estimated GA 
In Bhutan, the MCH book advises that if the difference between the LMP and US estimates are 
different by less than one week and US is done early, then the GA should be based on the LMP 
estimates and if the difference is more than one week, then it should be based on the US estimates. 
The difference in estimated GA between LMP and US was within +/-7 days for 39% of the 
mothers (Table 4.5). Twenty percent (132/669) had a GA difference of greater than +7 days (LMP 
estimate > US estimate), while 13% (89/669) had a GA difference of less than -7 days (LMP 
estimate < US estimate).  
Table 4.4 and Table 4.5 describe magnitude of difference in estimated GA in days, between 
LMP and US estimates by adverse birth outcomes and selected maternal and infant characteristics. 
Mothers with late scans had 3.5 times higher odds of the GA estimated by LMP  being 
shorter than the one by US, by more than 7 days, controlling for any other variables in the model 
(Figure 4.5 and Table 4.6), thus, classifying fewer babies as PTB by US based estimate. This could 
indicate that there is a chance of underestimating the burden of PTB if the LMP based estimate was 
more accurate than late US scans.  
 
 
Figure 4.5. Magnitude of difference in estimated GA in days, between LMP and US estimates and timing 
of the first US scan. 
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Table 4.4. Magnitude of difference in estimated GA in days, between LMP and US estimates by adverse 
birth outcomes. 
Adverse birth outcomes 
GA difference (in days): LMP-US estimate 
P 
value 
<-14 
-14 to -
8 
±7 
8 to 
14 
>+14 Missing Total 
Case Case 10% 3% 39% 7% 10% 31% 100% 0.213 
 Control 8% 6% 38% 11% 11% 26% 100%  
          
Preterm GA<259 9% 5% 38% 5% 10% 33% 100% 0.375 
 GA >=259 9% 4% 39% 11% 11% 26% 100%  
 Missing 0% 0% 0% 0% 0% 100% 100%  
          
Low 
birthweight 
Birthweight 
<2500 
10% 2% 39% 8% 9% 31% 100% 0.046 
 
Birthweight 
>=2500 
7% 6% 38% 11% 11% 26% 100%  
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Table 4.5. Magnitude of estimated difference in GA, in days between LMP and US estimates by selected maternal and infant characteristics. 
Maternal and infant characteristics 
GA difference (in days): LMP-US estimate 
<-14 -14 to -8 ±7 8 to 14 >+14 Missing Total 
Delivery hospital JDWNRH 10% 4% 44% 10% 10% 22% 100% 
 Gelephu 9% 9% 34% 7% 12% 29% 100% 
 Mongar 5% 1% 25% 8% 12% 53% 100% 
         
Timing of scans <=24 7% 5% 43% 10% 11% 24% 100% 
 >24 15% 3% 16% 6% 9% 50% 100% 
         
Sex of infant Male 9% 5% 36% 9% 12% 28% 100% 
 Female 9% 4% 41% 10% 9% 28% 100% 
         
Age <20 20% 2% 24% 10% 5% 39% 100% 
 20-<25 10% 6% 34% 10% 11% 29% 100% 
 25-<30 7% 6% 44% 12% 12% 20% 100% 
 30-<35 8% 2% 43% 6% 10% 32% 100% 
 35-<40 6% 5% 37% 5% 11% 37% 100% 
 40+ 11% 0% 36% 7% 7% 39% 100% 
         
Marital status Single, divorced, widow  6% 0% 35% 6% 0% 53% 100% 
 Married or living with a partner 9% 5% 39% 9% 11% 28% 100% 
 Missing 0% 0% 25% 25% 25% 25% 100% 
         
Education Never attended school 10% 2% 32% 4% 10% 42% 100% 
 Non-formal education (NFE) 8% 6% 27% 14% 8% 37% 100% 
 Primary 7% 8% 37% 5% 9% 34% 100% 
 Middle Secondary or Secondary 10% 5% 44% 12% 10% 19% 100% 
 
Diploma, College, and 
postgraduate 
2% 2% 49% 12% 18% 16% 100% 
 Missing 0% 0% 0% 0% 0% 100% 100% 
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Occupation Housewife 9% 5% 37% 9% 11% 29% 100% 
 Unemployed 0% 0% 14% 0% 0% 86% 100% 
 Student  14% 0% 29% 0% 0% 57% 100% 
 Self-employed 10% 3% 34% 7% 9% 37% 100% 
 Employee 8% 3% 47% 13% 12% 17% 100% 
 Missing 0% 0% 50% 0% 0% 50% 100% 
         
Wealth Quintile Poorest 10% 1% 30% 7% 12% 40% 100% 
 Second 14% 7% 33% 7% 8% 31% 100% 
 Third 8% 9% 34% 8% 8% 32% 100% 
 Fourth 5% 3% 50% 14% 11% 18% 100% 
 Richest  7% 2% 47% 11% 14% 20% 100% 
 Missing 0% 0% 60% 0% 0% 40% 100% 
         
Ethnicity Southern Bhutanese 10% 5% 47% 9% 9% 19% 100% 
 Northern Bhutanese 8% 4% 35% 9% 11% 32% 100% 
         
Parity 0 9% 4% 44% 9% 13% 21% 100% 
 1 10% 7% 37% 11% 10% 26% 100% 
 2 or 3 8% 4% 35% 8% 9% 36% 100% 
 4>= 7% 0% 21% 3% 3% 66% 100% 
 Missing 0% 0% 0% 0% 0% 4% 100% 
         
Maternal height categorical <145 19% 4% 25% 12% 17% 23% 100% 
 145 - <150 10% 4% 38% 10% 11% 26% 100% 
 150-<155 8% 5% 39% 11% 9% 27% 100% 
 155<= 6% 4% 47% 7% 11% 25% 100% 
 Missing 7% 5% 22% 5% 5% 55% 100% 
         
Pre-pregnancy BMI Underweight (< 18.5) 9% 6% 46% 9% 9% 23% 100% 
 Average (18.5–25.0) 9% 4% 44% 11% 10% 21% 100% 
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 Overweight (≥25)  5% 2% 44% 12% 12% 25% 100% 
  Obese (≥30) 5% 5% 35% 15% 25% 15% 100% 
 Missing 10% 6% 28% 6% 9% 41% 100% 
         
Betel nut chewing during pregnancy  Yes 9% 4% 37% 10% 11% 29% 100% 
 Missing 0% 0% 1% 0% 0% 2% 100% 
         
Smoking during pregnancy  Yes 5% 0% 42% 5% 16% 32% 100% 
         
Snuff and chewing tobacco during pregnancy Yes 8% 4% 28% 6% 16% 38% 100% 
 Missing 13% 0% 50% 0% 13% 25% 100% 
         
Pan Masala during pregnancy Yes 9% 8% 42% 11% 7% 23% 100% 
 Missing 10% 0% 80% 0% 0% 10% 100% 
         
Alcoholic drinks during pregnancy Yes 9% 6% 38% 8% 11% 28% 100% 
         
Hypertensive disorder No hypertensive complications  9% 5% 40% 10% 11% 25% 100% 
 
Pre-existing or chronic 
hypertension 
11% 0% 37% 5% 11% 37% 100% 
 Gestational hypertension 5% 5% 35% 7% 9% 38% 100% 
 Pre-eclampsia 15% 0% 30% 3% 18% 33% 100% 
 Eclampsia 14% 0% 29% 0% 14% 43% 100% 
 Missing 8% 5% 35% 5% 3% 45% 100% 
         
Mode of Delivery SVD 9% 5% 38% 10% 10% 28% 100% 
 CS-Elective 8% 5% 33% 13% 15% 25% 100% 
 CS-Emerg.  8% 4% 42% 6% 11% 29% 100% 
 Vacuum 13% 0% 38% 13% 0% 38% 100% 
 Breech 33% 0% 33% 0% 0% 33% 100% 
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Table 4.6. Results of logistic regression analysis for the odds of having a difference in estimated GA of more than ±7 days. 
 GA difference 
>7 vs. -7≥ to +7  <-7 vs. -7≥ to +7 
Adjusted 
Odds Ratio 
(n=377) 
95% CI P value  
Adjusted 
Odds Ratio 
(n=337) 
95% CI P value 
Timing of US (ref: early scans) Late scans 1.61 0.74-3.49 0.231  3.45 1.58-7.55 0.002 
         
Delivery hospital (ref: JDWNRH) Gelephu 1.46 0.74-2.90 0.277  1.63 0.75-3.53 0.214 
 Mongar 1.49 0.74-3.01 0.265  0.65 0.23-1.80 0.404 
         
Age (ref: 25-<30) <20 1.36 0.40-4.65 0.620  2.57 0.78-8.51 0.122 
 20-<25 1.23   0.69-2.22 0.480  1.42 0.70-2.86 0.328 
 30-<35 0.54 0.27-1.08 0.082  0.54 0.23-1.26 0.153 
 35-<40 0.63 0.26-1.55 0.318  0.78 0.26-2.33 0.658 
 40+ 0.47 0.12-1.77 0.263  0.46 0.10-2.08 0.311 
         
Marital status  
(ref: Married or living with a partner) 
Single, divorced, widow  0.32 0.03-2.99 0.318  0.27 0.03-2.86 0.277 
         
Education (ref: Never attended school) Non-formal education (NFE) 1.52 0.55-4.16 0.417  1.71 0.53-5.56 0.370 
 Primary 0.78 0.34-1.80 0.558  1.04 0.42-2.54 0.934 
 Middle Secondary or Secondary 1.15 0.58-2.30 0.685  1.15 0.52-2.52 0.733 
 
Diploma, College, and post 
graduate 
1.66 0.58-4.76 0.342  0.56 0.10-3.24 0.515    
         
Occupation (ref: Housewife) Student - - -  1.78 0.10-30.60 0.691 
 Self-employed 0.92 0.44-1.94 0.828  1.44 0.60-3.49 0.415 
 Employee 0.99 0.54-1.82 0.978  0.91 0.42-1.94 0.803 
         
Wealth quintile (ref: Third) Poorest 1.37 0.63-2.97 0.433  0.87 0.37-2.06 0.755 
 Second 1.04 0.47-2.30 0.914  1.30 0.60-2.82 0.509 
 Fourth 1.05 0.52-2.10 0.898  0.32 0.13-0.79 0.014 
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 Richest  1.21 0.57-2.55 0.626  0.43   0.17-1.08 0.073 
         
Ethnicity (ref: Northern Bhutanese) Southern Bhutanese 0.64 0.38-1.07 0.089  0.64 0.35-1.19 0.163 
         
Parity (ref: Multiparty) Nulliparity 0.72 0.42-1.22 0.217  0.57 0.30-1.11 0.096 
         
Chewing betel or pan masala during pregnancy 1.13 0.70-1.84 0.618  1.08 0.60- 1.94 0.794 
        
Chewing smokeless tobacco or smoking during pregnancy 1.56 0.70-3.47 0.274  0.66 0.22-1.97 0.454 
        
Drinking during pregnancy 1.03 0.61-1.74 0.899  0.73   0.37-1.44 0.363 
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4.4. Conclusions 
In the sample population, for mothers with both LMP and US information, the LMP and US based 
estimate demonstrated a good agreement. The average difference between LMP and US based 
estimates was 1 day (±17 days). Uncertainty of classification of PTB could be mostly introduced 
by estimating GA from late US scans.   
There were no statistical differences between mothers with early scans and mothers with 
late scans in terms of proportion of cases, LBW and PTB. However, more mothers with late scans 
were missing LMP estimates than mothers with early scans. In terms of socio-economic background, 
more mothers with late scans were younger than 25 years old, divorced, or widowed, students, self-
employed and unemployed. More mothers with late scans had a parity greater than one and smoked 
during pregnancy according to a logistic regression model controlling for any other variables in the 
model. Wealthier mothers had a more than 50% reduced odds of having late scans or no scans 
compared to the middle quintile.  
With regard to the magnitude of the difference in estimated GA between LMP and US 
based estimates, mothers with late scans had higher odds of having a difference between LMP and 
US estimates of GA of greater than 7 days. 
In order to examine the impact of this uncertainty, in the multivariate analyses examining 
the potential risk factors of adverse birth outcomes, an analysis limited to mothers with early scans 
before 24 weeks of gestation will be conducted and compared to the analyses using the whole 
dataset.  
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Chapter 5  
Results of descriptive analysis of the study population and 
selected maternal and infant characteristics 
 
In the previous chapter, the validity of the outcome measures was explored and it was concluded 
that the classification of PTB was relatively reliable with slight uncertainties in estimating GA due 
to late US scans or no scans.  Using these outcome measures, a descriptive analysis was performed 
in order to understand the socioeconomic situation, nutritional status, physical activity and key 
obstetric factors of the study participants.  
For categorical variables, the differences in the proportion of controls and cases were tested 
using the chi-squared test. If any expected values were equal to or smaller than five, Fisher’s exact 
test was used. The number of study participants in each category, percentages and the corresponding 
P value were presented. 
  For continuous variables, the two-sample t test was used. When variance was not equal, 
Welch's t test was used. The number of study participants in each category, mean, standard 
deviation, and the corresponding P value were presented. 
Similarly, controls and mothers of LBW or PTB babies were compared and presented in 
the same tables as cases.   
These analyses will inform the logistic regression models using a statistical approach and 
missing data and subsequent sensitivity analysis using the directed acyclic graph approach.   
 
5.1 Recruitment of cases and controls at the three referral hospitals  
According to the national surveillance data, there were 5601 deliveries at these hospitals, of which 
64  were stillbirths, in the year 2015 [1]. 
During the study period from February 2015 to the beginning of March 2016, 5,472 
mothers of singleton live births were eligible (468 mothers for cases and 5,000 for controls) based 
on the birth register from the three study sites (Figure 5.1). There were 464 mothers of LBW babies 
and 302 mothers of PTB babies (204 babies were both LBW and PTB). In the source population 
(singleton live births), prevalence of LBW was 8.5% [464/5468]. Of the eligible cases, 76% 
[357/468] were asked for consent and 74% [348/468] participated in the study (Figure 5.2). The 
main reasons for not approaching the cases for consent was that the mothers had already been 
discharged. Approximately 2% of the mothers did not consent. The main reasons given by the 
mothers were that they were feeling tired or feeling shy.  
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Figure 5.1. Number of total singleton live births from mothers aged >=17 at the three referral hospitals in Bhutan between February 2015 and February 2016. 
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Figure 5.2. Recruitment of cases and controls (the number of refusals in the control group at ERRH is not reflected in the chart as the information was not documented). 
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5.2  Delivery hospital  
In total, 672 mothers were interviewed. Three mothers with low LBW and/or PTB babies were 
excluded due to the exclusion criteria (age <17 years). A total of 669 mother-baby pairs were 
included in the analysis (Figure 5.4).  Case mothers comprised 193 mothers of PTB babies, 152 
mothers of term LBW babies, and three mothers of babies whose birthweight was less than 2500 
grams but whose GA was uncertain. About 68% of the total study participants were recruited at 
JDWNRH, followed by ERRH in Mongar (17%) and CRRH in Gelephu (15%) (Figure 5.3, Table 
5.2, and Table 5.3). 
 
 
 
Figure 5.3. Number of participants by hospital. 
 
 
Table 5.1. Number of recruited cases and controls by hospital 
Hospital 
Total (n=669)  Control (n=321)  Case (n=348) 
N %  N %  N % P value 
JDWNRH 455 68%  215 67%  240 69% 0.853 
Gelephu 98 15%  49 15%  49 14%  
Mongar 116 17%  57 18%  57 17%  
 
 
 
 
 
JDWNRH , 68.0%
Gelephu, 14.7%
Mongar, 17.3%
Number of participants by hospital (n=669)
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Table 5.2. Number of term LBW and controls by hospital 
Hospital 
Control (n=321)  Term LBW (n=152) 
N %  N % P value 
JDWNRH 215 67%  102 67% 0.999 
Gelephu 49 15%  23 15%  
Mongar 57 18%  27 18%  
 
 
Table 5.3. Number of PTB and controls by hospital 
Hospital 
Control (n=321)  PTB (n=193) 
N %  N % P value 
JDWNRH 215 67%  138 70% 0.708 
Gelephu 49 15%  26 13%  
Mongar 57 18%  32 16%  
 
 
 
Figure 5.4. Description of the study participants 
 
 
5.3. Distribution by delivery month 
The number of recruited cases and controls varied by month (p<0.05) (Figure 5.5 and Figure 5.6). 
In February 2015, as the study was just launched, the research team focused on interviewing more 
cases to become familiar with the process. The focus was on not missing cases thereafter. While 
the actual study period was from February 2015 to the beginning of March 2016, it was originally 
planned to end in December 2015 and was extended due to insufficient sample size. There was 
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some confusion at JDWNRH in January 2016 and data collection was suspended for two weeks, 
which could explain the lower number of participants in January 2016. In the last month of the 
study period, the team focused on interviewing more controls to match the number of cases to avoid 
overloading staff during the royal birth13.  
 
 
 
Figure 5.5. Recruitment of cases compared to the total number of eligible mothers. 
 
 
Figure 5.6. Recruitment of controls compared to the total number of eligible mothers. 
 
                                                          
13 Bhutan’s Queen gave birth to the Crown Prince in February 2016. 
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5.4 Descriptive analysis of maternal and infant characteristics (general) 
5.4.1 Socioeconomic status  
(a) Age, marital status, and education  
Mean maternal age at the time of delivery was 27.5 years old. There were more mothers aged under 
20 years and over 40 years in the cases compared to the controls (<20 years :control 4.4% [14/321] 
vs case 7.8% [27/348]; and 40+years : control 1.6% [5/321] vs case 6.6% [23/348]). Data suggested 
an association between age categories and adverse outcomes in the descriptive analysis (p=0.003) 
(Table 5.4).  
Of the sample, 98% of the women were married.  More than 20% of the mothers had not 
had any form of education, while 60% attended middle secondary education or more. The 
percentage of mothers who completed professional diploma, college or postgraduate education was 
9%. Similarly, 17% of the husbands or partners never had any form of education. Two percent had 
non-formal education and another 2% had monastic education. More than 50% had middle 
secondary education or more. 
Other national surveys reported notably lower levels of highest education attainment. For 
example, a national non-communicable disease survey conducted in 2014 reported that out of 2,819 
respondents aged between 18 and 69 years old, 63% had no formal schooling, 14% had less than 
primary school, 9% had completed primary school, 7% had completed secondary school, 5% had 
completed high school, 2% had completed college/university, and 1% had completed postgraduate 
degree studies [2]. 
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Table 5.4. Age, marital status, education and adverse birth outcomes. 
Age, marital status, education  
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P value  N % P value  N % P value 
Age (years) <20  14 4.4%  27 7.8% 0.003  9 5.9% 0.049  18 9.3% 0.002 
 20-<25 85 26.5%  99 28.5%   40 26.3%   57 29.5%  
 25-<30 123 38.3%  106 30.5%   51 33.6%   54 28.0%  
 30-<35 66 20.6%  58 16.7%   24 15.8%   34 17.6%  
 35-<40 28 8.7%  36 10.1%   18 11.8%   17 8.8%  
 40+ 5 1.6%  23 6.6%   10 6.6%   13 6.7%  
                
Marital Status Married or living with a partner 321 97.2%  336 96.6% 0.295  149 98.0% >1.000  185 95.9% 0.129 
 Missing 3 0.9%  1 0.3%   1 0.3%   0 0.0%  
                
Mother's Highest level of 
education attained 
Never attended school 72 22.4%  95 27.3% 0.180  48 31.6% 0.094  47 24.4% 0.472 
 Non-formal education (NFE) 28 8.7%  21 6.0%   11 7.2%   10 5.2%  
 Primary 43 13.4%  59 17.0%   26 17.1%   33 17.1%  
 Middle Secondary or Secondary 154 48.0%  147 42.2%   55 36.2%   89 46.1%  
 Diploma, College, and postgraduate 24 7.5%  25 7.2%   12 7.9%   13 6.7%  
 Missing 0 0.0%  1 0.3%   0 0.0%   1 0.5%  
                
Husband education's highest 
level of education attained 
Never attended school 44 13.7%  72 20.7% 0.203  38 25.0% 0.122  34 17.6% 0.601 
 NFE 8 2.5%  8 2.3%   3 2.0%   5 2.6%  
 Primary 71 22.1%  72 20.7%   32 21.1%   39 20.2%  
 Middle Secondary or Secondary 132 41.1%  127 36.5%   52 34.2%   74 38.3%  
 Diploma, College, and postgraduate 53 16.5%  47 13.5%   19 12.5%   28 14.5%  
 Monastic Education 8 2.5%  6 1.7%   3 2.0%   3 1.6%  
 Divorced 5 1.6%  10 2.9%   2 1.3%   7 3.6%  
 Missing 0 0.0%  6 1.7%   3 2.0%   3 1.6%  
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(b) Wealth Index  
After examining 17 asset variables, 13 (ownership of watch, mobile phone, bicycle, motor cycle, 
car, computer, foreign bow, camera, VCR/VCD, DVD player, silk dress (gho, kira, sari or suits), 
access to improved sanitation, finished walls, finished floor, number of persons in a sleeping room) 
were included to create a wealth index which was used to group the study population into quintiles. 
Access to improved water supply, using solid fuel for cooking, having a kitchen as a separate room, 
and a finished roof were not included after checking the correlation matrix (Table 5.6). Data shows 
weak or no association between adverse birth outcomes and wealth quintile (p<0.198) (Table 5.7). 
Compared to the 2010 BMIS, the percentage of asset ownership was higher in general in 
the present study (Table 5.5). This could be the result of capturing more urban dwellers in the 
sample population or rapid urbanisation and modernisation especially after democratisation in 2008.   
 
 
Table 5.5. Proportion of asset ownership and comparison with the BMIS 2010 survey. 
Asset variables 
The present study  BMIS (2010) 
% or Means (SD)  % or Means (SD) 
Use of solid fuel for cooking 4.8%  39.5% 
Motorcycle 5.4%  3.6% 
Foreign bow 9.4%  5.8% 
Bicycle 10.8%  5.2% 
Computer 30.2%  8.0% 
Car 30.5%  14.2% 
Camera 35.1%  13.2% 
Silk dress 43.1%  12.7% 
VCR/VCD/DVD Player 45.1%  25.4% 
Finished Floor 56.5%  26.5% 
Watch 67.6%  58.9% 
Finished walls 76.4%  46.3% 
Improved sanitation 80.9%  63.3% 
Finished roof 95.4%  85.4% 
Not cooking in the bedroom 96.4%  74.3% 
Mobile phone 96.7%  84.7% 
Improved water 98.4%  96.1% 
Number of persons per bed room 0.6 (0.4)  3.2 (1.7) 
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Table 5.6. Factor scores for each variable included in principal component analysis. 
Asset variables Factor1 Factor2 Factor3 
Camera 0.22862 -0.02727 -0.28036 
Computer 0.18760 0.00484 0.12733 
Car 0.17632 -0.04161 -0.07731 
Bicycle 0.13905 -0.19183 0.23474 
Silk dress 0.10328 -0.00387 -0.14417 
Improved sanitation 0.09590 0.04286 0.07146 
Finished walls 0.09560 0.11267 0.22284 
Foreign bow 0.08458 -0.27825 -0.22346 
VCR/VCD/DVD Player 0.08097 0.03214 -0.05779 
Mobile phone 0.06870 0.49561 -0.19115 
Watch 0.06844 0.15903 -0.06327 
Finished Floor 0.05733 0.10405 0.41615 
Motor cycle 0.04665 -0.12558 0.12586 
Number of persons per bed room 0.02734 0.03598 0.02199 
 
 
Table 5.7. Wealth quintile and adverse birth outcomes. 
Wealth 
quintile 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % 
P-
value 
 N % 
P-
value 
 N % 
P-
value 
Poorest 55 17.2%  78 22.4% 0.198  37 24.3% 0.372  40 20.7% 0.402 
Second 67 20.9%  65 18.7%   29 19.1%   36 18.7%  
Middle 59 18.4%  74 21.3%   29 29.1%   44 22.8%  
Fourth 63 19.7%  70 20.1%   31 20.4%   38 19.7%  
Richest 73 22.8%  59 17.0%   26 17.1%   33 17.1%  
Missing 3 0.9%  2 0.6%   0 0.0%   2 1.0%  
 
 
(c) Ethnicity 
A previous study reported that there was a statistical significant difference in birth weight by 
ethnicity [3]. In the study, which used the information from the national referral hospitals on 13,647 
singleton neonates of GA between 37 completed weeks and 41 weeks 6 days between January 2011 
and December 2014, the mean birthweight was 3,177± 435 g (the mean birth weight of northern 
Bhutanese was: 3,260 ± 436 g and the mean of southern Bhutanese was: 3,060 ± 411 g). Ethnicity 
was classified by the mother’s name and language by a member of the research team. About 31% 
(205/669) were identified as southern Bhutanese. There were no statistically significant differences 
in proportion of mothers of southern Bhutanese origins between cases and controls (p=0.572) 
(Table 5.8).  
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Table 5.8. Ethnicity and adverse birth outcomes. 
Ethnicity 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % 
P-
value 
 N % P-value  N % P-value 
Southern 
Bhutanese 
95 29.6%  110 31.6% 0.572  58 38.2% 0.063  193 26.42% 0.440 
 
 
(d) Urban and rural residence  
Residential status was classified as urban or rural based on the population census classification 
using a list of villages and thromdes codes obtained from the National Statistics Bureau and 
reviewed by a local research assistant for consistency.  Permanent address is where the mothers  
registered for the census whereas current residence is where they were staying at the point of 
delivery. Only 9% (60/669) of the study population were originally from urban areas whereas 55% 
(372/669) were staying in urban areas at the point of delivery, indicating the mothers moved from 
their original rural residence to an urban residence at some point before delivery.  Of those who 
stayed in urban areas at the point of delivery, more were in the richest category compared to the 
rural areas (p=0.003) (Table 5.9), suggesting urban and rural disparities of wealth. However, the 
data show weak or no association between adverse birth outcomes and urban residence (p=0.932) 
(Table 5.10).  
 
 
Table 5.9. Wealth quintile and urban residence. 
Ethnicity 
Urban (n=372)  Rural (n=296) 
N %  N % P-value 
Poorest 64 17.3%  69 23.3% 0.003 
Second 65 17.5%  67 22.6%  
Middle 73 19.7%  60 20.3%  
Fourth 74 20.0%  58 19.6%  
Richest 92 24.8%  40 13.5%  
 
 
Table 5.10. Urban residence and adverse birth outcomes. 
Urban 
residence 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
Urban 
current 
residence 
(n=372) 
178 55.5%  193 55.5% 0.932  82 54.0% 0.759  108 56.0% 0.810 
Missing 0 0.0%  2 0.6%   0 0.0%   2 1.0%  
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(e) Altitude 
Bhutan’s elevation varies from 160 to 7,500 meters above sea-level. Thimphu (JDWNRH), the 
capital, is located 2,320 meters above sea-level; Mongar town (ERRH) is located 1,541 meters 
above sea-level and Gelephu town (CRRH) is situated 224 meters above sea-level. 
The altitude of gewog centre (administrative unit below prefecture or dzongkhag level) was 
used as a proxy for altitude of residence. Mean altitude of current gewog was 1,823 meters above 
sea-level (Figure 5.8). On average, mothers moved to a gewog 557 meters higher than their original 
gewog at some point before delivery (Figure 5.7 and Figure 5.9). Data show weak or no association 
between adverse birth outcomes and difference in altitudes (p=0.2305) (Table 5.11). 
 
 
 
Figure 5.7. Birth weight and permanent gewogs (in meters). 
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Figure 5.8. Birth weight and altitude of current gewog (in meters). 
 
 
 
Figure 5.9. Birth weight and differences in altitudes (meters) between permanent and current gewogs.  
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Table 5.11. Altitude (in meters) and adverse birth outcomes 
Altitude (in meters) 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
Altitude of current residence (meters) 307 1791 (781)  338 1853 (753) 0.3067  149 1796 (763) 0.9483  186 1890 (748) 0.1611 
Difference between current and permanent altitudes (meters) 301 512 (918)  333 596 (888) 0.2305  147 593 (880) 0.3680  183 591 (895) 0.3475 
                
                
By ethnicity: Southern 
Bhutanese (n=205) 
Altitude of current residence (meters) 91 1662 (883)  108 1731 (844) 0.5707  56 1755 (844) 0.5251  51 1693 (854) 0.834 
 
Difference between current and 
permanent altitudes (meters) 
88 898 (1043)  106 1008 (953) 0.4486  56 1028 (966) 0.4450  49 961 (135) 0.7169 
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(f) Employment situations of study participants and partner  
Among the case mothers, 61% were housewives including those who were engaged in farming 
(16%) or weaving (7%) at home. Among 245 (36%) employed mothers, 36% were self-employed 
and 28% were employed in the public sector including education and health. The majority of the 
self-employed mothers were engaged in retail shop-keeping (42%) or farming (35%). Employment 
activities of the rest included weaving, embroiling, herding, managing a travel agency and other 
businesses. In total, 15% of the case mothers were engaged in farming either as self-employed 
farmers or assisting with family farming. Partner’s occupation is described in Figure I.1 in 
Appendix I. 
Sixty one percent of the employed mothers and 47% of the self-employed mothers worked 
more than 40 hours per week (Figure I.2 in Appendix I). Although information regarding timing 
was not included in the survey, a few mothers mentioned that they resigned or went on leave in 
their third trimester.  
Among mothers who worked in weaving, farming, shop-keeping and office work, in 
addition to house chores, most of the pregnant women (91%) worked during the day time while 5% 
worked in rotating shift work with night or fixed night work, or stayed from morning to night in 
their own shops (Figure I.3 in Appendix I). Occupations of mothers who worked in rotating shift 
work included police officers, security-related workers, service-related workers including hotel 
managers, housekeepers and bar or karaoke staff.   
There were no statistically significant different associations between pregnancy outcomes 
and maternal occupation, working hours or working shifts in the descriptive analyses (maternal 
occupation p= 0.362; working hours: p=0.990; and working shift: p= 0.753, table not presented).   
 
(g) A summary of key findings from the analysis of socio-economic factors  
The study was able to capture more than 70% of the total PTB and/or LBW mothers and 
the refusal rate was low. However, there is a possibility of interview bias in that those mothers who 
cannot speak or write may not be willing to participate in research. The descriptive analysis of 
socio-economic factors suggested an association between age and adverse outcomes but showed 
little variation by education, wealth quintile, ethnicity, occupation, marital status, urban residence 
and altitude. The analysis also revealed that the study participants had a higher level of educational 
attainment and more often lived in urban areas compared to other national level surveys such as a 
recent STEPS survey in 2014. This could imply that the study participants represent those who had 
complications or were referred by primary health care facilities, also those who preferred to deliver 
at the referral hospitals who have the means and knowledge to come to the referral hospitals and 
may have a higher education, better access to the health facilities and higher wealth level compared 
to the general population. Selected socioeconomic factors are further examined in the multivariable 
analysis in Chapter 7 and discussed in comparison with other studies in Chapter 8.   
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5.4.2 Health seeking behaviour 
(a) Number of ANC visits and timing of ANC 
Of the sample mothers, only 2% (13/669) had no ANC visits. 83% (558/669) of the mothers had at 
least four ANC visits as per WHO recommendation. Three mothers were missing information on 
the number of ANC visits.   
Mean number of ANC visits was 5.6 (SD=6.2, 95% CI 5.4-5.7) (Table 5.12). Mothers of 
LBW and PTBs had fewer ANC visits (term LBW vs no-LBW: 5.7 vs 6.7; PTB vs Non-PTB: 3.8 
vs 6.7) and the difference was statistically significant (p<0.0001).  Number of ANC visits was coded 
into four categories: 0 (no ANC visits), 1-3, 4-8, more than 8 times (Table 5.12). The cut-off of four 
was used as WHO recommended at least four ANC visits.  The data suggest a strong association 
between number of ANC visits and adverse birth outcomes.  
Mean gestational weeks at the first ANC visit was 15 weeks (mean 15.2, SD=6, 95% CI 
14.7-15.7). There were no statistically significant differences in the mean gestational weeks 
between cases and controls (Table 5.13).   
This indicates that the timing of the first ANC was not particularly late for the mothers of 
adverse delivery outcomes (Figure 5.10). However, the number of ANC visits was lower. This 
could be due to shorter pregnancy duration or could indicate insufficient management of pregnancy 
or screening of potential high risk pregnancy.  
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Table 5.12. Mean number of ANC and standard deviation by adverse birth outcomes. 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
Number of ANC visits 319 6.7 (1.7)  346 4.6 (2.0) <0.0001  151 5.7 (1.8) <0.0001  193 3.8 (1.7) <0.0001 
 
 
Table 5.13. Number of ANC (categorical) and adverse birth outcomes. 
Number of ANC 
GA weeks  
at the 1st visit (n=652) 
 Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
Mean (SD) P-value  N %  N % P-value  N % P-value  N % P-value 
Number of ANC visits - <0.0001  0 0.0%  12 3.5% <0.0001  2 1.3% <0.0001  9 4.6% <0.0001 
1 to 3 times 21 (7)   7 2.2%  88 25.3%   14 9.2%   73 37.6%  
4 to 7 times 15 (6)   204 63.6%  222 63.8%   112 73.7%   110 56.7%  
8 times or more 12 (4)   108 33.6%  24 6.9%   23 15.1%   1 1.0%  
Missing -   2 0.6%  2 0.6%   1 0.7%   0 0.0%  
 
 
Table 5.14. Gestational weeks at the 1st ANC visit by adverse birth outcomes. 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
GA weeks at 1st ANC 319 14.9 (6.2)  333 15.6 (6.5) 0.1705  294 15.7 (6.2) 0.2052  184 15.5 (6.8) 0.3222 
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Figure 5.10. Number of ANC visits in relation to the timing of the 1st ANC visit. 
 
 
(b) Location of ANC visits 
The following map (Figure 5.11) summarises the cases and controls by location of ANC visits.  
 
 
 
Figure 5.11. Number of participants with the proportion of cases by ANC facility (n=610). The size of the 
graph represents the size of the total number of participants who registered at ANC clinics. Red represents 
the proportion of cases out of the total while green represents the proportion of controls. Note: the 
following ANC centres were not included in the map due to lack of geographic information. Chuhukha 
(Baikunza Sub-Post and Chapchha BHU), Dagana (Lunana BHU), Haa (Haa IMTRAT Hospital), Lhuentse 
(Dangling BHU, Ganglakhema BHU, and Thimyul BHU), Pema Gatshel (Borangma Sub-Post, Khangma Sub-
Post, and Naskhar Sub-Post), Punakha (Goenshari BHU), Samdrup Jongkhar (Maenjiwoong BHU), Samtse 
(Ganthong BHU, Sangang Chhoeling BHU, Sengteng BHU, and Ugyentse BHU), Sarpang (Chokorling BHU, 
Jangchubling BHU, and Lhayul BHU), Thimphu (Kuzugchen BHU), Trashigang (Jeonkhar BHU), 
Tashiyangtse (Jangphutse sub-post), Trongsa(Kella Sub-post), Tsirang(Barshong BHU and Pungtenschuu 
BHU), Wandue Phodrang (Esa BHU I, Khotokha sub-post, Manas BHU, and Namregang BHU). 
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(c) Reasons for delivery at this hospital 
The most common reason was for better health care and services (Table 5.15). Second, 30% 
(201/669) was referral from other hospitals. In addition to those referred, 3% (19/669) had a medical 
condition such as pain or bleeding or had been advised by doctors due to high blood pressure, 
bleeding, or past obstetric records and came voluntarily to the referral hospitals. Among those who 
were referred, advised, or had a medical condition (pain or bleeding), 57% delivered by caesarean 
section and approximately half of the mothers delivered LBW (54%) or PTB babies (40%).   
More control mothers delivered at the referral hospital for better health care and services 
than cases (control 51.1% [164/321] vs case 43.1% [150/348]). On the other hand, more case 
mothers were referred to the delivery hospital (control 25.6% [82/321] vs case 34.2% [119/348]) or 
had some medical condition that motivated them to deliver at the referral hospitals voluntarily 
(control 0.6% [2/321] vs case 4.3%[15/348]) (p=0.003) than controls.  
 
 
Table 5.15. Reasons of delivery and adverse birth outcomes. 
 
Control 
(n=321) 
 Case (n=348)  
Term LBW 
(n=152) 
 Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
Because I or my relatives live 
or work nearby 
57 17.8%  45 12.9% 0.003  22 14.5% 0.251  23 11.9% <0.0001 
For better health care and 
services 
164 51.1%  150 43.1%   77 50.7%   71 36.8%  
Better equipped 3 0.9%  4 1.2%   3 2.0%   1 0.5%  
Has more qualified staff 9 2.8%  10 2.9%   3 2.0%   6 3.1%  
Referral from other hospitals 
or BHUs 
82 25.6%  119 34.2%   42 27.6%   77 39.9%  
Medical condition or advised 
by a doctor 
2 0.6%  15 4.3%   5 3.3%   10 5.2%  
Other (please specify) 3 0.9%  5 1.4%   0 0.0%   5 2.6%  
Missing 1 0.3%  0 0.0%   0 0.0%   0 0.0%  
 
 
(d) Transportation and travel time  
In Bhutan, the road is fairly rough and most of the case mothers travel by land. About half of the 
mothers (367/669) travelled on rough roads during pregnancy. Mean travel time from home to the 
delivery hospital was 1.9 hours (95% CI 1.5-2.3) (Table 5.16). The travel time was not statistically 
significantly different between delivery outcomes (Table 5.17). However, more mothers of LBW 
or PTB babies travelled by ambulance (p=0.011) (Table 5.19). 
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Table 5.16. Mean travel time to each delivery hospital from place of residence. 
 
JDWNRH (n=455)  Gelephu (n=98)  Mongar (n=116) 
N Mean (SD)  N Mean (SD)  N Mean (SD) P-value 
Travel time (hours) 448 1.4 (4.1)  97 2.8 (9.8)  114 3.1 (2.7) 0.0011 
 
 
Table 5.17. Mean travel time in hours by different adverse outcome. 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
Travel time 
(hours) 
319 2.0 (7.0)  343 1.7 (2.5) 0.5069  150 1.7 (2.5) 0.5111  190 1.8 (2.5) 0.5767 
 
 
Table 5.18. Mean travel time in hours by reason. 
Reason N Mean (SD) 
Because I or my relatives live or work nearby 101 1.5 (9.6) 
For better health care and services 312 0.8(1.7) 
Better equipped 7 1.0 (1.8) 
Has more qualified staff 19 0.7(1.0) 
Referral from other hospitals or BHUs 195 4.0(5.7) 
Medical condition or advised by a doctor 17 0.8(1.4) 
Other 8 0.4(0.2) 
Total 659 1.9(5.2) 
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Table 5.19. Mode of transport and adverse outcomes 
Mode of transport 
Mean travel time (hours)  Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
Mean 
(SD) 
P-value  N 
Mean 
(SD) 
 N 
Mean 
(SD) 
P-value  N 
Mean 
(SD) 
P-value  N 
Mean 
(SD) 
P-value 
By car 1.4 (6.2) <0.0001  143 44.6  119 34.2 0.011  54 35.5 0.149  65 33.5 0.001 
By bus 7.0 (12.4)   13 4.1  19 5.5   13 8.6   6 3.1  
By taxi 0.7 (1.3)   97 30.2  101 29.0   51 33.6   47 24.2  
By ambulance 3.4 (2.9)   54 16.8  86 24.7   25 16.5   61 32.0  
On foot  0.8 (1.5)   12 3.7  23 6.6   9 5.9   14 7.2  
Others  -   1 0.3  0 0.0   0 0.0   0 0.0  
Missing -   1 0.3  0 0.0   0 0.0   0 0.0  
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(e) A summary of key findings from analysis of health seeking behaviours 
The descriptive analysis suggested an association between number of ANC visits and adverse birth 
outcomes. The timing of the ANC was not particularly late for the mothers with adverse birth 
outcomes. More mothers with adverse outcomes travelled by ambulance and had been referred. The 
referred mothers travelled longest (4 hours on average) on the journey from home. More than half 
of those mothers referred or those who had a medical condition and came voluntarily to the referral 
hospitals delivered a baby by caesarean section and approximately half of these mothers delivered 
LBW and/or PTB babies.  
 
5.4.3 General health, infectious or chronic diseases  
(a) Mean BMI, weight gains 
Mean height was 152.5 cm (SD=6.0, 95% CI 152.0-153.0). 8% (55/669) of the mothers were 
missing height information. This is similar to the results from the Bhutan 2014 STEPS survey, 
which reported that the mean height was 153.2 cm (152.6-153.8) for females aged between 18 and 
69 [2]. There were no statistical significant differences in means for mothers of LBW and/or PTB 
babies compared to the control mothers (Table 5.20).  
Mean pre-pregnancy weight was 53.7 kg (SD=9.5, 95% CI 52.9 – 54.6). Of the study 
participants, 187/669 (28%) of mothers were missing pre-pregnancy weight information. Compared 
to the control mothers, mothers of term LBW babies were slightly lower in weight (term LBW 52.2 
[SD=8.7] vs non-LBW 54.6 [SD=9.1], p=0.0209). There was no statically significant difference for 
PTB (p=0.2423).  
Mean maternal weight at first antenatal care was 55.8 kg (SD=9.3, 95% CI 55.0-56.5). 5% 
(36/669) of mothers were missing maternal weight information.  
Mean pre-pregnancy BMI was 23 (SD=3.75, 95% CI 22.7-23.4). There were no statistically 
significant differences in the mean BMI for different birth outcomes (control vs case, p=0.0870; 
control vs term LBW, p=0.1824; and control vs PTB, p=0.1637). While 33.3% of the mothers were 
missing information on BMI due mainly to lack of pre-pregnancy weight information, 44.3% of 
(296/669) mothers had a BMI within an average range between 18.5 and 25.0; 5.2% of mothers 
were underweight (BMI< 18.5); 14.2% were overweight (BMI≥25); and 3.0% were obese 
(BMI≥30).  
Mean gestational weight gain (defined as the difference between the self-reported pre-
pregnancy weight and pre-delivery weight measured at the last ANC visit) was 9.4 kg (SD= 5.9, 
95% CI 8.8-9.9) (Figure 5.12). Approximately one third (29.9% [200/669]) of the women were 
missing information on gestational weight gain. Gestational weight gain was statistically 
significantly smaller for the case mothers than the controls (control 10.6 kg [SD=5.6] vs case 
8.1[SD=6.0, <0.0001]). The Institute of Medicine recommends the gestational weight gain range 
according to pre-pregnancy BMI (for underweight: 28-40 lbs/ 12.5-18 kg; normal BMI: 25-35 
lbs/11.5-16 kg; for overweight:15-25lbs/7.0-11.5 kg; obese:11-20 lbs/5-9 kg) [4]. By this 
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classification, 17.32% had the recommended gestational weight gain whereas 41% had a lower 
weight gain than recommended (Figure 5.13 and Figure 5.14). On the other hand, 12% had a higher 
weight gain than recommended.   
 
 
Table 5.20. Mean height, pre-pregnancy weight, weight at 1st ANC visit, pre-pregnancy BMI, and 
gestational weight gain. 
 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N 
Mean 
(SD) 
 N 
Mean 
(SD) 
P-value  N 
Mean 
(SD) 
P-
value 
 N 
Mean 
(SD) 
P-
value 
Height 300 
152.7 
(5.5) 
 314 
152.3 
(6.6) 
0.4450  146 
151.5 
(7.6) 
0.0962  168 
153.0 
(5.4) 
0.5356 
Pre-pregnancy 
weight 
241 
54.6 
(9.1) 
 241 
52.9 
(9.9) 
0.0403  102 
52.2 
(8.7) 
0.0209     138 
53.4 
(10.7) 
0.2423 
Weight at 1st 
ANC 
309 
56.2 
(8.8) 
 324 
55.3 
(9.8) 
0.2245  149 
53.6 
(8.3) 
0.0019  174 
56.9 
(10.7) 
0.5009 
Pre-pregnancy 
BMI 
227 
23.3 
(3.5) 
 219 
22.7 
(3.8) 
0.0870  97 
22.7 
(3.8) 
0.1824  122 
22.7 
(4.1) 
0.1637 
Gestational 
weight gain 
237 
10.6 
(5.6) 
 232 
8.1 
(6.0) 
<0.0001  99 
7.9 
(6.0) 
0.0002  133 
8.3 
(5.9) 
0.0003 
 
 
 
Figure 5.12. Distribution of gestational weight gain (kg) defined as the difference between the self-
reported pre-pregnancy weight and pre-delivery weight measured at last ANC visit. 
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Figure 5.13. Scatterplot of gestational weight gain (kg) and pre-pregnancy BMI 
 
 
 
Figure 5.14. Distribution of gestational weight gain by pre-pregnancy BMI category among singleton 
mothers (n=669). Note: BMI categories were used (underweight, < 18.5 kg/m2; normal, 18.5 to 26.0 
kg/m2; overweight, 26.1 to 29.0 kg/m2; obese, > 29.0 kg/m2). 
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(b) Infectious diseases 
i) HIV, syphilis and hepatitis B 
More than 30% of mothers were missing information on the test results in the MCH book (mothers 
missing results of HIV 259/669; mothers missing results of syphilis 267/669; and hepatitis B 
286/669). This could be due to the MOH guideline which advised against writing the test results in 
the MCH book. Absence of test results could imply negative results. If positive, it was indicated in 
the MCH book and hospital medical records. According to the positive records, assuming the 
absence of data indicates negative results, the prevalence of HIV, syphilis, and hepatitis B was less 
than 1% (HIV 0.2%, syphilis 0.3%, and hepatitis B 1.5%). This is comparable with the government 
report and other studies where HIV prevalence was reported as below 0.2% [5]. In a study 
conducted among 4885 people in the most-at-risk populations (MARPS), sero positivity was 0.7% 
for HIV, 1.2% for syphilis and 1.3% for hepatitis B [6].  
 
ii) Urinary tract infection (UTI)  
Less than 10% (60/669) of mothers had a recorded UTI. More mothers in the case group 
experienced UTI compared to the control group (control 6.9% [22/321] vs case 10.9% [38/348], 
p=0.036). More mothers in the case group were missing information on UTI compared to the control 
group (control 7.8% [25/321] vs case 13.2% [46/348]) (Table 5.21).  
 
 
Table 5.21. UTI and adverse birth outcomes. 
 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % 
P-
value 
 N % P-value  N % 
P-
value 
Urinary 
tract 
infection 
22 6.9%  38 10.9% 0.036  19 12.5% 0.040  19 9.8% 0.118 
Missing 25 7.8%  46 13.2%   12 7.9%   32 16.6%  
 
 
iii) Symptoms of potential infectious diseases  
Mothers were asked if they had had selected symptoms of infectious diseases at some point during 
pregnancy. Even though only about 11% of the mothers with adverse birth outcomes had a recorded 
UTI, about 16% reported possible symptoms such as fever, feeling very hot and sweating and 28% 
of the mothers reported feeling very sick or weak at some point during pregnancy, which could 
indicate a possible unscreened or untreated infectious diseases. More mothers in the cases group 
reported pain in the lower belly, behind the front of the pelvis (control 22.7% [73/321] vs 31.3% 
[109/348], p=0.012) and flank pains (control 24.9% [80/321] vs case 35.1% [122/348], p=0.005) 
compared to the controls (Table 5.22). 
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Table 5.22. Symptoms of potential infectious diseases and adverse birth outcomes. 
 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
Constant feeling of needing to urinate, even after having just urinated 117 36.5%  152 43.7% 0.053  63 41.5% 0.282  89 46.1% 0.029 
Missing 1 0.3%  2 0.6%   1 0.7%   1 0.5%  
               
Pain or burning while urinating, or straight afterwards 43 13.4%  62 17.8% 0.121  25 16.5% 0.376  37 19.2% 0.086 
Missing 2 0.6%  1 0.3%   1 0.3%   0 0.0%  
               
Pain in the lower belly, behind the front of the pelvis 73 22.7%  109 31.3% 0.012  45 29.6% 0.105  64 33.2% 0.009 
Missing 4 1.3%  5 1.4%   2 1.3%   3 1.6%  
               
Cloudy or bloody urine 29 9.0%  37 10.6% 0.507  9 5.9% 0.231  28 14.5% 0.057 
Missing 4 1.3%  2 0.6%   0 0.0%   2 1.0%  
               
Fever, feeling very hot and sweating 31 9.7%  57 16.4% 0.012  24 15.8% 0.060  33 17.1% 0.015 
Missing 5 1.6%  1 0.3%   0 0.0%   1 0.5%  
               
Feeling very sick or weak 51 15.9%  96 27.6% <0.0001  36 23.7% 0.039  60 31.1% <0.0001 
Missing 3 0.9%  3 0.9%   2 1.3%   1 0.5%  
               
Flank pain (in one or both sides) 80 24.9%  122 35.1% 0.005  58 38.2% 0.003  63 32.6% 0.065 
Missing 4 1.3%  3 0.9%   2 1.3%   1 0.5%  
               
Repeated vomiting requiring medical treatment  31 9.7%  45 12.9% 0.184  21 13.8% 0.168  24 12.4% 0.338 
Missing 4 1.3%  5 1.2%   3 2.0%   1 0.5%  
               
Chills, rigours, or shivering persistently 10 3.1%  24 6.9% 0.028  12 7.9% 0.022  12 6.2% 0.099 
Missing 4 1.3%  1 0.3%   1 0.7%   0 0.0%  
               
Having a rash 16 5.0%  20 5.8% 0.671  8 5.3% 0.908  12 6.2% 0.555 
Missing 4 1.3%  3 0.9%   1 0.7%   2 1.0%  
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(c) Chronic diseases  
The prevalence of anaemia defined as Hb<100g/L based on antenatal records and hospital records 
was 12.4%. There was no statistical difference in the proportion of anaemic mothers in each 
adverse pregnancy outcome (control 11.2% [36/321] vs case 13.5% [47/348], p=0,279) (Table 
5.23). More mothers in adverse outcome groups were missing information on Hb level (control 
0.6% [2/321] vs case 4.3% [15/348]).  
The prevalence of diabetes based on medical records was 1.1%. There was no statistical 
difference in the proportion of diabetic mothers in each adverse pregnancy outcome (control 1.6% 
[5/321] vs case 0.6% [2/348], p=0.275) (Table 5.23). 
 
 
Table 5.23. Selected chronic diseases (anaemia and diabetes) and adverse birth outcomes. 
 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % 
P-
value 
Anaemia 36 11.2%  47 13.5% 0.279  20 13.2% 0.474  27 14.0% 0.270 
Missing 2 0.6%  15 4.3%   5 3.3%   9 4.7%  
               
Diabetes 5 1.6%  2 0.6% 0.275  0 0.0% 0.183  2 1.0% >0.999 
Missing 6 1.9%  16 4.6%   5 3.3%   11 5.7%  
 
 
(d) Obstetric history (previous preterm, previous history, pregnancy interval, parity) 
In Bhutan, termination of pregnancy at the mother’s request is illegal. The prevalence of previous 
history of a LBW  infant was statistically significantly higher in the adverse birth outcome groups 
(p<0.0001) (Table 5.24). Similarly, previous admission for gestational hypertension, pre-eclampsia, 
eclampsia was significantly higher among mothers with PTB babies (p=0.013) but not among 
mothers with term LBW babies. 
Pregnancy intervals could be subject to a recall bias. Although the questionnaire asked the 
month that the last pregnancy ended, more than 40% of the mothers (42.78%) did not remember 
the month. Thus, difference between the year of last pregnancy and the year of the most recent 
delivery was used to calculate pregnancy intervals when mothers were missing the month of last 
pregnancy. Mean pregnancy interval was 4 years (mean=4.4, SD=3.5, 95% CI: 4.0-4.8).   
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Table 5.24. Obstetric history and adverse birth outcomes. 
Selected obstetric history 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
Parity 0 131 40.8%  165 47.4% 0.032  71 46.7% 0.166  93 48.2% 0.058 
 1 100 31.2%  83 23.9%   38 25.0%   44 22.8%  
 2 to 3 80 24.9%  78 22.1%   34 22.4%   43 22.3%  
 4 or more 9 2.8%  20 5.8%   9 5.9%   11 5.7%  
 Missing 1 0.3%  3 0.9%   0 0.0%   2 1.0%  
                
Pregnancy intervals for the mothers less than 12 months 10 5.2%  12 6.2% 0.445  4 4.6% 0.097  8 7.7% 0.818 
 12 to <18 months 10 5.2%  9 4.6%   4 4.6%   5 4.8%  
 18 to <24 months 4 2.1%  3 1.6%   0 0.0%   3 2.9%  
 24 to <60 93 47.9%  76 39.2%   32 36.4%   44 42.3%  
 60 months or more 54 27.8%  68 35.1%   38 43.2%   30 28.9%  
 Missing 23 11.9%  26 13.4%   10 11.4%   14 13.5%  
                
Abortions 0 291 90.7%  305 87.6% 0.226  132 86.8% 0.155  172 89.1% 0.532 
 1 26 8.1%  33 9.5%   15 9.9%   17 8.8%  
 2 or more 3 0.9%  9 2.6%   5 3.3%   4 2.1%  
 Missing 1 0.3%  1 0.3%   0 0.0%   0 0.0%  
                
Previous stillbirth or neonate loss Yes 17 5.3%  25 7.2% 0.310  9 5.9% 0.787  16 8.3% 0.196 
 Missing 1 0.3%  2 0.6%   0 0.0%   1 0.5%  
                
Previous history of PTB Yes 14 4.4%  38 10.9% 0.002  13 8.6% 0.106  25 13.0% <0.0001 
 Missing 6 1.9%  7 2.0%   3 2.0%   2 1.0%  
                
Previous history of LBW Yes 11 3.4%  41 11.8% <0.0001  36 11.8% 0.017  27 14.0% <0.0001 
 Missing 6 1.9%  6 1.7%   6 2.0%   2 1.0%  
                
Last pregnancy: admission for 
hypertension, pre-eclampsia, or eclampsia 
Yes 1 0.3%  6 1.7% 0.125  0 0.0% >0.999  6 3.1% 0.013 
 Missing 7 2.2%  8 2.3%   2 1.3%   5 2.6%  
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(e) Pregnancy induced hypertension (PIH) 
More mothers in the case group had hypertensive disorders (pre-exiting or chronic hypertension, 
gestational hypertension, preeclampsia and eclampsia) compared to the control group (pre-existing 
or chronic hypertension: control 2.2% [7/321] vs case 7.8% [27/348]; gestational hypertension: 
control 3.4%[11/321] vs case 13.2%[46/348]; pre-eclampsia control 1.3% [4/321] vs case 8.3% 
[29/348]; and eclampsia: control 0.0% vs 2.0% [7/348], p<0.0001) (Table 5.25).  
Strength of associations of different hypertensive disorders and adverse birth outcomes are 
further examined in the multivariable analysis.   
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Table 5.25. Hypertensive disorders and adverse birth outcomes. 
Hypertensive disorders 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
No hypertensive complications 285 88.8%  218 62.6% <0.0001  106 69.7% <0.0001  111 57.5% <0.0001 
Pre-existing or chronic hypertension 7 2.2%  27 7.8%   11 7.2%   16 8.3%  
Gestational hypertension 11 3.4%  46 13.2%   23 15.1%   23 11.9%  
Pre-eclampsia 4 1.3%  29 8.3%   6 4.0%   23 11.9%  
Eclampsia 0 0.0%  7 2.0%   0 0.0%   7 3.6%  
Missing 14 4.4%  21 6.0%   6 4.0%   13 6.7%  
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(f) A summary of key findings from analysis of general health, infectious or chronic 
diseases  
Data suggested an association between gestational weight gain and adverse outcomes. Recorded 
positives for HIV, syphilis, and hepatitis B in the study participants were fairly low and comparable 
to other studies in Bhutan. Data suggested an association between UTI and other symptoms of 
potential infectious diseases and adverse birth outcomes. Nulliparity, previous history of preterm, 
and LBW were statistically significantly associated with adverse birth outcomes. Chronic and 
pregnancy-induced hypertension was strongly associated with adverse birth outcomes. These 
factors are further examined in the multivariable analysis in the statistical approach.  
 
5.4.4 Mode of delivery  
More mothers in the case group delivered by caesarean section (CS) (elective and emergency) than 
in the control group (control 31.5% [101/321] vs case 41.4% [144/348], p=0.001) (Table 5.26). 
Nearly half (45%) of the PTB babies and 37% of the term LBW babies were delivered by CS.  
About 62% of the mothers of premature babies with gestational hypertension or 
preeclampsia and/or eclampsia delivered their babies by CS (Figure 5.15).   
 
 
Table 5.26. Mode of delivery and adverse birth outcomes. 
Hypertensive 
disorders 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % 
P-
value 
 N % 
P-
value 
 N % P-value 
SVD 215 67.0%  198 56.9% 0.001  93 61.2% 0.344  102 52.9% <0.0001 
CS-Elective 41 12.8%  34 9.8%   17 11.2%   17 8.8%  
CS-Emergency 60 18.7%  110 31.6%   39 25.7%   71 36.8%  
Vacuum 5 1.6%  3 0.9%   3 2.0%   0 0.0%  
Breech 0 0.0%  3 0.9%   0 0.0%   3 1.6%  
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Figure 5.15 Mode of delivery among mothers of preterm babies with PIH, PE and/or eclampsia. 
 
 
5.4.5 Sex of the infants 
More female babies were born in the case group than in the control group (control 47.4% [152/321] 
vs case 55.8% [194/348], p=0.030) (Table 5.27). Among mothers of term LBW babies, there were 
more female babies than in the control group and the difference was significant (control vs term 
LBW 63.8% [97/152], p=0.001). There was no statistically significant difference between the 
control group and the preterm group (p=0.323). 
 
 
Table 5.27. Sex of the infants and adverse birth outcomes. 
Sex of the 
infants 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % 
P-
value 
 N % 
P-
value 
 N % 
P-
value 
Male 169 52.7%  153 44.0% 0.030  55 36.2% 0.001  95 49.2% 0.323 
Female 152 47.4%  194 55.8%   97 63.8%   97 50.3%  
Ambiguous 0 0.0%  1 0.3%   0 0.0%   1 0.5%  
 
 
 
 
SVD, 37.11%
CS-Elective, 17.53%
CS-Emergency, 
44.33%
Breech, 1.03%
Mode  of delivery among mothes of preterm with PIH, PE and/or 
eclampsia
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5.4.6 Physical activity during pregnancy  
In the study sample, the majority of the mothers reported having engaged in at least 10 minutes of 
vigorous (18% [119/669]) or moderate physical activity (81% [544/669]) through work including 
domestic chores and travel between places (66% [439/669]) at least once during pregnancy.  In a 
typical day, mean hours of work-related vigorous intensity activities and moderate intensity 
activities were 4.6 hours and 3.4 hours respectively (Table I.2 in Appendix I). Among the mothers 
who engaged in vigorous activities, 34% were involved in farming.  
On the other hand, engaging in recreational activities during pregnancy was not very 
common (Table I.1 in Appendix I). Only 4% (29/669) engaged in vigorous intensity sport, fitness, 
or recreational activities such as running, swimming, football, badminton, basketball or martial arts 
and 17% (113/669) engaged in moderate-intensity recreational activity such as brisk walking or 
dancing for leisure at least once during pregnancy.  
Less than 10% of the mothers (8%, [51/669]) mothers reported they did not engage in any 
moderate or vigorous intensity activities during pregnancy and 17% of the mothers did not meet 
the ACOG recommendation (150 minutes physical activity per week) (Table I.3 in Appendix I).  
The data did not suggest an association between level and hours of physical activity and 
adverse outcomes except for work-related moderate physical activity.  More mothers of preterm 
babies reported that they engaged in work-related moderate physical activity (control 78.2 % 
[251/321] vs case 86.5 [167/193], p=0.03).  Almost 25% of the mothers reported being very active 
while 6% reported being not active.  In the case group, more mothers reported being not active 
compared to the control group (control 1.3% [4/321] vs case 5.2% [18/348], p=0.03) (Table 5.28).  
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Table 5.28. Self-evaluation of physical activities during pregnancy. 
Self-evaluation of physical activity level 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %   N %  P-value  N %  P-value  N %  P-value 
Very active 79 24.6%  85 24.4% 0.03  34 22.4% 0.158  51 26.4% 0.02 
Moderately active 171 53.3%  179 51.4%   76 50.0%   100 51.8%  
Somewhat active 62 19.3%  57 16.4%   31 20.4%   26 13.5%  
Not active 4 1.3%  18 5.2%   7 4.6%   11 5.7%  
Missing 5 1.6%  9 2.6%   4 2.6%   5 2.6%  
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5.4.7 Dietary habits, fruits and vegetable consumption  
WHO recommends eating at least 400 g, or five portions, of fruit and vegetables per day to reduce 
the risk of non-communicable diseases, and help ensure an adequate daily intake of dietary fibre. 
In addition, WHO recommends limiting salt, oil and sugar [2]. 
Traditionally, Bhutanese food often contains green or red chilli; salt, butter and oil and are 
taken with one or two plates of rice while small portions of green and yellow vegetables and fruits 
are also served.  
The number of cups of daily green and yellow vegetables and fruits, and intake and 
frequency of common sources of salt, oil, sugar were described.  
One average, the study sample mothers consumed two servings of green vegetables (mean 
1.95, SD=2.2, 95% CI 1.78 - 2.12) every day.  Similarly, the mean number of fruit servings per day 
was 1.8 (mean 1.77, SD=1.7, 95% CI 1.63-1.90).  There was no difference in the means of vegetable 
or fruit intake across mothers with different pregnancy outcomes (vegetable p=0.82; and fruits 
p=0.58, table not presented). Vegetable oil was the most commonly used oil for cooking (99%). On 
average, the mothers consumed roughly 40 ml of oil in total for cooking per day including vegetable 
oil and butter (mean 39.18 g, SD=23, 95% CI 37.41 - 40.95). There was no difference in the means 
of total oil intake for cooking across mothers of different pregnancy outcomes (p= 0.90, table not 
included). 
Seventy seven percent of mothers did not have the recommended five servings of fruits 
and/or vegetables a day. This is comparable to the results from the 2014 STEPS survey which 
reported that 70% of the women aged between 18 and 69 years old ate less than five servings of 
fruits and/or vegetables, thus not meeting the WHO recommendation [2]. 
Bhutanese traditional “Ezay” (chilli pickles with cheese and salt) and “Suja” (butter tea 
with salt) are common sources of salt (Figure.I.4 in Appendix I). In total, 74% of the mothers 
consumed ezay at least once a week during pregnancy while 16% consumed it daily. Also, 24% of 
the mothers consumed suja at least once a week and 4% consumed it daily. About 23% consumed 
dried meat at least once a week. There were no differences in the frequency of ezay, suja, or dried 
meat consumption across mothers of different pregnancy outcomes (ezay p= 0.134; suja p= 0.157; 
and dry meat= 0.260, table not presented). 
The majority (74%) of the pregnant women consumed milk tea with sugar at least once a 
week and 30% consumed it daily. Coffee was consumed less than milk tea during pregnancy; less 
than 26% drank coffee during pregnancy and 6% of the mothers consumed coffee at least once a 
week. There were no differences in the frequency of milk tea and coffee consumption across the 
mothers of different pregnancy outcomes (milk tea p= 0.594; and coffee p= 0.613). In terms of 
caffeine from tea and coffee, the daily recommended maximum is 200 mg of caffeine, equivalent 
to two mugs or four cups of coffee [7]. Unfortunately, this study did not include information on 
daily caffeine intake. Therefore, examining the amount of caffeine and adverse pregnancy outcomes 
is beyond the scope of this study. 
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On average, pregnant women had meals three times a day (mean 3.1, SD=0.6, 95% CI 3.1-
3.2) and snacks twice a day (mean 1.7, SD=1.0, 95% CI 1.7-1.8). The mothers of LBW, PTB or 
SGA neonates reported slightly fewer meals per day and mean differences were statistically 
significant at 5% level of significance (control 3.2 times [SD=0.6] vs case 3.0 times [SD=0.5], 
p=0.0001 (Table 5.29).  
Likewise, the proportion of mothers who reported having poor appetite during pregnancy 
was slightly higher among the mothers of LBW, PTB or SGA babies (control 2% [5/321] vs 7% 
[22/348], p<0.0001) (Table 5.30).  
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Table 5.29. Mean frequency of meals and snacks during pregnancy. 
Frequency of meals and snacks during 
pregnancy 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
# of meals 319 3.2 (0.6)  347 3.0 (0.5) 0.0001  151 3.1 (0.5) 0.0061  193 3.0 (0.5) 0.0001 
# of snacks 309 1.8 (1.0)  332 1.7 (1.1) 0.277  140 1.7 (1.1) 0.4319  189 1.7 (1.0) 0.395 
 
 
Table 5.30. Self-evaluation of appetite during pregnancy. 
Self-evaluation of appetite during 
pregnancy 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
Good 260 81%  185 60% <0.0001  93 61% <0.0001  118 61% <0.0001 
Fair 53 17%  90 29%   47 31%   55 29%  
Poor 5 2%  22 7%   12 8%   11 6%  
Missing 3 1%  9 5%   0 0%   9 5%  
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5.5 Mother’s subjective assessment of the baby’s size 
Although birth weight is the most reliable and widely-reported measure to assess size at birth, not 
all infants are weighed at birth globally, especially when they are not delivered in health facilities. 
When infants are not weighed at birth, mother’s recall is often used to assess LBW in order to 
estimate the percentage of LBW infants in Demographic and Health Surveys (DHS) and other 
surveys.  In the present study, mother’s subjective concept of the baby’s size was explored in 
relation to birth weight and gestational age (Figure 5.16 and Table 5.31).  When both cases and 
controls were averaged, the categories seem to match up well with the mean birthweight if the 
extreme large category was excluded. However, among mothers of LBW neonates, more than 38% 
assessed their babies as average or larger (Table 5.32). Ten mothers of preterm babies did not 
answer this question as the baby had been taken to the NICU directly and mothers had not seen the 
baby at the time of the interview. The mean birth weight was 1450 g (95% CI: 1109 g -1791 g) and 
mean gestational age for these babies was 221 days (95% CI: 207- 234) (Table 5.31). The results 
suggest that the current survey-based estimates of the prevalence of LBW could be underestimated.   
 
 
Figure 5.16. Mother’s subjective assessment and birth weight (grams). 
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Table 5.31. Distribution of mother’s subjective assessment. 
Mother’s subjective assessment 
Total (n=669)  Gestational age (days)  Birth weight (grams) 
N %  Mean (SD, 95% CI)  Mean (SD, 95% CI) 
Very large 3 0.45%  279 (17, 236-321)  3200 (890, 989-5411) 
Large 47 7.03%  278 (9, 276-281)  3468 (570, 3301-3635) 
Larger than average 32 4.78%  279 (10, 275-282)  3414 (511, 3230-3598) 
Average 354 52.91%  271 (18, 269-273)  2868 (559, 2810-2927) 
Smaller than average 179 26.91%  260 (20, 257-263)  2211 (440, 2146-2275) 
Very small 39 6.13%  228 (31, 218-238)  1448 (559, 1272-1624) 
Baby has not been seen 10 1.49%  221 (19, 207-234  1450 (477, 1109-1791) 
Missing 2 0.3%  287 (4, 255-318)  3040 (356, -136-6217) 
 
 
Table 5.32. Mother’s subjective assessment and adverse birth outcomes. 
Mother’s subjective assessment 
Control (n=321)  Term LBW (n=152)  Preterm (n=193) 
N %  N %  N % 
Very large 2 0.6%  1 0.7%  0 0.0% 
Large 41 12.8%  4 2.6%  2 1.0% 
Larger than average 30 9.4%  1 0.7%  1 0.5% 
Average 225 70.1%  53 34.9%  76 39.4% 
Smaller than average 20 6.2%  86 56.6%  73 37.8% 
Very small 1 0.3%  7 4.6%  31 16.1% 
Baby has not been seen 0 0.0%  0 0.0%  10 5.2% 
Missing 2 0.6%  0 0.0%  0 0.0% 
 
 
5.6 Summary 
Descriptive analyses suggest an association between adverse birth outcomes and the following 
variables: age of the mother, nulliparity, sex of the infant, urinary tract infection, hypertensive 
disorders, previous history of PTB, previous history of LBW, gestational weight gain, number of 
meals per day, number of ANC visits, mode of transportation to the hospital, and mode of delivery. 
Data suggest weak or no evidence of association between adverse birth outcomes and socio-
economic factors such as education, ethnicity, wealth quintile, and urban residence. Data did not 
suggest sufficient evidence for an association between adverse birth outcomes and difference in 
altitudes between permanent and current gewogs.  These findings will inform the multivariable 
regression analysis. Patterns and prevalence of betel quid chewing, tobacco and alcohol are 
described in Chapter 6.  
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Chapter 6  
Results of descriptive analysis of maternal betel quid chewing, 
tobacco, and alcohol  
 
In the previous chapter, descriptive analyses of the study population and selected maternal and 
infant characteristics were provided. In this chapter, betel quid and packaged betel products (6.1), 
cigarette and smokeless tobacco (6.2), and alcohol consumption (6.3) are examined in detail to 
identify patterns of use during pregnancy and investigate the effects on birth weight and gestational 
age. Descriptive analyses were conducted to understand the patterns of consumption, followed by 
quantification of consumption.  The chapter ends with a summary. 
 
6.1 Betel quid chewing and packaged betel products 
6.1.1 Patterns of betel nut chewing during pregnancy among study participants 
(i) Prevalence 
Among 669 mothers who participated in the study, 471/669 (70.40%) reported chewing betel quid 
at least once in their lifetime and 359 mothers (53.7%) chewed betel quid during pregnancy. The 
observed difference of prevalence between the cases and controls was small and not statistically 
significant (control 52.3% [168/321] vs case 54.9% [191/348], p=0.485) (Table 6.2). 
Most commonly, mothers preferred to chew after meals (69.9%) (Figure 6.1) and when 
they felt cold (54.5%) (Figure 6.2).  The mean starting age was 18 years old (95% CI: 17.6-18.6) 
and the mean duration of betel chewing is 9.5 years (95% CI: 8.8-10.2) (Table 6.1). Comparing the 
mothers of LBW and/or PTB babies to the control mothers, the mean duration of betel chewing was 
slightly longer (10.2 vs 8.7, p=0.04). Betel quid chewing during pregnancy was more common 
among the mothers who delivered at JDWNRH (59.6%) than CRRH (32.7%) and ERRH (48.3%) 
(p<0.001) (Table 6.4). The number of betel quids consumed during the last three months of 
pregnancy was higher at JDWNRH (mean 380, SD=677) than CRRH (mean 102, SD=151) and 
ERRH (mean 122, SD=234) (Figure 6.3).  
 
(ii) Pattern of betel quid chewing and adverse birth outcomes 
The majority of the mothers chewed a combination of piper leaf (always: 87.5% vs never: 4.5%), 
lime (always: 87.5% vs never: 7.0%), and one quarter of a ripe nut, and spit after chewing (always 
spit: 47.1% vs never-spit: 18.9%) (Table 6.3). Of the mothers who chewed during pregnancy 
(n=359), 40.7% (146/359) were daily users. The majority (76.3%) used weekly or more than weekly.  
Only 10.9% of the total chewers during pregnancy added tobacco to betel nut chewing. More 
mothers in the case group added tobacco compared to the mothers in the control group (always add 
tobacco, control 6.0% [10/168] vs case 13.1% [25/168], p=0.045; control vs term LBW 10.5% 
[9/86], p=0.111; and PTB 15.4% [16/104], p=0.027).   
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(iii) Quantity 
On average, mothers consumed 5.5 quids (95% CI: 4.7-6.3) or approximately 1.4 nuts per day and 
cumulative consumption during the last three months of pregnancy was 324 quids (95% CI: 252 – 
396) or approximately 81 nuts among the mothers who chewed betel quid during pregnancy (Table 
6.3). The majority of the mothers continued chewing throughout pregnancy (Figure 6.6).  
 
(iv) Comparison of chewers and non-chewers  
In the descriptive analyses comparing chewers and non-chewers, there was no statistically 
significant difference in education or wealth index by status of betel quid chewing (Table 6.4). On 
the other hand, more mothers who chewed betel quid used other substance such as alcohol (Non-
chewers: 17.6% [54/307] vs chewers: 34.8% [125/359], p<0.0001), pan masala (Non-chewers: 
11.1% [34/307] vs chewers: 32.3% [116/359], p<0.0001), cigarettes (Non-chewers: 1.3% [4/307] 
vs chewers: 4.2% [15/359], p=0.034), and smokeless tobacco (Non-chewers: 3.3% [10/307] vs 
chewers: 10.9% [39/359], p<0.0001) compared to the mothers who did not chew during pregnancy. 
More mothers who chewed betel quid were anaemic compared to non-chewers (non-chewers: 8.1% 
[25/168] vs chewers 16.2% [58/168], p=0.004). The daily vegetable intake among betel quid 
chewers was lower compared to non-chewers (non-chewers: 1.7[SD=1.8] vs chewers: 2.2[SD=2.5], 
p=0.004).  
 
 
 
Figure 6.1. The timing of chewing betel quid during pregnancy. 
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Figure 6.2. The reasons for chewing betel quid during pregnancy. 
 
 
 
Figure 6.3. Betel quid chewing during pregnancy and mean total number of betel quids among pregnant 
chewers by delivery hospital. 
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Table 6.1. Mean age of starting betel quid chewing, duration of consumption and amount of consumption (per day and cumulative for the last three month of pregnancy). 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
Age of starting BQ  212 18.4 (5.5)  244 17.9 (5.6) 0.311  107 18.2 (5.5) 0.8314  135 17.5 (5.6) 0.1644 
Years of chewing 160 8.7 (5.7)  184 10.2 (7.2) 0.0352  84 10.0 (6.9) 0.1505  99 10.4 (7.46) 0.0564 
Daily consumption 144 5.4 (6.3)  160 5.6 (7.9) 0.7587  75 
6.6 
 (9.8) 
0.3356  84 4.8 (5.6) 0.5032 
Cumulative consumption 134 317 (553)  134 317 (553) 0.8746  69 388 (845) 0.5297  81 282 (478) 0.6236 
 
 
Table 6.2. Prevalence of BQ chewing during pregnancy. 
Prevalence of BQ chewing and patterns of 
consumption 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
Ever chewed BQ (n=669) Yes 220 68.5%  251 53.3% 0.339  109 71.7% 0.513  140 72.5% 0.364 
 Missing 1 0.3%  0 0.0%   0 0.0%   0 0.0%  
                
Age of starting (n=471) <10 yrs old 9 4.1%  11 4.4% 0.866  5 4.6% 0.747  6 4.3% 0.362 
 10-<18 yrs old 83 37.7%  101 40.2%   37 33.9%   63 45.0%  
 >=18 yrs old 120 54.6%  132 52.6%   65 59.6%   66 47.1%  
 Missing 8 3.6%  7 2.8%   2 1.8%   5 3.6%  
                
Chewed during pregnancy 
(n=669) 
Yes 168 52.3%  191 54.9% 0.485  86 56.6% 0.406  104 53.9% 0.669 
 Missing 1 0.3%  2 0.6%   0 0.0%   2 1.0%  
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Table 6.3. Prevalence of BQ chewing and patterns of consumption during pregnancy. 
Prevalence of BQ chewing and patterns of consumption 
Control 
(n=168) 
 Case (n=191)  Term LBW (n=86)  Preterm (n=104) 
N %  N % P-value  N % P-value  N % P-value 
Frequency of chewing during pregnancy 
(n=359) 
Daily 70 41.7%  76 39.8% 0.726  32 37.2% 0.773  44 42.3% 0.693 
 Weekly or more 60 35.7%  68 35.6%   29 33.7%   39 37.5%  
 Monthly or more 31 18.5%  36 18.9%   19 22.1%   16 15.4%  
 Rarely 4 2.4%  8 4.2%   4 4.7%   4 3.9%  
 Other (not specified) 3 1.8%  1 0.5%   1 1.2%   0 0.0%  
 Missing 0 0.0%  2 1.1%   1 1.2%   1 1.0%  
                
Add tobacco (n=359) Always 10 6.0%  25 13.1% 0.045  9 10.5% 0.111  16 15.4% 0.027 
 Usually  0 0.0%  1 0.5%   1 1.2%   0 0.0%  
 Sometimes 1 0.6%  2 1.1%   2 2.3%   0 0.0%  
 Never 156 92.9%  162 84.8%   74 86.1%   87 83.7%  
 Missing 1 0.6%  1 0.5%   0 0.0%   1 1.0%  
                
Add slaked lime (n=359) Always 144 85.7%  170 89.0% 0.015  78 90.7% 0.382  91 87.5% 0.005 
 Usually  6 3.6%  1 0.5%   1 1.2%   0 0.0%  
 Sometimes 1 0.6%  7 3.7%   1 1.2%   6 5.8%  
 Rarely 0 0.0%  2 1.1%   1 1.2%   1 1.0%  
 Never 15 8.9%  10 5.2%   5 5.8%   5 4.8%  
 Missing 2 1.2%  1 0.5%   0 0.0%   1 1.0%  
                
Add piper leaf (n=359) Always 143 85.1%  171 89.5% 0.044  79 91.9% 0.372  91 87.5% 0.180 
 Usually  7 4.2%  0 0.0%   0 0.0%   0 0.0%  
 Sometimes 5 3.0%  8 4.2%   2 2.3%   6 5.8%  
 Rarely 4 2.4%  4 2.1%   2 2.3%   2 1.9%  
 Never 9 5.4%  7 3.7%   3 3.5%   4 3.9%  
 Missing 0 0.0%  1 0.5%   0 0.0%   1 1.0%  
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Spit after chewing (n=359) Always 76 45.2%  93 48.7% 0.172  43 50.0% 0.119  50 48.1% 0.788 
 Usually  13 7.7%  5 2.6%   1 1.2%   4 3.9%  
 Sometimes 39 23.2%  53 27.8%   26 30.2%   26 25.0%  
 Rarely 6 3.6%  4 2.1%   1 1.2%   3 2.9%  
 Never 33 19.6%  35 18.3%   15 17.4%   20 19.2%  
 Missing 1 0.6%  1 0.5%   0 0.0%   1 1.0%  
                
Duration of BQ chewing (n=359) 0 to 5 years 57 33.9%  57.0 29.8% 0.103  28 32.6% 0.270  29 27.9% 0.125 
 5< to 10 years 52 31.0%  48.0 25.1%   21 24.4%   26 25.0%  
 >10 yrs 51 30.4%  79.0 41.4%   35 40.7%   44 42.3%  
 Missing 8 4.8%  7.0 3.7%   2 2.3%   5 4.8%  
                
Daily number of quids of chewing (n=359) >20 7 4.2%  9 4.7% 0.892  6 7.0% 0.632  3 2.9% 0.738 
 11 to 20 11 6.6%  14 7.3%   5 5.8%   9 8.7%  
 1 to 10 126 75.0%  137 71.7%   64 74.4%   72 69.2%  
 Missing 24 14.3%  31 16.2%   11 12.8%   20 19.2%  
                
Cumulative consumption during the last 
three months of pregnancy (n=359) 
Stopped 10 6.0%  10 5.2% 0.745  4 4.7% 0.723  6 5.8% 0.640 
 
<=total 280 quid or <=1 
nut per day 
85 50.6%  105 55.0%   47 54.7%   57 54.8%  
 
280 < to <=1800 quids or 
1-5 nuts per day 
34 20.2%  31 16.2%   14 16.3%   17 16.4%  
 
1800 quids+ or more than 
5 nuts per day  
5 3.0%  5 2.6%   4 4.7%   1 1.0%  
 Missing 34 20.2%  40 20.9%   17 19.8%   23 22.12%  
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Figure 6.4. The daily consumption during pregnancy for controls and cases. Delivery # represents # of 
month from the month of delivery (n=359, 53 missing details of daily consumption). 
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Table 6.4. Baseline characteristics by status of betel quid chewing during pregnancy (n=666). 
Selected characteristics 
Betel quid non-
users 
 (n=307) 
Betel quid users  
(n=359) 
P-value 
 Delivery hospital (%) JDWNRH 182 (59.3%) 271 (75.5%) <0.0001 
  Gelephu (CRRH) 66 (21.5%) 32 (8.9%)  
  Mongar (ERRH) 59 (19.2%) 56 (15.6%)  
      
 Season of delivery (%) Spring 75 (24.43%) 112 (31.2%) 0.076 
  Summer 85 (27.7%) 79 (22.0%)  
  Fall 79 (25.7%) 77 (21.5%)  
  Winter 68 (22.2%) 91 (25.4%)  
      
 Maternal age, mean (S.D.)  27.5 (6.1) 27.5 (5.6) 0.890 
      
 Maternal education level (%) "No school or NFE"  106 (34.5%) 108 (30.1%) 0.424 
  Primary or middle secondary 44 (14.3%) 60 (16.7%)  
  High school/Masters/college/diploma  157 (51.1%) 190 (52.9%)  
  Missing 0 (0.0%) 1 (0.3%)  
      
 Wealth Quintile (%) Poorest 62 (20.2%) 72 (20.1%) 0.518 
  Second 68 (22.2%) 62 (17.3%)  
  Middle 61 (19.9%) 72 (20.1%)  
  Fourth 58 (18.9%) 75 (20.9%)  
  Richest 55 (17.9%) 76 (21.2%)  
  Missing 3 (1.0%) 2 (0.6%)  
      
 Maternal pre-pregnancy BMI, mean (S.D.)  22.8 (3.6) 23.2 (3.9) 0.270 
      
 
Gestational weight gain as per IOM 
recommendation, number (%) 
Within recommendations 59 (19.2%) 57 (15.9%) 0.309 
  High GWG 31 (10.1%) 47 (13.1%)  
  Low GWG 129 (42.0%) 144 (40.1%)  
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  Missing 88 (28.7%) 111 (30.9%)  
      
 Alcohol drinking during pregnancy, number (%) Yes 54 (17.6%) 125 (34.8%) <0.0001 
  
Total number of days of drinking in the last 3 months of pregnancy 
(n=661), mean(S.D.) 
3 (12.9) 5 (13.6)  
      
 Cigarette smoking during pregnancy, number (%) Yes 4 (1.3%) 15 (4.2%) 0.034 
  Total number of cigarettes in the last 3 months(n=665), mean(S.D.) 2 (26) 1 (14)  
      
 Smokeless Tobacco during pregnancy, number (%) Yes 10 (3.3%) 39 (10.9%) <0.0001 
  Missing 5 (1.6%) 3 (0.8%)  
  Total ST in grams in the last 3 months of pregnancy (n=652), mean(S.D.) 4.2 (33.3) 19.1 (73.0)  
      
 Pan masala during pregnancy, number (%) Yes 34 (11.1%) 116 (32.3%) <0.0001 
  Missing 5 (1.6%) 5 (1.4%)  
      
 Anaemia (recorded), number (%) Yes  25 (8.1%) 58 (16.2%) 0.004 
  Unknown 13 (4.2%) 2 (0.6%)  
  Missing 1 (0.3%) 1 (0.3%)  
      
 Hypertensive disorders, number (%) Chronic or existing hypertension 18 (5.9%) 16 (4.5%) 0.518 
  Gestational hypertension 23 (7.5%) 34 (9.5%)  
  Pre-eclampsia 11 (3.6%) 21 (5.9%)  
  Eclampsia 3 (1.0%) 4 (1.1%)  
  Missing 18 (5.9%) 17 (4.7%)  
      
 Daily cup of vegetables (n=613), mean (S.D.)  2.2 (2.5) 1.7 (1.8) 0.004 
      
 Daily cup of fruits (n=595), mean (S.D.) 1.8 (1.7) 1.7 (1.7) 0.596 
     
 Number of meals per day (n=663), mean (S.D.) 3.1(0.5) 3.1(0.6) 0.307 
      
 Sex of the infants, male (%) 154 (50.2%) 168 (46.8%) 0.482 
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6.1.2  Packaged betel nut products - Pan masala (PM) 
Pan masala (PM) refers to packaged betel nut products which are available under several names, 
mostly marketed as a mouth refresher. About 22% or 150/669 of the mothers used pan masala 
during pregnancy (Figure 6.6). Mothers who used packaged betel products also chewed betel quid 
(77% [116/150]). Use of packaged betel products during pregnancy was more common among the 
mothers who delivered at JDWNRH (26.1%) compared to CRRH (19.2%) and ERRH (12.4%) (p= 
0.005) (Figure 6.5). 
There was no statistical difference in the proportion in different adverse outcome groups 
(Table 6.5).  
 
 
 
Figure 6.5. BQ products by delivery hospital. 
 
 
Table 6.5. Use of BQ products and adverse birth outcomes. 
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Figure 6.6. Frequency of BQ product use among study participants. 
 
 
6.1.3  A summary of key findings from analysis of betel nut and betel product use 
Betel quid chewing or use of betel products such as pan masala during pregnancy was highly 
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(77%) of the mothers who used packaged betel products chewed betel quid. It was more common 
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However, the data does suggest an association between betel quid chewing with added tobacco and 
adverse outcomes. This may imply that previous studies that reported an association between birth 
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quid. Chewers were more anaemic compared to non-chewers. This will be further examined in the 
logistic regression analysis.  
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6.2 Cigarette smoking and smokeless tobacco 
6.2.1 Cigarette smoking  
Among 669 mothers who participated in the study, 15.3% (102/669) of mothers had smoked at least 
once in their lifetime and less than 3% (19/669, 3.9% of the control group and 1.9% of the case 
group) smoked during pregnancy (Table 6.6). There was no statistically significant difference in 
proportion of mothers who smoked during pregnancy by delivery hospital (3.5% at JDWNRH, 
3.1% at CRRH, and 0% at ERRH, p= 0.125). 
Mean starting age of smoking was 19 years old (mean =19.5, SD=3.6, 95% CI 18.8 - 20.2 
years). Mean duration of smoking for mothers who smoked during pregnancy was 5.5 years 
(mean=5.5, SD=3.6, 95% CI 3.6-7.3).  More than 50% of them were daily smokers. Mean number 
of cigarettes per day was 3 (SD=4.5, 95% CI 1.0- 5.5). Sixty seven percent of the mothers stopped 
smoking during the third trimester. On average, mothers smoked 2 cigarettes per day during 
pregnancy among mothers who smoked during pregnancy (mean= 2.2, SD=1.7, 95% CI: 1.3- 3.0) 
(Figure 6.10). The total consumption in the last three months of pregnancy was 51 cigarettes (mean 
50.6, SD=116, 95%CI: -7.2 -108.3) (Table 6.7).  The observed difference of prevalence of smoking 
during pregnancy in the cases and controls was small and not statistically significant (controls 1.6% 
[5/321] vs cases 4.0% [14/348], p=0.055).  This could be due to the low prevalence (2.8%) and low 
level of consumption (2.2 cigarettes per day). 
 
6.2.2 Smokeless tobacco 
On the other hand, 7.5% of the mothers (50/669) consumed smokeless tobacco during pregnancy 
(Figure 6.6). The majority (98%) of the mothers who used smokeless products did not smoke 
cigarettes.  Smokeless tobacco use during pregnancy was more common among the mothers who 
delivered at JDWNRH (9.5%) compared to CRRH (5.1%) and ERRH (1.7%) (p= 0.007) (Figure 
6.7). Mean total consumption during the last three months of pregnancy was 190 grams (SD=141) 
among mothers delivered at JDWNRH, 194 grams (SD=151) at CRRH and 123 grams (SD=144) 
at ERRH. 
The majority of the mothers (76%) were daily users and chewing tobacco was the most 
popular type of product (78%) (Figure 6.8 and Figure 6.9). Interestingly, the majority of the mothers 
kept using smokeless tobacco while many of the mothers who smoked cigarettes quit smoking 
during pregnancy. More mothers of LBW and/or PTB babies used smokeless tobacco compared to 
the control mothers (control 4.1%[13/321] vs case 10.6% [37/348], p=0.001]. 
On average, mothers who used smokeless tobacco during pregnancy consumed 2.4 grams 
per day during pregnancy (SD= 1.4, 95% CI: 1.9-2.8) (Table 6.7). The total consumption in the last 
three months of pregnancy was 187 grams (SD= 142, 95% CI: 144-230) (Figure 6.11). At this level 
of consumption, the data did not suggest a statistical difference in the mean of daily consumption 
during pregnancy or total consumption during the last three months of pregnancy between the case 
and control groups.  
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Table 6.6. Proportion of mothers who ever smoked, smoked during pregnancy and used smokeless 
tobacco during pregnancy by different adverse outcomes. 
 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % 
P-
value 
 N % 
P-
value 
 N % 
P-
value 
Cigarette 
Ever 
smokers 
52 16.2%  50 14.4% 0.488  27 17.8% 0.505  22 11.4% 0.126 
 
Smoked 
during 
pregnancy 
5 1.6%  14 4.0% 0.055  6 4.0% 0.187  7 3.6% 0.132 
                
Smokeless 
tobacco 
Used 
during 
pregnancy 
13 4.1%  37 10.6% 0.001  19 12.5% 0.001  18 9.3% 0.016 
 
 
Table 6.7. Mean total consumption of cigarettes and smokeless tobacco (grams) during the last three 
months of pregnancy among users. 
 
Control 
(n=321) 
 Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N 
Mean  
(SD) 
 N 
Mean  
(SD) 
P-
value 
 N 
Mean 
(SD) 
P-value  N 
Mean  
(SD) 
P-
value 
Total number of cigarettes 
during the last three 
months of pregnancy 
(n=19) 
5 0 (0)  13 
70 
(133) 
0.0818  6 52 (95) 0.2410  6 25 (40) 0.1852 
Total ST consumption in 
grams during the last three 
months of pregnancy 
(n=50) 
11 
173 
(178) 
 33 
192 
(130) 
0.7421  18 
204 
(147) 
0.6347  15 
179 
(110) 
0.9227 
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Figure 6.7. Use of smokeless tobacco (ST) and mean total use in grams during the last 3 months of 
pregnancy among users by delivery hospital. 
 
 
 
Figure 6.8. Type of smokeless tobacco used during pregnancy (n=50). 
 
JDWNRH Gelephu Mongar Total
Missing 1.1% 2.0% 0.9% 1.2%
No 89.5% 92.9% 97.4% 91.3%
Yes 9.5% 5.1% 1.7% 7.5%
Mean(grams) 190 194 123 187
9.5% 5.1% 1.7%
7.5%
89.5%
92.9% 97.4%
91.3%
1.1% 2.0% 0.9% 1.2%
0
50
100
150
200
250
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
M
ea
n
 t
o
ta
l S
T 
gr
am
s 
d
u
ri
n
g 
th
e 
la
st
 3
 m
o
n
th
s 
o
f 
p
re
gn
an
cy
%
  o
f 
 m
o
th
er
s
Delivery hospital
Use of ST and mean total use in grams during the last 3 months of 
pregnancy among users 
Yes No Missing Mean(grams)
Missing, 2%
snuff by 
nose, 2%
snuff by 
mouth, 
8% Dried betel with 
tobacco (Sakila), 
10%
chewing tobacco (such as Baba 
and Khaini), 78%
Type of smokeless tobacco (n=50)
 212 
 
 
Figure 6.9. Frequency of smokeless tobacco use during pregnancy. 
 
 
 
Figure 6.10. Boxplots of daily cigarette consumption during pregnancy for controls and cases. Delivery # 
represents # of month from the month of delivery (n=18). 
Daily or almost 
daily, 76%
Weekly, 14%
Monthly, 2%
Others 
(chewed when 
having morning 
sickness), 4%
Missing, 4%
Frequency of smokeless tobacco (n=50)
0
5
1
0
1
5
n
u
m
b
e
r 
o
f 
c
ig
a
re
tt
e
 p
e
r 
d
a
y
control case
delivery-9 delivery-8 delivery-7 delivery-6 delivery-5
delivery-4 delivery-3 delivery-2 delivery-1
 213 
 
 
Figure 6.11. Boxplots of daily smokeless tobacco package consumption during pregnancy for controls 
and cases. Delivery # represents # of month from the month of delivery (n=44). 
 
 
6.2.3  A summary of key findings of analysis of cigarette and smokeless tobacco use 
Among the study participants, smoking during pregnancy or use of smokeless tobacco was low, 
accounting for 10.2% of the total. Cigarette smoking was less than 3% (2.8%), whereas smokeless 
tobacco use was 7.5%. The majority (98%) of the users of smokeless tobacco did not smoke 
cigarettes. The low cigarette smoking was comparable to the results in the 2011 report [1]. Most of 
the mothers quit before the last three months of pregnancy. The observed difference of prevalence 
of smoking during pregnancy between the cases and controls was small and not statistically 
significant (controls 1.6% [5/321] vs cases 4.0% [14/348], p=0.055).  This could be due to the low 
level of prevalence and consumption. For example, other studies which reported a strong 
association used exposure criteria of smoking less than 20 cigarettes per day versus non-smokers 
[2]. More mothers of LBW and/or PTB babies used smokeless tobacco compared to the control 
mothers (control 4.1% [13/321] vs case 10.6% [37/348], p=0.001]. In the logistic regression 
analysis, a binary variable of cigarette smoking or use of smokeless tobacco will be examined.  
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6.3 Alcohol 
6.3.1 Prevalence and adverse birth outcomes 
About half (49.6%) of the mothers had consumed alcohol at least once in their lifetime (controls 
45.5% [146/321] vs cases 53.5% [186/348], p=0.048) (Table 6.8). Mean age of starting drinking 
was 19 years old (SD=5.3) with 5% starting before reaching 10 years old (Table 6.9). Twenty seven 
percent of the mothers drank during pregnancy. More mothers of LBW and/or PTB babies drank 
during pregnancy compared to the controls (controls 21.5% [69/321] vs cases 31.6% [110/348], 
p=0.003; controls vs term LBW 35.5% [54/152], p=0.001; and PTB 28.5% [55/193], p=0.072). 
Mean duration of drinking was 9.1 years (SD=7.5) among the mothers who drank during pregnancy 
(controls 7.6 years [SD=6.8] vs cases 10.0 years [SD=8.0], p=0.03]. Pregnancy drinking was more 
common among the mothers who delivered at the Eastern Region Referral Hospital (ERRH) (37%) 
compared to JDWNRH in the capital (27%) and Central Region Referral Hospital (CRRH) in South 
(13%) (p<0.0001) (Figure 6.12). Mean maximum level of ethanol grams per occasion was higher 
at the Eastern Referral hospital (mean 79.8 grams, SD 99.6) compared to JDWNRH (mean 46.6 
grams, SD 47) and CRRH (39.4 grams, SD 27.9).  
 
6.3.2 Pattern and adverse birth outcomes 
The most commonly consumed alcoholic drink among the mothers during their pregnancy was 
“Changkey” (home-made rice wine, 32%), followed by Ara (home-made spirit, 31%) and wine 
(15%) (Figure 6.13). On average, mean days of drinking during the last three months of pregnancy 
was 14 days (SD=22.9, 95%CI: 11-18 days). Mothers drank on average 3 days per month for 
controls and 6 days per month for cases (p=0.0219(Figure 6.17). This suggests that control mothers 
drank less than once a week whereas case mothers drank once or twice a week. About 40% of the 
mothers had a heavy episodic drinking (>40grams) at least once during pregnancy.  
 
6.3.3 Quantity 
The maximum amount of alcohol consumed during pregnancy reported by the study participants 
on the F-GF measure (n=179) had a mean value of 54.1 g (SD=64.2) of ethanol in any day with a 
skewed distribution extending to 476g of ethanol on any day in the past 10 months (Table 6.10 and 
Table 6.11).  
The data suggested that the higher the maximum ethanol grams per occasion, the more the 
mother drank during the last three months of pregnancy (Figure 6.15).  
Mean total ethanol consumption in the past 10 months among the study participants who 
consumed alcohol was 7753 grams (SD= 15764, 95% CI: 5395-10112 grams).  The results confirm 
a study from Tashiyangtse, which reported the annual consumption was 8554 grams (SD=12501) 
among drinking women and the main motivation for drinking was medical reasons [3].  This is 
equivalent to approximately 33 bottles (700ml) of whisky in the past 10 months or 3 bottles of 
whisky per month during pregnancy. 
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Figure 6.12. Pregnancy drinking by delivery hospital and mean maximum ethanol grams per occasion 
among pregnant drinkers. 
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Table 6.8. Descriptive statistics of drinking among study participants. 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % 
P-
value 
 N % 
P-
value 
 N % P-value 
Ever drank Yes 146 45.5%  186 53.5% 0.048  84 55.3% 0.054  101 52.3% 0.15 
 Missing 2 0.6%  0 0.0%   0 0.0%   0 0.0%  
                
Age of starting drinking (n=332) <10 yrs old 12 8.2%  5 2.7% 0.048  2 2.4% 0.099  3 3.0% 0.212 
 10-<19 yrs old 43 29.5%  68 36.6%   33 39.3%   34 33.7%  
 >=19 yrs old 87 59.6%  111 59.7%   47 56.0%   64 63.4%  
 missing 4 2.7%  2 1.1%   2 2.4%   0 0.0%  
                
Drank during pregnancy (n=669) Yes 69 21.5%  110 31.6% 0.003  54 35.5% 0.001  55 28.5% 0.072 
                
Duration of drinking among pregnant drinkers 
(n=179) 
0 to 5 years 28 40.6%  41 37.3% 0.295  18 33.3% 0.185  23 41.8% 0.738 
 5< to 10 years 17 24.6%  20 18.2%   9 16.7%   11 20.0%  
 >10 yrs  21 30.4%  46 41.8%   25 46.3%   20 36.4%  
 missing 3 4.4%  3 2.7%   2 3.7%   1 1.8%  
                
Drinking intensity among pregnant drinkers (n=179) Low (<20g) 19 27.5%  27 24.6% 0.308  10 18.5% 0.151  17 30.9% 0.533 
 Moderate (20-40g) 28 40.6%  35 31.8%   17 31.5%   17 30.9%  
 High(40g) 22 31.9%  47 42.7%   26 48.2%   21 38.2%  
 Missing 0 0.0%  1 0.9%   1 1.9%   0 0.0%  
 
 
 
 
 
 217 
 
Table 6.9. Age of starting drinking and years of drinking among mothers with adverse birth outcomes. 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
Age (years old) of starting drinking 
(n=332) 
142 19.0 (5.5)  183 19.4 (5.2) 0.521  82 19.1 (5.2) 0.9667  100 19.8 (5.0) 0.262 
Years of drinking (n=179) 66 7.6 (6.3)  107 10.0 (8.0) 0.030  52 10.9 (8.4) 0.0225  54 9.1 (7.6) 0.255 
 
 
Table 6.10. Mean maximum ethanol grams per occasion, total ethanol grams in the past 10 months, number of days of drinking in the last 3 months of pregnancy among 
drinking study participants (n=179). 
 
Control (n=69)  Case (n=110)  Term LBW (n=54)  Preterm (n=55) 
N Mean (SD)  N Mean (SD) P-value  N Mean (SD) P-value  N Mean (SD) P-value 
Maximum ethanol grams per occasion  69 53 (71)  108 55 (61) 0.8093  52 69 (78) 0.2393  55 42 (34) 0.2934 
Total ethanol grams in the past 10 months 69 6443 (14046)  105 8614 (16808) 0.3583  50 
12541 
(22507) 
0.0948  54 
5122 
(7607) 
0.5063 
Number of days of drinking in the last 3 
months of pregnancy  
65 9 (18)  109 18 (25) 0.0108  54 24 (29) 0.0022  54 12 (18) 0.4139 
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Figure 6.13. Type of alcohol used during pregnancy. 
 
 
  
Figure 6.14. Frequency of drinking among study participants (n=179). 
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Figure 6.15. The fractional graduated frequencies (F-GF measure): The maximum amount of ethanol 
during pregnancy on one occasion and number of days of drinking during last 3 months of pregnancy. 
 
 
Table 6.11. The fractional graduated frequencies (F-GF) measure: mean quantities and percentage of 
each level of drinking out of total ethanol grams at four levels of F-GF measure. 
 Mean (SD) quantity grams ETOH Percent of total volume 
The maximum 54.1 (64.2) 40.7% 
3/4 maximum 40.6 (48.2) 29.8% 
1/2 maximum 27.0 (32.1) 20.2% 
1/4 maximum 13.5 (16.1) 9.3% 
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Figure 6.16. Frequency of drinking for four levels of F-GF measure. 
 
 
 
Figure 6.17. Boxplots of number of drinking days per month among pregnant drinkers by controls (0) 
and cases (1). Delivery # represents # of months from the month of delivery (n=176). 
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6.3.4 A summary of the key findings from analysis of pregnancy drinking  
In Bhutan, 27% of the study mothers drank during pregnancy. Although chemical analyses of actual 
alcohol content were not conducted, estimates based on the assumptions produced a similar result 
to past studies and suggested a high volume of drinking during pregnancy. More mothers of LBW 
and/or PTB babies drank during pregnancy compared to the controls (controls 21.5% [69/321] vs 
cases 31.6% [110/348], p=0.003; controls vs term LBW 35.5% [54/152], p=0.001; and PTB 28.5% 
[55/193], p=0.072). Mothers drank on average 3 days per month for controls and 6 days per month 
for cases (p=0.0219). In the logistic regression models, this will be further examined. The number 
of days of drinking during the last three months of pregnancy will be classified into 3: No-drinking, 
less than or equal to once a week, more than once a week. 
 
6.4 Summary  
Bhutanese pregnant women are exposed to a wide variety of substances, most commonly betel quid 
and alcohol (Figure 6.18). Substance use seems to continue throughout pregnancy except for 
cigarette smoking where the majority of the mothers stopped smoking before the last three months 
of pregnancy. The most common substance use during pregnancy was betel quid chewing (53%, 
359/669) followed by alcohol (27%, 179/669) and pan masala (23%, 153/669). Prevalence of 
cigarettes and smokeless tobacco was 3% and 5% respectively. Mean age of starting betel quid 
chewing was 18. Drinking was more common in the eastern part of Bhutan whereas betel quid 
chewing, use of other betel nut products and smokeless tobacco were more common among the 
mothers who delivered at the national referral hospital located in the western part of the country. 
The descriptive analyses suggest associations between drinking and smokeless tobacco and adverse 
birth outcomes. While the data did not provide sufficient evidence of association between adverse 
outcomes and betel quid chewing, betel quid seems to be associated with anaemia. The high 
prevalence of drinking and high intensity of drinking during pregnancy raises a public health 
concern in Bhutan. A recent national survey on risk factors for non-communicable diseases (NCD) 
in 2014 reported that NCD risk factors such as use of tobacco and alcohol, unhealthy diet including 
high dietary salt consumption, and high blood pressure were highly prevalent among Bhutanese 
adults [4]. Descriptive analyses in Chapters 5 and 6 confirmed that this pattern was also observed 
among the Bhutanese pregnant women in our study and it could be leading to pregnancy 
complications. This may have resulted in delivering LBW and/or PTB babies directly and indirectly. 
The potential risk factors identified in the descriptive analyses will be further examined in the 
regression analysis.  
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Figure 6.18. Common potentially toxic behaviour among study participants 
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Chapter 7  
Results of the logistic regression analyses  
and sensitivity analyses 
 
As proposed in Chapter 3, a statistical approach and a causal directed acyclic graph (DAG) approach 
were used for building logistic regression models. In this chapter, firstly, results from the logistic 
regression models using a statistical approach are provided, followed by the results from the logistic 
regression analyses using the DAG approach. Univariable analysis and multivariable analysis were 
conducted for both approaches. Using the DAG approach, sensitivity analyses were conducted. As 
a secondary outcome, association between betel quid use during pregnancy and maternal anaemia 
was examined using the DAG approach. The chapter ends with a summary of the overall analysis.  
 
7.1 A statistical approach 
7.1.1 Methods 
Multivariable analysis models were built using Akaike Information Criterion (AIC) to minimise the 
AIC (Table J.1 in Appendix J). Multicollinearity was checked to see how the standard error changed 
as variables were added to the model (Table J.2 in Appendix J). If there was a sudden large increase 
in a standard error when a variable was added to the model, it was considered to indicate a problem.  
Two models were used. They only differed in the modelling of betel quid chewing, tobacco, 
and drinking. Model 1 used a binary variable of betel quid chewing during pregnancy, tobacco use 
during pregnancy, and drinking during pregnancy. Model 2 used a categorical variable of number 
of betel quids consumed during the last three months of pregnancy with three categories (0: none; 
1: less than or equal to 1 nut per day; 2: more than 1 nut per day), a categorical variable of the total 
grams of smokeless tobacco with 2 categories (0: none; and 1: less than 5 grams per day), and a 
categorical variable of number of days of drinking during the last three months of pregnancy with 
3 categories (0: none; 1: less than or equal to once a week; and more than once a week) 
Delivery hospital, season of delivery, sex of the infant, highest level of education 
attainment, mother’s age at the time of delivery, ethnicity, GWG, hypertensive disorders, UTI, 
mode of delivery, nulliparity, previous history of preterm birth, number of ANC visits per 
gestational week after the first visit, number of meals per day, drinking during pregnancy, and 
smoking or using smokeless tobacco during pregnancy were adjusted based on the findings from 
the univariable analysis. 
Modelling of each variable was finalised considering its distribution and nature of the 
relationship with the outcome. After examining the dataset, the regression analysis was restricted 
to mothers who delivered by spontaneous vaginal delivery or caesarean section, either elective or 
emergency. The mothers who delivered by breech or vacuum were omitted due to the empty cells, 
which resulted in 658 mothers in the final models. Eclampsia and pre-eclampsia were combined 
into one category. As a result, hypertension was modelled as a categorical variable with four 
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categories (0: None hypertensive disorder; 1: chronic hypertension; 2: gestational hypertension; and 
3: Pre-eclampsia or eclampsia). The following tables present the results from the logistic regression 
analyses.  
Analyses of term LBW and PTB were conducted separately. The results are provided in 
Table 7. 1. The results of the LBW and/or PTB (cases) are provided in Table J.3 in Appendix J.  
 
7.1.2 Results 
Multivariable analyses using a statistical approach did not provide clear evidence of the impact of 
betel quid use, including packaged betel products or pan masala, at the level of consumption of 1.4 
nuts per day on LBW and/or PTB in the present study. Adjusting for delivery hospital, season of 
delivery, maternal age, number of ANC visits, wealth quintile, mother’s education level, nulliparity, 
history of previous PTB, smoking or using smokeless tobacco during pregnancy, drinking during 
pregnancy, hypertensive disorders, UTIs, number of meals per day, and mode of delivery, the data 
did not provide sufficient evidence of association between betel quid chewing during pregnancy 
and adverse birth outcomes compared to those who did not chew during pregnancy in Model 1 
(term LBW: the adjusted odds [aOR] 1.07, 95% CI: 0.54-2.13, p=0.845; and PTB: aOR 1.23, 95% 
CI: 0.65-2.34, p=0.529) (Table 7.1). In Model 2, compared to the mothers who did not chew during 
the last three months of pregnancy, the aOR for mothers who chewed less than or equal to one nut 
per day in the last three months of pregnancy was 1.36 for term LBW (95% CI: 0.61-3.00, p=0.452) 
and 0.62 for PTB (95%CI: 0.28-1.37, p=0.236) (Table 7.2). The aOR for mothers who chewed more 
than one nut per day was 1.40 for term LBW (95% CI: 0.37-5.24, p=0.621) and 0.62 for PTB (95% 
CI: 0.16-2.36, p=0.481) compared to non-chewers.   
As discussed in the Methods section, the aforementioned statistical models embody many 
parametric assumptions that are not known to be correct and may well be incorrect [1]. Without 
taking direct and indirect causal assumptions into account, covariates informed in a statistical 
approach may lead to biased estimates by controlling for an intermediate variable such as previous 
history of PTB which may share many causal factors with the present preterm birth. In fact, history 
of previous PTB was positively associated with term LBW (aOR 4.26, 95% CI: 1.18-15.32, p 
=0.027) and PTB (aOR 3.45, 95% CI: 1.01-10.09, p=0.036) adjusting for all other variables in 
Model 1. In the next section, results from logistic regression models using the DAG approach are 
provided.  
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Table 7.1. Results of logistic regression models using a statistical approach for Model 1. 
Model 1   
Term LBW(n=289) 
Adjusted Odds ratio 
 PTB (n=310) 
Adjusted Odds Ratio 
Independent variables   
Odds 
Ratio 
95% CI P-value   Odds Ratio 95% CI P-value 
Hospital (ref: JDWNRH) CRRH  0.53 0.18-1.52 0.236  0.79 0.30-2.13 0.646 
  MRRH  0.29 0.10-0.81 0.019   0.32 0.13-0.81 0.016 
          
Season (ref: Winter) Fall   1.00 0.37-2.66 0.995  0.82 0.32-2.13 0.689 
 Spring  0.96 0.38-2.43 0.926  1.07 0.44-2.64 0.875 
 Summer  3.67 1.41-9.54 0.008  3.57 1.44-8.82 0.006 
          
Sex of the infant (ref: Male) Female  3.76 1.88-7.56 <0.0001   0.95 0.52-1.75 0.872 
           
Age (ref: 20-35) <20  0.79 0.12-5.42 0.813   2.24 0.64-7.87 0.208 
 35<  0.96 0.31-2.97 0.938  0.65 0.23-1.80 0.404 
                   
Education (ref: Never attended school) Non-formal education (NFE)  0.20 0.03-1.20 0.079  0.42 0.11-1.65 0.168 
  Primary  1.34 0.43-4.16 0.616   1.03 0.35-3.04 0.984 
 Middle Secondary or Secondary 
School 
 
0.31 0.11-0.91 0.033 
 
0.51 0.21-1.28 
0.152 
  Diploma, college, and postgraduate  0.53 0.12-2.35 0.402   0.29 0.06-1.27 0.166 
           
Wealth Quintile (ref: Middle) Poorest  0.76 0.23-2.46 0.646   1.29 0.46-3.60 0.622 
 Second  0.81 0.28-2.32 0.695  1.03 0.40-2.65 0.959 
  Fourth  2.05 0.75-5.61 0.161   1.35 0.51-3.57 0.539 
 Richest  1.37 0.49-3.81 0.543  1.46 0.56-3.79 0.435 
                   
Number of ANC visits per gestational week after the first ANC visit  0.07 0.00-17.89 0.352  0.32 0.06-1.66 0.177 
                   
Ethnicity (ref: northern Bhutanese) Southern Bhutanese  1.92 0.93-3.96 0.076  0.74   0.36-1.54 0.422 
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GWG (ref: IOM recommendations) High GWG  0.57 0.19-1.77 0.334  0.47 0.16-1.37 0.169 
  Low GWG  3.12 1.42-6.84 0.004   2.19 1.06-4.52 0.034 
           
Number of meals per day    0.65 0.37-1.14 0.134   0.53 0.31-0.92 0.023 
           
UTI    2.13 0.70-6.50 0.183   2.49 0.92-6.78 0.073 
           
Nulliparity    2.14 1.00-4.59 0.050   1.58 0.80-3.11 0.189 
           
Previous history of PTB    4.26 1.18-15.32 0.027   3.45   1.01-10.09 0.036 
           
Hypertension (ref: Non-hypertensive disorder) Chronic or pre-existing   2.97 0.61-14.47 0.177   6.19 1.60-23.88 0.008 
 Gestational hypertension  4.68 1.39-15.73 0.013  3.90 1.18-12.86 0.026 
 Pre-eclampsia or eclampsia  0.76 0.12-4.88 0.771  9.39 2.44-36.11 0.001 
                   
Mode of delivery (ref: SVD) CS-elective  1.08 0.35-3.38 0.891  1.05 0.37-3.03 0.923 
  CS-emergency  1.35 0.60-3.03 0.469   3.74 1.80-7.76 <0.0001 
           
Chewing betel quid or pan masala during pregnancy   1.07 0.54-2.13 0.845   1.23 0.65-2.34 0.529 
           
Chewing smokeless tobacco or smoking during pregnancy  3.74 1.25-11.14 0.018   1.13 0.32-4.03 0.854 
           
Drinking during pregnancy    1.78 0.84-3.81 0.134   1.26 0.61-2.58 0.529 
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Table 7.2. Results of logistic regression models using a statistical approach for Model 2. 
Model 2   
Term LBW  
(n=261) 
Adjusted Odds ratio 
 
PTB 
(n=280) 
Adjusted Odds ratio 
Independent variables   
Odds 
Ratio 
95% CI P-value   Odds Ratio 95% CI P-value 
Hospital (ref: JDWNRH) CRRH  0.53 0.16-1.81 0.315  0.66 0.21-2.10 0.486 
  MRRH  0.24 0.07-0.83 0.025   0.25 0.09-0.70 0.008 
          
Season (ref: Winter) Fall   0.98 0.30-3.19 0.967  0.67 0.22-2.01 0.473 
 Spring  1.32 0.44-3.97 0.617  1.26 0.45-3.51 0.657 
 Summer  4.94 1.51-16.18 0.008  3.79 1.35-10.65 0.012 
          
Sex of the infant (ref: Male) Female  4.08 1.89-8.84 <0.0001   1.09 0.54-2.19 0.818 
          
Age (ref: 20-35) <20  1.28 0.15-10.75 0.818   2.75 0.67-11.19 0.159 
 35<  0.86 0.23-3.31 0.831  0.67 0.20-2.19 0.509 
                   
Education (ref: Never attended school) Non-formal education (NFE)  0.26 0.04-1.79 0.171  0.54 0.12-2.50 0.431 
  Primary  1.34 0.38-4.73 0.652   1.27 0.38-4.33 0.697 
 Middle Secondary or Secondary School  0.28 0.08-0.93 0.038  0.61 0.21-1.75 0.356 
  Diploma, college, and postgraduate  0.78 0.15-4.11 0.771   0.48 0.09-2.52 0.385 
          
Wealth Quintile (ref: Middle) Poorest  0.84 0.23-3.02 0.788   1.60 0.48-5.30 0.44 
 Second  0.57 0.17-1.89 0.356  1.27 0.43-3.75 0.665 
  Fourth  3.21 1.02-10.09 0.046   2.91 0.95-8.88 0.061 
 Richest  1.05 0.33-3.42 0.929  2.03 0.69-5.95 0.197 
                   
Number of ANC visits per gestational week after the first ANC visit  0.32 0.00-97.70 0.694  0.32 0.05-2.22 0.248 
                   
Ethnicity (ref: northern Bhutanese) Southern Bhutanese  3.06 1.34-7.02 0.008  0.63 0.27-1.47 0.285 
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GWG (ref: IOM recommendations) High GWG  0.68 0.18-2.52 0.567  0.58 0.18-1.84 0.358 
  Low GWG  4.18 1.66-10.52 0.002   2.26 1.03-4.97 0.043 
          
Number of meals per day    0.69 0.38-1.28 0.241   0.51 0.27-0.95 0.033 
          
UTI    2.56 0.68-9.57 0.163   2.70 0.89-8.23 0.08 
          
Nulliparity    1.77 0.76-4.15 0.188   1.95 0.92-4.15 0.083 
          
Previous history of PTB    6.71 1.55-29.05 0.011   4.81 1.29-17.88 0.019 
          
Hypertension (ref: Non-hypertensive disorder) Chronic or pre-existing   2.85 0.49-16.39 0.241   8.69 2.18-34.59 0.002 
 Gestational hypertension  2.76 0.69-11.09 0.153  2.69 0.70-10.42 0.151 
 Pre-eclampsia or eclampsia  0.74 0.08-7.10 0.791   11.07 2.30-53.24 0.003 
            
Mode of delivery (ref: SVD) CS-elective  1.54 0.41-5.79 0.519   1.43 0.41-5.02 0.573 
  CS-emergency  1.57 0.63-3.91 0.337  4.26 1.91-9.49 <0.0001 
                 
Total number of betel nuts during the last 3 months 
of pregnancy (ref: None) 
<=90 nuts during the 3 months or 1 nut per 
day 
 
1.36 0.61-3.00 0.452 
 
0.62 0.28-1.37 0.236 
 More than 1 nut per day  1.40 0.37-5.24 0.621   0.62 0.16-2.36 0.481 
          
Chewing smokeless tobacco or smoking during 
pregnancy (ref: None) 
Less than 5 grams per day  
1.59 0.36-7.11 0.541 
  
0.22 0.02-2.19 0.196 
           
Total number of days of drinking during the last 
three months of pregnancy (ref: no drinking) 
Less or equal to once a week  
1.55 0.57-4.24 0.392 
  
2.14 0.88-5.19 0.093 
  More than once a week  9.74 1.59-59.60 0.014   13.23 1.68-104.18 0.014 
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7.2 A causal directed acyclic graph approach 
7.2.1 Methods 
Separate logistic regression analyses were conducted to estimate the total effect of different 
exposure variables on adverse birth outcomes using the minimum sets of covariates for different 
exposure variables as described in Chapter 3. In the logistic models, wealth quintile and education 
variables were used to represent socioeconomic status (SES). Delivery hospital was used as a proxy 
for regionality. Number of meals per day was used as a proxy of imbalanced diet. 
Term LBW and PTB were used as separate outcomes. Three sensitivity analyses were 
conducted: (1) Limiting data to mothers with early scans and certain LMP dates for PTB; (2) 
multiple imputation based on MAR assumption; and (3) sensitivity analysis using a pattern mixture 
approach under MNAR assumptions. In the pattern mixture sensitivity analysis, two assumptions 
under MNAR were made for UTI. UTI was selected as it was one of the variables with more than 
10% missing observations and as the literature provides a substantial amount of evidence of an 
association between UTI and adverse birth outcomes.  
 
(a) Multiple imputation 
As the total number of observations included in the multivariable analyses decreased by roughly 
50% due to missing data, the multiple imputation model was used to compare the results to see the 
validity of the analyses assuming MAR.  
The percentage of missing values across the 19 variables varied between 0 and 30%. Many 
mothers were missing pre-pregnancy weight.   
The minimum number of cases with complete data for the analyses of interest was 282/473 
for term LBW and 247/516 for PTB models. The multiple imputation model (Rubin, 1987a) [2] 
was used to create 100 multiply imputed datasets. Model parameters were estimated with multiple 
regression applied to each imputed dataset separately. These estimates and their standard errors 
were combined using Rubin’s rules.  
The STATA “mi impute chained” command was used to create 100 imputed datasets. The 
variables included in the model and model specifications are provided in Table 7.3 and Table 7.4.  
The Monte-Carlo error represents how much variability there is due to the fact we have 
used 100 imputations. With an infinite number of imputations, the Monte-Carlo error would be zero. 
From Table J.4 in Appendix J, it was confirmed that the conditions proposed by White et al. (2010)  
were met [3] as described in Chapter 3.  Convergence was checked by plotting the mean estimate 
against the cycle (iteration) number (in this study, 100) for each variable with a high proportion of 
missing data. In the trace plots, it was confirmed that the values varied randomly (Figures J.1 – J.6 
in Appendix). 
MNAR Model 1 assumes that the odds of having UTI during pregnancy for mothers who 
were missing information on UTI was two times more than that of mothers who have information 
on UTI (OR=2). The MNAR Model 2 odds of having UTI during pregnancy for mothers who were 
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missing information on UTI was 50% less than that of mothers who have information on UTI 
(OR=0.5). The imputation datasets were produced with 100 times of iteration in SAS 9.4 (SAS 
Institute Inc., Cary, NC, USA) using a fully conditional specification (FCS) statement, MNAR, and 
ADJUST option with an adjustment parameter (SHIFT). The MNAR statement imputes missing 
values by using the pattern-mixture model approach, assuming the missing data are MNAR [4]. 
The rest of the analyses were conducted using the aforementioned methods in STATA 14.1. 
 
 
Table 7.3. Completeness of variables included in the model and model specification for multiple 
imputation (all numbers are counts of available and missing data). 
    Complete Missing 
Model specification  
in the imputation Model 
Outcome 
variable 
LBW 473 0 logistic 
Independent 
variable 
GWG (kg) 336 137 regress 
  Maternal pre-pregnancy weight (kg) 343 130 regress 
  UTI 436 37 logistic 
  Maternal height (cm) 446 27 regress 
  Hypertension 453 20 mlogit 
  
Smoking or smokeless tobacco during 
pregnancy 
467 6 logistic 
  Betel quid during pregnancy 468 5 logistic 
  Wealth quintile 470 3 mlogit 
  Number of meals per day 470 3 regress 
  Betel quid chewing before pregnancy 472 1 logistic 
  Nulliparity 472 1 logistic 
  Mother's age at delivery 473 0 regress 
  Ancestry by name 473 0 logistic 
  C-section 473 0 logistic 
  Education 473 0 mlogit 
  Delivery hospital 473 0 mlogit 
 Season 473 0 mlogit 
  Sex of infant 473 0 logistic 
  Drinking during pregnancy 473 0 logistic 
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Table 7.4. Completeness of variables included in the model and model specification for multiple 
imputation (all numbers are counts of available and missing data). 
    Complete Missing 
Model specification  
in the imputation Model 
Outcome 
variables 
PTB  513 3 logistic 
Independent 
variables 
GWB (kg) 369 147 regress 
  Maternal pre-pregnancy weight in (kg) 379 137 regress 
  UTI 457 59 logistic 
  Maternal height (cm) 467 49 regress 
  Hypertension 487 29 mlogit 
  
Smoking or smokeless tobacco during 
pregnancy 
509 7 logistic 
  Betel quid during pregnancy 509 7 logistic 
  Wealth quintile 511 5 mlogit 
  Number of meals per day 514 2 regress 
  Betel quid chewing before pregnancy 515 1 logistic 
  Education 515 1 mlogit 
  Drinking during pregnancy 516 0 logistic 
  Sex of the infant 516 0 logistic 
  Delivery hospital 516 0 mlogit 
 Season 516 0 mlogit 
  C-section 516 0 logistic 
  Ancestry by name 516 0 logistic 
  Mother's age at delivery 516 0 regress 
 
 
7.2.2 Results 
The results from the complete case analysis and sensitivity analyses varied little. Thus, the results 
were integrated and presented. The following section mainly summarises the results from the 
complete case multivariable analyses unless the results of multiple imputation substantially changed. 
If the results from the complete case analysis and results from multiple imputation models were 
different, the discrepancies were addressed. Inferential results for these values under MNAR and 
results for imputed values that were obtained under MAR were virtually identical (Table 7.7 and 
Table 7.8). Therefore, it may indicate that the MAR assumption is plausible.  
The differences in the statistical approach and DAG approach were addressed where the 
results substantially changed. Possible reasons for discrepancies are discussed.  
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(a) Modifiable risk factors in the short run 
I. Maternal potential health-risk behaviours 
(1) Betel quid chewing or pan masala use during pregnancy 
The aOR of delivering a term LBW baby among the mothers who chewed betel quid or 
used pan masala during pregnancy compared to those who did not chew betel quid or betel 
products was 1.30 (95% CI: 0.74-2.27, p-value=0.361) adjusting for ethnicity, wealth 
quintile, education, chronic hypertension, maternal height, maternal age, pre-pregnancy 
weight, delivery hospital and season of delivery (Table 7.5). The aOR of PTB was 1.20 
(95% CI: 0.72-2.00, p-value=0.481) adjusting for ethnicity, wealth quintile, education, 
chronic hypertension, maternal height, maternal age, pre-pregnancy weight, delivery 
hospital, and season of delivery (Table 7.6). When a categorical variable of the total number 
of betel nuts chewed during the last three months of pregnancy was used in the model 
instead of the binary variable, the aOR of term LBW among the mothers who chewed betel 
quid less than or equal to one nut per day was 1.32 (95% CI: 0.69-2.51, p-value=0.402) 
adjusting for ethnicity, wealth quintile, education, chronic hypertension, maternal height, 
maternal age, pre-pregnancy weight, delivery hospital, and season of delivery in the model 
compared to the mothers who did not chew during pregnancy. The aOR of PTB among the 
mothers who chewed betel quid less than or equal to one nut per day was 0.76 (95% CI: 
0.39-1.47, p-value=0.411) compared to the non-chewers during pregnancy.  
 
(2) Tobacco 
The level of consumption was low compared to past studies (on average 3 cigarettes per 
day or 2.4 grams of smokeless tobacco per day). In the present study, the maximum amount 
of smokeless tobacco was 5 grams per day on average during the last three months of 
pregnancy and the majority of women quit smoking cigarettes during the last three month 
of pregnancy. The aOR of term LBW among mothers who used smokeless tobacco and/or 
smoked cigarettes during pregnancy was 3.12 (95% CI: 1.62-5.99, p=0.001) adjusting for 
wealth quintile and maternal education compared to mothers who did not use any tobacco. 
The aOR of PTB was 2.14 (95% CI: 1.12-4.11, p=0.022).   
Tobacco was one of the variables that had significantly different estimates in the 
statistical and DAG approaches. In the model using a statistical approach, the aOR of PTB 
was 1.13 (95% CI: 0.32-4.03, p=0.854). This estimate may be biased due to the over-
adjustment of the variables that could be in the causal pathway such as hypertensive 
disorders. Hypertensive disorders, assumed to be on the causal pathway between tobacco 
and adverse pregnancy outcomes in the DAGs was adjusted for in the statistical approach, 
allowing only direct effect to be estimated. This may explain why the odds ratio in the 
statistical approach was 50% smaller than the DAG analysis.  
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(3) Alcohol during pregnancy 
Mothers who drank during pregnancy had 1.96 times higher odds of term LBW compared 
to non-drinkers after adjusting for betel quid chewing during pregnancy, wealth quintile, 
education, chronic hypertension, maternal height, maternal age, pre-pregnancy weight, and 
season of delivery (aOR 1.96, 95% CI: 1.10-3.49, p=0.022). Mothers who drank less than 
or equal to once a week had 2.16 higher odds of PTB (95% CI: 1.11-4.19, p=0.023) and 
mothers who drank more than once a week had 3.43 times higher odds of PTB (95% CI: 
0.88-13.37, p=0.075) compared to non-drinkers. Association between alcohol during 
pregnancy and pregnancy outcomes was not clear in the statistical approach (Term LBW: 
aOR 1.78, 95% CI: 0.84-3.81, p=0.134; and PTB: aOR 1.26, 95% CI: 0.61-2.58, p=0.529). 
This estimate may be biased due to the over-adjustment of the variables that could be on 
the causal pathway such as hypertensive disorders. Hypertensive disorders, assumed to be 
on the causal pathway between alcohol and adverse pregnancy outcomes in the DAGs, was 
adjusted for in the statistical approach, allowing only direct effect to be estimated. In 
addition, the number of observations included in the statistical approach was smaller than 
the DAG approach due to the different portions of missing data as they include different 
covariates. As a result, loss of information in the statistical model decreased the power. 
 
II. Nutritional factors (GWG) 
Having lower GWG than recommended by the Institute of Medicine (IOM) according to pre-
pregnancy BMI, had a 2.62 times higher odds ratio (aOR 2.62, 95% CI: 1.33-5.15, p=0.005) of 
term LBW and a 2.15 times higher odds ratio (aOR 2.15, 95% CI:1.14-4.04, p=0.018) of  PTB 
compared to those with GWG as per IOM recommendations (For underweight: 28-40 lbs/ 12.5-
18 kgs ; normal BMI: 25-35 lbs/11.5-16 kgs; For overweight:15-25lbs/7.0-11.5 kgs; obese:11-
20 lbs/5-9 kgs), adjusting for betel quid chewing during pregnancy, ethnicity, wealth quintile, 
education, chronic hypertension, imbalanced diet, maternal height, maternal age, delivery 
hospital, and season of delivery. 
 
III. Infectious disease (UTI) 
The aOR of term LBW association with UTI was 2.17 (95% CI: 1.11-4.26, p=0.023) and the 
aOR of PTB was 1.98 (95% CI 1.00-3.90, p=0.049), adjusting for wealth, education, and season 
of delivery. 
 
(b) Modifiable risk factors in the long-run or non-modifiable risk factors 
I. Socio-economic status 
(1) Wealth quintile  
The data did not provide sufficient evidence of the impact of wealth quintile on term LBW 
after adjusting for delivery hospital (middle quintile [reference] vs poorest quintile [aOR: 
1.37, 95% CI 0.73-2.54]; middle vs second [aOR: 0.88, 95% CI 0.47-1.65]; middle vs 
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fourth [aOR: 1.01, 95% CI 0.54-1.89]; and middle vs richest [aOR: 0.73, 95% CI: 0.39-
1.37]). The results were similar for PTB.   
 
(2) Education 
The data suggested evidence of an association between middle secondary or secondary 
school compared to no education, with reduced odds of term LBW after adjusting for 
delivery hospital (None [reference] vs non-formal education [aOR: 0.59, 95% CI 0.27-
1.29]; none vs primary[aOR: 0.91, 95% CI 0.49-1.67]; none vs  middle secondary or 
secondary school [aOR: 0.54, 95% CI 0.33-0.86]; and none vs diploma, college, or 
postgraduate [aOR: 0.75, 95% CI: 0.34-1.64]).  
The aOR of PTB for education varied a little by each category of highest education 
attainment (none [reference] vs non-formal education [aOR: 0.56, 95% CI 0.25-1.27]; none 
vs primary [aOR: 1.20, 95% CI 0.66-2.15]; none vs  middle secondary or secondary school 
[aOR: 0.89, 95% CI 0.57-1.39]; and none vs diploma, college, or post graduate [aOR: 0.82, 
95% CI: 0.38-1.78]). 
 
II. Maternal age 
The aOR for maternal age substantially changed in the DAG approach compared to the 
statistical approach. In the DAG approach, the aOR among mothers who were under 20 years 
old compared to mothers aged between 20 and 35 at time of delivery was 1.65 (95%CI: 0.68-
4.01, p=0.272) for term LBW and 2.37 (95%CI: 1.13-4.98, p=0.023) for PTB adjusting for 
wealth and education.  
In the statistical approach, the aOR among mothers who were under 20 years old 
compared to mothers aged between 20 and 35 at time of delivery was 0.79 (95% CI: 0.12-5.42, 
p=0.813) for term LBW and 2.24 (95% CI: 0.64-7.87, p=0.208) for PTB. 
The aOR of term LBW in the statistical approach is less than half of the aOR in the 
DAG approach. This could be due to underestimation by adjusting for some of the variables on 
the causal pathway such as hypertensive disorders and previous history of PTB. This only 
allowed the model to estimate the direct causal effect of age.   
The evidence of association between maternal age older than 35 years and adverse birth 
outcomes was clearer in the multiple imputation models than complete case analysis although 
the point estimates were virtually identical. In the complete case analysis, the aOR among 
mothers over 35 years old was 1.77 (95%CI: 0.996-3.13, p=0.052) for term LBW and 1.72 
(95%:1.01-2.93, p-value=0.047) for PTB compared to mothers aged between 20 and 35.  In the 
multiple imputation model under MAR, the corresponding aOR of term LBW was 1.76 
(95%CI: 1.02-3.06, p=0.044) and the aOR of PTB was 1.80 (95%:1.01-3.18, p-value=0.045). 
Loss of information in the complete case analysis due to missing data may account for 
decreased power.   
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III. Hypertensive disorders 
(1) Chronic hypertension 
In the complete case analysis, the aOR of term LBW among mothers with chronic 
hypertension was 2.68 (95% CI: 0.70-10.31, p-value=0.151) and the aOR of PTB was 3.23 
(95% CI: 1.01-10.30, p-value=0.047) after controlling for betel quid chewing during 
pregnancy, ethnicity, wealth quintile, education, maternal height, maternal age, pre-
pregnancy weight, delivery hospital, and season of delivery. The association between 
chronic hypertension and adverse pregnancy outcomes was clearer in the multiple 
imputation models. Under MAR, the aOR of term LBW was 4.24 (95% CI: 1.44-12.42, 
p=0.009) and the aOR of PTB was 4.73 (95% CI: 1.83-12.19, p=0.001). The results under 
MNAR were almost identical to those under MAR. The large number of missing data in 
maternal height and pre-pregnancy weight may have decreased the power for the complete 
case analysis, resulting in an unclear association between chronic hypertension and term 
LBW.  
 
(2) Pregnancy-induced hypertension, pre-eclampsia and eclampsia: 
The mothers with pregnancy-induced hypertension (PIH), pre-eclampsia, or eclampsia had 
a 7.08 times higher odds ratio (95% CI: 3.58-14.00, p-value<0.0001) of PTB compared to 
mothers without hypertensive disorders adjusting for alcohol during pregnancy, betel quid 
chewing during pregnancy, ethnicity, chronic hypertension, number of meals per day, 
maternal age, tobacco use during pregnancy. The total effect of PIH, pre-eclampsia, or 
eclampsia on term LBW cannot be estimated by adjusting for covariates in the proposed 
DAG. 
 
IV. Maternal and obstetric factors 
(1) Nulliparity 
The aOR of nulliparous mothers compared to non-nulliparous mothers was 1.50 for term 
LBW (aOR 1.50, 95% CI 0.98-2.30, p=0.061) after adjusting for maternal age.  
 
(2) Sex of the infant 
Female infants had a 1.96 times higher odds ratio of being LBW (crude OR 1.96, 95% CI: 
1.32-2.92, p=0.001). The association between male infants and PTB was not clear (crude 
OR 0.88, 95 % CI: 0.62-1.26, p=0.487). 
 
V. Ethnicity 
The crude OR of term LBW among southern Bhutanese compared to northern Bhutanese was 
1.47 (95% CI: 0.98-2.20, p=0.064). The crude odds ratio of PTB among southern Bhutanese 
compared to northern Bhutanese was 0.85 (95% CI: 0.57-1.27, p=0.440). 
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VI. Altitude difference between the current residence and the permanent residence 
The OR of term LBW differed little by altitude difference between the current residence and 
the permanent residence in the univariable analysis (0-1000 m (reference) vs < 0 m [term LBW: 
OR 0.81, 95% CI: 0.46-1.42; and PTB: OR 0.93, 95% CI: 0.56-1.55]; 1000-<2000 m [term 
LBW: OR 1.18, 95% CI: 0.72-1.95; and PTB:1.27, 95% CI: 0.79-2.02]; and 2000 m and above 
[OR 1.03, 95% CI: 0.51-2.06; and PTB: OR 1.18, 95% CI: 0.62-2.23]). 
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Table 7.5. Results from the logistic regression models based on DAGs for term LBW. 
 Exposure Category Factors adjusted for n Crude 95%CI P-value  n AOR 95%CI P-value 
Maternal Potential 
Risk Factors 
Betel quid chewing 
during pregnancy 
  
Covariate set 1: Ethnicity, SES, 
chronic hypertension, maternal 
height, maternal age, pre-pregnancy 
weight, regionality, seasonality 
468 1.10 
0.74-
1.63 
0.648  317 1.30 
0.74-
2.27 
0.361 
     
Covariate set 2: BQ chewing before 
pregnancy, seasonality 
     468 1.04 
0.61-
1.78 
0.876 
             
 
Total number of betel 
nuts during the last 3 
months of pregnancy  
(ref: No betel quid 
chewing) 
<=90 nuts during the last 3 
months or=<1 nut per day 
Covariate set 1: Ethnicity, SES, 
chronic hypertension, maternal 
height, maternal age, pre-pregnancy 
weight, regionality, seasonality 
421 1.28 
0.81- 
2.01 
0.286  282 1.32 
0.69-
2.51 
0.402 
   
More than 90 nuts during 
the last 3 months or >1 nut 
per day 
   1.07 
0.57-
2.00 
0.836   1.39 
0.52-
3.68 
0.514 
             
 
Tobacco use during 
pregnancy 
  DAG 3: SES 467 3.28 
1.73- 
6.23 
<0.0001  465 3.12 
1.62-
5.99 
0.001 
             
 
Grams of ST in the last 
3 months of pregnancy 
(ref: did not use during 
pregnancy) 
Less than 5 grams per day DAG 3: SES 463 3.55 
1.62-
7.78 
0.002  461 3.04 
1.36-
6.80 
0.007 
             
 
 Alcohol use during 
pregnancy 
  
DAG 3:BQ during pregnancy, 
ethnicity, SES, chronic hypertension, 
maternal height, maternal age, pre-
pregnancy weight, seasonality 
473 2.01 
1.31-
3.08 
0.001  320 1.96 
1.10-
3.49 
0.022 
             
 
Number of drinking 
days 
Less than or equal to once 
a week 
DAG 3: BQ during pregnancy, 
ethnicity, SES, chronic hypertension, 
maternal height, maternal age, pre-
pregnancy weight, seasonality 
469 1.43 
0.81-
2.52 
0.221  317 1.92 
0.94-
3.90 
0.069 
   More than once a week    6.07 
2.81- 
13.12 
<0.0001   6.30 
1.66-
23.91 
0.007 
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Nutritional Factors 
GWG (ref: as per IOM 
recommendation) 
High GWG 
Covariate set 1: BQ during 
pregnancy, ethnicity, SES, chronic 
hypertension, imbalanced diet, 
maternal height, maternal age, 
regionality, seasonality 
336 0.69 
0.29-
1.64 
0.398  310 0.72 
0.27-
1.87 
0.494 
   Low GWG    2.47 
1.38-
4.43 
0.002   2.62 
1.33- 
5.15 
0.005 
   High GWG 
Covariate set 2: Imbalanced diet, 
maternal height, pre-pregnancy 
weight 
     316 0.92 
0.37-
2.29 
0.859 
   Low GWG         2.69 
1.43-
5.04 
0.002 
             
Infectious Diseases UTI   SES, seasonality 436 1.96 
1.02-
3.75 
0.043  433 2.17 
1.11-
4.26 
0.023 
             
Hypertensive 
disorders 
Chronic hypertension   
BQ during pregnancy, ethnicity, 
SES, maternal height, maternal age, 
pre-pregnancy weight, regionality, 
seasonality 
468 3.55 
1.35- 
9.36 
0.010  317 2.68 
0.70-
10.31 
0.151 
             
 PIH, PE/Eclampsia   
The total effect cannot be estimated 
by covariate adjustment  
452 4.79 
2.48-
9.26 
<0.0001      
             
Socio-economic 
Status 
 Wealth quintile 
(ref: Middle) 
Poorest  Regionality 470 1.34 
0.73- 
2.47 
0.341  470 1.37 
0.73-
2.54 
0.330 
   Second    0.88 
0.47-
1.64 
0.689   0.88 
0.47-
1.65 
0.700 
   Fourth    1.00 
0.54-
1.86 
0.997   1.01 
0.54-
1.89 
0.975 
   Richest     0.72 
0.39- 
1.36 
0.317   0.73 
0.39-
1.37 
0.320 
             
 
 Education 
(ref: No education) 
Non-formal education  Regionality 473 0.59 
0.27-
1.29 
0.188  473 0.59 
0.27-
1.31 
0.196 
   Primary    0.91 
0.49-
1.67 
0.753   0.91 
0.49-
1.67 
0.753 
   
Middle secondary or 
secondary  
   0.54 
0.33-
0 .86 
0.010   0.53 
0.33-
0.86 
0.010 
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Diploma, college, and post- 
graduate 
   0.75 
0.34-
1.64 
0.472   0.75 
0.34-
1.64 
0.469 
             
 
 Maternal age 
(ref: 20-35) 
<20  SES 473 1.53 
0.64-
3.64 
0.334  470 1.65 
0.68-
4.01 
0.272 
    35<    2.02 
1.16-
3.50 
0.012   1.77 
0.996-
3.13 
0.052 
             
Hypertensive 
disorders 
Chronic hypertension   
BQ during pregnancy, ethnicity, 
SES, maternal height, maternal age, 
pre-pregnancy weight, regionality, 
seasonality 
468 3.55 
1.35- 
9.36 
0.010  317 2.68 
0.70-
10.31 
0.151 
             
 PIH, PE/Eclampsia   
The total effect cannot be estimated 
by covariate adjustment  
452 4.79 
2.48-
9.26 
<0.0001      
             
Obstetric Factors 
Sex of the infant  
(ref: Male) 
  No adjustment is necessary 473 1.96 
1.32-
2.92 
0.001      
             
 Nulliparity   Maternal age 472 1.26 
0.86-
1.87 
0.237  472 1.50 
0.98-
2.30 
0.061 
             
Ethnicity Ethnicity  Southern Bhutanese No adjustment is necessary  473 1.47 
0.98-
2.20 
0.064      
             
Altitude 
Altitude between the 
current residence and 
the permanent 
residence  
(ref: 0-1000)  
 <0   No adjustment is necessary 448 0.81 
0.46-
1.42 
0.453      
   1000-2000     1.18 
0 .72-
1.95 
0.513      
    >=2000      1.03 
0.51-
2.06 
0.943      
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Table 7.6. Results from the logistic regression models based on DAGs for PTB. 
 Exposure category Factors adjusted for 
Complete case analysis  
Data restricted to mothers  
with early scans only 
n Crude 95%CI 
P-
value 
 n AOR 95%CI 
P-
value 
 n 
AO
R 
95%C
I 
P-
value 
Maternal 
Potential 
Health Risk 
Behaviour 
Betel quid chewing 
during pregnancy 
  
Covariates set 1: Ethnicity, SES, 
chronic hypertension, maternal 
height, maternal age, pre-
pregnancy weight, regionality, 
seasonality 
507 1.16 
0.80-
1.67 
0.433  333 1.20 
0.72-
2.00 
0.481  279 1.17 
0.66-
2.05 
0.594 
     
Covariate set 2: BQ chewing 
before pregnancy, seasonality 
- - - -  507 1.10 
0.68-
1.79 
0.702  414 1.03 
0.60-
1.76 
0.924 
                  
 
Total number of betel 
nuts during the last 3 
months of pregnancy  
(ref: No betel quid 
chewing) 
<=90 nuts during 
the last 3 months 
or=<1 nut per day 
Covariate set 1: Ethnicity, SES, 
chronic hypertension, maternal 
height, maternal age, pre-
pregnancy weight, regionality, 
seasonality 
455 1.19 
0.78-
1.81 
0.420  299 0.85 
0.47-
1.54 
0.586  247 0.76 
0.39-
1.47 
0.411 
   
More than 90 nuts 
during the last 3 
months or >1 nut 
per day 
  - 0.80 
0.44-
1.49 
0.486  - 0.66 
0.27-
1.66 
0.383  - 0.77 
0.28-
2.14 
0.623 
                  
 
 Tobacco use during 
pregnancy 
  DAG 3: SES  507 2.38 
1.25-
4.51 
0.008  502 2.14 
1.12-
4.11 
0.022  411 1.64 
0.73-
3.68 
0.233 
                  
 
Grams of ST in the last 3 
months of pregnancy (ref: 
did not use during 
pregnancy) 
Less than 5 grams 
per day 
DAG 3: SES  502 2.39 
1.07-
5.32 
0.033  497 2.11 
0.93- 
4.81 
0.076  409 1.71 
0.64- 
4.61 
0.287 
                  
 
 Alcohol use during 
pregnancy 
  
DAG 3: BQ during pregnancy, 
Ethnicity, SES, chronic 
hypertension, maternal height, 
514 1.46 
0.97- 
2.19 
0.073  337 1.53 
0.89-
2.65 
0.126  282 1.61 
0.89-
2.90 
0.117 
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maternal age, pre-pregnancy 
weight, seasonality 
     
DAG 3: Ethnicity, SES, 
regionality, seasonality 
- - - -  508 1.46 
0.95-
2.25 
0.082  416 1.46 
0.91-
2.36 
0.118 
                  
 
 Number of drinking days 
(ref: no drinking) 
Less than or equal 
to once a week 
DAG 3: BQ during pregnancy, 
Ethnicity, SES, chronic 
hypertension, maternal height, 
maternal age, pre-pregnancy 
weight, seasonality 
509 1.50 
0.90-
2.49 
0.121  333 2.16 
1.11-
4.19 
0.023  279 2.44 
1.22-
4.89 
0.011 
   
More than once a 
week 
  - 2.37 
1.01- 
5.54 
0.046   3.43 
0.88-
13.37 
0.075  - 2.54 
0.48-
13.44 
0.272 
   
Less than or equal 
to once a week 
DAG 3:Ethnicity, SES, 
regionality, seasonality 
- - - -  503 1.54 
0.90-
2.64 
0.116  412 1.62 
0.91-
2.89 
0.174 
   
More than once a 
week 
  - - - -  - 2.37 
0.96-
5.85 
0.061  - 1.55 
0.50- 
4.82 
0.451 
                  
Nutritional 
Factors 
GWG 
(ref: as per IOM 
recommendation) 
High GWG 
Covariate set 1: BQ during 
pregnancy, ethnicity, SES, 
chronic hypertension, 
imbalanced diet, maternal 
height, maternal age, 
regionality, seasonality 
370 1.20 
0.59-
2.42 
0.614  328 1.17 
0.52-
2.63 
0.697  275 1.17 
0.49-
2.77 
0.724 
   Low GWG   - 2.61 
1.52- 
4.50 
0.001  - 2.15 
1.14-
4.04 
0.018  - 2.59 
1.28- 
5.25 
0.008 
   High GWG 
Covariate set 2: Imbalanced 
diet, maternal height, pre-
pregnancy weight 
- - - -  343 1.34 
0.64-
2.81 
0.441  284 1.50 
0.67-
3.36 
0.329 
   Low GWG   - - - -    - 2.23 
1.26-
3.93 
0.006  - 2.77 
1.45-
5.29 
0.002 
                  
Infectious 
Diseases 
UTI   SES, seasonality 457 1.67 
0.87-
3.18 
0.122  451 1.98 
1.00-
3.90 
0.049  372 1.61 
0.74-
3.49 
0.231 
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Hypertensiv
e disorders 
Chronic hypertension   
BQ during pregnancy, 
ethnicity, SES, maternal height, 
maternal age, pre-pregnancy 
weight, regionality, seasonality 
499 4.35 
1.75-
10.78 
0.002  333 3.23 
1.01-
10.30 
0.047  279 3.48 
0.99-
12.14 
0.051 
                  
 
PIH, Pre-
eclampsia/Eclampsia 
  
Alcohol during pregnancy, BQ 
during pregnancy, ethnicity, 
chronic hypertension, 
imbalanced diet, maternal age, 
tobacco during pregnancy 
482 7.83 
4.24-
14.44 
<0.00
01 
 460 7.08 
3.58-
14.00 
<0.0
001 
 383 8.97 
4.05-
19.87 
<0.00
01 
                  
Mode of 
Delivery 
C-section   
PIH, pre-eclampsia or 
eclampsia, chronic 
hypertension, gestational 
weight gain, infectious disease 
514 1.83 
1.26-
2.64 
0.001  329 2.16 
1.26-
3.70 
0.005  268 1.81 
0.99-
3.34 
0.056 
                  
Socio-
economic 
status 
 Wealth quintile 
(Ref: Middle) 
Poorest  Regionality 509 0.96 
0.55-
1.68 
0.881  509 0.94 
0.53-
1.66 
0.833  416 1.16 
0.60-
2.26 
0.660 
   Second   - 0.72 
0.41-
1.26 
0.253  - 0.72 
0.41-
1.27 
0.255  - 0.86 
0.45-
1.66 
0.663 
   Fourth   - 0.81 
0.46-
1.42 
0.458  - 0.81 
0.46-
1.42 
0.460  - 1.10 
0.58-
2.07 
0.772 
   Richest    - 0.61 
0.34-
1.07 
0.084  - 0.60 
0.34-
1.06 
0.078  - 0.79 
0.42-
1.50 
0.471 
                  
 
 Education 
(Ref: No education) 
Non-formal 
education 
 Regionality 513 0.55 
0.24-
1.23 
0.145  513 0.56 
0.25-
1.27 
0.165  420 0.61 
0.23-
1.58 
0.304 
   Primary   - 1.18 
0.66-
2.11 
0.587  - 1.20 
0.66-
2.15 
0.551  - 1.35 
0.69-
2.66 
0.380 
   
Middle secondary 
or secondary  
  - 0.89 
0.56-
1.39 
0.596  - 0.89 
0.57-
1.39 
0.604  - 0.99 
0.59-
1.65 
0.955 
   
Diploma, college, 
and postgraduate 
  - 0.83 
0.38-
1.79 
0.634  - 0.82 
0.38-
1.78 
0.623  - 0.98 
0.43-
2.22 
0.953 
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Maternal 
age 
 Maternal age (ref: 20-35) <20  SES  514 2.43 
1.17-
5.03 
0.017  508 2.37 
1.13-
4.98 
0.023  416 2.09 
0.86-
5.07 
0.102 
    35<   - 1.72 
1.01-
2.93 
0.047  - 1.70 
0.97-
2.95 
0.062  - 1.63 
0.85-
3.14 
0.144 
                  
Sex of the 
infant 
Male infant   No adjustment is necessary 513 0.88 
0.62-
1.26 
0.487  - - - -  419 1.03 
0.69-
1.54 
0.894 
                  
Ethnicity Ethnicity 
Southern 
Bhutanese  
No adjustment is necessary  514 0.85 
0.57-
1.27 
0.440  - - - -  420 0.88 
0.56-
1.38 
0.573 
                  
Altitude 
Altitude between the 
current residence and the 
permanent residence  
(ref: 0-1000) 
 <0   No adjustment is necessary 484 0.93 
0.56-
1.55 
0.782  - - - -  396 1.02 
0.58-
1.78 
0.958 
   1000-2000    - 1.27 
0.79-
2.02 
0.326  - - - -  - 1.46 
0.87-
2.46 
0.152 
    >=2000     - 1.18 
0.62-
2.23 
0.614  - - - -  - 1.20 
0.57-
2.53 
0.633 
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Table 7.7. Missing data imputation for term LBW under MAR and MNAR in comparison with complete case analysis. 
Exposure Category Factors adjusted for 
Complete case  MAR (n=473)  
MNAR (ODDS 
ratio=0.5) (n=473) 
 
MNAR (ODDS 
ratio=2) (n=473) 
n OR 95%CI 
P-
value 
 OR 95%CI 
P-
value 
 OR 95%CI 
P-
value 
 OR 
95%C
I 
P-
value 
Betel quid chewing 
during pregnancy 
  
Covariate set 1: Ethnicity, SES, 
chronic hypertension, maternal 
height, maternal age, pre-
pregnancy weight, regionality, 
seasonality 
317 1.30 
0.74-
2.27 
0.361  1.40 
0.90-
2.19 
0.140  1.38 
0.89- 
2.16 
0.151  1.39 
0.89- 
2.17 
0.145 
    
Covariate set 2: BQ chewing before 
pregnancy, seasonality 
468 1.04 
0.61-
1.78 
0.876  1.06 
0.62-
1.80 
0.873  1.06 
0.62-
1.80 
0.837  1.06 
0.62-
1.81 
0.834 
                   
Tobacco use 
during pregnancy 
  DAG 3: SES 465 3.12 
1.62-
5.99 
0.001  3.31 
1.74-
6.28 
<0.000
1 
 3.22 
1.68-
6.19 
<0.000
1 
 3.19 
1.66-
6.14 
0.001 
                   
Alcohol use during 
pregnancy 
  
DAG3: BQ during pregnancy, 
ethnicity, SES, chronic 
hypertension, maternal height, 
maternal age, pre-pregnancy 
weight, seasonality 
320 1.96 
1.10-
3.49 
0.022  2.08 
1.30-
3.32 
0.002  2.08 
1.31- 
3.31 
0.002  2.07 
1.30- 
3.30 
0.002 
                   
GWG 
 (ref: as per IOM 
recommendation) 
High GWG 
Covariate set 1: BQ during 
pregnancy, ethnicity, SES, chronic 
hypertension, imbalanced diet, 
maternal height, maternal age, 
regionality, seasonality 
310 0.72 
0.27-
1.87 
0.494  0.61 
0.25-
1.47 
0.266  0.61 
0.25-
1.49 
0.280  0.63 
0.26-
1.52 
0.304 
  Low GWG    2.62 
1.33- 
5.15 
0.005  2.18 
1.20-
3.96 
0.011  2.16 
1.18-
3.97 
0.013  2.19 
1.28-
4.17 
0.016 
  High GWG 
Covariate set 2: imbalanced diet, 
maternal height, pre-pregnancy 
weight 
316 0.92 
0.37-
2.29 
0.859  0.65 
0.28-
1.53 
0.327  0.65 
0.28-
1.54 
0.332  0.68 
0.29-
1.57 
0.364 
  Low GWG    2.69 
1.43-
5.04 
0.002  2.13 
1.22-
3.73 
0.008  2.11 
1.19-
3.72 
0.010  2.15 
1.19-
3.88 
0.011 
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Chronic 
hypertension 
  
BQ during pregnancy, ethnicity, 
SES, maternal height, maternal 
age, pre-pregnancy weight, 
regionality, seasonality 
317 2.68 
0.70-
10.31 
0.151  4.24 
1.44-
12.42 
0.009  4.12 
1.39-
12.17 
0.010  4.05 
1.39-
11.81 
0.010 
                   
UTI   SES, seasonality 433 2.17 
1.11-
4.26 
0.023  2.23 
1.15-
4.33 
0.018  2.20 
1.14-
4.28 
0.019  2.23 
1.15-
4.31 
0.018 
                   
Nulliparity   Maternal age 472 1.50 
0.98-
2.30 
0.061  1.50 
0.98-
2.30 
0.061  1.50 
0.98-
2.30 
0.060  1.50 
0.98-
2.30 
0.061 
                   
 Wealth quintile 
 (ref: Middle) 
Poorest  Regionality 470 1.37 
0.73-
2.54 
0.33  1.35 
0.73-
2.52 
0.339  1.36 
0.73- 
2.54 
0.328  1.36 
0.73- 
2.53 
0.333 
  Second    0.88 
0.47-
1.65 
0.700  0.88 
0.47-
1.64 
0.693  0.89 
0.48-
1.65 
0.705  0.88 
0.47-
1.65 
0.698 
  Fourth    1.01 
0.54-
1.89 
0.975  1.01 
0.54-
1.89 
0.971  1.01 
0.54- 
1.89 
0.970  1.01 
0.54- 
1.89 
0.974 
  Richest     0.73 
0.39-
1.37 
0.320  0.73 
0.39-
1.37 
0.323  0.73 
0.39-
1.38 
0.332  0.73 
0.39-
1.37 
0.330 
                   
Education (ref: No 
education) 
Non-formal 
education 
 Regionality 473 0.59 
0.27-
1.29 
0.188  0.59 
0.27-
1.31 
0.196  0.59 
0.27-
1.31 
0.196  0.59 
0.27-
1.31 
0.196 
  Primary    0.91 
0.49-
1.67 
0.753  0.91 
0.49-
1.67 
0.753  0.91 
0.49-
1.67 
0.753  0.91 
0.49-
1.67 
0.753 
  
Middle 
secondary 
or 
secondary  
   0.54 
0.33-
0 .86 
0.010  0.53 
0.33- 
0.86 
0.010  0.53 
0 .33-
0.86 
0.010  0.53 
0 .33-
0.86 
0.010 
  
Diploma, 
college, and 
post-
graduate 
   0.75 
0.34-
1.64 
0.472  0.75 
0.34-
1.64 
0.469  0.75 
0.34- 
1.64 
0.469  0.75 
0.34- 
1.64 
0.469 
                   
 Maternal age  
(ref: 20-35) 
<20  SES 470 1.65 
0.68-
4.01 
0.272  1.66 
0.68-
4.03 
0.267  1.66 
0.68- 
4.03 
0.268  1.66 
0.68- 
4.03 
0.267 
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   35<    1.77 
0.996-
3.13 
0.052  1.80 
1.01-
3.18 
0.045  1.80 
1.01-
3.18 
0.045  1.80 
1.01-
3.18 
0.045 
                   
Sex of infant  
(ref: Male) 
  No adjustment is necessary  473 1.96 
1.32-
2.92 
0.001  1.96 
1.32-
2.92 
0.001  1.96 
1.32- 
2.92 
0.001  1.96 
1.32- 
2.92 
0.001 
                   
Ethnicity 
Southern 
Bhutanese 
No adjustment is necessary  473 1.47 
0.98-
2.20 
0.064  1.47 
0.98-
2.20 
0.064  1.47 
0.98- 
2.20 
0.064  1.47 
0.98- 
2.20 
0.064 
*MNAR Model 1 assumes that the odds ratio of having UTI during pregnancy for mothers who were missing information on UTI was two times more than that of mothers who have 
information on UTI (OR=2). MNAR Model 2 assumes the odds ratio of having UTI during pregnancy for mothers who were missing information on UTI was 50% less than that of 
mothers who have information on UTI (OR=0.5). The imputation datasets were produced in SAS9.4 using MNAR and shift option and analysed in STATA 14.1.   
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Table 7.8. Missing data imputation for PTB under MAR and MNAR assumptions in comparison with complete case analysis. 
Exposure Category  Factors adjusted for 
Complete case analysis  
MAR 
 (n=516) 
 
MNAR (OR=0.5)  
(n=516) 
 
MNAR (OR=2)  
(n=516) 
n AOR 95%CI 
P-
value 
 AOR 95%CI 
P-
value 
 AOR 95%CI 
P-
value 
 AOR 95%CI 
P-
value 
Betel quid chewing 
during pregnancy 
 
Covariate set 1: Ethnicity, 
SES, chronic hypertension, 
maternal height, maternal 
age, pre-pregnancy weight, 
regionality, seasonality 
333 1.20 
0.72-
2.00 
0.481  1.21 
0.81- 
1.81 
0.343  1.21 
0.81-
1.81 
0.343  1.21 
0.82- 
1.81 
0.461 
  
Covariate set 2: BQ 
chewing before pregnancy, 
seasonality 
507 1.10 
0.68-
1.79 
0.702  1.07 
0.66-
1.74 
0.776  1.07 
0.66-
1.74 
0.776  1.08 
0.67- 
1.92 
0.627 
                   
Tobacco during 
pregnancy 
  DAG 3: SES 502 2.14 
1.12-
4.11 
0.022  2.23 
1.17-
4.27 
0.015  2.23 
1.17-
4.26 
0.015  2.23 
1.17- 
4.27 
0.015 
                   
Alcohol during 
pregnancy 
  
DAG 3 : BQ during 
pregnancy, ethnicity, SES, 
chronic hypertension, 
maternal height, maternal 
age, pre-pregnancy weight, 
seasonality 
337 1.53 
0.89-
2.65 
0.126  1.47 
0.94-
2.28 
0.083  1.47 
0.95- 
2.28 
0.083  1.47 
0.95-
2.27 
0.083 
    
DAG 3: Ethnicity, SES, 
regionality, seasonality 
508 1.46 
0.95-
2.25 
0.082  1.44 
0.90-
2.20 
0.097  1.44 
0.94-
2.20 
0.097  1.44 
0.94-
2.20 
0.096 
                   
GWG 
 (ref: as per IOM 
recommendation) 
High GWG 
Covariate set 1: BQ during 
pregnancy, ethnicity, SES, 
chronic hypertension, 
imbalanced diet, maternal 
height, maternal age, 
regionality, seasonality 
328 1.17 
0.52-
2.63 
0.697  1.03 
0.51-
2.09 
0.936  1.03 
0.51- 
2.09 
0.936  1.02 
0.49-
2.11 
0.958 
  Low GWG   - 2.15 
1.14-
4.04 
0.018  2.08 
1.19-
3.62 
0.010  2.08 
1.19-
3.62 
0.010  2.05 
1.14-
3.68 
0.016 
  High GWG 
Covariate set 2: 
Imbalanced diet, maternal 
343 1.34 
0.64-
2.81 
0.441  1.06 
0.54-
2.10 
0.857  1.06 
0.54-
2.10 
0.857  1.07 
0.53- 
2.14 
0.857 
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height, pre-pregnancy 
weight 
  Low GWG    - 2.23 
1.26-
3.93 
0.006  2.17 
1.29-
3.66 
0.004  2.17 
1.29-
3.66 
0.004  2.15 
1.24-
3.73 
0.006 
                   
UTI   SES, seasonality 451 1.98 
1.00-
3.90 
0.049  1.81 
0.93-
3.53 
0.081  1.81 
0.93- 
3.53 
0.081  1.79 
0.90-
3.55 
0.097 
                   
Chronic hypertension   
BQ during pregnancy, 
ethnicity, SES, maternal 
height, maternal age, pre-
pregnancy weight, 
regionality, seasonality 
333 3.23 
1.01-
10.30 
0.047  4.73 
1.83-
12.19 
0.001  4.73 
1.83-
12.19 
0.001  4.18 
1.60-
10.87 
0.003 
                   
PIH, PE/Eclampsia   
Alcohol during pregnancy, 
BQ during pregnancy, 
Ethnicity, chronic 
hypertension, imbalanced 
diet, maternal age, tobacco 
during pregnancy 
460 7.08 
3.58-
14.00 
<0.00
01 
 8.00 
4.27- 
15.00 
<0.00
01 
 8.00 
3.27-
15.00 
<0.000
1 
 7.08 
3.78-
13.26 
<0.000
1 
                   
C-section   
PIH_PE/E, chronic 
hypertension, gestational 
weight gain, UTI 
329 2.16 
1.26-
3.70 
0.005  1.41 
0.91-
2.19 
0.122  1.36 
0.87-
2.11 
0.175  1.46 
0.94- 
2.27 
0.090 
                   
 Wealth quintile 
(ref: Middle) 
Poorest  Regionality 509 0.94 
0.53-
1.66 
0.833  0.96 
0.54-
1.70 
0.894  0.96 
0.54-
1.70 
0.894  0.97 
0.55-
1.71 
0.906 
  Second   - 0.72 
0.41-
1.27 
0.255  0.74 
0.42- 
1.29 
0.286  0.74 
0.42-
1.29 
0.286  0.74 
0.42-
1.30 
0.300 
  Fourth   - 0.81 
0.46-
1.42 
0.460  0.83 
0.47-
1.45 
0.508  0.83 
0.47-
1.45 
0.508  0.82 
0.47-
1.44 
0.494 
  Richest    - 0.60 
0.34-
1.06 
0.078  0.61 
0.35-
1.08 
0.090  0.61 
0.35 - 
1.08 
0.090  0.61 
0.35-
1.09 
0.094 
                   
 Education (ref: No 
education) 
Non-formal 
education 
 Regionality 513 0.56 
0.25-
1.27 
0.165  0.51 
0.22-
1.18 
0.116  0.51 
0.22- 
1.18 
0.116  0.51 
0.22-
1.18 
0.116 
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  Primary   - 1.20 
0.66-
2.15 
0.551  1.20 
0.66-
2.15 
0.540  1.20 
0.67-
2.16 
0.540  1.20 
0.66-
2.15 
0.550 
  
Middle 
secondary or 
secondary  
  - 0.89 
0.57-
1.39 
0.604  0.89 
0.56-
1.39 
0.613  0.89 
0.57-
1.40 
0.613  0.89 
0.57-
1.40 
0.616 
  
Diploma, 
college, and 
postgraduate 
  - 0.82 
0.38-
1.78 
0.623  0.82 
0.38-
1.77 
0.615  0.82 
0.38-
1.77 
0.615  0.82 
0.38- 
1.77 
0.619 
                   
 Maternal age  
(ref: 20-35) 
<20  SES 508 2.37 
1.13-
4.98 
0.023  2.34 
1.11-
4.91 
0.025  2.34 
1.11-
4.91 
0.025  2.34 
1.11- 
4.90 
0.025 
   35<   - 1.70 
0.97-
2.95 
0.062  1.76 
1.02-
3.06 
0.044  1.76 
1.02-
3.06 
0.044  1.77 
1.02- 
3.06 
0.043 
                   
Male infant   No adjustment is necessary 513 0.88 
0.62-
1.26 
0.487  0.88 
0.62-
1.26 
0.498  0.88 
0.62- 
1.26 
0.498  0.88 
0.62-
1.26 
0.492 
                   
Ethnicity 
 Southern 
Bhutanese 
No adjustment is necessary  514 0.85 
0.57-
1.27 
0.440  0.87 
0.58-
1.29 
0.478  0.87 
0.58- 
1.29 
0.478  0.86 
0.58-
1.29 
0.477 
*MNAR Model 1 assumes that the odds ratio of having UTI during pregnancy for mothers who were missing information on UTI was two times more than that of mothers who have 
information on UTI (OR=2). MNAR Model 2 assumes the odds ratio of having UTI during pregnancy for mothers who were missing information on UTI was 50% less than that of 
mothers who have information on UTI (OR=0.5). The imputation datasets were produced in SAS9.4 using MNAR and shift option and analysed in STATA 14.1.   
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7.3 Anaemia and betel quid chewing 
In this section, anaemia was analysed as a secondary outcome using the DAG approach. 
 
7.3.1 Background 
The evidence of anaemia and betel quid is mixed in the literature. As a secondary outcome, the 
relationship between anaemia and betel quid chewing was examined. First, two conditions 
suggested by Cousens et al. [5] when using data collected during a case-control study for another 
outcome, were checked.  
The first condition is that the effect of betel-quid chewing on the mother’s propensity to 
report for LBW or PTB is independent of any effect of anaemia status. As this was a case-control 
study and almost all the preterm weight and/or LBW babies were approached in the referral 
hospitals, the anaemia status is less likely to influence the mother’s propensity to report LBW or 
PTB babies. The Mantel-Haenszel test was conducted to examine the strata specific odds ratios 
after being stratified by anaemia status. The test suggests that the strata specific ORs are similar 
(p= 0.4317).  
The second condition is that the effects on PTB or LBW of the betel quid chewing and 
anaemia do not interact. The interaction term was examined (p= 0.432). The data suggest that there 
is no evidence of an interaction between the effect of betel quid and anaemia.  
As described in Chapter 3, season of delivery was adjusted based on the assumed causal 
framework provided in DAG 4 and season of delivery and SES were adjusted based on the assumed 
casual framework in DAG 5. Although there seemed to be no causal effect between SES and betel 
quid chewing in Bhutan, DAG 5 was compared to DAG 4 to see the plausibility of causal 
assumptions in DAG 4. As was suggested in the literature, smoking and altitude were included in 
the DAGs. Physiological haemoglobin needs are greater at high altitude due to the lower 
concentration of oxygen in the atmosphere and smoking increases haemoglobin concentrations [6].  
 
7.3.2 Results 
The results based on the causal assumptions in DAG 4 and DAG 5 were virtually identical (Table 
7.9). Betel quid chewing during pregnancy was associated with increased odds of anaemia during 
pregnancy. Compared to those who did not chew betel nuts, mothers who chewed during pregnancy 
had a 2.2 times higher odds ratio of being anaemic (AOR 2.16, 95% CI 1.31-3.58, p=0.003) 
adjusting for season of delivery and (aOR 2.2, 95% CI 1.31-3.64, p=0.003) adjusting for season of 
delivery, education, and wealth quintile.  Compared to non-chewers, mothers who chewed more 
than 1 nut or 4 quids had a 3 times higher odds ratio of being anaemic (aOR 3.41, 95% CI: 1.81-
6.42, p<0.0001) adjusting for season of delivery and (aOR 3.46, 95% CI: 1.82 – 6.58, p<0.0001) 
adjusting for season of delivery, education, and wealth quintile in Model 2.  
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Table 7.9. Anaemia and betel quid based on DAG 4 and DAG 5. 
 
 
7.4 Summary  
In this chapter, both the statistical approach and DAG approach were used to build logistic 
regression models in order to estimate the impact of potential risk factors on adverse birth outcomes. 
Comparing the results in the two approaches suggests that results in the statistical approach may be 
biased due to the over-adjustment or unnecessary adjustment of covariates. Using the DAG 
approach, three sensitivity analyses were conducted: limiting data to mothers with early US scans, 
missing data imputation under MAR and MNAR. Results in the complete case and sensitivity 
analyses were virtually identical. In the logistic regression models, there was no clear evidence of 
an association between betel quid chewing and adverse birth outcomes. For the secondary outcome, 
the data suggest an association between anaemia and betel quid chewing during pregnancy.  
Using the DAG approach, tobacco and alcohol use during pregnancy, low GWG, and UTI showed 
a clear association with term LBW and PTB. The factors that show clear evidence of association 
with term LBW were female infant and middle secondary education compared to no education. On 
the other hand, being under 20 years old compared to 20-35 years old and having PIH, pre-
eclampsia, or eclampsia was clearly associated with PTB. Chronic hypertension shows a clear 
association with PTB. The association between chronic hypertension with term LBW was clearer 
in the multiple imputation models, suggesting loss of information in the complete case analysis due 
to a large amount of missing data.  The association between term LBW and PTB and mothers over 
35 years old compared to 20-35 years old was clearer in the multiple imputation models than 
complete case analysis. The results will be discussed in detail in the next chapter. 
  
Exposure Category 
Factors 
adjusted for 
N 
Crud
e OR 
95% 
CI 
P-
value 
N AOR  
95% 
CI 
P-value 
Model 1: Chewing 
betel quid during 
pregnancy 
 DAG 4: 
Seasonality 
649 2.09 
1.27-
3.43 
0.004 649 2.16 
1.31-
3.58 
0.003 
  
DAG 5: 
Seasonality, 
SES 
 - - - 643 2.19 
1.31-
3.64 
0.003 
           
Model 2: Average 
number of betel 
nuts per day 
during pregnancy 
(ref: None) 
<= 1nut 
DAG 4: 
Seasonality 
594 1.69 
0.94- 
3.02 
0.078 594 1.75 
0.97-
3.14 
0.063 
  
more than 
1 nut per 
day 
 - 2.99 
1.62- 
5.51 
<0.000
1 
 3.41 
1.81-
6.42 
<0.0001 
 <= 1nut 
DAG 5:  
Seasonality, 
SES 
 - - - 588 1.78 
0.98-
3.24 
0.058 
 
more than 
1 nut per 
day 
  - - -  3.46 
1.82-
6.58 
<0.0001 
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Chapter 8  
Conclusions and Discussions 
 
In the following sections (Section 8.1-8.3), the key results are highlighted and compared with 
previous studies and the implications for policy and practice are discussed. In Chapter 7, both the 
statistical approach and DAG approach were used to build logistic regression models in order to 
estimate the impact of potential risk factors on adverse birth outcomes. Neither approach provided 
clear evidence of an association between betel quid use and term LBW or PTB, at the level of 
consumption of 5.5 quids or 1.4 nuts per day. Comparing the results between the two approaches 
suggests that results in the statistical approach may be biased due to the over-adjustment or 
unnecessary adjustment of covariates. Using the DAG approach, three sensitivity analyses were 
conducted; limiting data to mothers with early US scans, missing data imputation under MAR and 
under MNAR. Results in the complete case and sensitivity analyses were almost identical.  
For the secondary outcome, the data suggest an association between anaemia and betel quid 
chewing during pregnancy. Using the DAG approach, tobacco and alcohol use during pregnancy, 
low GWG, and UTI showed a clear association with term LBW and PTB. The factors that show 
clear evidence of association with term LBW were female infant and middle secondary education 
compared to no education. On the other hand, being younger than 20 years old compared to 20-35 
years old and having PIH, pre-eclampsia, or eclampsia was clearly associated with PTB. Chronic 
hypertension shows a clear association with PTB. The association between chronic hypertension 
and term LBW was clearer in the multiple imputation models, suggesting loss of information in the 
complete case analysis due to a large amount of missing data.  The association between term LBW 
and PTB and mothers older than 35 years old compared to 20-35 years old was clearer in the 
multiple imputation models than in the complete case analysis. The limitations of the research 
findings are discussed in Section 8.4. The chapter ends with recommendations for future research 
in Section 8.5. and conclusion in Section 8.6. 
 
8.1 Primary findings from analyses of potential modifiable risk factors 
8.1.1 Betel quid chewing during pregnancy 
(a) A summary of key findings 
Neither the statistical approach nor DAG approach provided clear evidence of an association 
between betel quid use and LBW or PTB, at the level of consumption of 5.5 quids or 1.4 nuts per 
day.  
In the DAG, it was hypothesised that betel quid chewing during pregnancy has both a direct 
and indirect impact on term LBW and PTB. It was assumed that seasonality causes betel quid 
chewing before and during pregnancy and betel quid chewing during pregnancy is associated with 
the adverse birth outcomes indirectly through reduced appetite, increased periodontal disease, and 
increased micronutrient deficiency, whereas betel quid chewing before pregnancy has an impact on 
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chronic hypertension. The detailed causal assumptions were graphically presented in the DAGs in 
Chapters 2 and 3. Covariates adjusted in the logistic regression to estimate the total effect of betel 
quid chewing during pregnancy, informed by the DAG, were ethnicity, SES (education and wealth 
quintile), chronic hypertension, maternal height, maternal age, pre-pregnancy weight, regionality 
(delivery hospital), and season of delivery. 
The estimated odds ratio of term LBW was slightly smaller and 95% CIs were slightly 
wider in the statistical approach compared to the DAG approach. This could be due to over-
adjustment of factors that could stand on the casual pathway between betel quid chewing and 
adverse birth outcomes such as GWG. For example, using the statistical approach, the adjusted odds 
ratio (aOR) of term LBW was 1.07 (95% CI: 0.54-2.13, p=0.845) while the aOR of term LBW was 
1.30 (95% CI: 0.74-2.27, p=0.439) in the DAG approach.  
Using the DAG approach, three sensitivity analyses were conducted; limiting data to 
mothers with early US scans, missing data imputation under MAR and under MNAR. Results in 
the complete case and sensitivity analyses were virtually identical. Hence, the results of the 
complete case analysis of the DAG approach are reported below. 
The aOR of PTB in association with betel quid chewing during pregnancy was 1.20 (95% 
CI: 0.72-2.00, p=0.614). When the total number of betel nuts consumed during the last three months 
of pregnancy was used as an exposure variable, the aOR among mothers who consumed less than 
or equal to one nut per day compared to the mothers who did not chew during pregnancy was 1.32 
for term LBW (95% CI: 0.69-2.51) and 0.85 for PTB (95% CI: 0.47-1.54). The aOR for mothers 
who consumed more than one nut per day was 1.39 for term LBW (95%:0.52-3.68) and the aOR of 
PTB was 0.66 (95% CI: 0.27-1.66).  
The observed difference in betel quid chewing between cases and controls was small and 
not statistically significant. Of the 669 study participants, 55% of the case mothers and 52% of the 
control mothers chewed betel quid during pregnancy. About 22% of cases and controls used 
commercial betel products during pregnancy. In total, 60% of the case mothers and 57% of the 
control mothers chewed either betel quid or packaged betel products during pregnancy  
 Other surveys and reports conducted in Bhutan reported similar prevalence. According to 
the 2010 Gross National Happiness Survey, 72% of respondents aged 15 to 98 had ever chewed 
betel quid in their lives and 59% of men and 62% of women were currently chewing [1]. The 
National Nutrition Survey in 2015 reported that 43% of 148 pregnant women in the survey reported 
consuming betel nuts regularly during the week before the survey and 50% reported that had they 
chewed betel in the first trimester [2].  
In this study, there was no statistically significant difference between users and non-users 
in terms of demographic factors such as maternal age, highest level of education attained, wealth 
quintile, pre-pregnancy BMI, and GWG. Of the mothers who chewed betel during pregnancy 
(n=359), the majority (76%) chewed weekly or more than weekly with 41% reporting daily use, 
and 70% of the mothers who chewed during pregnancy chewed after meals. This confirms past 
literature which suggests that the users of betel nut believe it is helpful for the digestion [3]. On 
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average, mothers consumed 5.5 quids (95% CI: 4.7-6.3) or approximately 1.4 nuts per day. Almost 
half (47 %) always spit after chewing versus 19% never-spiting.  
Adding tobacco to betel quid was not common in Bhutan. The majority used one quarter of 
a ripe nut and chewed it combined with piper leaf and lime. On the other hand, more mothers who 
chewed betel quid used other substances such as alcohol, pan masala, cigarettes, and smokeless 
tobacco compared to the mothers who did not chew during pregnancy. In Bhutan, the sale of tobacco 
was banned in 2004 and this ban was legislated for and strengthened by the Tobacco Act of 2010 
[4]. This policy may account for the low prevalence of cigarette smoking during pregnancy in 
Bhutan.  
It should be noted that the study sample size was designed to be able to show an odds ratio 
of at least 1.5 based on the assumption that 60% of cases and 50% of controls had been exposed. 
However this assumption of a 10% difference in betel quid chewing between cases and controls did 
not hold.  The actual observed difference in the study was very small (52% in the controls and 55% 
in the cases), resulting in a large p-value for the association between betel chewing and term LBW 
or PTB. Therefore, there was no evidence for an association between betel chewing and adverse 
birth outcomes. However, this is not evidence of no association. The 95% C.I. around the OR 
provides an indication of how large any association might be. In the present study, the 95% CIs 
were 0.74-2.27 for term LBW and 0.72-2.00 for PTB. 
Among the singleton live born babies delivered at the three referral hospitals during the 
study period, the proportion of babies born LBW and PTB could be estimated as 8.5% (464/5472) 
and 5.5% (302/5472) respectively. Given that the proportions of LBW and PTB are relatively small, 
the ”rare” disease assumption is met and the odds ratios provide an estimate of the relative risk. To 
examine the odds ratio in the context of the relative and absolute risk, if the risk of LBW in the 
general singleton live born infants is 8.5%, the 1.3 times increased risk with betel quid chewing 
during pregnancy would result in an incidence in 11.1%, a 2.6 % increase. Similarly, if the risk of 
PTB in the general singleton live born infants is 5.5%, the 1.2 times increased risk with betel quid 
chewing during pregnancy would result in an incidence of 6.6%, a 1.1% increase.  
 
(b) Comparison with other observational studies 
Association with birth outcomes 
As described in Chapter 2, the pooled crude RRs from the meta-analysis using the random effect 
model for LBW suggests slightly increased odds of LBW. However, this was not statistically 
significant (RR: 1.20, 95% CI: 0.81 - 1.80). This is similar to the crude odds ratio for term LBW 
obtained in the present study (1.10, 95% CI: 0.74 -1.63).  
There was a high heterogeneity across studies (𝐼2= 83.2 %, p<0.0001) (Figure 2.1). The 
estimates of effect size  in the meta-analysis and corresponding 95% CIs were 0.94 (95%CI: 0.79-
1.27) (Ome-Kaius et al. (2015)) [5] , 0.92 (95% CI: 0.80-1.06) (Chue et al. (2012)) [6], 1.70 (95% 
CI: 0.45-6.40) (Senn et al. (2009))[7], and 1.95 (95% CI: 1.41-2.71) (Yang et al. (2008)) [8].   
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To understand why there might be differences in the results, the details of similarities and 
differences between this study and previous studies are discussed below. Studies were compared in 
terms of characteristics of the study populations, patterns and level of consumption of betel quid 
chewing, timing of measurement, and covariates adjusted in the model. Association between betel 
quid chewing and anaemia is also discussed.  
 
(i) Characteristics of the study populations 
Differences in sample size and study population may account for the differences in the results. 
In the present study, the total number of women included in the logistic analysis was 473 for 
term LBW and 513 for PTB. The largest study was by Chue et al. (2012) [6] and included 7,685 
refugee pregnant women, followed by 2,700 in the Ome-Kaius et al. study (2015) [5], 1,264 in 
the Yang et al. study (2008) [8] and 310 in the Senn et al. study (2009).   
In the present study, there was no statistically significant difference between chewers 
and non-chewers by socio-economic characteristics in the descriptive analyses. This was 
similar to the Senn et al. (2009) study [7]. In the Ome-Kaius et al.(2015) study, more areca 
(betel) nut chewers tended to reside in rural areas and pursue an income-generating activity but 
numbers were similar for literacy rate, maternal age, and primigravida [5]. However, in the 
Yang et al. study, the chewers were more likely to have a lower educational level, be unmarried, 
or be unemployed p<0.0001) [8]. In the Chue et al. (2012) study, chewers were older and more 
chewers were multigravida compared to non-chewers (p<0.001)[6]. They did not provide 
information on maternal education level or SES of the study participants. In the present study, 
like the Chue et al. (2012) study [6], there was no statistically significant difference of BMI. In 
Taiwan, the pre-pregnancy BMI was higher among chewers (non-chewers: 22.3 vs 24.4, 
p<0.0001) whereas maternal GWG during pregnancy was lower among chewers (non-chewers: 
15.3 kg (SD=6.1) vs 13.6 kg (SD=7.1), p<0.0001) [8].  
 
(ii) Patterns and level of consumption of betel quid chewing 
The differences in the patterns and level of consumption do not provide a clear explanation for 
the differences in the results.  In Bhutan ripe nuts are preferred as on the Thai-Myanmar border 
[6], unlike PNG [5, 7] and Taiwan [8] where unripe nuts are more often consumed. The level 
of consumption in Bhutan was lower (on average 5.5 quids or 1.4 nuts per day) than PNG (44% 
chewed more than 5 nuts per day in the Senn et al.(2009) study [7] and 47.8% chewed more 
than 3 nuts per day in the Ome-Kaius et al. (2015) study[5]). It was, however, similar to Taiwan 
(the prevalence rate of betel quid chewing during pregnancy was 36.7% with a daily average 
of 5.68 quids consumed among the chewers in the Yang et al. (2008) study [8]) and the patterns 
of Karen and Burmese pregnant women at the Thai-Myanmar border [6]. At the Thai-Myanmar 
border [6] , more than 50% (53.9%) of the women used less than one whole nut per day and 
31.6% used one to four whole nuts per day [6]).  
 258 
 
Adding tobacco to betel quid chewing was rare in Bhutan like the rest of the studies 
and thus would not account for the differences.  
Tobacco use (cigarette smoking and smokeless tobacco) and alcohol use were more 
common among chewers than non-chewers in Bhutan. This was similar to PNG [5, 7]  and 
Taiwan .  There was not enough information to assess if alcohol may account for discrepancies. 
Information on alcohol was not collected in Thailand as alcohol was banned in the refugee 
camp where the study was conducted [6]. 
 
(iii) Timing of assessing betel nut use 
The timing of assessing betel nut use may account for the discrepancies. The large studies in 
Thailand [6] and in PNG [5] did not report any evidence of association. As discussed in Chapter 
2, these two studies enquired about mother’s betel nut use at the first ANC clinic and assumed 
they did not stop during pregnancy. This could lead to biasing the effect of betel quid chewing 
towards the null. The present study aimed to overcome this methodological challenge by 
collecting information on consumption over the past 10 months at delivery.  As a result, the 
crude OR in the present study suggested slightly increased odds of term LBW whereas crude 
ORs in Thailand and in PNG suggest reduced odds. The 95% CI was slightly wider in the 
present study. This could be due to the small sample size of the present study compared to the 
other two studies. 
 
(iv) Covariates adjusted in the models 
Differences in covariates may explain the differences in the results. As described in Chapter 2, 
most of the previous studies seemed to use a statistical approach such as the stepwise approach, 
and covariates controlled in the model were highly heterogeneous.   
For example, all studies controlled for parity and some maternal anthropometric 
characteristics such as weight, height, or BMI. Smoking was controlled for in the Chue et al. 
study (2012) and the Ome-Kaius et al study. (2015) but not in the Yang et al. (2008) and Senn 
et al. (2009) studies. In PNG, malaria was controlled for in the Ome-Kaius study but not in the 
Senn et al. (2009) study. Yang et al. (2008) and Ome-Kaius et al. controlled for some 
socioeconomic characteristics whereas Senn et al. (2009) and Chue et al. (2012) did not control. 
Gestational weeks was controlled for in Yang et al (2008) and Chue et al. (2012) not in the 
PNG studies. Maternal age and GWG were only adjusted in the Yang et al. (2008) study. No 
studies controlled for hypertensive disorders or season of delivery.  
In the study by Yang et al. (2008), nine variables were included (parity, pre-pregnancy 
BMI, maternal age, marital status, education level, employment status, gestational weeks, 
weight gain during pregnancy, maternal drug use, and newborn sex). In Chue et al. (2012), six 
variables were included (primigravida, maternal weight at the first ANC visit, timing of the first 
ANC visit after the first trimester, malaria infection, smoking, gestational age at birth (weeks)). 
Ome-Kaius et al. (2015) controlled for nine covariates (primigravida, mother’s height, mid-
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upper arm circumference of the mothers, smoking, ethnic group (highlander), income, 
frequency of antenatal visits, malaria, and receipt of insecticide treated bed net). Senn et al. 
(2009) controlled for primigravida and low BMI for birth weight analysis but did not specify 
the covariates used to estimate the effect on LBW. 
In the present study, maternal age, ethnicity, SES (education and wealth quintile), 
chronic hypertension, maternal height, pre-pregnancy weight, delivery hospital, and season of 
delivery were adjusted in the logistic regression model based on the causal assumptions in the 
DAGs. Primigravidity was controlled for in all studies but not in the present study. Instead, 
maternal age was controlled for as it was assumed to have a direct causal relationship on 
primigravida, which is associated with increased odds of term LBW in the literature but not 
with PTB. GWG was not controlled for as it was assumed to stand on the causal pathway 
through reduced appetite due to betel quid chewing. Gestational weeks was not included as the 
outcome was restricted to term LBW. Malaria prevalence was low in Bhutan.  Chronic 
hypertension was not adjusted for in any of the studies. Association between hypertension and 
betel quid chewing is not well-studied in the literature.  A systematic review by Yamada et al. 
(2013) identified two studies that reported an association between betel quid chewing and high 
blood pressure between 1951 and January 2013 [9]. There were no studies on pregnancy-
induced hypertension. Ome-kaius et al. (2015) reported that there was no statistical difference 
in the mean arterial pressure (mmHg) among chewers and non-chewers (p=0.41)[5]. De Costa 
(1982) reported 39/400 of chewers presented signs of preeclampsia not requiring drug treatment 
compared to 45/400 among non-chewers matched on parity and province of origin. 
Preeclampsia requiring drug treatment was excluded from this study [10].  Other studies did 
not provide any information on hypertensive disorders during pregnancy [6, 11-13]. 
Several studies suggest that betel quid chewing is associated with increased odds of 
periodontal diseases as described in Chapter 2. Periodontal diseases were included in the DAG 
as an unmeasured factor in the present study and it is worth examining the impact of betel quid 
on periodontal diseases and association with adverse birth outcomes. 
 
 (v) Association between anaemia and betel quid chewing 
Although the multivariable analyses did not provide clear evidence of the impact of betel quid 
on term LBW or PTB, the data suggest betel quid chewing is associated with increased odds of 
anaemia. Compared to those who did not chew betel nuts, mothers who chewed during 
pregnancy had 2.1 times higher odds of being anaemic (aOR 2.09, 95% CI 1.27-3.43, p=0.004). 
Compared to non-chewers, mothers who chewed more than 1 nut or 4 quids had 3 times higher 
odds of being anaemic (aOR 2.99, 95% CI: 1.62-5.51, p <0.0001).  
Two previous studies have reported an association between betel quid chewing and 
maternal anemia [5, 14]. Ome-Kaius et al. (2015) reported pregnant chewers were more likely 
to be anaemic (haemoglobin <11g/dL) at delivery than non-chewers (aOR 1.67, 95% CI: 1.27-
2.20, p<0.001) [5]. Prior to this study, two studies in PNG reported no association between 
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anaemia and betel quid chewing. Senn et al. (2009) reported that mean haemoglobin level was 
94 g/l (95% CI 92-96) slightly lower among chewers and 100 g/l (95% CI 95-106) among non-
chewers but not statistically significant. This could be due to the small sample size and high 
prevalence of betel chewing (94%). De costa (1982) reported that slightly more chewers (48%, 
192/400) had a haemoglobin value of less than 10 g/100ml on at least one occasion compared 
to non-chewers matched on parity and province of origin (46%, 184/400) but the difference 
was not statistically significant. This could be due to baseline differences between chewers and 
non-chewers. Chue et al. (2012) reported that chewers were more anaemic (defined as 
Haematocrit <30%) than non-chewers (non-chewers:17.3% [425/2,459] vs chewers: 19.4% 
[868/4,422], p=0.031) in the univariate analysis but no association was apparent after 
controlling for smoking, malaria, multigravida, anaemia at first ANC visit, and first ANC visit 
after the first trimester. Anaemia was treated at each ANC visit. However, using the same 
population, Stuetz et al. (2016) reported that daily betel quid chewing had a negative effect on 
haemoglobin level (g/L) after adjusting for smoking, parity and BMI at the time of sampling 
(Beta -2.90., 95% -4.62 to -1.16). Anaemia treatment was not controlled for. Differences in 
classification of betel users (users/nonusers vs daily use) and covariates in the models might 
account for these discrepancies.  Chue el al. could be adjusting for factors on the causal pathway 
such as anaemia at first ANC visit after the first trimester. 
There are several potential pathways for betel quid causing maternal anaemia. One of 
the pathways is through suppressed appetite. Several studies suggest that betel nut chewers had 
a higher resting metabolic rate due to betel nut metabolites that effect the thermoregulatory 
pathways, altering the thermogenic effects of the meal and also through centrally mediated 
effects by decreasing the appetite for food [3]. Another study suggests betel nut chewing could 
aggravate the effects of vitamin-D deficiency [15]. Although causation between vitamin-D 
deficiency and anaemia is not established, a meta-analysis of observational studies suggests 
vitamin-D deficiency is associated with anaemia [16, 17].   
In the present study, 12.4% of the mothers were identified to be anaemic from medical 
records during pregnancy. Anaemia was defined as haemoglobin level less than 10g/dL by the 
interviewers from antenatal records and medical records; altitude was not controlled for as 
details of haemoglobin were not collected in the present study. The 2015 National Nutrition 
Survey (NNS), which measured haemoglobin level using a Hemocue 301 and recorded to the 
nearest 0.1 g/dL, reported much higher prevalence of anaemia among pregnant women (27.3%) 
after adjusting for the altitudes of each chiwog (a basic electoral precinct) surveyed [2]. The 
lower anaemia prevalence in the present study could be because altitude was not adjusted for, 
which led to underestimated anaemia prevalence.  
 
(c) Summary 
In the present study, the results suggest that there is no evidence of an association between term 
LBW or PTB and betel quid chewing during pregnancy. This could be due to the small observed 
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difference in betel quid consumption between cases and controls. For a secondary outcome, the data 
suggest betel quid chewing is associated with increased odds of anaemia. 
 
  
8.1.2 Alcohol 
There was clear evidence of an association between drinking and term LBW or PTB. Mothers who 
drank during pregnancy had 1.96 times higher odds of term LBW compared to non-drinkers after 
adjusting for betel quid chewing during pregnancy, wealth quintile, education, chronic hypertension, 
maternal height, maternal age, pre-pregnancy weight, and seasonality (95% CI: 1.10-349, p=0.022). 
Mothers who drank more than once a week had 3.43 times higher odds of PTB (95% CI: 0.88-13.37, 
p=0.075) compared to non-drinkers. Mothers who drank less than or equal to once a week had 2.16 
higher odds of PTB (95% CI: 1.11-4.19, p=0.023). 
Of the study participants, 27% of the mothers reported drinking alcohol during pregnancy. 
About 38% of the pregnancy drinkers had a heavy drinking episode (defined as more than 40 grams 
of ethanol per one drinking occasion) at least once during pregnancy. Pregnancy drinking was more 
common among the mothers who delivered at the Eastern Region Referral Hospital (ERRH) (37%) 
compared to JDWNRH in the capital (27%) and the Central Region Referral Hospital (CRRH) in 
the south (13%) (p<0.0001). Mean maximum level of ethanol grams per occasion was higher at the 
Eastern Referral Hospital (ERRH) (mean 79.8 grams, SD 99.6) than JDWNRH (mean 46.6 grams, 
SD 47.x) and CRRH (39.4 grams, SD 27.9). This suggests that prevalence of drinking and intensity 
of drinking are higher in the eastern region. 
These results are comparable with other studies such as the NNS 2015 [2], a study in eastern 
Bhutan[18], and a population survey on risk factors for non-communicable disease using the WHO 
Stepwise Non-communicable Disease Risk Factor Survey (STEPS) method conducted in 2014[19].  
The NNS 2015 showed that 16% of 148 pregnant women reported consuming alcohol 
regularly during the week before the survey and 23.9% reported they drank once or twice a week 
in the second trimester [2].   
The research article showed that prevalence of alcohol consumption among women aged 
between 26 and 40 years old was 30% and prevalence of high intensity drinking (>40 grams) was 
18.5% [18]. The research article used a tri-level method where an interviewee was asked about up 
to three different kinds of types of beverage and amount in millilitres for maximum, medium, and 
low level.   
In the STEPS survey, data from 1,748 female respondents aged between 18 and 69 years 
showed that 32.8% were current drinkers (past 30 days) and 10.3% of the current drinkers reported 
a high level of alcohol intake (≥40 grams per occasion) [19]. The STEPS survey reported the lowest 
percentage of mothers of high intensity drinking. This could be due to a methodological difference 
as the survey asked the number of “standard drinks” participants consumed and quantified the 
response without taking different kinds of alcoholic drinks into account. The present study asked 
about the maximum number of alcoholic drinks for each different kind of drink per one occasion 
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and quantified grams of ethanol. The higher prevalence of heavy episodic drinking in the present 
study could be because more than half of the sample comprised mothers with adverse birth 
outcomes.  
In the present study, a Fractional Graduated Frequencies (F-GF) measure proposed by 
Greenfield et al.[20] was adapted to overcome the difficulty in measuring the volume of home-
brewed alcohol and unavailability of a standard drink.  Compared to a population survey conducted 
in northern Goa [20], number of ethanol grams at each level of drinking was slightly lower (Table 
8.1). The population difference (general male drinkers vs pregnant female drinkers) may account 
for some of the observed differences. Overall, the results were comparable and it may suggest that 
the F-GF is a practical tool to describe prevalence and intensity of alcohol where there is no standard 
drink size.  
 
 
Table 8.1. Comparison of mean ethanol (ETOH) in grams using F-GF measure for the maximum amount, 
¾, ½ and ¼ amount. 
 Present study  Greenfield et al. (2010) [20] 
Study population 
Among 177 women who drank during 
pregnancy interviewed at delivery in the 
three referral hospitals 
 Among 743 male drinkers in urban and rural 
cities in northern Goa   
 
Mean (SD) 
quantity grams 
ETOH 
Percent of total 
volume 
 Mean (SD) 
quantity grams 
ETOH 
Percent of total 
volume 
The maximum 54.1(64.2) 40.7%  65.8(56.9) 56.10% 
3/4 Maximum 40.6(48.2) 29.8%  49.4(42.6) 12.10% 
1/2 Maximum 27.0(32.1) 20.2%  32.9(28.4) 24.40% 
1/4 Maximum 13.5(16.1) 9.3%  16.5(14.2) 7.40% 
 
 
In addition to increased risk of LBW and PTB, maternal exposure to heavy drinking can 
lead to foetal alcohol syndrome (FAS). The royal government of Bhutan initiated birth defect 
surveillance on 1 January 2015 to collect information on number of stillbirths, birth defects 
including Down syndrome, congenital heart defects, and FAS [21]. According to the report, 
prevalence of FAS was 1.47 per 1000 births, and was more prevalent in births reported from ERRH 
(4/812). This coincides with the findings of the present study that show higher prevalence of 
pregnancy drinking and higher intensity of drinking among the mothers who delivered at ERRH.  
 
8.1.3 Tobacco 
Although the prevalence of tobacco consumption was low, there was clear evidence of an 
association between tobacco use and term LBW and PTB.  
Mothers who used smokeless tobacco and/or smoked cigarettes during pregnancy had  3.04 
times higher odds of term LBW (95% CI: 1.36-6.00, p=0.007) after adjusting for wealth quintile 
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and maternal education, compared to mothers who did not use tobacco. The aOR of PTB was 2.14 
(95% CI: 1.12-4.11, p=0.022). The confidence intervals were wider and the ORs were larger, 
compared to the systematic reviews which reported an association between PTB and any maternal 
smoking (OR 1.39, 95%CI 1.01-1.91) [22] and smokeless tobacco (OR 1.39, 95% CI:1.21-1.33) 
[23]. This could be due to the small sample size or due to some recall biases such as underreporting 
in the controls compared to the cases introduced in the case-control study design, which may lead 
to the overestimated point estimates.  
The prevalence of tobacco consumption was low. Smoking during pregnancy or use of 
smokeless tobacco was only 10.2% across all study participants. Cigarette smoking was less than 
3% (2.8%), while smokeless tobacco use was 7.5%. The majority (98%) of the users of smokeless 
tobacco did not smoke cigarettes. On average, mothers who used tobacco consumed three cigarettes 
per day or on average 2.4 grams of smokeless tobacco per day during pregnancy. The maximum 
amount of smokeless tobacco used was 5 grams per day on average during the last three months of 
pregnancy.  
The low cigarette smoking was comparable to the results in the 2011 report [4]. Most of 
the mothers quit cigarette smoking before the last three months of pregnancy. More mothers of 
LBW and/or PTB neonates used smokeless tobacco compared to the control mothers (control 4.1% 
[13/321] vs case 10.6% [37/348], p=0.001). The observed difference of prevalence of cigarette 
smoking during pregnancy in the cases and controls was small and not statistically significant 
(controls 1.6% [5/321] vs cases 4.0% [14/348], p=0.055).  
 
8.1.4 Low gestational weight gain and imbalanced diet  
This study showed clear evidence of an association between GWG and adverse pregnancy 
outcomes.  
Mothers who had a lower GWG than recommended by the IOM, according to pre-
pregnancy BMI, had 2.67 times higher odds (aOR 2.67, 95% CI: 1.38-5.19) of delivering a term 
LBW and 2.31 times higher odds (aOR 2.31, 95% CI:1.25-4.27) of  PTB compared to those with 
GWG as per IOM recommendations, after adjusting for betel quid chewing during pregnancy, 
ethnicity, wealth quintile, education, chronic hypertension, imbalanced diet, maternal height, 
maternal age, delivery hospital, and season of delivery. 
Although the IOM recommendation was the most accepted guidance in the literature [24], 
it was derived from studies in high-income countries where there is a greater problem of excessive 
GWG and therefore the results may need to be re-examined using a chart more relevant to low-and 
middle-income countries.   
On average, mothers consumed two servings of green vegetables per day (mean 1.96, 
SD=2.2, 95% CI 1.79 - 2.13).  Similarly, the mean number of servings of fruit per day was 1.8 
(mean 1.77, SD=1.7, 95% CI 1.63-1.90). This is comparable with the findings from the 2014 STEPS 
survey which reported that the mean number of vegetable servings per day was 3.5 servings and 
mean number of fruit servings per day was 0.7 days.   
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Seventy seven percent of the mothers did not have the recommended five servings of fruits 
and/or vegetables in a day. This is similar to the results from the 2014 STEPS survey which reported 
that 70% of the women aged between 18 and 69 years old ate less than five servings of fruits and/or 
vegetables, thus not meeting the WHO recommendation[19]. 
Maternal malnutrition and dietary imbalance may lead not only to maternal and child 
mortality and morbidity but also have intermediate effects as demonstrated in the associations 
between LBW and raised blood pressure in childhood and adult life in the literature [25].  
 
8.1.5 Urinary tract infection (UTI) 
This study showed clear evidence of an association between UTI and adverse pregnancy outcomes.  
The aOR of term LBW in association with UTI was 2.17 (95% CI: 1.11-4.26, p=0.023) and 
the aOR of PTB was 1.98 (95% CI 1.00-3.90, p=0.049), after adjusting for wealth, education, and 
season of delivery. 
Infection is thought to be one of the main biological pathways leading to PTB and UTI is 
recognized as one of the most important and potentially modifiable risk factors for early PTB [26]. 
Although there are other kind of infection that affect pregnant women, UTI was used as it was the 
best documented. 
 In the descriptive analysis, less than 10% of mothers had a recorded UTI. More mothers in 
the case group experienced UTI compared to the control group. More mothers in the case group 
were missing information on UTI compared to the control group. In terms of symptoms of potential 
UTIs, more mothers among the cases reported pain in the lower belly, behind the front of pelvis 
and flank pains compared to the controls.  
 
8.2 Modifiable risk factors in the long-run or non-modifiable risk factors 
8.2.1 Hypertensive disorders 
Having hypertensive disorders was associated with increased odds of term LBW and PTB compared 
to the mothers without hypertensive disorders.  
The mothers with pregnancy-induced hypertension (PIH), pre-eclampsia, or eclampsia had 
7.08 times higher odds (95% CI: 3.58-14.00, p <0.0001) of PTB compared to mothers without 
hypertensive disorders after adjusting for alcohol during pregnancy, betel quid chewing during 
pregnancy, ethnicity, chronic hypertension, number of meals per day, maternal age and tobacco use 
during pregnancy. The total effect of PIH, pre-eclampsia, or eclampsia on term LBW cannot be 
estimated by adjusting for covariates in the proposed DAG using the backdoor criterion due to an 
unobserved confounder that directly effects the exposure and outcome variables. Micronutrient 
deficiency was assumed to have a direct causal relationship with term LBW and PIH, pre-eclampsia, 
or eclampsia in the proposed DAG but was unobserved in the present study.  
The evidence of association between chronic hypertension and adverse birth outcomes was 
clearer in the multiple imputation models than the complete case analysis. In the complete case 
 265 
 
analysis, the aOR of term LBW among mothers with chronic hypertension was 2.68 (95% CI: 0.70-
10.31, p-value=0.151) and the aOR of PTB was 3.23 (95% CI: 1.01-10.30, p-value=0.047)  after 
controlling for betel quid chewing during pregnancy, ethnicity, wealth quintile, education, maternal 
height, maternal age, pre-pregnancy weight, delivery hospital, and season of delivery. The 
association between chronic hypertension and adverse pregnancy outcomes was clearer in the 
multiple imputation models. Under MAR, the aOR of term LBW was 4.24 (95% CI: 1.44-12.42, 
p=0.009) and the aOR of PTB was 4.73 (95% CI: 1.83-12.19, p=0.001). The results under MNAR 
were almost identical to those under MAR. The large amount of missing data on maternal height 
and pre-pregnancy weight may have decreased the power for complete case analysis, resulting in 
an unclear association between chronic hypertension and term LBW.  
The direction and strength of association was similar to previous studies but in the present 
study, the confidence interval was wider. This could be due to the small sample size in the present 
study. Morisaki et al. (2014) reported prevalence of chronic hypertension was 0.4% and 
preeclampsia or eclampsia was 2.4% using data from 299,878 singleton deliveries collected in 359 
health facilities from 29 countries in Africa, Asia, Latin America and the Middle East [27].  In the 
multi-nominal, multilevel, multivariate logistic regression models, the study reported that chronic 
hypertension and preeclampsia/eclampsia was associated with increased odds of PTB (chronic 
hypertension: aOR 2.28, 95% CI: 1.94-2.68 and preeclampsia/eclampsia: aOR 5.03, 95% CI: 4.72-
5.37) after adjusting for maternal age, marital status, education, parity and previous caesarean 
section. Gestational hypertension was not reported in the study.  
 
8.2.2 Wealth index 
The data did not show a clear association between social gradient and term LBW and PTB. The 
odds of term LBW varied a little by different wealth quintiles after adjusting for delivery hospital 
(middle quintile [reference] vs poorest quintile [aOR: 1.37, 95% CI 0.73-2.54]; middle vs second 
[aOR: 0.88, 95% CI 0.47-1.65]; middle vs fourth [aOR: 1.01, 95% CI 0.54-1.89]; and middle vs 
richest [aOR: 1.43, 95% CI: 0.68-3.05]). The results were similar for PTB.    
There are two main possible explanations for this. Firstly, most of the mothers were 
sufficiently well-off to go to the referral hospitals for delivery. Secondly, free education and free 
access to health care is mitigating the effect of socio economic factors on adverse health outcomes.  
 
8.2.3 Education 
The data suggested middle secondary or secondary school compared to no education was associated 
with reduced odds of term LBW after adjusting for delivery hospital. On the other hand, the adjusted 
odds of PTB for education varied a little by each category of highest educational attainment. The 
impact of education may be underestimated. The population in the present study is relatively more 
educated than in other national surveys. For example, the STEPS 2014 survey using a nationally 
representative sample aged between 18 and 69 years old (total 2822 respondents) reported that more 
than 60% of participants had no formal schooling [19]. This could imply that the study participants 
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included more mothers who preferred to deliver at the referral hospitals, had the means and 
knowledge to access the referral hospitals and may have a higher education level, access to health 
facilities and higher wealth level compared to the mothers who deliver at primary health care level 
or at home.  
 
8.3 Primary findings from validation of outcome measurements 
In the present study, for mothers with both LMP and US information, the LMP and US estimates 
demonstrated good agreement. The mean LMP overestimated US estimate was 1 day (±17 days) 
and was similar to previous studies. In the literature, mean LMP underestimated gestational age by  
0.6 day  in Gambia [28], 0.77 weeks in Guatemala [29], and 1 day in Bangladesh [30] while 
overestimating by 3 days in PNG [31]. 
There was no statistical difference between mothers with early scans and mothers with late 
scans in terms of proportion of cases that were LBW and PTB in the sample. Hence, it could be 
assumed that classification of LBW and PTB in the present study was reasonably reliable. However, 
more mothers with late scans were missing LMP estimates and US estimates, compared to the 
mothers with early scans. In terms of demographic and socio-economic background, more mothers 
with late scans were under 25 years old, divorced, or widowed, students, self-employed and 
unemployed. More mothers with late scans had a parity greater than one and smoked during 
pregnancy according to a logistic regression model controlling for any other variables in the model. 
Wealthier mothers compared to the middle quintile had more than 50% reduced odds of having late 
or no scan (adjusted odds ratio 0.37, 95% CI: 0.16-0.86 vs reference group (middle quintile)).  
The findings may inform identification of the mothers who do not receive adequate ANC. 
Interventions targeted at mothers who are under 25 years old, divorced or widowed, students, self-
employed, unemployed, smokers, have a parity greater than one and are in the lower wealth quintile 
may help improve coverage of ANC.  
Although birth weight is the most reliable and widely-reported measure to assess size at 
birth, not all the infants are weighed at birth globally, especially when they are not delivered in 
health facilities. When infants are not weighed at birth, mother’s recall is often used to determine 
if the infant is LBW in order to estimate the percentage of LBW infants in Demographic and Health 
Surveys (DHS) and other surveys.  In the present study, mother’s subjective concept of the baby’s 
size was explored in relation to birth weight and gestational age. Among mothers of LBW infants, 
more than 33% assessed their babies as average or larger. The results suggest that the current 
survey-based estimates of the prevalence of LBW could be underestimated.   
 
8.4 Limitations 
In this section, limitations are discussed in terms of selection bias, recall bias, measurement errors, 
confounding and sample size. There are three main biases that can arise in observational studies: 
biases related to the selection of subjects into the study, biases arising from the way in which the 
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data are collected such as recall bias, truncation bias, measurement error and finally bias due to 
confounding [32]. The retrospective case-control study is more susceptible to selection bias than 
other epidemiological studies [32].  
 
8.4.1 Selection bias 
Selection bias is introduced when the association between exposure and outcome within the study 
population is different from that in the target population or cases and controls are not drawn from 
the same source population. In the study design, in order to capture regional variations, a multi-
centre case-control study was conducted rather than a single site study design. Given that the present 
study recruited cases in a hospital setting, controls were recruited from among mothers who would 
have attended the hospital if they had experienced the outcome of interest i.e. LBW or PTB in the 
present study. By recruiting controls from the same hospital, it could reasonably be assumed that 
they would have been recruited as cases if they had been delivered PTB or LBW babies. The usual 
concern with recruiting hospital-based controls is that they tend to be more similar to cases with 
respect to exposure than the general population, which would lead to an underestimate of the effect 
of the exposure of interest. This happens when the exposure leads to conditions other than the 
outcome of interest which led the control to attend the facility. For example, if controls included 
some mothers who had been referred for conditions which are linked to betel quid chewing, this 
could bias the odds ratio towards the null.  
 The hospital population could differ from deliveries at primary health care facilities and 
home deliveries on a number of points. According to a systematic review in Africa, facility 
deliveries in general are associated with first births or those lower in the birth order, maternal higher 
level of education, higher household wealth, from urban residence, shorter? distance to the nearest 
facility, higher number of ANC visits [33]. In the present study, cases and controls were identical 
in terms of socio-economic factors such as highest level of educational attainment, wealth quintile, 
marital status and baseline characteristics such as ethnicity and pre-pregnancy BMI. Thus, by 
capturing relatively well-educated or wealthier population compared to the general population, the 
effect of education or wealth could be underestimated compared to the community-based case 
control study in the present study. 
 
8.4.2 Recall bias 
Case-control studies can be subject to a number of sources of recall bias. Chemical analyses or 
laboratory tests were not conducted in the present study to measure exposure to and quantification 
of betel quid chewing, smoking, and drinking. Betel quid was widely consumed and had no stigma 
attached. As a result, mothers were generally open about answering. However, it is still possible 
that betel quid chewing, smoking, and alcohol use were underreported if mothers felt hesitant about 
sharing the actual consumption due to some attached stigma, which may bias the estimates towards 
the null. Generally, it is said that controls underreport exposure more than cases in case-control 
studies due to differential reporting of exposure information between cases and controls based on 
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their disease status or interviewer’s knowledge of an individual's disease status 
(interviewer/observer bias). In such case, the odds may be overestimated. In the present study, betel 
quid chewing had a similar prevalence among cases and controls but alcohol and tobacco were more 
common in the cases than controls. The point estimates and 95% CIs were comparable to others 
studies and systematic reviews for alcohol but larger for tobacco. Therefore, the results should be 
interpreted with these limitations in mind.   
 
8.4.3 Measurement errors 
The ambiguity on the accuracy of gestational age used to classify PTB is one of the biggest 
limitations that could impact the results of the study. To examine this ambiguity, validity of 
outcome measure was examined in detail and sensitivity analyses limiting to mothers with early 
scans were conducted. 
The second methodological challenge was missing data in the independent variables. The 
present study collected information such as mother’s self-reported symptoms or subjective 
assessment to supplement hospital records to deal with this challenge. The multiple imputation 
method was used to deal with missing information. 
In terms of measurement of exposure, a tool was developed after careful consideration of 
the culture and context. The present study used a modified calendar method to assess the betel quid 
consumption during pregnancy in Bhutan. Compared to other studies, the practice of mixing betel 
quid with tobacco among pregnant women was less common, allowing the researchers to look at 
the effect of betel quid separately. For alcohol use, the graduate frequency method was used to 
overcome the challenge of not having a standard drink size. Amount of ethanol was calculated based 
on the conservative assumptions of alcohol concentration of home-brewed alcohol. It might have 
been overestimated if the assumptions of alcohol concentration were higher. In the logistic 
regression, whether mothers drink alcohol or not and the number of drinking days were used as an 
exposure. Thus, this limitation does not materially influence the results.   
The questionnaire was not validated in terms of the concurrent validity and construct 
validity.  Concurrent validity can be demonstrated by correlating the measure with related and or 
dissimilar measures [34]. Construct validity refers to the degree of how well the items in the 
questionnaire represent the underlying conceptual structure [34, 35].  In addition to validity, it is 
also important that a measure can demonstrate reliability as defined as repeatability, stability or 
internal consistency [34, 35]. This could have been explored by asking the mothers about their 
consumption of betel quid, alcohol, and smoking at every ANC visit using the same questionnaire 
to check stability using test-retest reliability [34] or by keeping track of expenditure or asking 
mothers to keep diaries of the amount consumed.  
 
8.4.4 Confounders 
Pregnancy and birth outcomes may be influenced by a multitude of biological, behavioural, and 
socio-economic factors. For the present study this complexity was addressed by using both 
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statistical and directed acyclic graphs approaches. The causal assumptions were explicitly presented 
in the DAGs and covariates controlled for in the logistic regression models were determined based 
on the causal assumptions. However, it should be noted that several factors such periodontal disease 
were not measured and not controlled for in the model. The causal assumptions made in the DAGs 
substantially impact the results of the logistic regressions. In relation to this point, a statistical 
approach was also conducted and compared to the results from the DAG approach. Any substantial 
discrepancies were addressed in Chapter 7.   
 
8.4.5 Sample size 
The study did not recruit long enough to get the planned 485 sample size for cases (Chapter 3.3). 
In addition, given the very large number of eligible controls, many opportunities were missed to 
recruit controls (Chapter 5.1). As the research nurses were trained for the first time to conduct a 
case control study, it was difficult to institutionalise the study in the beginning and it was often the 
case that mothers were discharged before nurses had a chance to contact them. The study period 
was extended from the original time period and additional research assistant was recruited to assist 
the data collection. As a result, the resources were running short. To avoid pressuring the health 
system and compromising the quality of data collection, the study ended before reaching the panned 
sample size. 
The sample size was based on the assumption of 10% difference in prevalence of betel 
chewing. The observed small difference in the prevalence led to a bigger P-value.  This limited the 
ability to produce clear evidence of association or no association between betel quid chewing and 
adverse birth outcomes. 
 
8.4.6  Translation Bias 
Although the research nurses were fluent in English and Dzongka, verbal translations were agreed 
during the training and monitoring visits (Chapter 3.6), the lack of a formal written translation 
(back-translation, validation) process could have led to some bias if different interviewers translated 
differently and conveyed different meanings of some questions to respondents. About 20% of the 
interviews were done in English, combined with other languages such as Dzongkha (40% of the 
total interviews), Sharchop (33%), and Lhotsham (29%) (Figure I.5).  
 
8.4.7  Statistical approach 
The statistical model have too many variables for the number of outcome events and as a result, 
may be lacking power (Table 7.1 and Table 7.2). There are 32 variables and the number of outcome 
events were less than 200. This may partially explain considerable uncertainty around the estimates 
[36]. In this point, the DAG analyses were used to inform the statistical model to reduce the number 
of variables that should be controlled for in the models. 
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8.4.8  Imputation of missing data 
MNAR analysis was conducted using only UTI (Chapter 7.2.2) in the present study. However, there 
could be a number of other MNAR scenarios. For example, multiple variables can have MNAR 
missingness mechanism at the same time. More MNAR analysis with more variables may be needed 
in order to determine whether or not the missing data is MAR or not more robustly.  
 
8.5 Recommendations 
Globally, the Sustainable Development Goals set targets for major reductions in maternal, neonatal, 
and child mortality and call for universal access to sexual and reproductive health services by 2030 
[37]. 
In Bhutan, several initiatives are being taken to increase awareness of the importance of the 
first 1000 days between the beginning of a woman’s pregnancy and her child’s second birthday in 
the child’s health, ultimately to reduce maternal and child mortality through improved health and 
nutritional status of adolescents, pregnant and lactating women as well as young children. The 
present study provides rich baseline data for mothers and established a cohort of cases and controls, 
which could be followed up to understand the short- and long-term effects of LBW and PTB.  
The following recommendations are made to inform policy makers on modifiable risk 
factors. 
 
8.5.1 Recommendations for further research 
In order to reduce the burden of LBW and PTB, research into both prevention and care are necessary 
[38]. The present study focused on prevention by exploring potential risk factors for LBW and PTB. 
The present study also identifies possible areas for future studies as follows:  
 
▪ Further research on association between betel quid chewing during pregnancy and 
adverse birth outcomes  
The studies so far could not provide sufficient evidence that betel is not associated with 
adverse outcomes due to sample size, confounders, and measurement issues. The present 
study aimed to develop methods for assessing betel quid use during pregnancy and 
described the pattern of betel quid chewing during pregnancy among Bhutanese women. In 
addition, the present study tried to quantify the amount of betel quid chewing during 
pregnancy. However, the observed difference of betel chewing in cases and controls were 
smaller than the assumption used to calculate the sample size, which limited the ability to 
provide clear evidence of association. An association between the amount, timing, and type 
of betel and adverse birth outcomes may be further examined. Although further research 
with larger sample size may be warranted to build on the findings, given the very small 
differences in exposure to betel quid between cases and controls, an effect may be very 
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small.  As described in Section 8.1.1., in relation to a possible relative and absolute risk 
according to the results, if the risk of LBW in the general singleton live born infants is 8.5%, 
the 1.3 times increased risk with betel quid chewing during pregnancy would result in an 
incidence in 11.1%, a 2.6 % increase. Similarly, if the risk of PTB in the general singleton 
live born infants is 5.5%, the 1.2 times increased risk with betel quid chewing during 
pregnancy would result in an incidence of 6.6%, a 1.1% increase. Following up the cohort 
of babies may be useful to examine the short term and long term impact of betel quid 
chewing on growth, morbidity, and morbidity of babies if any. 
 
▪ Further research on validation of measurement of betel quid chewing during 
pregnancy 
A prospective cohort study is required to establish the utility of the questionnaire developed 
in this study. Test-retest reliability can be established by asking the mothers how much 
betel quid they chewed, alcohol they drank and tobacco they smoked at every ANC visit 
using the same questionnaire [34] or by keeping track of expenditure or asking mothers to 
keep diaries of the amount consumed.  
 
▪ Research on mechanisms or causal association between betel quid chewing and 
anaemia 
While the present study shows clear evidence of association between anaemia and betel 
quid chewing during pregnancy, causality is not established and the mechanism is not 
clearly understood. Further research on potential mechanisms may be warranted. Such 
research may include systematic research on chemical constituents of betel nuts and 
packaged betel products. 
 
▪ Research on association between betel quid chewing and periodontal disease and 
adverse birth outcomes 
Several studies suggest that betel quid chewing is associated with increased odds of 
periodontal disease as described in Chapter 2. Periodontal disease was included in the DAG 
as an unmeasured factor in the present study. To estimate the precise effect of betel quid 
chewing, it is worth examining the impact of betel quid on periodontal disease and 
association with adverse birth outcomes. 
 
▪ Qualitative study on practice of alcohol and betel quid chewing 
Considering the high prevalence of alcohol and betel quid chewing during pregnancy, 
qualitative research is necessary to understand the cultural and social norms that encourage 
use of alcohol and betel quid chewing during pregnancy. There might be cultural beliefs 
about health benefits associated with alcohol and betel quid chewing during pregnancy. 
This would help design effective prevention and intervention programmes and policies.  
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▪ Research and development of more accurate measurement of home-brewed alcohol 
Considering the large amount of home-brewed alcohol and high burden of alcohol-related 
disease, a greater understanding of alcohol consumption needs to be built. There is no 
accurate information on the ethanol concentration of home-brewed alcohol. Validation 
research of F-GF with the obstetric population using chemical analysis is recommended. 
 
 
 
▪ Research and development of alcohol screening tools for obstetric population 
Studies indicate that even the low levels of prenatal alcohol exposure can negatively affect 
the birth outcomes [39]. The present study showed mothers who drank less than or equal 
to once a week at 2.16 higher odds of PTB compared to non-drinkers. Screening pregnant 
women for alcohol use at the primary care level is necessary. Although the Maternal and 
Child Health Handbook and National Standards of Midwifery Practice for Safe 
Motherhood state that alcohol use during pregnancy should be discouraged, no concrete 
screening process exists and no screening questions are asked.  
There are a number of validated screening questions on harmful drinking 
recommended at the primary care level such as the 10-item Alcohol Use Disorders 
Identification Test (AUDIT) [40] and the 4-item CAGE [41]. Of these screening tools, the 
4-item T-ACE [42] is developed and validated for routine use in obstetric-gynecological 
practice.  Based on the CAGE questions, the T-ACE consists of four questions:  
 
(1) How many drinks does it take to make you feel high? (Tolerance);  
(2) Have people Annoyed you by criticizing your drinking?;  
(3) Have you ever felt you ought to Cut down on your drinking?;  
(4) Have you ever had a drink first thing in the morning to steady your nerves 
or get rid of a hangover? (Eye opener). 
 
However, these screenings tools seem to be developed and validated in societies 
where alcohol drinking during pregnancy is associated with some negative value judgement. 
Considering the high prevalence of drinking during pregnancy in Bhutan, research to 
develop the screening tools applicable to the Bhutanese population is required to initiate 
screening. 
 
▪ Research and development of culturally appropriate interventions on alcohol during 
pregnancy 
To reduce consumption of alcohol, there are pharmacological, psychological and 
educational interventions described in the literature [43]. However, Cochrane reviews of 
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pharmacological [44], psychological and educational interventions [43] showed that the 
effect of such interventions is inconclusive. There is an urgent need for research and 
development of effective interventions among pregnant mothers. In order to introduce 
interventions for Bhutanese population, such interventions should be culturally appropriate 
and validated for the Bhutanese obstetric population.  
▪ Research on management of hypertensive disorders during pregnancy 
The association between hypertensive disorders and adverse outcomes is well established. 
Additionally, hypertension is the second most common direct cause of maternal deaths after 
haemorrhage, accounting for 14% of all deaths (11.1-17.4%) [45]. Although not the focus 
of the present study, a relatively high prevalence of hypertensive disorders was found and 
was associated with an increased odds of PTB and LBW.  Further research focusing on the 
detection, management and outcome of hypertensive disorders of pregnancy in Bhutan may 
be helpful in order to identify whether prevention and treatment can be optmised. 
▪ Follow-up study of the cohort established in this case control study 
Having established a cohort of mother –baby pairs, by enrolled and obtained baseline data 
on these cases and control, it would be very interesting to do a follow-up study on this 
cohort in order to describe the short- and long-term impacts of term LBW and PTB in 
Bhutan. The short-term outcomes may include hospital admission rate, neonatal mortality 
and morbidity. The long-term outcomes may include health, growth and development in 
childhood and even into adulthood. Qualitative and quantitative research on care of LBW 
and PTB by following up the cohort, in combination with the baseline data the present study 
provides, may contribute to building a comprehensive understanding of prevention and care 
in Bhutan and help design and scale up low-cost interventions.  
▪ Qualitative study on psychosocial factors such as stress, anxiety and partner violence 
Recent studies show an association between psychosocial factors and adverse birth 
outcomes as described in Chapter 2. Although not the focus of the present study, 
unstructured memos by the interviewers identified some of the repeated keywords such as 
divorce, unbooking (no ANC), problem with partner or family, alcohol, and PIH.  In the 
present study, psychosocial problem was included as an unobserved factor that has a causal 
relationship with alcohol and tobacco use during pregnancy and was not investigated in 
depth. It may be worth conducting qualitative research focusing on the psychosocial factors 
that Bhutanese women are facing in the rapidly modernising society.  
 
8.5.2  Implications for policy and practice 
Antenatal Care (ANC) is a key strategy to improve maternal and infant health.  Of the sample 
mothers, 83% had at least four ANC visits as per WHO recommendation.  Mean number of ANC 
visits was 5.6 and mean gestational weeks at the first ANC visit was 15 weeks. This indicates that 
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ANC is an effective intervention to reach the obstetric population. Improving the coverage and 
quality of ANC, focusing on the factors that have clear evidence of an association with adverse 
pregnancy outcomes, may contribute to improving health outcomes of mothers and babies in 
Bhutan. 
The research shows that more mothers in the case group were missing information on UTI 
compared to the control group. In terms of symptoms of potential UTIs, more mothers in the cases 
reported pain in the lower belly, behind the front of the pelvis and flank pains compared to the 
controls. This may suggest that efforts to screen for and treat UTI during pregnancy at antenatal 
care could be strengthened.   
The present research also reveals imbalanced and inadequate diet during pregnancy in the 
Bhutanese population. Nutritional interventions that involve correction of micronutrient and 
macronutrient imbalances in mothers before conception or at critical periods of early development 
is required. 
The present research suggests that prevalence of drinking and intensity of drinking are 
higher in the eastern region. Alcohol interventions targeting especially in the eastern region should 
be prioritised.  
The present research can help identify the population that comes to ANC late or does not 
come at all. Policies or campaigns targeted at mothers who are under 25 years old, divorced or 
widowed, students, self-employed, unemployed, smokers, have a parity greater than one and are in 
the lower wealth quintile may benefit from improved ANC coverage. 
In this study, the main potentially modifiable risk factors in the short-term, associated with 
PTB and LBW were alcohol, tobacco, low GWG, and UTI. As described above, it should be a 
priority to design, implement and evaluate interventions aimed at reducing these risks as much as 
possible and to improve the understanding of other modifiable risks such as other infectious 
diseases and hypertensive disorders.  However, these interventions are likely to take time to put into 
place, and even with optimal efforts at prevention, a substantial proportion of adverse outcomes 
may not be avoidable.  It is therefore very important that the care of pre-term and low birth weight 
babies is optimised. As has been highlighted recently, there are a number of effective inexpensive 
solutions that have not been implemented or scaled up in low income countries that could save the 
lives of many LBW and PTB babies [1]. Among cost-effective interventions, Kangaroo Mother 
Care (KMC) has been named as one of the highest impact facility-based interventions that are 
scalable in low-resource settings and act as entry points for strengthening health systems [2].  KMC 
includes thermal care through continuous skin-to-skin contact between the mother and baby, 
support for exclusive breastfeeding or other appropriate feeding, and early recognition of, and 
response to, complications [46]. A meta-analysis of KMC using three randomized controlled trials 
showed that KMC in the first week of life reduced the risk of mortality by 51%  (relative risk 0.49, 
95% confidence interval 0.29-0.82) compared with standard care [46]. In Bhutan, KMC was 
implemented as a pilot project at JDWNRH in September 2013 and expanded to ERRH and CRRH 
during the study period.  
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8.6 Conclusion 
In the present study, the results did not provide clear evidence that there are increased odds of an 
association between term LBW or PTB and betel quid chewing during pregnancy. For a secondary 
outcome, the data suggest betel quid chewing is associated with increased odds of anaemia. The 
present study provides rich baseline data for mothers and established a cohort of cases and controls, 
which could be followed up to understand the short- and long-term effects of LBW and PTB and 
may help design effective interventions.  
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Appendix A  
 
Table A.1. Burden of preterm birth and low birth weight. 
 Outcome  Author Review method Summary of findings 
Mortality Mortality Mortality risk in 
preterm and SGA 
infants in low and 
middle income 
countries 
Katz et al. (2013) [1] Systematic review to identify 
datasets from published studies and 
cohorts which may have collected 
the information and a pooled 
country analysis (1982 – 2010) 
20 studies from Asia, Africa and Latin America were included (2,015,019 
live births). Pooled overall RRs for preterm were 6.82 (95% CI 3.6-13.07) 
for neonatal mortality and 2.50 (95% CI 1.48-4.22) for post-neonatal 
mortality. Pooled overall RRs for SGA infants were 1.83(95% CI 1.34-
2.50) for neonatal mortality and 1.90 (95% CI 1.32-2.73) for post-neonatal 
mortality. Neonatal mortality rates and relative risks increased as 
gestational age decreased across studies and regions. 
  Adult mortality from 
all causes, CVD or 
cancer 
Risnes et al.(2011) [2] Meta-analysis of observational 
studies (before October 2010) 
22 prospective or longitudinal cohort studies from the UK, Denmark, 
Sweden, Finland, Norway, the Netherland, Australia, and Israel were 
included (36,834 deaths).  Fixed-effect meta-analysis showed that a 6% 
lower risk (adjusted HR 0.94, 95% CI: 0.92-0.97) per kg higher 
birthweight for men and women combined.  Inverse association with 
cardiovascular mortality (HR=0.88, 95% CI 0.85-0.91) was reported. 
Cancer mortality was HR 1.13 95% CI 1.07-1.10 for men and HR 1.04, 
95% CI 0.98-1.10) for women.  
      
Long-term 
morbidity 
Neuro-
development 
/behavioral 
effects 
Long-tern 
neurodevelopmental 
outcome in high-risk 
newborns in 
resource-limited 
settings 
Milner et al. (2015) [3] Systematic review to identify 
literature (January 1996 to April 
2012), narrative review and median 
prevalence of key 
neurodevelopmental outcomes 
where data quality allowed 
33 studies of LBW/PTB populations from resource-limited settings were 
included. The median sample size was 122 (IGR 84-171). The medial 
overall prevalence of moderate-to-severe neurodevelopmental impairment 
was 21.4% (11.6-30.8). 
  Language difficulties Van Noort-van der Spek 
et al. (2013) [4] 
Meta-analysis (January 1995-March 
2011) 
13 studies were included for simple language function tests and 7 studies 
were included for complex language function tests. Random effects meta-
analysis revealed statistically significant differences between preterm-born 
children and term-born children both for simple (d= -0.45, 95% CI -0.59 to 
-0.30) and complex language tests (d=-0.62, 95% CI -0.82 to -0.43) in the 
absence of major disabilities and independent of SES. 
  Brain Development  de Kieviet et al. (2012) 
[5]  
Meta-analysis (before 1 August 
2012) 
15 studies were included (419 very preterm or very low birth weight 
(VLBW) and 307 term-born children). Very preterm (<32 weeks) or very 
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low birth weight (<1500g) was associated with a significantly smaller total 
brain volume (d= -0.58, 95% CI -0.43 to -0.73). 
  Cognitive and 
behavioral outcome 
Bhutta et al (2002) [6, 
7] 
Meta-analysis (1980-November 
2001) 
15 studies were included for cognitive data (1556 school-aged children 
who were born preterm and 1720 school-aged children who were term-
born). Term born children had significantly higher cognitive scores than 
preterm children (weighted mean difference, 10.9, 95% CI 9.2-12.5). 
  Motor Impairment de Kieviet et al. (2009) 
[8] 
Meta-analysis (January 1992-
August 2009) 
41 studies were included. Very preterm and VLBW children obtained 
significantly lower scores on all 3 established and widely used motor tests. 
BSID-II: d = -0.88 (95% CI -0.96 to -0.80), MABC: d = -0.65, 95% CI, -
0.70 to -0.60, and BOTMP: d = -0.57, 95% CI, -0.68 to -0.46). 
 Specific 
Physical 
effects 
Visual impairment Fetus and Newborn 
Committee, Canadian 
Paediatric Society 
(1998) [9] 
Systematic review (January 1966 – 
December 1997) 
8 population-based studies of retinopathy of prematurity were included.  
Studies from Canada, New Zealand, Great Britain, Sweden, Norway, and 
Denmark suggested that infants at greatest risk of ROP were 1500g or less 
at birth, or 30 weeks gestational age or younger.  
  Chronic lung disease Colin et al. (2010) [10] Structured review (2000-2009) 24 studies were included. These studies consistently revealed that infants 
born at 32 to 36 weeks' gestational age, including infants of 34 to 36 
weeks' gestational age, have substantial respiratory morbidity compared 
with term infants. 
  Hypertension  Mu et al.(2012) [11] Systematic review (1995-2011) 20 studies from Japan, Spain, Finland, England, Sweden, USA, China, 
Brazil were included. Using 9 studies, the fixed effect models revealed that 
LBW was associated with and increased risk of hypertension (OR 1.21, 
95% CI 1.13-1.30) and BW more than 4000g had a negative association  
with hypertension (OR 0.78, 95% CI, 0.71-0.86). 
  Long-term 
cardiovascular ill-
health and non-
communicable 
disease 
Parkinson et al. (2013) 
[12] 
Systematic review and meta-
analysis (before October 1, 2011) 
40 studies were included (17030 preterm and 295261 term-born adults) In 
adults, preterm birth was associated with significantly higher systolic 
blood pressure (mean difference: 4.2 mm HG, 95% CI 2.8-5.7, p <0.001).  
Economic 
Costs 
 Long-term economic 
costs 
Petrou et Khan (2012) 
[13] 
Non-systematic review (January 
1980-2011) 
20 studies from developed countries defined by OECD were included. 
Data on economic consequences of moderate and late preterm birth 
consistently suggest that service provision for infants born between 33 and 
36 weeks’ gestation is associated with substantial incremental costs during 
the initial hospital stay and throughout childhood.   
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Appendix B  
 
B.1 Search Strategy in Medline (2.1) 
Gestational age 
Gestational age.mp. or exp Gestational Age/ OR last menstrual period.mp. OR pregnancy 
duration.mp. OR pregnancy length.mp. OR pregnancy dating.mp. 
LMP 
LMP.mp. OR menstruation.mp. or exp Menstruation/ OR menstrual cycle.mp. or exp Menstrual 
Cycle/ OR menstru*.mp. OR last menstrual period.mp. OR LMP.mp. 
US 
exp Ultrasonography, Prenatal/ or Ultrasonography/ or ultrasonography.mp OR ultrasound.mp. 
 
Embase ALL LMIC countries List from World Bank, 2014 was added. 
Abstracts were then screened for possible relevance (n=491). Other academic papers were 
searched in PubMed and the Cochrane library. Table 2.1 summarizes the six studies. 
 
B.2 Comparison of ultrasound birth weight references and the International Fetal 
and Newborn Grown Consortium for the 21st century standard using the data 
from case-control study (3.11.1) 
Small for gestational age (SGA) was defined as a birth weight below the 10th percentile of a sex-
specific birth weight distribution by gestational age. SGA of cases and controls was calculated using 
2 different distributions: the US 2000 birth weight reference for gestational ages 20-44 weeks and 
the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-
21st) birth weight standard for gestational ages 24-42 weeks. INTERGROWTH-21st is a description 
of optimal birth weight and the US 2000 birth weight is a description of measured birth weight in 
the population. 
gIn total, by the US 2000 birth weight reference, 269 infants (41.5%) were classified as 
SGA while 201(31.0%) infants were classified as were classified as SGA using the US 2000 
reference. The agreement was 89.6%. The Kappa coefficient for classification was 0.78, which 
indicates good agreement. INTERGROWTH-21 classified less study participants as SGA 
compared to the US 2000. This confirms the previous study by Kozuki et al [1], which compared 
the two references using data from 10 low- and middle-income countries and reported that a greater 
than one quarter differences in SGA classifications by the two different distributions.   
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Figure B.1. Birthweight by gestational age for boys. 
 
 
Figure B.2. Birthweight by gestational age for girls. 
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Table B.1. The 10th percentile birth weight values by gestational age and sex comparing the US2000 reference to the INTERGROWTH-21 Standard in this study participants  
 
Gestational age  
(weeks) 
Boys  Girls 
Total 
 
US 2000 10th 
percentile 
No and % of SGA 
by the US 2000 
Intergrowth-
21st 
SGA by 
Intergrowth 21 
 
Total 
US 2000 10th 
percentile 
SGA by US 2000 
Intergrowth-
21st 
SGA by 
Intergrwoth-21 
N Weight, g N % Weight, g N %  N Weight, g n % Weight, g n % 
22 0 393 0 0 - 0 0  1 362 0 0 - 0 0 
23 0 453 0 0 - 0 0  0 416 0 0 - 0 0 
24 0 498 0 0 500 0 0  0 470 0 0 470 0 0 
25 0 554 0 0 570 0 0  1 504 0 0 540 0 0 
26 2 594 0 0 650 0 0  0 556 0 0 610 0 0 
27 1 674 0 0 740 0 0  3 622 0 0 700 0 0 
28 4 766 1 25 840 1 25.00  1 693 0 0 790 0 0 
29 5 906 0 0 950 0 0  3 845 0 0 900 0 0 
30 5 1044 1 20 1070 1 20.00  7 965 0 0 1010 0 0 
31 6 1241 0 0 1210 0 0  3 1180 1 33.33 1140 1 50.00 
32 8 1475 1 12.5 1360 1 12.50  9 1390 2 22.22 1280 1 12.50 
33 3 1712 2 50 1430 1 33.33  10 1638 3 30.00 1410 3 33.33 
34 9 1957 5 55.56 1710 2 22.22  12 1872 4 33.33 1680 4 36.36 
35 16 2192 4 25.53 1950 3 18.75  17 2099 6 35.29 1920 3 18.75 
36 24 2410 12 46.15 2180 6 25  25 2299 10 40.00 2140 5 20.83 
37 27 2609 19 70.37 2380 13 48.15  34 2495 25 73.53 2330 18 52.94 
38 36 2807 18 48.57 2570 12 34.29  52 2694 38 73.08 2500 33 64.46 
39 69 2947 30 43.48 2730 22 31.88  70 2834 32 45.71 2650 22 31.88 
40 54 3029 14 25.45 2880 10 18.52  61 2919 23 37.70 2780 20 33.33 
41 36 3063 9 25 3010 8 22.22  35 2949 10 28.57 2890 9 25.71 
42 6 2979 0 0 3120 1 16.67  2 2893 1 50.00 2980 1 50.00 
43 1 2949 0 0 - 0 0  0 2849 0 0 - 0 0 
44 0 2954 0 0 - 0 0  0 2863 0 0 - 0 0 
Total 311 - 116 36.36 - 81 26.05  346 - 155 44.80  120 35.61 
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B.3 Hypertension during pregnancy (2.2.2) 
Hypertension in pregnancy is a leading cause of maternal mortality and adverse birth outcomes [2]. 
Many efforts during antenatal care are made to  detect and manage  hypertensive disorders during 
pregnancy [3]. A meta-analysis concluded that chronic hypertension increased preterm delivery and 
low birth weight by 2.7 times[4]. The association between preeclampsia or gestational hypertension 
and poor foetal growth is inconclusive [5-13]. 
Pre-eclampsia is defined as hypertension (diastolic blood pressure of ≥ 90 mm Hg) 
accompanied by proteinuria (≥ 300 mg or more per 24- hour period) , usually occurs during the 
second half of pregnancy (at or after 20 weeks’ gestation)[6, 7].  Pre-eclampsia complicates 2%-
8% of pregnancies [6-8, 14]. Women with moderate pre-eclampsia generally have no symptoms[6]. 
Women with severe pre-eclampsia, or with very high blood pressure, may feel unwell, with 
symptoms such as headache, upper abdominal pain, or visual disturbances[6]. 
  Pre-eclampsia can affect blood supply to the placenta, leading to poor intrauterine growth, 
and can precipitate preterm birth related either to the spontaneous onset of preterm labor or to early 
deliver to protect the mother or the fetus[6]. In order to examine the strength of association between 
pre-eclampsia/eclampsia and adverse birth outcomes, relevant literature was systematically 
searched in MEDLINE, EMBASE, and Cochrane Library from the inception of each database in 
March 2016. For pre-eclampsia/eclampsia, “exp Pre-eclampsia/”OR “exp Eclampsia/”OR 
“hypertensive disorder*”, OR  “Pregnancy Complications/”, OR ”exp Hypertension, Pregnancy-
induced/” were used. The reference list was manually searched and other academic papers were 
searched in Google scholar and PubMed. No language restriction was applied. There was no study 
type restriction. All papers that referred to the relationship between adverse pregnancy outcomes 
and pre-eclampsia/eclampsia in humans were assessed. Research shows mixed-evidence, observing 
inconsistent associations between preeclampsia and the risk of birth complications.  
Naeye (1989) presented an evidence that preeclampsia and low uteroplacental blood flow 
are an important cause of spontaneous preterm delivery using the data from an US-based cohort 
study of 55,908 pregnancy women in 12 medical school-affiliated hospitals in different regions of 
the US between 1959 and 1966[15].   
Xion et al. conducted several research to explore relationship between pregnancy-induced 
hypertension and fetal growth in China and Canada [9-11]. In 2001, a study which examined 97,270 
pregnancies between 1991 and 1996 at 35 hospitals in northern and central Alberta, Canada  
reported that the birthweight were statistically significant lower among mothers with pre-eclampsia 
who delivered at or before 37 weeks of gestation after adjusting for maternal smoking, maternal 
age, maternal pre-pregnancy weight of ≥91 kg or ≤45 kg, prior spontaneous and induced abortions, 
prior SGA new-born, prior large-for-gestational-age newborn, anemia, and premature rupture of 
membranes (PROM)[9]. However, the birth weights were not lower among mothers with pre-
eclampsia who delivered after 37 weeks of gestation. In 1999, Xion et al. reported that preeclampsia 
and severe preeclampsia increased the risk of intrauterine growth restriction and low birth weight 
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but not associated with preterm birth using a population-based perinatal database of 16,939 
pregnancies from 10 hospitals between 1989 and 1990 in Suzhou, China [11].  Yet, when the group 
stratified the population by type of hypertension and gestational age in 2004 and adjusted for 
maternal age, education, parity, BMI at the first antenatal visit, prior induced abortion, PROM, and 
severe anaemia (< 8g/dL) during pregnancy, the authors concluded that there were no differences 
in mean birthweight between women with gestational hypertension and women with normal blood 
pressure [10].  
Villar et al. (2005) analysed 39,615 pregnancies collected in the WHO Antenatal Care Trial 
between August 1990 and December 1998 in Rosario, Argentina, Havana, Cuba, Jeddah, Saudi 
Arabia, and Khon Kaen, Thailand and reported women with pre-eclampsia had a lower mean 
gestational age(37.5 weeks) and mean birth weight(2845g) compared to women without any 
hypertensive conditions and/or IUGR infants and 74% of the preterm deliveries were medically 
indicated[8].   
Bakker et al. (2011) used a multi-linear model with repeated measure to analyse 8,623 
women who participated in a population-based prospective cohort study between 2001 and 2005 in 
Rotterdam, the Netherlands [5]. The authors restricted their analyses to spontaneous deliveries and 
reported an increase in blood pressure from the second trimester to the third trimester was associated 
with an increased risk of adverse birth outcomes after adjusting for gestational age at birth (only in 
birth weight analyses), maternal age, educational level, ethnicity, parity, folic acid supplement use, 
smoking, alcohol, caffeine intake, weight, height, stress, and fetal sex (SGA OR 5.03, 95% CI: 
3.31-7.62; PTB OR 5.89, 95% CI: 2.63-13.14; and LBW OR 8.94, 95% CI: 6.19-12.90)[5].  
Ota et al. (2014) analysed 295,829 singleton infants from the WHO Multi-Country Survey 
on Maternal and Newborn Health between May 2010 and December 2011, collected in 359 health 
facilities from 29 countries in Africa, Asia, Latin America and the Middle East, and reported that 
the risk of preterm SGA infants was significantly higher among nulliparous mothers and mothers 
with chronic hypertension (aOR 1.68, 95% CI 1.22-2.30) and preeclampsia/eclampsia (aOR 2.89, 
95% CI: 2.55-3.28) compared to preterm appropriate-for-gestational age (AGA), controlling for 
maternal age, marital status, education in years, anaemia, malaria/dengue, HIV/AIDs, other heart, 
lungs, liver and kidneys conditions, and the human development index[13]. The study did not adjust 
for other potential risk factors such as smoking, alcohol and caffeine intake, maternal BMI, 
malnutrition, gestational weight gain, maternal stature, psychosocial, stress, interpregnancy interval, 
and previous history of miscarriage. The study also did not mention regarding mode of delivery of 
the babies included for the analyses.  
Using 299,878 singleton from the same data as Ota et al. (2014) (the WHO Multicounty 
Survey on Maternal and Newborn Health), Morisaki et al. (2014) reported prevalence of chronic 
hypertension was 0.4% and preeclampsia/eclampsia was 2.4% [12].  In the multi-nominal, 
multilevel, multivariate logistic regression models, the study reported that chronic hypertension and 
preeclampsia/eclampsia was associated with increased risk of preterm (chronic hypertension: aOR 
2.28, 95% CI: 1.94-2.68 and preeclampsia/eclampsia: aOR 5.03, 95% CI: 4.72-5.37) adjusting for 
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maternal age, marital status, education, parity and previous caesarean section. Gestational 
hypertension was not reported in the study. 
Although there are differences in the study design (prospective[5, 8] vs retrospective[9-11, 
15], treatment of missing data (simply omitting missing data[8-11] vs multiple imputations[5]), 
confounders included in the models, and definitions of hypertension (≥130/90 mmHg in China[10, 
11]), the origins of the heterogeneous observed associations are still not clear.  
Moreover, preterm could be a result of treatment for pre-eclampsia[16].  Steegers et 
al.(2010) did not suggest any specific gestational weeks for delivery for mothers with pre-eclampsia 
but suggested that timing of delivery should be designed to keep perinatal outcomes at an optimum 
while avoiding maternal risks[7]. Sibai (2003 & 2006) recommended delivery for women who 
develop preeclampsia at 37 weeks or more and for all women with sever preeclampsia at ≥34 weeks’ 
gestation, and at 35 to 37 weeks in the presence of any of the following factors: severe pre-eclampsia, 
preterm labor or PROM, suspected IUGR-oligohydraminos, vaginal bleeding, or abnormal fetal 
testing (variable or late decelerations, absent or reverse umbilical artery diastolic flow, or 
biophysical profile ≤6)[17, 18]. 
Furthermore, a systematic review and meta-analysis of randomized controlled trials of 
antihypertensive therapy for mild-to moderate pregnancy hypertension found that there was a 
statistical trend towards an increase in small-for-gestational age infants among women taking 
antihypertensive therapy, compared with those who took placebo or no therapy combining 15 trials 
with 1782 women (OR 1.31, 95% CI: 0.988-1.75)[19]. This systematic review was updated in 2004 
and reported that 176g birth weight difference or 19% attributable to differential blood pressure 
control when they analysed 34 RCTs [20].  
Measurement of blood pressure and assessment for presence of proteinuria are the 
cornerstones of screening for pre-eclampsia, and part of routine antenatal care throughout the world 
[6, 7]. Both are subject to error due to inadequate training in how to make reliable measurements 
and to poor equipment. Although dipstick testing for screening of proteinuria has issues of 
intraobserver and interobserver variability and limited sensitivity and specificity, it is widely used 
and might be the only test available in low-income and middle-income countries[7].  
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Table B.2. A summary of key findings from studies on high altitude and pregnancy/birth outcomes. 
Authors 
(years) 
Altitude (m) Lowland 
comparison  
Data Outcome Ancestry Confounders Model Key findings 
Jensen et 
al.(1997)[21] 
USA, Colorado: 
 
3,000 m-3,500m (n=3,836) 
Retrospective 
cohort study: 
Birth certificates 
in 
Colorado(1989-
1991) 
Birthweight(BW) - Gestational weeks, weight 
gain, parity, smoking, 
prenatal care visits, 
Hypertensive 
complications of 
pregnancy  
ANOVA, 𝒙𝟐, 
Stepwise 
regression 
BW declined 102 g for every 
1000-m gain. 
Palmer et 
al.(1999)[22] 
USA, Colorado: 
3,100 
m(Leadville, 
n=93) 
1260m 
(Burlington, 
Colorado,  
n=116) 
Retrospective 
cohort study: 
Hospital records 
BW, Pre-
eclampsia(PE), 
blood pressure 
_ Population matched on 
population size, age, 
economic characteristics) 
Confounders: 
Maternal weight, 
diabetes, age, gravidity, 
previous pregnancy 
complications, smoking, 
parity 
ANOVA, 𝒙𝟐, 
Stepwise 
regression  
BW: 285g lower at 3100m  
PE: 16% (3100 m) vs 3% 
(1260m) 
(OR 3.6, 95% CI:1.1-1.9) 
 
 
Giussani et al. 
(2001)[23] 
Bolivia: 
3,649 m (La Paz, 
Bolivia, 
n=200 :100 each 
from low/high 
income area) 
 
437 m (Santa 
Cruz) 
n=200:100 each 
from low/high 
income area) 
Retrospective 
cohort study: 
Hospital records 
between 1997 and 
1998  
BW, body 
length(Lt), head 
circumference(HC) 
- Stratified by low and high 
income regions 
ANOVA, 
𝒙𝟐, 
The cumulative frequency curve 
across all compiled BW was 
shifted to the left in babies from a 
high altitude compared with those 
in a low altitude, regardless of 
economic status. 
Moore et al. 
(2001)[24] 
The Tibetan Autonomous Region, 
China  
2,700 m- 4,700 m 
n=452   
 
8 hospitals for 18 
months between 
1992- 1993. 
BW, Preterm(PTB), 
prenatal/post-natal  
mortality  
Tibetan 
Han(Chinese)  
 
By parents 
information, 
language, and 
dress 
Maternal age, parity, 
and/or gravity 
ANOVA,  
Linear regression  
At 2,700 -3,000m: 
Tibetan babies weighed more 
than Hans, averaging 310g 95% 
CI: 126-494) heavier  
At 3,000-3,800: 530g (95% CI: 
210-750g). 
Keyes et al. 
(2002)[25] 
Bolivia: 
3,649 m (La Paz, 
Bolivia, n=1,607) 
437 m (Santa 
Cruz, n=813) 
Retrospective 
cohort study: 
Data from the 
national health 
fund (Jan 1998-
April 1998) and 
BW, IUGR,PE 
 and gestational 
hypertension(GH) 
- Parity, maternal age, 
weight at delivery for PE 
and GH analysis 
ANOVA, and 
stepwise logistic 
regression to 
estimate the 
effect of altitude 
on PE or GH. 
BW: 
3084±12g vs 3366 ±18 g 
(p<0.01) 
IUGR: 
16.8%; 95% CI: 14.9-18.6 vs 
5.9%; 95% CI: 4.2-7.5 (p<0.01) 
 288 
 
private clinics(Jan 
1996-April 1998)  
PE and GH: 1.7(95% CI: 1.3-2.3) 
Hartinger et 
al. (2006)[26] 
Peru: 
3,800m (Juliaca, 
n=5,603) & 
3,400m(Cuzco, 
n=3068) & 
3,280m 
(Huancayo, 
n=12,321)) 
150 m (Lima, 
n=63,181) 
Retrospective 
cohort study: 
Peruvian 
Perinatal 
Information 
System (1995-
2002) 
BW Aymara 
(Juliaca), 
Quechua 
(Cuzco), 
Huancayo 
 
By place of 
residence 
Mother’s age, marital 
status, education, parity, 
maternal BMI, smoking, 
PE, hemoorhage during 
pregnancy, gestational 
age, infant’s sex 
ANOVA, 𝒙𝟐, 
Multivariate 
regression  
BW reduction relative to Lima  
Huancayo: 
208g  
Cuzo:170.5g 
Juliaca: 
110.1g 
 
BW reduction may be less severe 
in populations that have resided 
longer at high altitudes 
Julian et al. 
(2007)[27] 
Bolivia: 
3,200-4,100 (La 
Paz or Oruro) 
& 2,500m 
(Cochabamba) 
437 m (Santa 
Cruz) 
Retrospective 
cohort study: 
Hospital records 
in public 
hospitals(Jan 
1996 - May 
1998 ) and public 
clinics(Jan 1996-
May 1999)  
BW, preterm, and 
SGA 
Andean 
(Aymara/ 
Quenchua), 
Mestizo  
European,  
 
By last names 
For BW: gestational age, 
maternal weight at term, 
parity, prenatal visits, 
PE/GH, infant’s sex,  
ANOVA, 𝒙𝟐, 
Logistic 
regression for 
SGA, and linear 
regression for 
BW 
BW: 
Low altitude 
Andean:3328 (29)g, Mestizo: 
3315 (18)g, European: 3215(40)g 
Intermediate: 
High altitude 
Andean:3329 (33)g, Mestizo: 
3325 (22)g, European: 3200(45)g 
High: 
Andean:3122(20) g, Mestizo: 
3119 (13)g, European: 2999(37)g 
SGA: Andean  
SGA: European relative to 
Andean ancestry increased 
frequency of SGA at high altitude 
(OR:4.94, 95% CI 2.35-10.38) 
Wehby et al. 
(2010)[28] 
1,854-3,600m 
(Bolivia, Colombia,  Ecuador, 
n=5803) 
5 -1,280 m 
(Argentina, Brazil, Chile and 
Colombia, n=58,143) 
 
High altitude:1,854-3,600 m  
Low altitude: 5-1,280m 
117 primary 
hospital affiliated 
with the Latin 
American 
Collaborative 
Study of 
Congenital 
Abnormalities 
between 1982 and 
2008 
BW, GA Native, 
African,  
European Latin, 
European non-
Latin, 
Other 
Maternal age, infant’s 
sex, ethnic ancestry, 
characteristics of 
healthcare institution of 
birth , time effects, 
country fixed effects,  
Quintile 
regression  
BW reduction: 270-280g decrease 
in BW mean with moving from 
5m up to 3,600m. 
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Appendix C  
Consent form in Dzongkha 
 
 
  
 
 
སྤྱི་ལ་ོ ༢༠༡༤ དང་ ༢༠༡༥ ལའོྤྱི་ འདྤྱི་དཔྱད་གྲལ་གཏགོས་ཀྤྱི་ཁས་ལནེ་གྤྱི་འབྤྱི་ཤགོ། 
 
འདྤྱི་དཔྱད་ཀྤྱི་ནང་ལུ་གྲལ་ཁར་གཏགོས་མྤྱི་ཚུ་གྤྱིས་ ཁས་ལནེ་གྤྱི་འབྤྱི་ཤགོ་འདྤྱི་ངསོ་ལནེ་འབད་ནྤྱིའྤྱི་དནོ་ལུ་ ཞྤྱིབ་འཚལོ་པ་ཡང་ཅྤྱིན་ འདྤྱི་དཔྱད་ཀྤྱི་ནང་ལུ་གྲལ་ཁར་གཏགོས་མྤྱི་ཚུ་
གྤྱིས་ སྐད་ཡར་སངེ་ས་ེལྷག་དག།ོ 
བརྡ་དནོ་སདོ་ཡདོ་པའྤྱི་ཁས་ལནོ་གྤྱི་འབྤྱི་ཤགོ་འདྤྱི་ལུ་ དུམ་ཚན་ཁག་གཉྤྱིས་ཡདོ། 
• གནས་ཚུལ་གྤྱི་ཤགོ་ལབེ། ༼ཁདོ་ལུ་ ཞྤྱིབ་འཚལོ་འབད་དག་ོཔའྤྱི་སྐརོ་ལས་བཤད་ནྤྱི།༽ 
• འདྤྱི་དཔྱད་ཀྤྱི་ནང་ལུ་གྲལ་ཁར་གཏགོས་ཡདོ་པའྤྱི་ཆྤྱིངས་ཡྤྱིག ༼གལ་སྤྱིད་བཅའ་མར་གཏགོས་ཡདོ་པའྤྱི་བ་ོའདདོ་དང་འཁྤྱིལ་ཏ་ེ ལག་རྟགས་ལནེ་ནྤྱིའྤྱི་དནོ་ལུ།༽ 
ཁདོ་ལུ་ བརྡ་དནོ་སདོ་ཡདོ་པའྤྱི་ཁས་ལནོ་གྤྱི་འབྤྱི་ཤགོ་གྤྱི་ འད་གཅྤྱིག་བྤྱིན་ནྤྱི་ཨྤྱིན། 
 
ཞྤྱིབ་འཇུག་གྤྱི་མྤྱིང་ :འབྲུག་རྒྱལ་ཁབ་ནང་ལུ་ཨ་ལུ་གསར་སེས་ ཟླཝ་མ་ཚང་བ་དང་ལྤྱིད་ཚད་མ་ལངས་པར་སེ་བའྤྱི་རྒྱུ་རེན་ཚུ་འགྱུར་བཅོས་འབད་ཐབས་ཀྤྱི་ཞྤྱིབ་འཇུག། 
 
རྒྱལ་སྤྱིའྤྱི་ཞྤྱིབ་དཔྱད་པ་གཙོ་བོ། མོངྒར་ལུང་ཕོགས་གཙོ་བསེན་སྨན་ཁང་  
ཡུ་ཀ་ཀ་ར་ཟ་ཝ།    ནང་ལས་མཉམ་འབེལ་ཞྤྱིབ་དཔྱད་པ་འགོ་འཛིན། 
མཁས་དབང་སོབ་ཕྲུག ཌོག་ཀོར་ ཏ ཱུལ་སྤྱི་རམ་ཤར་མ་              བྤྱིས་ནད་མཁས་མཆོག། 
ལོན་ཌནོ་འཕོད་བསེན་དང་གསོ་རྤྱིག་གཙུག་ 
ལག་སོབ་སེ།  ཨྤྱིང་ལནེཌ། 
(London School of Hygiene and Tropical Medicine, UK) 
Yuka.karasawa@Ishtm.ac.uk 
 
འགྲུལ་འཕྤྱིན་ཨང་། ༡༧༧༥༠༥༥༥ 
སྐུ་གཟུགས་བཟང་པོ་ལགས། ངེ་གྤྱི་མྤྱིང་་་་་་ ཟེར་སབ་ཨྤྱིན། 
ད་རེས་ ཨྤྱིང་ལེནཌ་རྒྱལ་ཁབ་ནང་གྤྱི་ལནོ་ཌནོ་འཕོད་བསེན་དང་གསོ་རྤྱིག་གཙུག་ལག་སོབ་སེ་ གྤྱིས་འགོ་འདེན་འཐབ་ཡོད་པའྤྱི་ ཞྤྱིབ་འཇུག་འདྤྱི་ནང་ལུ་ རྒྱལ་སྤྱིའྤྱི་ཞྤྱིབ་དཔྱད་པ་
གཙོ་བོ། ཡུ་ཀ་ཀ་ར་ཟ་ཝ། མ་ོར་དང་ མོང་སྒར་ ཤར་་ཕོགས་གཙོ་བསེན་སྨན་ཁང་ནང་ལས་མཉམ་འབེལ་ཞྤྱིབ་དཔྱད་པ་འགོ་འཛིན། བྤྱིས་ནད་མཁས་མཆོག་ ཌོག་ཀོར་ཏ ཱུལ་སྤྱི་རམ་
ཤར་མ། ཨྤྱིན་ཟེར་ཞུ་ནྤྱི་ཨྤྱིན།ཡུ་ཀ་ཀ་ར་ཟ་ཝ། མ་ོར་ ཨྤྱིང་ལེནཌ་རྒྱལ་ཁབ་ནང་ལུ་ཡདོ་པའྤྱི་ ལོན་ཌོན་འཕོད་བསེན་དང་གསོ་རྤྱིག་གཙུག་ལག་སོབ་སེ་ ནང་ལུ་མཁས་དབང་གྤྱི་ཤེས་
ཚད་སྦྱང་མྤྱི་སོབ་ཕྲུག་གཅྤྱིག་ཨྤྱིནམ་མ་ཚད་ ད་ལོ་ ང་བཅས་འབྲུག་རྒྱལ་ཁབ་ཀྤྱི་གསོ་བ་དང་མཚན་རྤྱིག་གཙུག་ལག་སོབ་སེའྤྱི་ནང་ལུ་ ཞྤྱིབ་འཚལོ་གྤྱི་འཐུས་མྤྱི་སེ་ གནས་སྐབས་ཅྤྱིག་
གྤྱི་དོན་ལུ་འངོ་ཡོདཔ་ཨྤྱིན། ང་བཅས་ཚུ་གྤྱིས་ ཞྤྱིབ་འཇུག་འབད་མྤྱི་འདྤྱི་གཙོ་བོ་རང་ མྤྱི་དམང་ག་ར་ལུ་ཕན་ཐབས་ལུ་དམྤྱིགས་ཏེ་ ཨ་ལུ་གསར་སེས་གནད་དོན་ག་ཅྤྱི་ལས་བརྟེན་ཏེ་ 
ཟླཝ་མ་ཚང་པར་དང་དེ་ལས་ ལྤྱིད་ཚད་ཡང་ཉུངམ་འབད་སེཝ་ཨྤྱིན་ན་ཤེས་ནྤྱིའྤྱི་དོན་ལུ་དང་ ཤུལ་ལས་ང་བཅས་ཚུ་གྤྱིས་ ཨ་ལུ་གསར་སེས་ཚུ་ལུ་དེ་བཟུམ་ མྤྱི་འབྱུང་ནྤྱི་དང་རེན་
ངན་བཀག་ཐབས་འབད་ནྤྱིའྤྱི་དོན་ལུ་ཨྤྱིན། ཞྤྱིབ་འཇུག་འདྤྱི་ ཐྤྱིམ་ཕུག་ལུ་ཡོད་པའྤྱི་འཇྤྱིགས་མདེ་རྡོ་རེ་དབང་ཕྱུག་རྒྱལ་ཡོངས་གཙོ་བསེན་སྨན་ཁང་དང་ དེ་ལས་མངོ་སྒར་དང་དགེ་
ལེགས་ཕུ་གཙོ་རྟེན་སྨན་ཁང་ནང་ལུ་འབད་ འབྲུག་མྤྱི་ཨམ་སྲུ་ཚུ་དང་མཉམ་འབེལ་འབད་ད་ེའགོ་འདནེ་འཐབ་ནྤྱི་ཨྤྱིན། ཞྤྱིབ་འཇུག་གྤྱི་སྐབས་ལུ་ ལོ་ན་ཆུང་ཀུ་དང་དུས་ཚོད་མ་
རནམ་ལས་ཨ་ལུ་སེས་མྤྱི་ཨ་ལུ་ཨའྤྱི་དང་ ན་ཚདོ་ཚད་ལྡན་གྤྱི་ཨམ་སྲུ་ཚུ་ལུ་འདྤྱི་དཔྱད་འབད་ནྤྱི་ཨྤྱིནམ་ལས་ ཁདོ་ཀྤྱིས་ ང་ེགྤྱི་ཞྤྱིབ་འཇུག་ནང་ལུ་བཅའ་མར་གཏོགས་གནང་ཟེར་
གསོལ་འདེབས་ཞུ་ནྤྱི་ཨྤྱིན། 
འདྤྱི་བ་དྤྱིས་ལན་གྤྱི་སྐབས་ལུ་ སྤྱིར་བཏང་ཁོད་རའྤྱི་གཟུགས་ཁམས་འཕོད་རྟེན་གྤྱི་སྐོར་ལས་དང་ ཨ་ལུ་ཆགས་པའྤྱི་སྐབས་ཀྤྱི་གནས་སངས། དེ་ལས་ ཁོད་རའྤྱི་བ་བ་སོད་ལམ་དང་
བཞེས་སྒོ་གྤྱི་སྐོར་ལས་དྤྱིས་ནྤྱི་ཨྤྱིན། ག་དེམ་ཅྤྱིག་འབད་དགོས་མཁོ་དང་བསྟུན་ཏེ་ ཁོད་རའྤྱི་བོ་འདོད་དང་འཁྤྱིལ་ཏ་ེ ཁོད་ལུ་གསོ་བའྤྱི་སྨན་བཅོས་ཀྤྱི་ཡྤྱིག་ཆ་ཡང་བལ་ནྤྱི་ཨྤྱིན།ག་
ལས་བསོྒར་རུང་ འདྤྱི་བ་དྤྱིས་ལན་གྤྱི་དུས་ཡུན་སྐར་མ་ ༣༠ དང་ ཆུ་ཚོད་ ༡ ནེ་ཅྤྱིག་ བསོྒར་བའྤྱི་འདྤྱི་བ་བཟོ་ཡོདཔ་ཨྤྱིན། གལ་སྤྱིད་ ཁདོ་ལུ་དྤྱིས་བའྤྱི་ལན་སབ་ནྤྱིའྤྱི་རེ་འདོད་མེད་
པ་ཅྤྱིན་ ཕང་སེ་གསུངས་དགོཔ་དང་ཁདོ་རའྤྱི་བོ་འདོད་ལར་དུ་ འདྤྱི་བ་གཞན་མྤྱི་བཀདོ་ནྤྱི་དང་ ཡང་ཅྤྱིན་ ནེམ་ཅྤྱིག་འབད་འཚམས་འཇགོ་འབད་བཞག་ནྤྱི་ཨྤྱིན། ཁདེ་ཚུ་ལས་ བསྡུ་
ལེན་འབད་ཡདོ་པའྤྱི་གནས་ཚུལ་ཚུ་ཆ་མཉམ་ གསང་བའྤྱི་ཐོག་ལུ་བཞག་ནྤྱི་ཨྤྱིན་རུང་ ལ་ཱའགན་དང་འབེལ་བ་ཡོད་པའྤྱི་སྨན་ཁང་གྤྱི་ལས་བེདཔ་རེ་གཉྤྱིས་ཀྤྱིས་མ་གཏོགས་ གཞན་
གྤྱིས་གནས་ཚུལ་འཐོབ་ཐབས་མདེ། ཞྤྱིབ་འཇུག་འདྤྱི་གྤྱི་སྙན་ཞུ་ཚུ་བསྡུ་གྲུབ་འབད་ཞྤྱིནམ་ལས་ ང་རའྤྱི་མཁས་འབད་སོབ་སྦྱོང་གྤྱི་ ལས་འགུལ་སྙན་ཞུ་འབད་བྤྱིས་ནྤྱི་དང་ གསོ་བའྤྱི་
ལྷན་ཁག་ལུ་ཡང་གནས་ཚུལ་སེ་ཕུལ་ནྤྱི་ཨྤྱིན། སྙན་ཞུ་ཕུལ་བའྤྱི་སྐབས་སུ་ ཁེད་ཚུ་གྤྱིས་སབ་པའྤྱི་ཚིག་ཚུ་བཙུགས་ནྤྱི་ཨྤྱིན་རུང་ ཁེད་ཚུ་གྤྱི་མྤྱིང་དང་ངོ་རྟགས་ཚུ་ གསང་སེ་བཞག་ནྤྱི་
ཨྤྱིན་ཟེར་ཞུ་ནྤྱི་ཨྤྱིན། 
ཞྤྱིབ་འཇུག་འདྤྱི་ནང་ནང་ལུ་བཅའ་མར་གཏོགས་ནྤྱི་འདྤྱི་ ཁས་བངས་ཀྤྱི་ཐོག་ལུ་ཨྤྱིནམ་མ་ཚད་ འདྤྱི་དཔྱད་ཀྤྱི་གལ་ཁར་བཅའ་མར་གཏོགས་མྤྱི་གཏོགས་འདྤྱི་ཁདོ་རའྤྱི་བོ་འདདོ་
ལར་དུ་ཨྤྱིན། ཁདེ་ཚུ་གྤྱིས་ཞྤྱིབ་འཇུག་འདྤྱི་ནང་ལུ་བཅའ་མར་གཏོགས་མྤྱི་འདྤྱི་གྤྱིས་ འབྲུག་རྒྱལ་ཁབ་ཀྤྱི་མ་འོངས་པའྤྱི་ཨམ་སྲུ་ཚུ་ལུ་ ཨ་ལུ་གསར་སེས་ཟླཝ་མ་ཚང་བ་དང་ལྤྱིད་ཚད་
ཉུང་སུ་སེས་མྤྱི་གྤྱི་གནས་སངས་ ཡར་དགས་བཏང་ཚུགས་ནྤྱི་ལུ་ཁེ་ཕན་སོམ་ཡོདཔ་ཨྤྱིནམ་ལས་ ཞྤྱིབ་འཇུག་འདྤྱི་ ཨྤྱིང་ལེནཌ་རྒྱལ་ཁབ་ནང་གྤྱི་ལནོ་ཌོན་འཕོད་བསེན་དང་གསོ་རྤྱིག་
གཙུག་ལག་སོབ་སེ་དང་ འབྲུག་གཞུང་གསོ་བའྤྱི་ལྷན་ཁག་གྤྱིས་ཆ་འཇགོ་འབད་ཡདོཔ་ཨྤྱིན་ཟེར་ཞུ་ཨྤྱིན།། 
 
  
  
 
འདྤྱི་དཔྱད་ཀྤྱི་ནང་ལུ་གྲལ་ཁར་གཏགོས་ཡདོ་པའྤྱི་ཆྤྱིངས་ཡྤྱིག 
 
ཞྤྱིབ་འཇུག་གྤྱི་མྤྱིང་ :འབྲུག་རྒྱལ་ཁབ་ནང་ལུ་ཨ་ལུ་གསར་སེས་ ཟླཝ་མ་ཚང་བ་དང་ལྤྱིད་ཚད་མ་ལངས་པར་སེ་བའྤྱི་རྒྱུ་རེན་ཚུ་འགྱུར་བཅོས་འབད་ཐབས་ཀྤྱི་ཞྤྱིབ་འཇུག། 
 
ཕན་རང་གྤྱིས་ཞྤྱིབ་འཇུག་དེ་གྤྱི་སྐོར་ལས་བརྡ་དནོ་ཚུ་ལྷག་ཡོདཔ་ཨྤྱིནམ་དང་ ཡང་ཅྤྱིན་ ང་ལུ་ལྷག་སེ་བྤྱིན་ཡོདཔ་ཨྤྱིན། རང་ལུ་ཞྤྱིབ་འཇུག་དེ་གྤྱི་འདྤྱི་བའྤྱི་ལན་སབ་ནྤྱིའྤྱི་གོ་སྐབས་
ཐོབ་ཡོདཔ་མ་ཚད་ ལན་ཚུ་ཡང་ངལ་རང་གྤྱི་ཐགོ་ལས་སབ་ཅྤྱི། དེ་འབདཝ་ལས་ ཕན་ཡང་གྤྱི་ཁ་ཐུག་ལས་ འབྲུག་རྒྱལ་ཁབ་ཀྤྱི་གཙོ་བསེན་སྨན་ཁང་དང་ ཡང་ཅྤྱིན་ ལནོ་ཌོན་འཕོད་
བསེན་དང་གསོ་རྤྱིག་གཙུག་ལག་སོབ་སེའྤྱི་འགན་འཁྤྱི་ཅན་དང་འབེལ་ཡདོ་ཀྤྱི་ལས་བེད་པ་ཚུ་གྤྱིས་ རང་གྤྱི་གསོ་བའྤྱི་སྨན་བཅོས་ཀྤྱི་ཡྤྱིག་ཆའྤྱི་རྤྱིགས་ཚུ་ གཟྤྱིགས་ཆགོ་པའྤྱི་གནང་བ་
བྤྱིན་ཡོདཔ་ཨྤྱིནམ་མ་ཚད་ རང་གྤྱིས་སབ་པའྤྱི་གཏམ་ལོ་རྒྱུས་ཚུ་ཡང་ ཞྤྱིབ་འཇུག་གྤྱི་སྙན་ཞུ་དང་དཔེ་དེབ་ནང་ལུ་བཙུགས་ཆགོ་ནྤྱི་ཨྤྱིན། ཞྤྱིབ་འཇུག་དེ་ནང་ལུ་ ཁས་བངས་ཀྤྱི་ཐོག་
ལས་རང་གྤྱིས་བཅའ་མར་གཏགོས་ཡོདཔ་ཨྤྱིན། 
 
 
བཅའ་མར་གཏོགས་མྤྱིའྤྱི་མྤྱིང་གསལ།   ལག་རྟགས།  སྤྱི་ཚེས།(སྤྱིྤྱི་ཚེས་/སྤྱི་ཟླ་/སྤྱི་ལོ།) 
 
གལ་སྤྱིད་ག་དེམ་ཅྤྱིག་འབད་ བཅར་མར་གཏོགས་མྤྱི་གྤྱིས་ལག་རྟགས་རབ་མ་ཤེས་པ་ཅྤྱིན་ དཔང་པོ་ཤེས་ཡོན་ཅན་གཅྤྱིག་གྤྱིས་རབ་དག།ོ ༼ རབ་བྱུང་པ་ཅྤྱིན་ དཔང་པོ་དེ་བཅའ་
མར་གཏོགས་མྤྱི་གྤྱིས་གདམས་དགོཔ་མ་ཚད་ ཞྤྱིབ་འཇུག་འབད་མྤྱི་ཚུ་དང་འབེལ་བ་མདེཔ་དགཔོ་ཨྤྱིན།༽ བཅའ་མར་གཏོགས་མྤྱི་འདྤྱི་ ཤེས་ཡནོ་མ་བལ་མྤྱི་ཨྤྱིན་པ་ཅྤྱིན་ མོ་གྤྱིས་
ལག་རེས་ཡང་བཀོད་དགོ། 
 
དཔང་པོའྤྱི་མྤྱིང་གསལ།   ལག་རྟགས།   སྤྱི་ཚེས། (སྤྱིྤྱི་ཚེས་/སྤྱི་ཟླ་/སྤྱི་ལོ།) 
 
བཅའ་མར་གཏོགས་མྤྱིའྤྱི་ལག་རྟགས། 
 
 
 
 
 
 
 
 
ཁས་ལནེ་ཅན་བཅའ་མར་གཏགོས་མྤྱི་དང་ ཡང་ཅྤྱིན་ ཞྤྱིབ་འཚལོ་པའྤྱི་ངག་བརདོ། 
 
ཞྤྱིབ་འཚོལ་པ་རང་གྤྱིས་འོས་འབབ་ཅན་གྤྱི་བཅའ་མར་གཏོགས་མྤྱི་ལུ་ ཏན་ཏན་འབད་ལྷག་བྤྱིན་ཡོདཔ་མ་ཚད་ རང་གྤྱི་ཁ་ཐུག་ལས་ བཅའ་མར་གཏོགས་མྤྱི་ལུ་གཤམ་གསལ་འཁདོ་
དེ་ཡོད་པའྤྱི་ འབད་དགོཔ་བཅའ་དགོཔ་ཚུ་གྤྱི་སྐརོ་ལས་ ཅྤྱི་ཤེས་གང་ལོགས་གྤྱི་སྒོ་ལས་ མ་བཏུབ་བཏུབ་འབད་བཤད་བྤྱིན་ཡོདཔ་ཨྤྱིན། 
༡་ གནད་བསྡུད་ཚུ་ མཁས་དབང་སོབ་སྦྱོང་གྤྱི་ལས་འགུལ་སྙན་ཞུའྤྱི་དོན་ལུ་ལག་ལེན་འཐབ་ནྤྱི་དང་ ལྷན་ཁག་གྤྱི་སྙན་ཞུའྤྱི་དོན་ལུ་ཡང་ལག་ལེན་འཐབ་ནྤྱི། 
༢་ གསོ་བའྤྱི་སོྨན་བཅོས་ཀྤྱི་ཡྤྱིག་ཆ་དང་འབེལ་བའྤྱི་གནས་ཚུལ་དང་ གནད་བསྡུས་ཚུ་ཆ་མཉམ་ འབྲུག་རྒྱལ་ཁབ་ཀྤྱི་གཙོ་བསེན་སྨན་ཁང་དང་ ཡང་ཅྤྱིན་ ལོན་ཌོན་
འཕོད་བསེན་དང་གསོ་རྤྱིག་གཙུག་ལག་སོབ་སེའྤྱི་འགན་འཁྤྱི་ཅན་དང་འབེལ་ཡོད་ཀྤྱི་ལས་བེད་རངམ་གཅྤྱིག་གྤྱིས་བལ་ནྤྱི། 
༣་ བཅའ་མར་གཏོགས་མྤྱི་གྤྱིས་སབ་པའྤྱི་གཏམ་ལ་ོརྒྱུས་ཚུ་ ཞྤྱིབ་འཇུག་གྤྱི་སྙན་ཞུ་དང་དཔེ་དེབ་ནང་ལུ་བཙུགས་ནྤྱི། 
ཕན་རང་གྤྱིས་ ཞྤྱིབ་འཇུག་འདྤྱི་གྤྱི་སྐོར་ལས་འདྤྱི་བ་ཚུ་དྤྱིས་ཆགོ་པའྤྱི་ ག་ོསྐབས་ཚུ་བཅའ་མར་གཏོགས་མྤྱི་ལུ་བྤྱིན་ཡོདཔ་མ་ཚད་ བཅའ་མར་གཏོགས་མྤྱི་ཚུ་གྤྱིས་དྤྱིས་པའྤྱི་ ལན་
གསལ་ཚུ་ཡང་རང་གྤྱིས་ཅྤྱི་ཤེས་གང་ལོགས་ཀྤྱི་སྒོ་ལས་ ནོར་འཁྲུལ་མདེ་པར་སབ་ཡོདཔ་ཨྤྱིན། ང་གྤྱིས་ འདྤྱི་བ་དྤྱིས་ལན་འབད་མྤྱི་ལུ་ ཞྤྱིབ་འཇུག་འདྤྱིའྤྱི་བརྡ་དོན་ག་ནྤྱི་ཡང་མ་
བཤད་པར་ འདྤྱི་དཔྱད་མ་འབདཝ་མ་ཚད་འདྤྱི་དཔྱད་འདྤྱི་ནང་ལུ་གྲལ་གཏགོས་འབད་མྤྱི་ཚུ་ལུ་བརྡ་དོན་དང་ དེའྤྱི་ནང་ལུ་གྲལ་གཏགོས་འབད་ནྤྱི་འདྤྱི་ རང་སོའྤྱི་བོ་འདོད་དང་
ཁས་བངས་ཀྤྱི་ཐོག་ལུ་ཨྤྱིན་ཟེར་སབ་ཅྤྱི། དེ་གྤྱི་དནོ་ལུ་ བརྡ་དནོ་སདོ་ཡདོ་པའྤྱི་ཁས་ལནོ་གྤྱི་འབྤྱི་ཤགོ་ འདྤྱི་ བཅའ་མར་གཏོགས་མུ་ཚུ་ལུ་ཕུལ་ཡདོཔ་ཨྤྱིན། 
 
 
 
ཞྤྱིབ་འཚོལ་པ། ཡང་ན་  ཞྤྱིབ་འཚོལ་པ། ཡང་ན་  སྤྱི་ཚེས། (སྤྱིྤྱི་ཚེས་/སྤྱི་ཟླ་/སྤྱི་ལོ།) 
ཁས་ལེན་ཡྤྱིག་ཆ་ལེན་མྤྱིའྤྱི་མྤྱིང་གསལ། ཁས་ལེན་ཡྤྱིག་ཆ་ལེན་མྤྱིའྤྱི་ལག་རྟགས །    
 
 
  
 
Appendix D  
Consent form in English 
 
  
 
Interview Participant Consent Form 2014-2015 
 
This form may be read by the participant or read out loud to the participant by the researcher to 
gain written consent.  
This Informed Consent Form has two parts:  
• Information Sheet (to share information about the research with you)  
• Interview Participant’s Agreement(for signatures if you agree to take part)  
You will be given a copy of the full Informed Consent Form. 
Study Title: Exploring modifiable risk factors of low birth weight and preterm birth in Bhutan 
Foreign Principal Investigator:   
Yuka Karasawa  
PhD Candidate 
London School of Hygiene and Tropical 
Medicine, UK 
Yuka.karasawa@lshtm.ac.uk 
Tel: XXXXXXXXX 
Lead co-investigator at JDWNRH:  
Dr. Phurb Dorji 
Head of Department of Obs & Gyne 
JDW National Referral Hospital 
 
 
 
Hello, my name is ……….I am a part of a research team that is carrying out a study by London School of 
Hygiene and Tropical Medicine and Ministry of Health, JDWNRH, CRRH, ERRH, and University of 
Medical Sciences of Bhutan. The principal investigators are Ms. Yuka Karasawa and Dr. Phurb Dorji is 
the lead co-investigator at JDWNRH. Ms. Yuka Karasawa is a student at London School of Hygiene and 
Tropical Medicine, UK and research fellow with University of Medical Sciences of Bhutan. She is 
conducting interviews for her PhD with members of the research team. We are doing research to 
understand why some babies are born too early or very small and to see if we can find ways of 
preventing low birth weight and preterm birth in the future for everyone’s benefit. This study will be 
conducted at JigmeDorji National Wangchuck Referral Hospital and the two referral hospitals in 
Mongar and Gelephu, in collaboration with Bhutanese partners. Both the mothers of new born babies 
who are born too early or very small andthe mothers of normal weight babies will be interviewed. I 
would like to ask your permission for you to participate in a research study. 
During this study, you will be asked to answer some questions about your general health and 
pregnancy, including your habits and diet. We would like to access your medical records if necessary 
with your permission. The interview was designed to be between 30and 60 minutes, depending on the 
number of questions we ask you. If there are questions you would rather not answer or that you do 
not feel comfortable answering, please say so and we will stop the interview or move on to the next 
question, whichever you prefer. 
All the information will be kept confidential. The data will be stored securely. Only a few trained staff 
who are closely concerned with the research will have access to the information. The results of the 
study will be written up in a PhD dissertation and in a report submitted to the Ministry of Health.  Your 
quotes may be used in the final reports. In such case your name and identity will be kept out of these 
reports, and your participation will be anonymous. 
All participation in this study is voluntary. You are free to decide if you want to take part or not.  If you 
do agree you can change your mind at any time.  Choosing not to take part will not disadvantage you 
in any way.There are no individual benefits to taking part, but in answering our questions you will help 
us improve our understanding of preterm birth and low birth weight for the benefit of all Bhutanesein 
the future.  The study is approved by London School of Hygiene and Tropical Medicine and Royal 
Government of Bhutan.  
  
 
 
Interview Participant’s Agreement: 
Study Title: Exploring modifiable risk factors of low birth weight and preterm birth in Bhutan 
I have read the foregoing information, or it has been read to me. I have had the opportunity to ask 
questions about it and any questions I have been asked have been answered to my satisfaction. I give 
permission for responsible individuals from the London School of Hygiene & Tropical Medicine, from 
regulatory authorities or from this hospital, to access my medical records, where it is relevant to my 
taking part in this research.I agree for my quote to be used in the publication or report released on the 
study.I consent voluntarily to be a participant in this study. 
 
If the participant is unable to sign, a literate witness must sign (if possible, this person should be 
selected by the participant and should have no connection to the research team). Participants who 
are illiterate should include their thumb print as well.  
I have witnessed the accurate reading of the consent form to the potential participant, and the 
individual has had the opportunity to ask questions. I confirm that the individual has given consent 
freely. 
 
And  
Thumb print of participant 
 
 
Statement by the researcher/person taking consent  
I have accurately read out the information sheet to the potential participant, and to the best of my 
ability made sure that the participant understands that the following will be done:  
1. The data will be used in a Final Report and a PhD dissertation.  
2. Sections of the medical notes and data collected during the study may be looked at by responsible 
individuals from the London School of Hygiene & Tropical Medicine, from regulatory authorities or 
from this hospital.   
3. The participant’squote may be used in the publication or report released on the study. I confirm 
that the participant was given an opportunity to ask questions about the study, and all the questions 
asked by the participant have been answered correctly and to the best of my ability. I confirm that 
the individual has not been coerced into giving consent, and the consent has been given freely and 
voluntarily.  A copy of this ICF has been provided to the participant.  
Print Name of Participant  Signature of Participant  Date               
(Day/month/year) 
 
Print Name of Witness  Signature of Witness  Date               
(Day/month/year) 
 
Print Name of 
Researcher/person taking the 
consent 
 Signature of Researcher 
/person taking the consent 
 Date               
(Day/month/year) 
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Appendix E  
Check-list during the pilot study 
 
For Pilot Study Only 
Please ask the mothers the following questions. 
(1) How was the length of the questionnaire? 
0 – Too long  1 – OK 2 – Too short 
 
(2) Are any of the words ambiguous or difficult to 
understand?  
0 – No  
1 – Yes (please specify the question numbers) 
 
(3) Were there any questions where the options you 
want were not available?  
0 – No  
1 – Yes (please specify the question numbers) 
 
 
For the research nurses: 
(1) How long did the interview take?  Hours  Minutes 
 
(2) Are any of the questions particularly difficult or 
sensitive? 
0 – No  
1 – Yes (please specify the question numbers) 
 
(3) Are the questions misinterpreted by the mothers? 
Are any of the words ambiguous or difficult to 
understand? 
0 – No  
1 – Yes (please specify the question numbers) 
 
(4) Does the questionnaire flow smoothly? Can the 
interviewers follow the instructions easily? Doe the 
interviewers misinterpret the questions? 
0 – No 1 – Yes (please specify the question 
numbers) 
 
(5) Is there adequate space on the form and the 
answers clearly coded? 
0 – No  
1 – Yes (please specify the question numbers) 
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Medical records 
Instructions for interviewers: For questions 7 – 55, please transcribe from the medical records. Please refer to the MCH handbook 
p2, 3, 4, 5, 6, 8, 12 and Immediate post partum record and maternity history sheet. If anything is not clear, please confirm with the 
mothers. 
8. Labor: spontaneous or induced 
        0-     Spontaneous 
1- Induced  
2- Others (Specify) 
9- Unknown 
 
9. Preterm Premature rupture of membranes (PPROM): 
        0-     No 
1- Yes 
        9-     Unknown 
 
10. MCH Reg. No (MCH p2)  
11. Full name of the mother (MCH p2):  
12. Date of birth of the mother (MCH p2) Date   
  
 If not known, write 98) 
Month  
  
(If not know, write 9998) 
Year 
    
(If not known, write 9998) 
General Information 
Instructions for interviewers:  Please write the number in the right column unless otherwise specified. 
1. Hospital 
1- JDWNRH (Birthing Center)     3-    Gelephu 
2- JDWNRH (Maternity Ward)   4-    Mongar 
 
2. Start  of the interview  
(Time & DD/MM/YYYY) 
        
D D M M Y Y Y Y 
Time:          :              (am /  pm) 
 
 
3. Name of the interviewer  
4. Study participant number:  
5. Interview language: 
 
 
 
 
 
6. Citizenship ID No.  
7. When admitted to the hospital?(DD/MM/YYYY)         
D D M M Y Y Y Y 
 
1 – English 
2 – Dzongkha 
3 – Sharchhop 
4 - Lhotsham 
5 – Bumtap 
6  –Khengkha 
7 – Others (please specify) 
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13. Age (in completed years): 
Probe: How old were you at your last birthday? 
  
 
 
 
 
 
 
14. Permanent address (MCH p3): 
Village 
 
Gewog/Town Name 
Village 
 
Gewog/Town Name 
 
 
15. Permanent address (MCH p3): Dzongkhag 
 
 
16. What is the highest education level you finished? (MCH 
p3) 
0 - Never attended school  
1 - Primary  
2 - Secondary 
3 – Graduate 
4 – NFE 
5 –Other(specify) 
6 – DON’T KNOW 
 
17.  Mobile or home phone numbers if available (MCH p3) 
 
18. Current address(MCH p3): 
Village 
 
Gewog/Town Name 
Village 
 
Gewog/Town Name 
 
 
19. Currentaddress(MCH p3): Dzongkhag 
 
 
11- Bumthang 
12 - Chukha 
13 – Dagana 
14 - Gasa 
15 – Haa 
16 – Lhuntse 
17 – Monggar 
18 – Paro 
19 – Pemagatshel 
20 – Punakha 
 
21 – SamdrupJongkhar 
22 – Samtse 
23 – Sarpang 
24 – Thimphu 
25 – Trashigang 
26 - Trashiyangtse 
27 – Trongsa 
28 – Tsirang 
29 – Wangdue 
30 - Zhemgang 
 
11- Bumthang 
12 - Chukha 
13 – Dagana 
14 - Gasa 
15 – Haa 
16 – Lhuntse 
17 – Monggar 
18 – Paro 
19 – Pemagatshel 
20 – Punakha 
21 – SamdrupJongkhar 
22 – Samtse 
23 – Sarpang 
24 – Thimphu 
25 – Trashigang 
26 - Trashiyangtse 
27 – Trongsa 
28 – Tsirang 
29 – Wangdue 
30 - Zhemgang 
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20. If currently/formerly married/living with a partner: What 
was the highest level of school your husband/partner 
attended: primary, secondary, or higher (MCH p4)? 
0 - Never attended school  
1 - Primary  
2 - Secondary 
3 – Graduate 
4 – NFE 
5 – Other (specify) 
6 – Don't know 
 
21.  ANC Initial General Examination (MCH p4) 
 
Record if available. 
If unknown, please write 9999. 
 
BP    
Height (cm)  
Weight (kg)  
 
22. Medical History (MCH p4): 
(Please tick “yes” or “no” for each line.) 
 
 
 
 
 
No   Yes    
☐  ☐   Diastolic BP over 90 
☐  ☐   Pelvic mass 
☐  ☐   Suspected STI/RTI 
☐  ☐   Vaginal bleeding  
☐  ☐   Cardiac disease 
☐  ☐   Hypertension 
☐  ☐   Thyroid Disease 
☐  ☐   Family history of twins 
☐  ☐   Family history of congenital defects 
☐  ☐   Known “substance “ abuse 
☐  ☐   Diabetes 
☐  ☐   Hepatitis 
☐  ☐   Tuberculosis 
☐  ☐   Blood Transfusion 
☐  ☐   Renal Disease 
☐  ☐   Other severe medical disease(list) 
23. Past Obstetric History(MCH p4) 
(Please tick “yes” or “no” for each line.) 
 
No   Yes 
☐  ☐   Previous still birth or neonate loss 
☐  ☐   History of 3 or more consecutive spontaneous abortions 
☐  ☐   Birth weight of last baby less than 2500 grams 
☐  ☐   Birth weight of last baby more than 4500 grams 
☐  ☐   Last pregnancy: admission for hypertension, pre-
eclampsia, or eclampsia 
24. List any medicine(MCH p4) 
☐ Tick if NONE 
☐ Tick if not available 
Regular medications(eg. for asthma) 
(                                                                                                                  ) 
 
Medication started during pregnancy (eg. for high blood pressure 
or antibiotics for infections)  
(                                                                                                                  ) 
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25. List any allergies (MCH p4)   
☐ Tick if NONE 
☐ Tick if not available 
 
26. Investigations(MCH p5)i 
Primary Test Date(DD/MM/YY) Results 
VDRL or RPR   
HBsAG   
HIV   
TPHA   
FBS   
OGTT   
PPBS   
 
27. Was gestational age estimated based on clinical 
assessment in the late stage of pregnancy due to lack of the 
first date of last menstrual period and USG scans? 
        0-     No 
1- Yes 
        9-     Unknown 
 
28. First date of Last Menstrual Period(MCH p6) 
☐   Tick if not available  
(comments if any:                                                            ) 
        
D D M M Y Y Y Y 
29. Estimated Date of Delivery (EDD) (MCH p6) 
 
        
D D M M Y Y Y Y 
30. EDD by 1st USG Scan(MCH p6) 
 
        
D D M M Y Y Y Y 
31. Date of 1st USG scan(MCH p6) 
 
        
D D M M Y Y Y Y 
32. POG at 1st scan (wks and days) (MCH p6) 
 
Wks                             Days 
33. Gravida (The woman’s total number of pregnancies, 
including the present pregnancy) (MCH p6) 
 
34. Para(The woman’s total number of deliveries taken place 
whether alive or dead) (MCH p6) 
 
35. Abortion (MCH p6)  
36. Living (number of children alive) (MCH p6)  
37. Dead (number of children dead) (MCH p6) 
 
Version 2.0  
15 December 2014 
 
 303 
38. When was last time you became pregnant before this 
pregnancy? 
☐   Tick if not available 
 
Year 
 
 
Month  
    
Y Y Y Y 
   
M M  
39. Did you attend antenatal care at least once during this 
pregnancy? 
0 – No      1 –Yes     9999 - Unknown 
 
40. How many times did you receive antenatal care during this 
pregnancy? (If unknown, please write 9999.) 
 
41. During your pregnancy, was your blood pressure 
measured at least once? 
0 – No    1 –Yes         9999 - Unknown 
 
42. Please check page 8 of MCH book and record BP and Urine 
(ALB) for Pregnancy Induced Hypertension. 
 
 Date 
(DD/MM/YYYY) 
Urine (Alb) Wt BP 
1     
2     
3     
4     
5     
6     
7     
8     
9     
10     
11     
43. Any records for  
Pre-eclampsia, Gestational hypertension, and eclampsia? 
 
No       Yes    Unknown 
☐  ☐     ☐    Pre-ecplamsia? 
☐  ☐     ☐    Gestational Hypertension? 
☐  ☐     ☐    Eclampsia? 
44.  Any records for urinary tract infection? 
0 – No   1 – Yes    9999 – None recorded 
 
45. Please check White Blood Cell count (WBCs) in urine from 
the urine test. Is WBCs >5-10? 
0 – No   1 – Yes     9999 – None recorded 
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46. Any records for diabetes?[ Interviewers tick “Yes” if 
mothers were diagnosed with diabetes in the ANC or medical 
records] 
0 – No   1 – Yes    9999 - None recorded 
 
47. Any records for anemia?[Interviewers tick “Yes” if 
mother’s haemoglobin level in the MCH book and medical 
records was less than 10 g/dL] 
0 – No   1 – Yes     9999 - None recorded 
 
48. Has the mother taken antenatal corticosteroids? 
0 – No   1 – Yes    9999 - None recorded 
 
49. Has the mother taken tocolysis? 
0 – No   1 – Yes    9999 - None recorded 
 
50. Has the mother taken any antibiotics? 
0 – No   1 – Yes    9999 - None recorded 
 
51. Delivery date and time? (MCH p12) 
 
Time                         :               am/pm 
 
        
D D M M Y Y Y Y 
52. Mode of delivery(MCH p12) 
        1-     SVD 
2- CS-Elective 
3- CS-Emerg. 
4- Vacuum 
5- Forceps 
6- Breech 
9999 - Unknown 
 
53. Sex of an infant (MCH p12) 
0 – Male    1-Female    9- Ambiguous 
 
54. Birth weight of an infant (grams) (MCH p12) 
 
grams 
55. Period of gestational age (POG) (wks) (MCH p12) 
 
Wks                             Days 
 
Questions to the mothers 
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56. Did you have any of these symptoms during 
pregnancy before delivery? 
 [a] Constant feeling of needing to urinate, even after 
having just urinated 
[b] Pain or burning while urinating, or straight 
afterwards 
[c] Pain in the lower belly, behind the front of the pelvis. 
[d] Cloudy or bloody urine 
[e] Fever, feeling very hot and sweating 
[f] Feeling very sick or weak 
[g] Flank pain (in one or both sides) 
[h] Repeated vomiting requiring medical treatment 
[i] Chills, rigors or shivering persistently 
[j] Having a rash. 
 
No     Yes   Unknown 
               [a] Constant feeling of needing to urinate, even               
after having just urinated 
               [b] Pain or burning while urinating, or straight 
afterwards 
               [c] Pain in the lower belly, behind the front of the 
pelvis. 
                [d] Cloudy or bloody urine 
                [e] Fever, feeling very hot and sweating 
                [f] Feeling very sick or weak 
                [g] Flank pain (in one or both sides) 
                [h] Repeated vomiting requiring medical treatment 
                [i] Chills, rigors or shivering persistently 
                [j] Having a rash. 
57. During your pregnancy, have you ever told by a doctor 
or other health professional that you had hypertension, 
so called high blood pressure? 
0 – No            1 – Yes               9  - Don’t Know 
 
58. During your pregnancy were you diagnosed with 
diabetes? 
0 – No           1 – Yes                9  - Don’t Know 
 
59.  When did your labor pain start? 
 
 
☐   Tick if not available  
(reasons if known (eg. emergency CS):                           ) 
 
 
 
 
        
D D M M Y Y Y Y 
Time                    :am/pm 
60. When did rupture of membranes occur? 
Prob: when did your water break? 
 ☐   Tick if not available  
(reasons(if known):                           ) 
 
        
D D M M Y Y Y Y 
Time                    :am/pm 
61. Pre-pregnancy weight 
(Please write 9999 if Unknown) 
                                                              
kg 
62. When your baby was born, was he/she very large, 
large, lager than average, 
average, smaller than 
average, or very small? 
1 – Very large 
2 – Large 
3 – Larger than 
average 
 
4 – Average 
5 – Smaller than 
average 
6 – Very small 
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63. Have you had any preterm births before this delivery? 
          0 – No     1 – Yes        9  - Don’t Know 
 
64.  How long was your travel time to the hospital on this 
occasion to give birth? (total travel time to the hospital) 
 Hours  Minutes 
 
65. How did you travel to this hospital? (multiple 
responses allowed) 
1 – By car  
2 – By motorbike 
3 – By bus 
4 – By taxi 
5 – By ambulance 
6 – By stretcher 
7 – On foot 
8 – Others (please specify) 
 
66. Where do you usually go for health care services? 
1 - Referral hospital 
2 - District hospital 
3 - Military hospital 
4 - Basic Health Unit I 
5 - Basic Health Unit 
6 - Sub-post 
7 - ANC satellite (Thimphu only) 
8 –Others(please specify) 
9  - Don’t Know 
 
67. Why did you come to this hospital to deliver your 
baby? 
(please select the best answer from the choices provided) 
 1- Because I or my relatives live near the 
hospital 
2 - For better health care and services 
3 - More equipped 
4 - Has more qualified staff 
5 - Referral from other hospitals or  BHUs 
6 - Others (please specify) 
 
68. What is your occupation? 
1 – Housewife     [skip to Q. 72] 
2 - Unemployed  [skip to Q. 72] 
3 – Student         [skip to Q. 72] 
4 - Self-employed 
5 – Employee 
 
69.  What kind of work do you mainly do? Please 
describe. 
(eg. farmers, weavers, civil servants, shop keepers, 
teachers, daily wage labors, members of parliament(MP) 
etc) 
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70. In the past 10 months, did you work:  
1 – Only during daytime 
2 – Fixed evening work 
3 – Fixed night work 
4 – Rotating shift work without night 
5 – Rotating shift work with night 
6 – Others (specify) 
 
71. How many hours did you work per week on average in 
the past 10 months? 
1-  Less than 20 hours  
2 - Between 20 and 40 hours 
                3 - More than 40 hours 
 
72. What is your current marital status? 
1 – Single [Skip to Q. 74] 
2 – Married 
3 – Divorced 
4 – Separated 
5 – Living with a partner 
6 – Widow 
7 – Others (specify) 
 
73. If currently/formerly married/living with a partner: 
What is (was) the occupation of your husband/partner? 
That is, what kind of work does (did) he mainly do? Please 
describe. (eg. guides, drivers, farmers, carpenters, civil 
servants, teachers, daily wage labors, monks, members of 
parliament(MP) etc)  
 
74. During your pregnancy, did you ever travel on a rough 
or bumpy road in a vehicle such as car, bus, truck? 
          0 – No  [Skip to Q. 76]    1 – Yes        9  - Don’t Know 
 
75. If yes, how often did you travel? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times during pregnancy 
7  Three to six times during pregnancy 
8  Twice during pregnancy 
9  Once time during pregnancy 
10  Never during pregnancy 
11  Don’t know 
12 Others (please specify) 
 
 
 
 
Life style 
Next I am going to ask you about the time you spent doing different types of physical activity in a typical week during your 
pregnancy. Please answer these questions even if you do not consider yourself to be a physically active person. Think first about the 
time you spent doing work. Think of work as the things that you had to do such as paid or unpaid work, studying/training, 
household chores, harvesting food/crops, fishing or hunting for food, seeking employment. In answering the following questions 
‘vigorous-intensity activities’ are activities that require hard physical effort and cause large increases in breathing or heart rate, 
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‘moderate-intensity activities’ are activities that require moderate physical effort and cause small increases in breathing or heart 
rate. 
76.During your pregnancy, did your work involve vigorous-intensity activity that 
causes large increases inbreathing or heart rate like carrying or lifting heavy 
loads, digging or construction work for at least 10 minutes continuously? 
0 – No [Skip to Q. 79]                     1 – Yes 
 
77. During your pregnancy, how often did you do vigorous-intensity activities as 
part of your work? 
1  Every day or nearly every day 
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times during pregnancy 
7  Three to six times during pregnancy 
8  Twice during pregnancy 
9  Once time during pregnancy 
10  Never during pregnancy 
11  Don’t know 
12 Others (please specify) 
  
78. During your pregnancy, how much time did you spend doing vigorous-
intensity activities at work in total on atypical day?  Hours  Minutes 
 
79. During your pregnancy, did your work involve moderate-intensity activity 
that causes small increases inbreathing or heart rate such as housework and 
domestic chores, brisk walking or carrying light loads for at least 10 minutes 
continuously?  
                 0 - No [Skip to Q. 82]                      1– Yes  
80. During your pregnancy, how often did you do moderate-intensity activities as 
part of your work? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times during pregnancy 
7  Three to six times during pregnancy 
8  Twice during pregnancy 
9  Once time during pregnancy 
10  Never during pregnancy 
11  Don’t know 
12 Others (please specify) 
 
 
81. During your pregnancy, how much time did you spend doing moderate-
intensity activities at work in total on atypical day?  Hours  Minutes 
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Travel to and from places: 
The next questions exclude the physical activities at work that you have already mentioned. 
Now I would like to ask you about the usual way you travel to and from places.  For example to work, for shopping, to market, to 
place of worship and health facility. 
82. During your pregnancy, did you walk or use a bicycle (pedal cycle) for at least 
10 minutes continuously to get to and from places on a typical day? 
0 – No [Skip to Q. 85]                                      1– Yes 
 
83. During your pregnancy, how often did you walk or bicycle for at least 10 
minutes continuously to get to and from places? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times during pregnancy 
7  Three to six times during pregnancy 
8  Twice during pregnancy 
9  Once time during pregnancy 
10  Never during pregnancy 
11  Don’t know 
12 Others (please specify) 
 
 
84. During your pregnancy, how much time did you spend walking or bicycling 
for travel in total on a typical day? 
 
 Hours  Minutes 
 
 
Recreational activities: 
The next questions exclude the work and transport activities that you have already mentioned. Now I would like to ask you about 
sports, fitness and recreational activities (leisure) during your pregnancy. 
85. During your pregnancy, did you do any vigorous-intensity sports, fitness or 
recreational (leisure) activities that cause large increases in breathing or heart 
rate like running or football, martial arts, swimming, badminton, basketball 
for at least 10minutes continuously? 
0 – No [Skip to Q. 88]                                 1 – Yes 
 
86. During your pregnancy how often did you do vigorous-intensity sports, 
fitness or recreational (leisure) activities? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times during pregnancy 
7  Three to six times during pregnancy 
8  Twice during pregnancy 
9  Once time during pregnancy 
10  Never during pregnancy 
11  Don’t know 
12 Others (please specify) 
  
87. How much time did you spend doing vigorous intensity sports, fitness or 
recreational activities in total on a typical day? 
 
 Hours  Minutes 
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88. Did you do any moderate-intensity sports, fitness or recreational (leisure) 
activities that cause a small increase in breathing or heart small increase in 
breathing or heart rate such as brisk walking, dancing, archery khuru or degor, 
volleyball for at least 10 minutes continuously? 
0 – No [Skip to Q. 91]                                1 – Yes 
 
89.  During your pregnancy, how often  did you do moderate-intensity sports, 
fitness or recreational (leisure) activities? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times during pregnancy 
7  Three to six times during pregnancy 
8  Twice during pregnancy 
9  Once time during pregnancy 
10  Never during pregnancy 
11  Don’t know 
12 Others (please specify) 
 
 
90. How much time did you spend doing moderate intensity sports, fitness or 
recreational (leisure) activities on a typical day? 
 
 Hours  Minutes 
91. How would you describe your daily activity? 
1 - Very active 
2 - Moderately active 
3 - Somewhat active 
4 - Not active 
 
 
 
Sedentary behavior: 
The following question is about sitting or reclining at work, at home, getting to and from places, or with friends including time spent 
[sitting at a desk, sitting with friends, travelling in car, bus, train, reading, playing cards or watching television], but do not include 
time spent sleeping. 
92. During your pregnancy, how much time did you usually spend sitting or reclining 
in total on a typical day? (both at home and at work place) 
 
 Hours  Minutes 
 
Household Characteristics 
93. How many people live in your household with you, including you but not 
including this baby. (one household is defined as sharing a single kitchen)? 
 
94. Number of Children under age 18 (not including this baby):  
95. Number of Adults over age 18 years(including you):  
96. What type of dwelling do you live in? 
1 - Apartment/flats 
2 - Detached house 
3 - Village housing 
4 - Other (please specify) 
 
97. How many rooms in your household are used for sleeping?  
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98. What is the main material of the dwelling floor? 
  96 – Others (specify)  
Natural floor Rudimentary floor Finished floor 
11 - Earthen / clay 
floor 
21- Planks / shingles 
22- Bamboo 
31- Polished wood  
33 - Tiles / marble  
34 - Cement / 
concrete / terrazzo 
 
99. What is the main material of the roof? 
Natural roofing Rudimentary Roofing Finished roofing 
 
11 - No Roof  
12 - Thatch 
 
 
22- Bamboo  
23 - Planks / shingles  
24 - Cardboard  
25 - Tarpaulin  
31 -Metal sheets  
32 -Tiles / slates 
34- Concrete / cement 
 96 – Others(specify) 
 
100. What is the main material of the exterior walls? 
Natural walls Rudimentary walls Finished walls 
11 - No walls  
12 - Cane / Palm / 
Trunks/ Bamboo  
21 - Bamboo with 
mud  
22 - Stone with mud  
24 - Plywood  
25 - Cardboard  
31 - Cement / RCC 
wall  
32 - Stone with lime / 
cement  
33 - Bricks  
34 - Cement blocks  
36 - Wood planks  
37 - Rammed earth 
38 - Mud blocks 
96 – Others (specify) 
 
101. What is the main source of drinking water for members of your household? 
Piped water Dug well Water from spring 
11 - Piped into dwelling 
12 - Piped into 
compound 
13 - Piped to neighbour 
14 - Public tap 
31 - Protected well 
32 - Unprotected 
well 
41 - Protected spring  
42 - Unprotected 
spring 
51 - Rainwater collection 
61 - Tanker-truck 
71 - Cart with small tank / drum 
81 - Surface water (river, stream, dam, lake, pond, canal, irrigation channel) 
91 - Bottled water  
96 - Other (specify) 
 
Version 2.0  
15 December 2014 
 
 312 
102. What kind of toilet facility do members of your household usually use? 
IF “FLUSH” OR “POUR FLUSH”, PROBE: WHERE DOES IT FLUSH TO? 
Flush / Pour flush  Pit latrine 
11 - Flush to piped sewer system 
12 - Flush to septic tank (without soak 
pit)  
13 - Flush to septic tank (with soak pit)  
14 - Flush to pit (latrine)  
15 - Flush to somewhere else 
16 - Flush to unknown place / Not sure 
/do not where 
21 - Ventilated Improved Pit 
latrine (VIP) 
22 - Pit latrine with slab  
23 - Pit latrine without slab / 
Open pit  
24 - Long drop latrine  
31 - Composting toilet  
41 - Bucket 
95 - No facility, Bush, Field  
96 - Other (specify) 
 
103. What type of fuel does your household mainly use for cooking curry? 
1 - Electricity  
2 - Liquefied Petroleum Gas (LPG) 
3 - Kerosene  
4 - Coal  
5 – Wood 
6 - Straw/Shrubs/Grass 
7 - Dung Cake 
8 - No food cooked in household 
9 - Other (Specify) 
 
104. Is the cooking usually done in the house, in a separate building, or 
outdoors? 
 If ‘In the house’, probe: IS IT DONE IN A SEPARATE ROOM USED AS A KITCHEN? 
               1 – In a separate room used as kitchen in the house 
               2 - Elsewhere in the house  
               3 - In a separate building  
               4 - Outdoors  
               5 - Other (specify) 
 
105. Does any member of your household own: 
                [A] A WRIST WATCH? 
                [B] A MOBILE PHONE? 
                [C] A BICYCLE? 
                [D] A MOTORCYCLE OR SCOOTER? 
                [E] A CAR OR TRUCK? 
[F] A COMPUTER? 
[G] A FOREIGN BOW? 
[H] A CAMERA? 
[I] A VCR/VCD/DVD PLAYER? 
[J] A SERSHO GHO/KIRA/SILK SARI/SILK SUITS? 
No       Yes   
☐    ☐  [A] A WRIST WATCH? 
☐    ☐  [B] A MOBILE PHONE? 
☐    ☐  [C] A BICYCLE? 
☐    ☐  [D] A MOTORCYCLE OR SCOOTER? 
☐    ☐  [E] A CAR OR TRUCK? 
☐    ☐  [F] A COMPUTER? 
☐    ☐  [G] A FOREIGN BOW? 
☐    ☐  [H] A CAMERA? 
☐    ☐  [I] A VCR/VCD/DVD PLAYER? 
☐    ☐  [J] A SERSHO GHO/KIRA/ A SILK 
SARI/SILK SUITS                
 
Behavioral factors 
Smoking: Now we are about to ask the smoking before, during pregnancy and currently. 
106. Have you ever smoked any cigarettes? 
0 - No [Skip to Q. 111] 
1 – Yes 
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107. If yes, at what age did you begin to smoke cigarettes?  
108. In the past 10 months, have you smoked any cigarettes 
even once?  
0 - No [Skip to Q. 111] 
                1 – Yes 
 
109. If yes, how often did you smoke cigarettes? 
1 - Daily or almost daily 
2 – Weekly 
3 – Monthly 
                4 – Other (Specify) 
 
110. In the past 10 months, could you tell us how many 
cigarettes did you smoke on an average day in each month 
during your pregnancy? (A pack has 20 cigarettes.)  
For example, did you smoke more in winter compared to 
the summer? How about during the festival and holidays? 
May 
2014 
June 
2014 
July 
2014 
Aug 
2014 
Sep 
2014 
Oct 
2014 
Nov 
2014 
Dec 
2014 
Jan 
2015 
         
Feb 
2015 
Mar 
2015 
April 
2015 
May 
2015 
June 
2015 
July  
2015 
Aug 
2015 
Sep 
2015 
Oct 
2015 
         
 
111. Have you used any smokeless tobacco such as snuff 
and chewing tobacco (not including doma) even once in the 
past 10 months? 
0 - No [Skip to Q.115] 
1 – Yes 
 
112. If yes, how often did you smokeless tobacco? 
1 - Daily or almost daily 
2 – Weekly 
3 – Monthly 
                4 – Other (Specify) 
 
113. What kind of smokeless tobacco did you use? (multiple 
responses allowed) 
1 - Snuff, by mouth  
2 - Snuff, by nose 
3 - Chewing tobacco (such as baba and khaini) 
4 - Others (specify) 
 
114. In the past 10 months, could you tell us how many 
packets of smokeless tobaccos did you use on an average 
day in each month? 
For example, did you use more in winter compared to the 
summer? How about during the festival and holidays? 
May 
2014 
June 
2014 
July 
2014 
Aug 
2014 
Sep 
2014 
Oct 
2014 
Nov 
2014 
Dec 
2014 
Jan 
2015 
         
Feb 
2015 
Mar 
2015 
April 
2015 
May 
2015 
June 
2015 
July  
2015 
Aug 
2015 
Sep 
2015 
Oct 
2015 
         
 
115.  Did you take pan masala such as “Rajnigandha” or 
“WIZ” in the past 10 months? 
0 - No [Skip to Q.118] 
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                1 – Yes 
116.  How often did you take Pan masala such as 
“Rajnigandha” or “WIZ” in the past 10 months? 
1 - Daily or almost daily 
2 – Weekly 
3 – Monthly 
                4 – Other (Specify) 
 
117.  How long does it take you to finish 20 g package of  
pan masala such as “Rajnigandha” or “WIZ”? 
1- One day 
2- One week 
3- One month 
4- Two to three month 
5- Other(specify) 
 
 
 
Doma: Now we are about to ask doma before, during pregnancy and currently. 
118. Have you ever chewed doma? 
0 - No [Skip to Q.129] 
1 – Yes 
 
119. If yes, at what age did you begin to chew doma?  
120. Did you chew doma even once in the past 10 months? 
0 - No   [Skip to Q.129]       
1 – Yes 
 
121. If yes, how often did you chew doma? 
1 - Daily or almost daily 
2 – Weekly 
3 – Monthly 
4 – Other (Specify) 
 
122.When do you take doma? Before meals, after meals, 
with alcohol etc…(multiple responses allowed) 
1 - Before meals 
2 - After meals 
3 - With alcohol 
4 - During tea/coffee break 
5 - In the morning 
6 - When driving 
7 - When I have a visitor 
8 - When a friend(s) or family offers  
9 - During rituals or ceremonies 
10 - Others (please specify)  
 
123. When do you feel like chewing doma?(multiple 
responses allowed)  
1 - When I am bored 
2 - When I am happy 
3 - When I am stressed 
4 - When I am sad 
5 - When I feel sick  
6 - When I feel sleepy 
7 - When I feel tired 
8 - When I feel cold 
9 - Others (please specify) 
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124. When you take doma nut do you take it with piper 
leaf? 
1 – Always 
2 - Usually 
3 – Sometimes 
4 – Rarely 
5 – Never 
 
125. Do you add tobacco when you take doma nut? 
1 – Always 
2 - Usually 
3 – Sometimes 
4 – Rarely 
5 – Never 
 
126. Do you add slaked lime when you take doma nut? 
1 – Always 
2 - Usually 
3 – Sometimes 
4 – Rarely 
5 – Never 
 
127. Do you spit when you are eating doma? 
1 – Always 
2 - Usually 
3 – Sometimes 
4 – Rarely 
5 – Never 
 
128. Could you tell us how many doma you chewed on an 
average day in each month during the past 10 months? For 
example, did you chew more doma in winter compared to 
the summer?  How about during the festival and holidays? 
May 
2014 
June 
2014 
July 
2014 
Aug 
2014 
Sep 
2014 
Oct 
2014 
Nov 
2014 
Dec 
2014 
Jan 
2015 
         
Feb 
2015 
Mar 
2015 
April 
2015 
May 
2015 
June 
2015 
July  
2015 
Aug 
2015 
Sep 
2015 
Oct 
2015 
         
 
 
Alcohol: Now we are about to ask alcohol before, during pregnancy and currently. 
129. Have you consumed any type of alcohol? 
0 - No [S0 - No [Skip to Q. 140] 
1 - Yes to Q.124] 
 
130. If yes, at what age did you begin to drink alcohol?  
131. Have you consumed any type of alochol in the past 10 
months? 
0 - No [Skip to Q. 140] 
1 - Yes to Q.124 
 
132. If yes, how often did you drink alcohol? 
1 - Daily or almost daily 
2 – Weekly 
3 – Monthly 
                4 – Other (Specify) 
 
133. What beverage do you drink most? 
1 – Ara 
2 – BANGCHANG’/ ‘SINGCHANG/’ TONGPA 
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3 –Changkey 
4 –Beer 
5 – Wine 
6 –LIQUOR (rum, whisky, brandy) 
7 –Others (please specify) 
 
 
The next few questions are about how much of any type of alcohol you may have had in any one day during the last 10 months. Think 
of all kinds of alcohol beverages combined that is any combination of beer, wine, liquor, ara, bangchang, singchang, and tongpa. 
134. During the last 10 months, what is the largest amount 
of each type of alcohol you drank on that day when you 
had the most to drink? (show the sample cup) 
Ara _______ cups 
BANGCHANG’____  cups 
SINGCHANG   _____ cups 
TONGPA _______cups 
Changkey_______cups 
Table Wine _______cups 
Port Wine _______cups 
Fortified Wine_______cups 
Spy  _______cups 
Beer A(Dansberg, Budweiser, Heineken, Singha beer, 
Chang beer, Carlsberg, Orchim, Haywards, Royal challenge, 
Golden eagle,  Sang Miguel, Tiger)    ____cups 
Beer B(Druk 11,000, HIT Beer) __cups 
Liquor (run, whisky, brandy)____cups 
Others (specify)                       cups 
Drinks Number of cups 
Ara  
BANGCHANG’  
SINGCHANG  
TONGPA  
Changkey  
Table Wine  
Port Wine  
Fortified Wine  
SPY  
Beer A (Dansberg, Budweiser, Heineken, 
Singha beer, Chang beer, Carlsberg, Orchim, 
Haywards, Royal challenge, Golden eagle, 
Sang Miguel, Tiger) 
 
Beer B (Druk 11,000, HIT Beer)   
Liquor (run, whisky, brandy)  
Others (specify)  
 
135.How many times did you drink as much as the 
maximum amount you mentioned above in the past 10 
months? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times in the last 10 months 
7  Three to six times in the last 10 months 
8  Twice in the past 10 months 
9  Once time in the past 10 months  
10  Never in the past 10 months 
11  Don’t know 
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136. How many times did you drink three-fourth of this 
amount in the past 10 months? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times in the last 10 months 
7  Three to six times in the last 10 months 
8  Twice in the past 10 months 
9  Once time in the past 10 months  
10  Never in the past 10 months 
11  Don’t know 
 
 
137. How many times did you drink half of this amount in 
the past 10 months? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times in the last 10 months 
7  Three to six times in the last 10 months 
8  Twice in the past 10 months 
9  Once time in the past 10 months  
10  Never in the past 10 months 
11  Don’t know 
 
 
138. How many times did you drink one-fourth of this 
amount in the past 10 months? 
1  Every day or nearly every day  
2  Three to four times a week 
3  Once or twice a week 
4 Two to three times a month 
5  About once a month 
6  Seven to eleven times in the last 10 months 
7  Three to six times in the last 10 months 
8  Twice in the past 10 months 
9  Once time in the past 10 months  
10  Never in the past 10 months 
11  Don’t know 
 
 
139. Could you tell us how many days did you drink 
approximately in each month during the past 10 months? 
For example, did you drink more in winter compared to the 
summer?  How about during the festival and holidays? 
May 
2014 
June 
2014 
July 
2014 
Aug 
2014 
Sep 
2014 
Oct 
2014 
Nov 
2014 
Dec 
2014 
Jan 
2015 
         
Feb 
2015 
Mar 
2015 
April 
2015 
May 
2015 
June 
2015 
July  
2015 
Aug 
2015 
Sep 
2015 
Oct 
2015 
         
 
 
Nutrition: 
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140. How many times a day do you usually eat including meals and 
snacks? (___ #meals per day __# snacks per day) 
 
 meals per 
day 
 snacks 
per day 
141. How would you describe your appetite in the past 10 months? 
1 - Good  2 – Fair 3 - Poor 
 
 
Fruits and vegetables: The next questions ask about the fruits and vegetables that you usually eat. I have a nutrition card here that 
shows you some examples of local fruits and vegetables. Each picture represents the size of a serving. As you answer these questions 
please think of a typical week in the past 10 months. 
142. In a typical week, on how many days did you eat fruit in the past 10 
months? If 0 days, skip to 144. If don’t know, please write “77”. 
Days 
 
Others (Please specify): 
143. How many servings of fruit do you eat on one 
of those days? (one fruit serving is (a) ½ cup of chopped, cooked or canned 
fruit; (b) 1 medium-sized piece of fruit such as banana , apple, orange; (c) 
½ cup of fruit juice (not artificially flavored) (USE SHOWCARD) 
 
Servings 
144. In a typical week, on how many days did you eat vegetables 
(excluding chilies and tubers such as potatoes) in the past 1- months? 
If 0 days, skip to 146. If don’t know, please write “77”. 
Days 
Others (Please specify): 
 
145. How many servings of vegetables did you eat on one of those days? 
(one vegetable serving is (a) 1 cup of raw green leafy vegetable such as 
spinach, salad greens, etc. (b) ½cup of other vegetables, cooked or 
chopped, such as carrots, pumpkin, corn, beans, onion, etc. but excluding 
chilies and tubers such as potatoes .)(USE SHOWCARD and sample cup) 
Servings 
146. What type of oil or fats most often used for meal preparation in your 
household? 
1 – Vegetable oil 
7- Lard or suet(animal fat/tselol) 
8- Butter or ghee 
9- Margarine 
10- Other (please specify) 
11- None in particular 
12- None used 
13- Don’t know 
 
147. Total amount of fat/oil used in a month (all forms together) 
 
 Liters  ml 
 
148. How many members of the family eat from the same pot?  
149. How frequently did you eat “Ezay” in the past 10 months? 
1 – Daily 
2- 5-6 days per week 
3- 1-4 days per week 
4 - 1-3 days per month 
5 - Less than once a month 
6 – Never 
7 – Stopped during pregnancy 
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150. How frequently do you eat dry meat in the past 10 months? 
1 – Daily 
2- 5-6 days per week 
3- 1-4 days per week 
4 - 1-3 days per month 
5 - Less than once a month 
6 – Never 
7 – Stopped during pregnancy 
 
151. How frequently do you drink Suja in the past 10 months? 
1 – Daily 
2- 5-6 days per week 
3- 1-4 days per week 
4 - 1-3 days per month 
5 - Less than once a month 
6 – Never 
7 – Stopped during pregnancy 
 
152. How often did you drink milk tea with sugar in the past 10 months? 
1 – Daily 
2- 5-6 days per week 
3- 1-4 days per week 
4 - 1-3 days per month 
5 - Less than once a month 
6 – Never 
7 – Stopped during pregnancy 
 
153. How often did you drink coffee in the past 10 months? 
1 – Daily 
2- 5-6 days per week 
3- 1-4 days per week 
4 - 1-3 days per month 
5 - Less than once a month 
6 – Never 
7 – Stopped during pregnancy 
 
154. End of the interview (Time & DD/MM/YYYY) 
 
Time:          :               (am /  pm) 
        
D D M M Y Y Y Y 
 
End of questionnaire. Thank you! 
 
 
 
 
 
 
 
 
i The following test results were recorded: Venereal Disease Research Laboratory (VDRL) or Rapid Plasma Reagin (RPR), 
Treponema pallidum hemagglutination assay (TPHA) for STI/RTI; HBsAG for hepatitis B;HIV; and Fasting Blood Sugar (FBS), 
Oral Glucose Tolerance Test (OGTT), and Post-prandial Blood-Sugar (PPBS). 
 320 
 
Appendix G  
Research Team 
 
Field Research Team 
Co-investigators: 
Dr. Shunmay Yeung (LSHTM) 
Dr. Hannah Blencowe (LSHTM) 
Dr. Kinzang Tshering (KhesarGyalpo University of Medical Science of Bhutan) 
Dr. Yoriko Nishizawa (KGUMSB) 
Dr. Phurb Dorji, (Jigme Dorji Wangchuck National Referral Hospital) 
Dr. Tulsi Ram Sharma (Eastern Region Referral Hospital) 
Dr. Purushotam Bhandari (Central Region Referral Hospital) 
Dr. Nidup Gyeltshen (CRRH) 
Mr. Sonam Wandhi (Ministry of Health, MoH) 
Ms. Tashi Tshomo (MoH) 
 
Research assistants: 
Ms. Asha Rai  
Mr. Tshering Samdrup 
Ms. Deo Maya Subba 
Mr. Dilli Ram Mongar 
Mr. Ugyen Tshering (Pilot study) 
 
Translator:  
Yeshi Lhendup 
 
Focal Points: 
Ms. Yangden Drukpa (JDWNRH) 
Ms. Geeta Giri (JDWNRH) 
Ms. Kinley Chhimi (CRRH) 
Mr. Dorji Gyeltshen (CRRH) 
Ms. Jigme Zangmo (CRRH)  
Mr. Karma (ERRH) 
Ms. Kezang Wangmo (ERRH) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 321 
 
Interviewers: 
JDWNRH 
Birthing Centre: 
CRRH ERRH 
Ms. Anju Thapa 
Ms. Bishnu Maya Rai 
Ms. Damanti Bhujel 
Ms. Dechen Zangmo 
Ms. Dipsika Rai 
Ms. Jamyang Dema 
Ms. Kinga Om 
Ms. Lali Maya Karki 
Ms. Puntsho Yangzom 
Ms. Rinchen Yangzom 
Ms. Sangay Zangmo 
Ms. Sonam Choden 
Ms. Sonam P Dorji 
Ms. Tshewang Gyem 
Ms. Ugyen Choden 
 
Maternity Ward: 
Ms. Choki Om 
Ms. Kezang Lhamo 
Ms. Nidup Chenzom 
Ms. Passang Kyipa 
Ms. Pem Choki 
Ms. Rinchen Zangmo 
Ms. Sherab Zangmo 
Ms. Sonam Pelzom 
Ms. Tshering Zangmo 
Ms. Tenzin Dema 
Ms. Yangchen Lham  
 
NICU: 
Ms. Tandin Om 
 
Ms. Arun Gautam 
Mr. Choki Dorji 
Ms. Deepak Gaga 
Ms. Dhan Maya 
Ms. Karma Yangchen 
Ms. Dawa Zangmo 
Ms. Hem Raj Rai 
Ms. Namgay  Pemo 
Ms. Pema  Zangmo 
Ms. Leki Nima 
Ms. Lhakpa Choki Sherpa 
Ms. Lhamo, 
Ms. Mindhu 
Ms. Rajesh Sapkota 
Ms. Sonam Wangmo 
Ms. Thinley Zangmo 
Ms. TsheringChoden 
Ms. TsheringTashi 
Ms. Ugyen Delma 
Ms. Ugyen Lhamo 
Ms. Zangpo 
Ms. Sadhna Gurung  
Ms. Tenzin Dema 
Ms. Dawa Dema 
Ms. Sangay Zangmo  
Mr. Khara Nanda 
Ghimery 
Ms.Laiba lepcha 
Ms.Khendu Pem 
Ms. Chonining Zangmo 
Ms. Karma Tshomo 
Mr. Khara Nanda Ghimray 
Mr. Chencho Dorji 
Ms. Rinzin Wangmo 
Mr. Ugyen Tshering 
Mr. Sherub Dorji 
Ms. Pelki Zangmo 
Ms. Choten Tshering 
Ms. Sonam Wangmo 
Mr. Sadha Gurung 
Ms. Sonam Dyakar 
Ms. Tashi Deki 
Ms. Yezer Tshomo 
Ms. Tshering Om  
Ms. Phuntsho Choden 
Ms. Sasha Hiring 
Ms. Khara Nanda 
 
 
Acknowledgements: 
Mothers who participated in this study and their babies 
Dr. Tashi Tobgay (KGUMSB) 
Dr. Pakila Drukpa (KGUMSB) 
Dr.Sonam Gyamtsho (ERRH)  
Dr. Gosar Pemba(JDWNRH) 
Dr.Tapas Gurung (CRRH) 
Mr. Phub Sangay (NSB)   
Mr. Cheku Dorji (NSB) 
 
 322 
 
Appendix H  
Validation of the baby scales in the study settings 
 
Birthweights were measured within 24 hours of delivery. During the monitoring visits, one identical 
bag which contains 2 kilo grams of rice were weighed twice at each hospital using their baby scales. 
The scales were accurate ±100 grams.  At the eastern referral hospital in Mongar, for babies who 
were taken to NICU, babies’ weights are crosschecked using Prestige.  
 
 
Table H.1. Validation of baby scales at the study sites. 
Hospitals Baby Scales 
During the study  After the study 
Weights 
(1st time) 
Weights 
(2nd time) 
Dates 
 Weights 
(1st time) 
Weights 
(2nd time) 
Dates 
JDWNRH 
(Birthing 
Center) 
Tanita Digital Baby 
Scale (BD-585-WH) 
1.99 kg 1.99 kg 19-Sep-15 
 
2.00 kg 2.00 kg 12-Jun-16 
JDWNRH 
(Maternity 
Ward) 
SECA 1.98 kg 1.98 kg 19-Sep-15 
 
- - - 
Mongar 
Hospital 
SECA 1.90 kg 1.90 kg 20-Oct-15 
 
1.99 kg 1.99 kg 21-Jun-16 
Mongar 
(NICU) 
Prestige 1.99 kg 1.99 kg 20-Oct-15 
 
2.01 kg 2.01 kg 21-Jun-16 
Gelephu SK-20 2.05 kg 2.10 kg 21-Sep-15  1.90 kg 1.90 kg 09-May-16 
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Appendix I  
Additional tables for descriptive analysis 
 
 
Figure I.1. Partner’s occupation. 
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Figure I.2. Weekly working hours by employment type (before maternity leave for employees). 
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Figure I.3. Type of work shift. 
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Table I.1. The percentage of the mothers who engaged in vigorous to moderate physical activities (work, leisure, transportation) and adverse birth ougtcomes. 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N %  N % P-value  N % P-value  N % P-value 
Work 
Vigorous activity 
(yes) 
54 16.8%  65 18.7% 0.54  32 21.1% 0.255  33 17.1% 0.956 
 Missing 5 1.6%  5 1.4%   3 2.0%   2 1.0%  
                
 
Moderate 
activity (yes) 
251 78.2%  291 83.6% 0.10  121 79.6% 0.804  167 86.5% 0.03 
 Missing 6 1.9%  4 1.2%   2 1.3%   2 1.0%  
                
Leisure 
Vigorous activity 
(yes) 
13 4.1%  15 4.3% 0.86  8 5.3% 0.549  7 3.6% 0.82 
 Missing 2 0.6%  3 0.9%   1 0.7%   2 1.0%  
                
 
Moderate 
activity (yes) 
49 15.3%  64 18.4% 0.29  32 21.1% 0.114  32 16.6% 0.73 
 Missing) 5 0.8%  2 0.7%   2 1.3%   0 0.0%  
                
Travel 
Walk or bike for 
at least 10 
minutes 
211 65.7%  228 65.5% 0.90  102 67.1% 0.832  126 65.28% 0.89 
 Missing 4 1.3%  3 0.9%   1 0.7%   2 1.04%  
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Table I.2. Mean minutes of physical activities in total on a typical day. 
Physical activities in total  
on a typical day 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N 
Mean 
minutes 
(SD) 
 N 
Mean minutes 
(SD) 
P-value  N 
Mean minutes 
(SD) 
P-value  N 
Mean 
minutes 
(SD) 
P-value 
Work related vigorous activities 
(n=119) 
50 295 (173)  65 269 (199) 0.47  32 295 (173) 0.93  33 249 (167) 0.23 
Work related moderate 
activities(n=542) 
244 198 (136)  285 204 (156) 0.64  120 213 (174) 0.42  162 196 (138) 0.89 
Leisure related-vigorous 
activities(n=28) 
13 47 (37)  14 81 (121) 0.33  7 101 (169) 0.43  7 61 (45) 0.50 
Leisure related moderate 
activities (n=113) 
48 68 (69)  64 58 (64) 0.42  32 63 (83) 0.80  32 52 (37) 0.18 
Travel related moderate activities 
(n=439) 
210 61 (62)  224 67 (94) 0.45  99 65 (98) 0.71  125 68 (91) 0.44 
Sedentary Activities (n=661) 317 212 (150)  344 193 (135) 0.09  150 193 (133) 0.18  191 191 (135) 0.10 
 
 
Table I.3. Proportions of the mothers who did not meet the ACOG guideline and adverse birth outcomes. 
 
Control (n=321)  Case (n=348)  Term LBW (n=152)  Preterm (n=193) 
N 
% or mean 
(SD) 
 N 
% or mean 
(SD) 
P-value  N %  P-value  N %  P-value 
Less than 150 minutes of any 
vigorous/moderate activities per 
week 
57 17.8  56 16.1 0.553  26 17.1% 0.850  30 15.5% 0.507 
Missing 1 0.3  0 0.0   0 0.0%   0 0.0%  
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Figure I.4. Patterns and frequency of common sources of sugar and salt among study participants 
(n=669). 
 
Figure I.5. Interview language.
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Appendix J  
 
Table J.1. AIC for the statistical approach. 
Added variable 
AIC 
Model 1 Model 2 
Hospital 916.8524 916.8524 
Age 909.5562 908.0641 
No. of ANC 882.8316 881.2978 
WQ 881.1862 879.7886 
Education 884.1807 882.3977 
Ethnicity 886.0866 884.3093 
Sex 881.553 881.553 
GWG 626.8252 626.8252 
Nulliparity 622.0839 622.0839 
history of PTB 604.6755 604.6755 
AN/PM 603.72  
Amount of AN  542.8519 
ST/Smoke 595.3904  
Amount of ST  538.1317 
Drinking 595.1822  
No. of drinking days  529.5396 
Hypertension 528.043 478.5081 
Mode of delivery 527.5638 477.6931 
UTI 499.8113 450.3702 
No. of meals 491.7174 442.4257 
Season 488.3853   431.8197   
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Table J.2. Regression SE for tatistical approach. 
Factors 
Standard Error  
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Hospital (ref: JDWNRH) Gelephu 0.198 0.189 0.205 0.208 0.218 0.218 0.218 0.235 0.238 0.244 0.257 0.256 0.272 0.269 0.294 0.292 0.264 0.279 
 Mongar 0.207 0.198 0.211 0.203 0.212 0.221 0.215 0.201 0.189 0.189 0.192 0.205 0.201 0.210 0.206 0.147 0.138 0.139 
                                       
Maternal age (ref: 20-35) <20  0.766 0.798 0.761 0.776 0.773 0.805 0.682 0.506 0.597 0.596 0.565 0.535 0.578 0.578 0.685 0.585 0.661 
  35<   0.448 0.483 0.472 0.47 0.471 0.48 0.368 0.465 0.506 0.489 0.446 0.441 0.359 0.343 0.351 0.332 0.339 
                     
Number of antenatal care per gestational week after the 
first ANC visit 
    0.216 0.237 0.236 0.237 0.231 0.422 0.393 0.461 0.46 0.441 0.436 0.264 0.224 0.260 0.268 0.231 
                     
Wealth Quintile (WQ) 
(ref: Middle) 
Poorest       0.26 0.256 0.255 0.271 0.329 0.336 0.368 0.372 0.364 0.377 0.394 0.402 0.416 0.430 0.490 
 Second    0.194 0.195 0.194 0.21 0.217 0.224 0.227 0.233 0.248 0.256 0.248 0.260 0.329 0.347 0.402 
  Fourth       0.222 0.232 0.232 0.24 0.313 0.313 0.33 0.328 0.331 0.334 0.381 0.380 0.454 0.576 0.669 
 Richest    0.169 0.181 0.181 0.185 0.261 0.291 0.302 0.299 0.309 0.312 0.385 0.397 0.468 0.503 0.553 
                                       
Education (ref: No education) NFE     0.208 0.21 0.203 0.164 0.162 0.164 0.16 0.154 0.155 0.147 0.152 0.161 0.163 0.184 
  Primary         0.267 0.267 0.271 0.421 0.42 0.446 0.426 0.435 0.434 0.467 0.464 0.512 0.531 0.525 
 High school or less     0.185 0.185 0.192 0.214 0.197 0.211 0.208 0.205 0.21 0.182 0.183 0.169 0.178 0.181 
  Masters/college/diploma         0.403 0.401 0.442 0.422 0.366 0.404 0.382 0.359 0.377 0.339 0.325 0.316 0.337 0.297 
                     
Ethnicity (ref: Northern 
Bhutanese) 
Southern Bhutanese           0.194 0.198 0.271 0.273 0.284 0.282 0.276 0.289 0.323 0.337 0.320 0.323 0.360 
                     
Sex of the infant (ref: Male) Female             0.235 0.269 0.272 0.293 0.289 0.303 0.311 0.370 0.395 0.401 0.408 0.433 
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Gestational weight gain 
(GWG) (ref: IOM 
recommendations) 
High               0.279 0.26 0.258 0.268 0.278 0.287 0.281 0.263 0.232 0.246 0.240 
 Low        0.578 0.582 0.587 0.578 0.567 0.557 0.732 0.753 0.742 0.764 0.717 
                                       
nulliparity         0.366 0.43 0.425 0.418 0.422 0.472 0.462 0.464 0.473 0.470 
                                       
History of previous preterm birth (PTB)          1.365 1.358 1.401 1.447 1.752 1.755 1.605 1.654 1.77 
                                       
PM or BQ during pregnancy           0.232 0.211 0.201 0.238 0.235 0.260 0.265 0.299 
                                       
Smokeless tobacco (ST) or smoking during pregnancy            0.913 0.887 0.734 0.791 0.737 0.779 0.893 
                                       
Drinking during pregnancy             0.36 0.426 0.434 0.434 0.446 0.503 
                                       
Hypertensive disorders 
(ref: None) 
chronic hypertension              3.476 2.898 2.696 2.907 3.209 
  Gestational hypertension                           2.641 2.750 2.313 2.117 2.205 
 PE or eclampsia              5.179 3.984 2.988 3.095 3.373 
                     
Mode of delivery 
(ref: SVD) 
CS-Elective                             0.429 0.446 0.434 0.414 
 CS-Emerg.               0.532 0.704 0.666 0.728 
                                       
UTI                0.769 0.830 0.926 
                                       
Number of meals per day                                 0.128 0.125 
                   
Season (ref. Winter) Fall                  0..336 
 Spring                  0.372 
 Summer                  1.161 
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Table J.3. Results of the uni-variable and multivariable models for LBW and/or PTB (case) using the statistical approach. 
Independent variables 
Crude Odd Ratio  
Model 1 (n=397) 
Adjusted Odds ratio 
 Model 2 (n=357) 
Adjusted Odds Ratio 
Odds 
Ratio 
95% CI P-value  
Odds 
Ratio 
95% CI P-value  
Odds 
Ratio 
95% CI P-value 
Hospital (ref: JDWNRH) CRRH 0.90 0.58 -1.39 0.621  0.67 0.30-1.52 0.338  0.66 0.26-1.66 0.372 
  MRRH 0.93 0.62 -1.40 0.717  0.37 0.18-0.77 0.008  0.35 0.15-0.79 0.012 
              
Season (ref: Winter) Fall 1.48 0.95-2.31 0.082  0.90 0.43-1.87 0.777  1.18 0.51-2.73 0.692 
 Spring 1.28  0.84-1.95 0.259  1.04   0.52- 2.10 0.902  1.44    0.69-3.01 0.331 
 Summer 2.13 1.37-3.32 0.001  3.16 1.54-6.50 0.007  3.94 1.88-8.24 <0.001 
             
Sex of the infant (ref: Male) Female 1.41 1.04 -1.91 0.027  1.73 1.06- 2.83 0.028  1.85 1.08-3.18 0.026 
              
Age (ref: 20-35) <20 2.01 1.03-3.92 0.04  1.10 0.34-3.57 0.872  1.30 0.36-4.66 0.894 
 35< 1.83 1.16-2.90 0.01  0.80 0.35-1.84 0.605  0.80 0.31-2.03 0.496 
               
Education (ref: Never attended 
School) 
Non-formal education (NFE) 0.57 0.30 -1.08 0.085  0.30 0.09-0.996 0.049  0.39 0.10-1.45 0.160 
  Primary 1.04 0.63 - 1.71 0.878  1.17 0.48-2.82 0.730  1.28 0.49-3.31 0.618 
 Middle Secondary or Secondary School 0.72 0.49 -1.06 0.096  0.46 0.23- 0.997 0.049  0.49 0.21-1.15 0.101 
  Diploma, college, and post graduate 0.79 0.42 -1.49 0.468  0.51 0.17-1.59 0.249  0.74 0.21-2.52 0.625 
              
Wealth Quintile (ref: middle) Poorest 1.11 0.68 -1.80 0.672  1.12 0.48-2.64 0.793  1.32 0.51- 3.38 0.567 
 Second 0.77 0.48 - 1.25 0.297  1.00 0.45-2.20 0.730  0.96 0.40- 2.30 0.924 
  Fourth 0.89 0.55 - 1.44 0.623  1.69 0.78- 3.67 0.184  2.66 1.12- 6.33 0.027 
 Richest 0.64 0.40 - 1.05 0.075  1.40 0.65-3.04 0.393  1.52 0.65- 3.58 0.335 
               
Number of antenatal care per gestational week after the first ANC visit 0.31 0.07 -1.31 0.11  0.28 0.06-1.40 0.122  0.32 0.04-2.30 0.255 
               
Ethnicity (ref: northern Bhutanese) Southern Bhutanese 1.10 0.79 -1.53 0.572  1.25 0.71-2.20 0.430  1.55 0.84- 2.89 0.164 
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Gestational weight gain  
(ref: IOM recommendations) 
High GWG 0.97 0.53-1.76 0.913  0.57 0.25-1.30 0.181  0.65 0.27-1.60 0.349 
  Low GWG 2.55 1.63- 3.99 <0.0001  2.42 1.35-4.32 0.003  2.68 1.42- 5.07 0.002 
              
Number of meals per day  0.58 0.44-0.76 <0.0001  0.56 0.36-0.87 0.010  0.57 0.35- 0.92 0.022 
             
Urinary Tract Infection  1.79 1.03-3.11 0.038  2.16 0.93- 5.01 0.071  2.12 0.83-5.38 0.114 
              
Nulliparity  1.32 0.97-1.80 0.074  1.69 0.98- 2.91 0.061  1.75 0.95- 3.23 0.072 
              
Previous History of preterm birth  2.70 1.43-5.08 0.002  3.57 1.35-9.44 0.010  4.93 1.61-15.11 0.005 
              
Hypertension (ref: Non-hypertensive 
disorders) 
chronic or pre-existing  5.04 2.12-11.80 <0.0001  5.03 1.44-17.57 0.011  5.67 1.58-20.36 0.008 
 gestational hypertension 5.47 2.77-10.80 <0.0001  4.40 1.65- 11.75 0.003  3.06   1.03-9.08 0.044 
  Pre-eclampsia or eclampsia 11.77 4.13-33.55 <0.0001  5.24 1.48-18.50 0.010  5.19 1.20-22.48 0.028 
              
Mode of delivery (ref: SVD) CS-Elective 0.90 0.55-1.48 0.677  0.97 0.42-2.24 0.947  1.38 0.53- 3.62 0.507 
 CS-Emergency 1.99 1.38-2.88 <0.0001  2.35 1.28-4.31 0.006  2.67 1.38-5.15 0.003 
               
Chewing betel quid or pan masala during pregnancy 1.09 0.80-1.49 0.478  1.13 0.67-1.90 0.646     
               
Chewing smokeless tobacco or smoking during pregnancy 2.81 1.60-4.92 <0.0001  1.92 0.77-4.78 0.161     
               
Drinking during pregnancy  1.69 1.19-2.40 0.003  1.69 0.94-3.03 0.077     
               
Total number of betel nuts during the 
last 3 months of pregnancy  
(ref: No betel quid chewing) 
<=90 nuts during the 3 months or  
=<1 nut per day 
1.22 0.86-1.75 0.268      0.90 0.49- 1.65 0.730 
  
more than 90 nuts during the 3 months or >1 
nut per day 
0.90 0.53-1.53 0.684      0.84 0.31- 2.28 0.735 
              
Total number of smokeless tobacco (grams) during the last three months of pregnancy 1.00 1.00-1.01 0.012      0.76 0.20-2.84 0.679 
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Total number of days of drinking 
during the last three months of 
pregnancy (ref: No drinking) 
less or equal to once a week 1.48 0.95-2.31 0.083      1.99 0.97-4.07 0.061 
 more than once a week 3.89 1.89-7.98 <0.0001      12.48 2.53-61.54 0.002 
               
Urban/rural residence Urban current residence 1.01 0.75 -1.38 0.932         
               
Difference between permanent and 
current altitude (ref: 0-<1000) 
<0 m 0.87 0.56 -1.34 0.524         
  1000-<2000 m 1.24 0.83 -1.85 0.301         
 2000 m and above 1.14 0.66 -1.96 0.648         
               
Pre-pregnancy BMI  
(ref: average BMI) 
Underweight 1.92 0.92-3.99 0.082         
  Overweight 0.64 0.40-1.02 0.061         
  Obese 1.22 0.49-3.04 0.666         
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Table J.4. Monte-Carlo Error (MCE) for term LBW model 
Term LBW 
MCE of 
Coef. 
MCE of 
Std. Err. 
10% of S.E. MCE of t MCE of P>t 
PM or BQ during pregnancy 0.003878 0.0004389 0.02281643 0.02 0.004 
Ethnicity(southern Bhutanese) 0.0028411 0.0002682 0.02348585 0.01 0.004 
Poorest 0.0050061 0.0005986 0.03552561 0.01 0.011 
Second 0.0042988 0.0004699 0.03448597 0.01 0.009 
Fourth 0.0044232 0.0004865 0.03437589 0.01 0.009 
Richest 0.0038387 0.000381 0.03572441 0.01 0.007 
NFE 0.0059927 0.0007771 0.04326635 0.01 0.008 
Primary 0.0048746 0.0007085 0.03360915 0.01 0.012 
High school or less 0.0057427 0.0009843 0.03085304 0.02 0.003 
Masters/college/diploma 0.0061996 0.0008012 0.04770796 0.01 0.01 
Chronic hypertension 0.0159643 0.0029736 0.05488909 0.03 0.001 
Maternal height 0.0006316 0.0001957 0.00192902 0.03 0.026 
<20 0.0061081 0.0007207 0.04733843 0.01 0.007 
35> 0.0048844 0.000625 0.03207688 0.01 0.001 
Pre-pregnacy weight 0.0009855 0.0004658 0.0016614 0.1 0.004 
Gelephu 0.0042834 0.0006236 0.03191694 0.01 0.009 
Mongar 0.0033428 0.0003473 0.03041451 0.01 0.008 
Fall 0.0035577 0.0004115 0.03106183 0.01 0.008 
Spring 0.0032335 0.0003349 0.02987462 0.01 0.008 
Summer 0.0039265 0.0003931 0.02988117 0.01 0 
 
 
Table J.5. MCE for Term PTB model 
PTB MCE of 
Coef. 
MCE of 
Std. Err. 
10% of S.E. MCE of t MCE of P>t 
PM or BQ during pregnancy 0.0036866 0.0004651 0.0204277 0.02 0.009 
Ethnicity(southern Bhutanese) 0.0030846 0.0003692 0.0229994 0.01 0.007 
Poorest 0.0058309 0.0006629 0.0316441 0.02 0.015 
Second 0.0047401 0.0005619 0.0308557 0.02 0.01 
Fourth 0.00517 0.0005576 0.0308698 0.02 0.013 
Richest 0.004643 0.0004611 0.0325238 0.01 0.004 
NFE 0.0051825 0.0005131 0.0456588 0.01 0.003 
Primary 0.003932 0.0003748 0.031796 0.01 0.007 
High school or less 0.0044583 0.0004781 0.0273764 0.02 0.013 
Masters/college/diploma 0.0043376 0.0004316 0.0461999 0.01 0.007 
Chronic hypertension 0.0173955 0.0042416 0.0483283 0.04 0 
Maternal height 0.000889 0.0002645 0.0013722 0.04 0.027 
<20 0.004702 0.0005637 0.0395791 0.01 0.002 
35> 0.0051432 0.0007427 0.0306124 0.02 0.001 
Pre-pregnacy weight 0.0007578 0.0003172 0.0013722 0.06 0.019 
Gelephu 0.00312 0.0003475 0.0290976 0.01 0.008 
Mongar 0.0028068 0.0002867 0.027822 0.01 0.006 
Fall 0.0019558 0.0001475 0.0287363 0.01 0.001 
Spring 0.0037732 0.0003598 0.0282172 0.01 0.006 
Summer 0.0020512 0.000155 0.3085231 0.01 0 
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Figure J.1. Trace plot of mean UTI for term LBW 
 
 
 
Figure J.2. Trace plot of mean pre-pregnancy weight for term LBW 
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Figure J.3. Trace plot of mean maternal height for term PTB 
 
 
 
Figure J.4.Trace plots of mean UTI for PTB 
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Figure J.5. Trace plots of mean pre-pregnancy weight for PTB 
 
 
 
Figure J.6.Trace plots of mean maternal height for PTB 
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